
<html lang="en"     class="pb-page"  data-request-id="3d4700ed-17aa-4e49-8c7a-c50ed200775c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.1c00206;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles" /></meta><meta name="dc.Creator" content="Alejandro  Revuelto" /></meta><meta name="dc.Creator" content="Héctor  de Lucio" /></meta><meta name="dc.Creator" content="Juan Carlos  García-Soriano" /></meta><meta name="dc.Creator" content="Pedro A.  Sánchez-Murcia" /></meta><meta name="dc.Creator" content="Federico  Gago" /></meta><meta name="dc.Creator" content="Antonio  Jiménez-Ruiz" /></meta><meta name="dc.Creator" content="María-José  Camarasa" /></meta><meta name="dc.Creator" content="Sonsoles  Velázquez" /></meta><meta name="dc.Description" content="Inhibition of Leishmania infantum trypanothione disulfide reductase (LiTryR) by disruption of its homodimeric interface has proved to be an alternative and unexploited strategy in the search for no..." /></meta><meta name="Description" content="Inhibition of Leishmania infantum trypanothione disulfide reductase (LiTryR) by disruption of its homodimeric interface has proved to be an alternative and unexploited strategy in the search for no..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00206" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00206" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00206" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00206" /></link>
        
    
    

<title>Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00206" /></meta><meta property="og:title" content="Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0015.jpeg" /></meta><meta property="og:description" content="Inhibition of Leishmania infantum trypanothione disulfide reductase (LiTryR) by disruption of its homodimeric interface has proved to be an alternative and unexploited strategy in the search for novel antileishmanial agents. Proof of concept was first obtained by peptides and peptidomimetics. Building on previously reported dimerization disruptors containing an imidazole-phenyl-thiazole scaffold, we now report a new 1,2,3-triazole-based chemotype that yields noncompetitive, slow-binding inhibitors of LiTryR. Several compounds bearing (poly)aromatic substituents dramatically improve the ability to disrupt LiTryR dimerization relative to reference imidazoles. Molecular modeling studies identified an almost unexplored hydrophobic region at the interfacial domain as the putative binding site for these compounds. A subsequent structure-based design led to a symmetrical triazole analogue that displayed even more potent inhibitory activity over LiTryR and enhanced leishmanicidal activity. Remarkably, several of these novel triazole-bearing compounds were able to kill both extracellular and intracellular parasites in cell cultures." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00206"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00206">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00206&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00206&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00206&amp;href=/doi/10.1021/acs.jmedchem.1c00206" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 6137-6160</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00173" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00242" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Efficient Dimerization Disruption of <i>Leishmania infantum</i> Trypanothione Reductase by Triazole-phenyl-thiazoles</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Alejandro Revuelto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alejandro Revuelto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Química Médica (IQM-CSIC), c/ Juan de la Cierva 3, E-28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alejandro++Revuelto">Alejandro Revuelto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Héctor de Lucio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Héctor de Lucio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Biología de Sistemas, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=H%C3%A9ctor++de+Lucio">Héctor de Lucio</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9840-0779" title="Orcid link">http://orcid.org/0000-0002-9840-0779</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Juan Carlos García-Soriano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juan Carlos García-Soriano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Biología de Sistemas, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juan+Carlos++Garc%C3%ADa-Soriano">Juan Carlos García-Soriano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pedro A. Sánchez-Murcia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pedro A. Sánchez-Murcia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Área de Farmacología, Departamento de Ciencias Biomédicas, Unidad Asociada al IQM-CSIC, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pedro+A.++S%C3%A1nchez-Murcia">Pedro A. Sánchez-Murcia</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8415-870X" title="Orcid link">http://orcid.org/0000-0001-8415-870X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Federico Gago</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federico Gago</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Área de Farmacología, Departamento de Ciencias Biomédicas, Unidad Asociada al IQM-CSIC, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federico++Gago">Federico Gago</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3071-4878" title="Orcid link">http://orcid.org/0000-0002-3071-4878</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio Jiménez-Ruiz</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Jiménez-Ruiz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Biología de Sistemas, Universidad de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#0e6f607a61606761206467636b606b744e7b6f66206b7d"><span class="__cf_email__" data-cfemail="e1808f958e8f888ecf8b888c848f849ba1948089cf8492">[email protected]</span></a>. Tel: (+34) 918855109.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Jim%C3%A9nez-Ruiz">Antonio Jiménez-Ruiz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María-José Camarasa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María-José Camarasa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Química Médica (IQM-CSIC), c/ Juan de la Cierva 3, E-28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa-Jos%C3%A9++Camarasa">María-José Camarasa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4978-6468" title="Orcid link">http://orcid.org/0000-0002-4978-6468</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sonsoles Velázquez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sonsoles Velázquez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Química Médica (IQM-CSIC), c/ Juan de la Cierva 3, E-28006 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7a130b17090c48433a130b175419091319541f09"><span class="__cf_email__" data-cfemail="a7ced6cad4d1959ee7ced6ca89c4d4cec489c2d4">[email protected]</span></a>. Tel: (+34) 912587689.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sonsoles++Vel%C3%A1zquez">Sonsoles Velázquez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2209-1751" title="Orcid link">http://orcid.org/0000-0003-2209-1751</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00206&amp;href=/doi/10.1021%2Facs.jmedchem.1c00206" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 6137–6160</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2021</li><li><span class="item_label"><b>Published</b> online</span>4 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00206" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00206</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6137%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlejandro%2BRevuelto%252C%2BH%25C3%25A9ctor%2Bde%2BLucio%252C%2BJuan%2BCarlos%2BGarc%25C3%25ADa-Soriano%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.1c00206%26title%3DEfficient%2BDimerization%2BDisruption%2Bof%2BLeishmania%2Binfantum%2BTrypanothione%2BReductase%2Bby%2BTriazole-phenyl-thiazoles%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6160%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00206"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">300</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00206" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alejandro&quot;,&quot;last_name&quot;:&quot;Revuelto&quot;},{&quot;first_name&quot;:&quot;Héctor&quot;,&quot;last_name&quot;:&quot;de Lucio&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Carlos García-Soriano&quot;},{&quot;first_name&quot;:&quot;Pedro&quot;,&quot;last_name&quot;:&quot;A. Sánchez-Murcia&quot;},{&quot;first_name&quot;:&quot;Federico&quot;,&quot;last_name&quot;:&quot;Gago&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Jiménez-Ruiz&quot;},{&quot;first_name&quot;:&quot;María-José&quot;,&quot;last_name&quot;:&quot;Camarasa&quot;},{&quot;first_name&quot;:&quot;Sonsoles&quot;,&quot;last_name&quot;:&quot;Velázquez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6137-6160&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00206&quot;},&quot;abstract&quot;:&quot;Inhibition of Leishmania infantum trypanothione disulfide reductase (LiTryR) by disruption of its homodimeric interface has proved to be an alternative and unexploited strategy in the search for novel antileishmanial agents. Proof of concept was first obtained by peptides and peptidomimetics. Building on previously reported dimerization disruptors containing an imidazole-phenyl-thiazole scaffold, we now report a new 1,2,3-triazole-based chemotype that yields noncompetitive, slow-binding inhibitors of LiTryR. Several compounds bearing (poly)aromatic substituents dramatically improve the ability to disrupt LiTryR dimerization relative to reference imidazoles. Molecular modeling studies identified an almost unexplored hydrophobic region at the interfacial domain as the putative binding site for these compounds. A subsequent structure-based design led to a symmetrical triazole analogue that displayed even more potent inhibitory activity over LiTryR and enhanced leishmanicidal activity. Remarkably, several of thes&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00206&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00206" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00206&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00206" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00206&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00206" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00206&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00206&amp;href=/doi/10.1021/acs.jmedchem.1c00206" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00206" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00206" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (13 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00206%26sid%3Dliteratum%253Aachs%26pmid%3D33945281%26genre%3Darticle%26aulast%3DRevuelto%26date%3D2021%26atitle%3DEfficient%2BDimerization%2BDisruption%2Bof%2BLeishmania%2Binfantum%2BTrypanothione%2BReductase%2Bby%2BTriazole-phenyl-thiazoles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D6137%26epage%3D6160%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290899" title="Dimerization">Dimerization</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of <i>Leishmania infantum</i> trypanothione disulfide reductase (<i>Li</i>TryR) by disruption of its homodimeric interface has proved to be an alternative and unexploited strategy in the search for novel antileishmanial agents. Proof of concept was first obtained by peptides and peptidomimetics. Building on previously reported dimerization disruptors containing an imidazole-phenyl-thiazole scaffold, we now report a new 1,2,3-triazole-based chemotype that yields noncompetitive, slow-binding inhibitors of <i>Li</i>TryR. Several compounds bearing (poly)aromatic substituents dramatically improve the ability to disrupt <i>Li</i>TryR dimerization relative to reference imidazoles. Molecular modeling studies identified an almost unexplored hydrophobic region at the interfacial domain as the putative binding site for these compounds. A subsequent structure-based design led to a symmetrical triazole analogue that displayed even more potent inhibitory activity over <i>Li</i>TryR and enhanced leishmanicidal activity. Remarkably, several of these novel triazole-bearing compounds were able to kill both extracellular and intracellular parasites in cell cultures.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Leishmaniasis is an infectious disease caused by intracellular protozoan parasites from more than 20 <i>Leishmania</i> species and transmitted to humans through the bite of infected female phlebotomine sandflies. According to the World Health Organization (WHO), leishmaniasis is one of the major neglected tropical diseases that affects 12 million people in 98 countries, being especially prevalent in tropical and subtropical areas.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Visceral leishmaniasis (VL), also known as Kala-azar, is the most severe form of the disease with more than 60 000 human deaths annually. VL is caused by <i>Leishmania donovani</i> and <i>Leishmania infantum</i> parasites worldwide, including Mediterranean countries.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> No effective vaccine for humans has so far been developed, and leishmaniasis control mainly relies on chemotherapy.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> However, currently available treatments are inadequate because of high costs, toxicity, drug resistance, and the need for parenteral administration.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Therefore, there is an urgent need to find new effective innovative drugs against this disease.</div><div class="NLM_p">Herein, we report a target-based approach for the discovery of novel agents against <i>L. infantum</i> parasites targeting a protein that is essential for parasite survival and exclusive for these parasites.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> We have focused on trypanothione (Try) disulfide reductase (TryR) because it is one of the few genetically and chemically validated drug targets, and validation is one important criterion in target assessment.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Among other highly relevant functions, this enzyme is essential for antioxidant defense in trypanosomatids. The Try/TryR couple in these parasites substitutes for the glutathione/glutathione-disulfide reductase (GR) pair characteristic of most eukaryotic organisms. Accordingly, the absence of TryR in mammalian cells, the significant differences between TryR and human GR (hGR) (the active sites of the two enzymes have opposite net charges and different volumes), and its crucial role for parasite survival make TryR an attractive target for new chemotherapeutics.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> Since this enzyme was identified, many potent and selective competitive polycationic TryR inhibitors (which mimic the positively charged Try in the active site) have been described. However, there are scarce reports of potent TryR-inhibiting compounds with adequate antiparasitic activity.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> This is so because it has been shown that survival of the parasites is only affected when TryR activity is reduced by more than 90%, probably as a consequence of the high intracellular concentrations of its natural substrate (Try) in the cell.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This implies that, to be effective against the parasites, competitive inhibitors must have very high binding affinities so as to give rise to inhibition constants in the low nanomolar range. Nonetheless, one of the most potent (submicromolar) competitive inhibitors of Trypanosoma <i>brucei</i> (<i>Tb</i>TryR) described to date is almost inactive against <i>L. donovani</i>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This limitation, together with the need for very high affinities imposed by the high intracellular concentrations of both the natural substrate (between 3 and 50 μM under steady-state conditions and up to 150 μM under oxidative stress) and TryR itself (0.5–1.3 μM), make noncompetitive and/or irreversible inhibitors emerge as more attractive alternatives for targeting this enzyme.<a onclick="showRef(event, 'cit20a cit20b ref21'); return false;" href="javascript:void(0);" class="ref cit20a cit20b ref21">(20a,b,21)</a></div><div class="NLM_p">The crystal structure of TryR from <i>L. infantum</i> (<i>Li</i>TryR) was first solved by Baiocco et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and is very similar to that of other trypanosomatids.<a onclick="showRef(event, 'ref13 ref14 ref16 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref16 ref23 ref24">(13,14,16,23,24)</a> This enzyme is a twofold symmetrical homodimer that contains two active sites and two reduced nicotinamide adenine dinucleotide phosphate (NADPH)- and flavin adenine dinucleotide (FAD)-binding domains separated by a large and well-characterized interface.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Each Try binding site is located in a large solvent-exposed cavity at the interface between the two monomers. Several X-ray crystal structures of TryR in complex with a variety of competitive reversible inhibitors have shown that the large pocket allows not only several binding modes for small-molecule inhibitors but also the simultaneous binding of more than one inhibitor molecule.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Such unpredictable binding modes, due to the large size of the active site, make the rational design of competitive, high-affinity inhibitors of TryR a very challenging task.</div><div class="NLM_p">Bearing in mind the homodimeric nature of this enzyme, back in 2013 we devised an alternative inhibition strategy that aims to disrupt the protein–protein interactions responsible for <i>Li</i>TryR homodimerization.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Initially, by means of a combination of molecular modeling and site-directed mutagenesis studies, we identified and validated E436—an amino acid located at an interfacial α-helix spanning from P435 to M447—as a hotspot for dimer stabilization and assessed its importance for the catalytic activity of the enzyme. As a “proof of concept” of this novel approach, we designed and tested a small library of linear peptides that represent rational variations of this α-helix. From these studies, the 13-mer-modified peptide sequence PKIIQSVGIS-Nle-K-Nle (<b>1</b>) emerged as a potent enzyme dimerization disruptor that also behaves as a strong inhibitor (in the submicromolar range) of the oxidoreductase activity of <i>Li</i>TryR.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Next, a variety of helix-stabilized cyclic peptides<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> and α,β<sup>3</sup>-peptide foldamers<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were successfully explored in our search to find peptidomimetics with increased proteolytic stability. However, conjugation with cell-penetrating peptides was always required to facilitate the cellular uptake of these peptide- or peptidomimetic-based <i>Li</i>TryR dimerization disruptors and to kill the parasites in cell culture.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Thus, the design of small molecules with druglike properties better than those of the prototype peptide or the previous peptidomimetics appeared as a desirable goal.</div><div class="NLM_p">In this regard, we recently disclosed the results of our first steps toward nonpeptide disruptors of <i>Li</i>TryR dimerization with promising leishmanicidal activity by an α-helical mimetic approach.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Among the reported proteomimetic scaffolds,<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> the pyrrolopyrimidine<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the 5-6-5 imidazole-phenyl-thiazole<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> cores were selected to dictate the spatial orientations of the side chains of three key residues (K2, Q5, and I9) in the linear peptide prototype <b>1</b>. Imidazole-based compounds <b>2</b> and <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), bearing a naphthalene or a biphenyl polyaromatic R<sub>3</sub> substituent to mimic the hydrophobic isoleucine residue, emerged as potent inhibitors of the <i>Li</i>TryR oxidoreductase activity, while pyrrolopyrimidines were shown to be much less active. Although these small molecules displayed a moderate capacity to disrupt the <i>Li</i>TryR dimer, this effect was much less pronounced than that observed for the previous peptide-based inhibitors. Remarkably, the imidazole-based compounds were cell-permeable and showed significant leishmanicidal activity against both amastigote and promastigote forms of <i>Leishmania</i> parasites. However, these molecules displayed a cytotoxic activity similar to that observed for their peptidic and peptidomimetic predecessors and exhibited low selectivity indexes (SIs).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. From a peptide dimerization disruptor of <i>Li</i>TryR (<b>1</b>) and in-house imidazoles <b>2</b> and <b>3</b> to the newly designed triazole-phenyl-thiazole scaffold <b>I</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">1,2,3-Triazole-containing compounds have been widely investigated because they are considered privileged scaffolds in different areas of medicinal chemistry,<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> including several examples in the antileishmanial field.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Interest in this molecular architecture has also been fueled by its expedient synthesis through “click chemistry”.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In this scenario, we decided to apply the bioisosteric replacement of imidazole by 1,2,3-triazole in our recently described imidazole-phenyl-thiazoles.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We herein report the synthesis and structure–activity relationship (SAR) studies of novel 1,2,3-triazole-phenyl-thiazole compounds of general formulae <b>I</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) to demonstrate the potential of this novel chemotype for <i>Li</i>TryR dimerization disruption and leishmanicidal activity against <i>L. infantum</i> parasites. A whole set of 26 triazole-based compounds modified at four different positions in the new scaffold (R<sub>1</sub>–R<sub>4</sub> substituents) was prepared and evaluated. Five of these molecules display activities that very closely resemble that of the peptide prototype <b>1</b> and likewise behave as noncompetitive, slow-binding inhibitors.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Molecular modeling studies identified a putative binding site for these compounds at an almost unexplored central interfacial cavity of the enzyme and provided a structural rationale to the observed SAR results that was supported by ensuing rational design, synthesis, and activity of a new symmetrical triazole analogue with the desired properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthesis of the target triazole-phenyl-thiazole type <b>I</b> compounds is exemplified by the preparation of the first series of 1,2,3-triazole derivatives <b>12a</b>–<b>c</b> (bearing R<sub>1</sub>–R<sub>3</sub> substituents similar to those present in the predecessor imidazole analogues <b>2</b> and <b>3</b>), as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The synthetic route started from the previously described bromide intermediate <b>4a</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> bearing an imidazolidinone ethyl R<sub>2</sub> group (used as a Gln mimetic in the previous imidazole derivatives) by treatment with sodium azide in anhydrous dimethyl sulfoxide (DMSO) at 100 °C for 72 h to afford the azide intermediate <b>5a</b> in 85% yield. The addition of molecular sieves with pore openings of 4 Å was required to avoid the partial hydrolysis of the azide group to the undesired amine. The next step in the synthetic route was the 1,3-dipolar cycloaddition of the azide intermediate with terminal alkynes substituted with the appropriate R<sub>1</sub> group (as a Lys mimetic) to generate the 1,2,3-triazole ring. Initial attempts to use the ruthenium-catalyzed azide–alkyne cycloaddition (RuAAC)<a onclick="showRef(event, 'cit40b'); return false;" href="javascript:void(0);" class="ref cit40b">(40b)</a> from <b>5a</b> and commercially available N-Cbz-protected terminal alkyne <b>6</b> in the presence of catalytic amounts (5 or 10%) of a cyclopentadienyl Ru catalyst [Cp*RuCl(PPh<sub>3</sub>)<sub>2</sub>] at different temperatures in dry dimethylformamide (DMF) and an inert atmosphere did not produce the expected 1,5-disubstituted 1,2,3-triazole <b>7</b>. Only unreacted starting materials or complex decomposition mixtures were observed under these conditions. In contrast, the 1,4-disubstituted 1,2,3-triazole regioisomer <b>8</b> could be easily obtained in 56% yield by the 1,3-dipolar copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC)<a onclick="showRef(event, 'cit40a'); return false;" href="javascript:void(0);" class="ref cit40a">(40a)</a> of azide <b>5a</b> and the terminal alkyne <b>6</b> using the CuSO<sub>4</sub>/sodium ascorbate catalyst system at room temperature for 8 h in H<sub>2</sub>O/EtOH (1:1 mixture) as the solvent. Subsequent treatment of nitrile <b>8</b> with aqueous (aq) 20% ammonium sulfide at 80 °C for 4 h provided the thioamide intermediate <b>9</b> in 74% yield. Next, Hantzsch thiazole synthesis from 1 equiv of <b>9</b> and 1 equiv of the commercially available α-bromomethylketone <b>10a</b> or the previously synthesized <b>10b</b> and <b>10c</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (bearing a naphthyl or a biphenylethyl hydrophobic R<sub>3</sub> substituent) heated in isopropanol at 70 °C for 36 h gave the expected α/β-unsaturated derivatives <b>11a</b>–<b>c</b> monosubstituted at the 4-position of the thiazole ring in 87, 51, and 63% yields, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Finally, treatment of <b>11a</b>–<b>c</b> with H<sub>2</sub>, Pd/C in tetrahydrofuran (THF)/MeOH mixture in the presence of trifluoroacetic acid (TFA) at room temperature allowed the simultaneous hydrogenolysis of NHCbz and hydrogenation of the double bond to afford the deprotected target compounds <b>12a</b>–<b>c</b> as monotrifluoroacetate salts in 35, 24, and 35% yields, respectively. Chromatographic purification by Biotage using reverse-phase columns was always required to obtain the final compounds with purities higher than 95% for their biological evaluation.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the First Series of 1,4-Disubstituted 1,2,3-Triazole Compounds <b>12a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaN<sub>3</sub>, DMSO, molecular sieves 4 Å, 100 °C, 72 h; (b) Cp*RuCI(PPh<sub>3</sub>)<sub>2</sub> (5 or 10 mol %), DMF, rt to 100 °C; (c) CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, H<sub>2</sub>O/EtOH 1:1, rt, 8 h; (d) (NH<sub>4</sub>)<sub>2</sub>S 20% aq, DMF, 80 °C, 4 h; (e) α-bromomethylketones <b>10a</b>–<b>c</b>, <sup><i>i</i></sup>PrOH, 70 °C, 5 h; (f) H<sub>2</sub>, Pd/C 10%, TFA, THF/MeOH 1:1, rt, 2 h.</p></p></figure><div class="NLM_p">As will be discussed below, the 1,2,3-triazole compounds <b>12a</b>–<b>c</b> emerged as more potent dimerization disruptors of <i>Li</i>TryR than the reference imidazoles and also behaved as strong inhibitors of the oxidoreductase activity of the enzyme. These results prompted us to develop a novel series of triazole derivatives <b>12d</b>–<b>s</b> (see structures in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Scheme S1</a>) modified at the R<sub>1</sub>–R<sub>3</sub> substituents to perform a SAR study. Regarding modifications at R<sub>1</sub> and R<sub>2</sub>, the protonated aminobutyl group linked to the triazole was replaced by OH, Me, or COOH (<b>12d</b>–<b>g</b>) or by a shorter aminopropyl substituent (<b>12h</b>, <b>12i</b>), while the R<sub>2</sub> imidazolidinone (attached to the central phenyl ring through an ethyl linker) was removed (<b>12j</b>, <b>12k</b>). In terms of R<sub>3</sub> modifications, bulky alkyl substituents (<b>12l</b>, <b>12m</b>) or a phenyl group linked to the thiazole ring through a polymethylene spacer of a different length (<b>12n</b>–<b>p</b><i>vs</i><b>12a</b>) were explored.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Half-Maximal Inhibitory Concentration (IC<sub>50</sub>) ± Standard Error (SE) Values for Triazole Compounds <b>I</b> and the Truncated Analogues <b>13</b> and <b>14</b> in the TryR Oxidoreductase Activity and <i>Li</i>TryR Monomer Displacement Assays<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">IC<sub class="stack">50</sub><sup class="stack">act</sup> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub class="stack">50</sub><sup class="stack">dim</sup> (μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">7.0 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>naphthyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">26%<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>biphenyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.6 ± 1.4</td><td class="colsep0 rowsep0" align="left">32%<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">14.6 ± 1.0</td><td class="colsep0 rowsep0" align="left">38.1 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>naphthyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.9 ± 1.1</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.6<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>biphenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10.9 ± 1.8</td><td class="colsep0 rowsep0" align="left">4.8 ± 0.6<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="center">Modifications at R<sub>1</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>biphenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">20.8 ± 2.3</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Biph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">19.7 ± 3.8</td><td class="colsep0 rowsep0" align="left">10.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="center">Modifications at R<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">20.1 ± 2.5</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2b</sub>iphenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">26.8 ± 5.7</td><td class="colsep0 rowsep0" align="left">16.1 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="center">Modifications at R<sub>3</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">O<i><sup>i</sup></i>Pr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">54.5 ± 4.4</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub><i><sup>t</sup></i>Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">24.1 ± 1.4</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">29.0 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12o</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">43.6 ± 1.1</td><td class="colsep0 rowsep0" align="left">61.2 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">14.6 ± 1.7</td><td class="colsep0 rowsep0" align="left">19.1 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>THQ*</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.9 ± 2.1</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>DHB*</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11.9 ± 0.6</td><td class="colsep0 rowsep0" align="left">10.7 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12s</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>DBF*</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.6 ± 1.9</td><td class="colsep0 rowsep0" align="left">8.8 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="center">Truncated Analogues</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="center">Modifications at R<sub>3</sub> and R<sub>4</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">4.3 ± 1.0</td><td class="colsep0 rowsep0" align="left">7.1 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">biphenyl</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">18.4 ± 3.9</td><td class="colsep0 rowsep0" align="left">11.3 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">PhOPh</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">16.9 ± 2.7</td><td class="colsep0 rowsep0" align="left">9.0 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>biphenyl</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">19.8 ± 2.3</td><td class="colsep0 rowsep0" align="left">5.7 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">NH<sub>3</sub><sup>+</sup></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>Im*</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>PhOPh</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">19.3 ± 3.7</td><td class="colsep0 rowsep0" align="left">6.7 ± 1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Linear peptide <b>1</b> and imidazole-based compounds <b>2</b> and <b>3</b> were included as reference compounds.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Enzymatic activity >75 indicates that the IC<sub>50</sub> value is higher than 75 μM (maximum assayed). Results are representative of three independent experiments, each performed in triplicate.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Dimer quantitation assay (enzyme-linked immunosorbent assay (ELISA)).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Percentage of inhibition observed at 20 μM as reliable IC<sub>50</sub> values could not be determined in this case.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Percentages of inhibition observed at 20 μM were 73 and 78% for <b>12b</b> and <b>12c</b>, respectively.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Im* = imidazolidinone, THQ* = tetrahydroquinoline (TFA salt), DHB* = dihydrobenzofuranyl, DBF* = dibenzofuranyl.</p></div></div></div><div class="NLM_p">Since the presence of a biphenyl or naphthyl substituent at R<sub>3</sub> was highly relevant for potent enzyme inhibition and antileishmanial activity, other polyheteroaromatic rings were also explored at R<sub>3</sub> (<b>12q</b>–<b>s</b>). The synthesis of the novel triazole analogues <b>12d</b>–<b>s</b> involved (i) a high-yielding nucleophilic aromatic substitution (SN<sub>Ar</sub>) of aryl fluorides with the appropriate alcohols (bearing the R<sub>2</sub> substituent),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (ii) CuAAC reactions between azide intermediates and terminal alkynes (containing the R<sub>1</sub> substituent), (iii) Hanztsch thiazole synthesis of thioamides with suitable α-bromomethylketones (with the R<sub>3</sub> substituent), and (iv) and a final step of catalytic hydrogenation to yield the deprotected final compounds using similar protocols to those described above. It should be noted that in the catalytic hydrogenation of the protected triazole compound intermediate <b>11q</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Scheme S1</a>) bearing a quinoline moiety as the R<sub>3</sub> substituent, the 1,2,3,4-tetrahydroquinoline compound <b>12q</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Scheme S1</a>) was isolated as a ditrifluoroacetate salt due to the partial hydrogenation and salt formation of the quinoline ring nitrogen atom. The synthetic experimental details of the target <b>12q</b>–<b>s</b> compounds and the noncommercially available key α-bromomethyl-ketone intermediates <b>10m</b>, <b>10p</b>–<b>s</b> are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Supporting Information</a>  (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Schemes S1 and S2</a>). Scaffold-truncated simplified compounds (<b>13</b> and <b>14</b>, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), possessing only two aromatic rings and substituents, were also prepared for the SAR studies following similar synthetic protocols (see also the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Supporting Information</a> for experimental details; <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Scheme S3</a>). To further investigate the SAR of the triazole-based compounds, we next focused on the preparation of an additional series of triazole analogues <b>19a</b>–<b>e</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) disubstituted at both positions 4 and 5 of the thiazole ring. Polyaromatic groups directly attached or linked through an ethyl spacer to the 4-position and a phenyl group at the 5-position were selected as R<sub>3</sub> and R<sub>4</sub> substituents, respectively. As shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, the preparation of these compounds required the previous synthesis of the noncommercially available α-bromobenzylketones <b>17a</b>–<b>d</b>. Thus, <b>17a</b>–<b>c</b> bearing a biphenyl or a phenyloxyphenyl group at R<sub>3</sub> directly attached to the carbonyl were synthesized by bromination of the commercially available benzylketones <b>16a</b>–<b>c</b> with <i>N</i>-bromosuccinimide (NBS) in <i>p</i>-toluensulfonic acid (<i>p</i>-TsOH) in good to excellent yields.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Triazoles Disubstituted at the Thiazole Ring (<b>19a</b>–<b>e</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PPh<sub>3</sub>, dry toluene, 110 °C, 6 h; (b) KOH, dry toluene, 110 °C, 3 h; (c) RCHO, 110 °C, 3 h; (d) NBS, <i>p</i>-TsOH, CH<sub>3</sub>CN, rt, 14 h; (e) thioamide <b>9</b>, <b>17a</b>–<b>e</b>, <sup><i>i</i></sup>PrOH, 70 °C, 5 h; (f) H<sub>2</sub>, Pd/C 10%, TFA, THF/MeOH 1:1, rt, 2 h. *Commercially available reagents.</p></p></figure><div class="NLM_p">On the other hand, α-bromobenzyl α,β-unsaturated ketone <b>17d</b> with a polyaromatic group was obtained by regioselective bromination of the most favorable benzylic position with NBS in <i>p</i>-TsOH of the corresponding benzylketones <b>16d</b>, which was previously synthesized from 1-chloro-3-phenylpropan-2-one by treatment with PPh<sub>3</sub> to give the phosphonium salt <b>15</b> followed by a Wittig procedure with the corresponding polyaromatic aldehydes in moderate yields. Next, Hantzsch thiazole synthesis from thioamide intermediate <b>9</b> with the commercial <b>17e</b> or synthetic α-bromobenzylketones <b>17a</b>–<b>d</b>, followed by catalytic hydrogenolysis of the N-Cbz group and simultaneous olefin hydrogenation of <b>18a</b>–<b>e</b> using 10% Pd/C in the presence of TFA, afforded the desired unprotected disubstituted thiazole derivatives <b>19a</b>–<b>e</b> as monotrifluoroacetate salts in low to moderate yields. Finally, we also designed (see section <a class="ref internalNav" href="#sec2_3" aria-label="Computational Studies">Computational Studies</a> below) and prepared (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) a new symmetrical triazole analogue (<b>22</b>) by treating 2 equiv of thioamide intermediate <b>9</b> with 1 equiv of α-bromomethylketone <b>20</b> (previously synthesized by bromination with NBS of commercially available 1,3-diacetyl benzene) under Hantzsch reaction conditions, followed by catalytic hydrogenolysis of the NHCbz group using similar procedures to those described above.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Newly Designed Symmetrical Analogue 22<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, <i>p</i>-TsOH, acetonitrile, rt, 14 h; (b) thioamide <b>9</b>, <sup><i>i</i></sup>PrOH, 70 °C, 5 h; (c) H<sub>2</sub> Pd/C 10%, TFA, THF/MeOH, 1:1, rt, 2 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biological and Structural Studies</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Enzymatic Assays</h4><div id="sec2_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i11" class="anchor-spacer"></div><h5 class="article-section__title" id="_i11"> <i>L. infantum</i> TryR Inhibition and Dimerization Assays</h5><div class="NLM_p">All of the novel triazole-phenyl-thiazole modified at substituents R<sub>1</sub>–R<sub>3</sub> (<b>12a</b>–<b>s</b>), disubstituted thiazole analogues bearing R<sub>3</sub> and R<sub>4</sub> substituents (<b>19a</b>–<b>e</b>), and truncated simplified compounds (<b>13</b> and <b>14</b>) were evaluated for their effect on both the oxidoreductase activity and the dimerization status of <i>Li</i>TryR.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The prototype peptide <b>1</b> and imidazole-containing compounds <b>2</b> and <b>3</b> were used as reference molecules. Screening was performed at different concentrations ranging from 0.1 to 75 μM. A concentration of 1 μM TS<sub>2</sub> was used for this initial screening. This low substrate concentration is sufficient for comparison of compound inhibitory activity in the oxidoreductase assay. The best candidates were then characterized further to obtain their dissociation constants. The IC<sub>50</sub> values determined in the activity (IC<sub class="stack">50</sub><sup class="stack">act</sup>) and dimerization (IC<sub class="stack">50</sub><sup class="stack">dim</sup>) assays are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">According to the results obtained with the first series of triazole-based compounds <b>12a</b>–<b>c</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), analogues containing a naphthyl or a biphenyl group at R<sub>3</sub> (<b>12b</b>, <b>12c</b>) potently inhibited the TryR oxidoreductase activity, showing similar IC<sub class="stack">50</sub><sup class="stack">act</sup> values (in the low micromolar range) to those obtained for the reference imidazole compounds <b>2</b> and <b>3</b>. Remarkably, <b>12a</b>–<b>c</b> were much more potent <i>Li</i>TryR dimerization disruptors than their imidazole counterparts. Thus, in contrast to <b>2</b> and <b>3</b>, for which no reliable IC<sub class="stack">50</sub><sup class="stack">dim</sup> could be measured and only ∼30% dimerization inhibition was observed at a concentration of 20 μM, the IC<sub class="stack">50</sub><sup class="stack">dim</sup> values for <b>12b</b>, <b>12c</b> (7.1 and 4.8 μM, respectively) were similar to (or even slightly lower than) those obtained for the potent prototype peptide <b>1</b>. Furthermore, replacement of the naphthyl or biphenyl groups at R<sub>3</sub> by a phenyl (<b>12b</b>, <b>12c</b><i>vs</i><b>12a</b>) slightly increased the IC<sub class="stack">50</sub><sup class="stack">act</sup> value, while it significantly decreased (in a 5–8-fold range) the ability to disrupt the <i>Li</i>TryR dimer. We took this result as a clear indication that the presence of a polyaromatic substituent at R<sub>3</sub> is relevant to potent <i>Li</i>TryR dimer disruption.</div><div class="NLM_p">SAR studies on the second series of triazole compounds (<b>12d</b>–<b>s</b>) with variations at the R<sub>1</sub>–R<sub>3</sub> substituents began with modifications at the R<sub>1</sub> position. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the presence of a positively charged amino alkyl group at R<sub>1</sub> appears as an absolute requirement for inhibition of both activity and dimerization, as evidenced by the complete loss of effect observed when the amino group was replaced by hydroxyl, methyl, or carboxylic acid groups (<b>12d</b>–<b>g</b><i>vs</i><b>12a</b>, <b>12c</b>). As regards the length of the R<sub>1</sub> spacer attached to the amino group, shortening the original tetramethylene linker to a trimethylene brought about a ∼2-fold reduction of potency in both assays (<b>12h</b>, <b>12i</b><i>vs</i><b>12a</b>, <b>12c</b>). The existence of the imidazolidinone ring as the R<sub>2</sub> substituent on the central phenyl ring also appeared important for optimal activity since its removal (<b>12j</b>, <b>12k</b><i>vs</i><b>12a</b>, <b>12c</b>) resulted in compounds twice or thrice less active in both assays. Modifications at the R<sub>3</sub> substituent (located at the 4-position of the thiazole ring) had a pronounced effect on enzymatic activity inhibition and, even more so, on dimerization disruption. Thus, the presence of a (poly)aromatic substituent at R<sub>3</sub> was crucial for enhanced potency since compounds <b>12l</b>, <b>12m</b>, with bulky aliphatic groups, exhibit much less inhibitory activity on the enzyme and no destabilization effect on the <i>Li</i>TryR homodimer in comparison with the (poly)aromatic analogues <b>12a</b>–<b>c</b>. In comparison, varying the length of the linker connecting the phenyl group to the thiazole (<b>12n</b>–<b>p</b><i>vs</i><b>12a</b>) turned out to be not so crucial because, in general, it did not significantly affect the inhibitory activity.</div><div class="NLM_p">In view of these results, and even though the phenylpropyl derivative <b>12p</b> displayed the lowest IC<sub class="stack">50</sub><sup class="stack">dim</sup> value, for the next round of modifications, we decided to focus on shortening the propylene linker at R<sub>3</sub> to an ethylene (<b>12a</b>) or even removing it altogether (<b>12n</b>) because of the better synthetic accessibility of the corresponding bromoketones. On the other hand, replacement of the naphthyl or the biphenyl group at R<sub>3</sub> in the most potent analogues <b>12b</b>, <b>12c</b> by polyheteroaromatics such as a dihydrobenzofuranyl substituent (<b>12r</b>) or a larger hydrophobic tricyclic dibenzofuranyl moiety (<b>12s</b>) also yielded very potent compounds but did not further increase the inhibitory activity of the most potent analogues (<b>12b</b>, <b>12c</b>) in any of the two assays. In contrast, the introduction of a positively charged tetrahydroquinoline ring (<b>12q</b>) annihilated the dimerization disruption capacity of the molecules even though potent inhibition of the redox activity of the enzyme was retained. In contrast, no activity in any of the assays was observed for the simplified truncated scaffold derivatives <b>13</b> and <b>14</b>, in which the appropriately substituted triazole or thiazole rings were removed. This additional evidence further supports the key role played by these two rings (and the R<sub>1</sub> and R<sub>3</sub> substituents) in this type of inhibitor.</div><div class="NLM_p">Finally, we also evaluated a new series of triazole compounds (<b>19a</b>–<b>e</b>) disubstituted at the 4- and 5-positions of the thiazole ring with R<sub>3</sub> and R<sub>4</sub> aromatic moieties. Some of these molecules combined excellent inhibition in the redox assay with potent <i>Li</i>TryR dimer disruption ability. Interestingly, both activities were significantly improved by a factor of 2–4 for <b>19a</b>, in which a phenyl group is bonded at both R<sub>3</sub> and R<sub>4</sub> positions, in comparison with the R<sub>3</sub> phenyl monosubstituted analogue <b>12n</b>. Introduction of a larger biphenyl or a diphenylether group as the R<sub>3</sub> substituent (maintaining the phenyl group at R<sub>4</sub>) significantly decreased the inhibitory activity of the highly potent diphenylsubstituted analogue, but their dimerization disruption ability was affected only slightly (<i>cf</i>. <b>19b</b>, <b>19c</b><i>vs</i><b>19a</b>). Also, the combination of R<sub>3</sub> polyaromatics attached to the thiazole ring through an ethylene linker with an R<sub>4</sub> phenyl group resulted in a significant deleterious effect on the potency of the compounds as inhibitors of the <i>Li</i>TryR oxidoreductase activity, although the potent disrupting effect on dimerization was maintained (<i>cf</i>. <b>19d</b>, <b>19e</b><i>vs</i><b>19b</b>, <b>19c</b> or the corresponding monosubstituted <b>12c</b>).</div><div class="NLM_p">In general, the most active compounds in the enzymatic activity assay were also the best dimerization disruptors in the ELISA with the exception of the highly potent tetrahydroquinoline inhibitor <b>12q</b>, which did not show any dimerization disruption effect, or the thiazole-disubstituted analogues <b>19b</b>–<b>e</b>, which behave as moderate redox inhibitors but highly potent dimerization disruptors of the enzyme. All in all, our SAR study showed that (i) a positively charged butylamine (R<sub>1</sub>), (ii) an imidazolidinone (R<sub>2</sub>) together with a hydrophobic poly(hetero)aromatic group as R<sub>3</sub> (<b>12b</b>, <b>12c</b>; <b>12r</b>, <b>12s</b>) substituents, or (iii) the combination of a phenyl as R<sub>3</sub> with an additional phenyl as R<sub>4</sub> (<b>19a</b>) are highly relevant to optimal enzyme inhibition and dimerization disruption in this series.</div><div class="NLM_p last">To gain insight into the selectivity of the compounds for <i>Li</i>TryR, representative molecules <b>12a</b>–<b>c</b>, <b>12n</b>, <b>12r</b>, and <b>19a</b> were studied as inhibitors of human glutathione-disulfide reductase (hGR), the closest related host enzyme. Remarkably, none of these compounds showed any inhibitory activity against this enzyme. As an example, a comparison of the activities of <i>Li</i>TryR and hGR in the presence of compounds <b>12b</b> and <b>12c</b> at 50 μM of their respective substrates is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S15</a>.</div></div><div id="sec2_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12"> Mechanism of <i>Li</i>TryR Inactivation</h5><div class="NLM_p">As already described for <b>1</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> the peptidic precursor of all other compounds, a progressive loss of <i>Li</i>TryR activity is observed during the course of the reaction in the presence of <b>12b</b>, <b>12c</b>, <b>12r</b>, <b>12s</b>, and <b>19a</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), selected as the most potent inhibitors in these series. In stark contrast, reaction rates in the presence of the classical competitive inhibitor mepacrine are almost constant until 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) (which allows substrate regeneration) is exhausted. The progress curves of the reactions in the presence of the selected compounds are typical of slow-binding inhibitors.<a onclick="showRef(event, 'cit42a cit42b'); return false;" href="javascript:void(0);" class="ref cit42a cit42b">(42a,b)</a></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time-dependent inhibition of <i>Li</i>TryR. Reaction progress curves of <i>Li</i>TryR in the absence (◆) and presence of 25 μM mepacrine (<b>□</b>), 10 μM peptide <b>1</b> (▲), 10 μM <b>12c</b> (<b>○</b>), 10 μM <b>12b</b> (●), 10 μM <b>12r</b> (◊), 10 μM <b>12s</b> (■), or 10 μM <b>19a</b> (<b>△</b>). [DTNB] = 100 μM. [NADPH] = 150 μM. Data represent the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the loss of activity observed during the reaction, dependency of the initial velocities (<i>v</i><sub>i</sub>) on <b>19a</b> and TS<sub>2</sub> concentrations could be fitted to a model in which a rapid equilibrium is reached between the free enzyme and inhibitor (E + I) and the enzyme/inhibitor (EI) complex (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). This analysis, based on <i>v</i><sub>i</sub> values, was performed both in a DTNB-coupled assay and in a direct NADPH-oxidation assay (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S1 and Table S1</a>). Our data consistently reveal a nonlinear noncompetitive hyperbolic inhibition mechanism.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Two-Step Mechanism of Time-Dependent Inhibition of <i>Li</i>TryR<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>The first step is a rapid equilibrium that generates the enzyme–inhibitor (EI) complex. This process is governed by the association rate (<i>k</i><sub>3</sub>) and the dissociation rate (<i>k</i><sub>4</sub>) constants. The second step consists of slow and reversible inactivation of the enzyme that is governed by the forward isomerization rate constant (<i>k</i><sub>5</sub>) and the much smaller reverse rate constant (<i>k</i><sub>6</sub>).</p></p></figure><div class="NLM_p">Peptide <b>1</b> has already been described as a pseudoirreversible time-dependent noncompetitive inhibitor that is able to promote a two-step process of enzyme isomerization (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The kinetic data obtained for <b>19a</b>, the most potent compound, were also analyzed considering a similar mechanism of enzyme inactivation.</div><div class="NLM_p">In this inactivation model, a rapid and reversible primary inhibition event generates an enzyme–inhibitor binary complex (EI complex). The process of generating an inactive form of <i>Li</i>TryR upon <b>19a</b> binding is governed by <i>k</i><sub>5</sub> and <i>k</i><sub>6</sub> first-order rate constants, which describe an isomerization equilibrium between the initial enzyme–inhibitor complex (EI) and a second high-affinity complex (E*I) (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). This slow isomerization process gives rise to a characteristic bending of the reaction curve that is defined by the first-order rate constant <i>k</i><sub>obs</sub>, whose value describes the conversion from the initial reaction rate (<i>v</i><sub>i</sub>) to the final steady-state velocity (<i>v</i><sub>s</sub>).</div><div class="NLM_p">Adjustment to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> (see equations in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) of the progress curves of the reactions catalyzed by <i>Li</i>TryR allowed us to obtain the <i>k</i><sub>obs</sub> values for six <b>19a</b> concentrations (4.4, 5.9, 7.9, 10.5, 14.1, and 18.7 μM) at six different TS<sub>2</sub> concentrations (3.1, 6.2, 12.5, 25, 50, and 100 μM) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figures S2–S7 and Table S2</a>). The different <i>k</i><sub>obs</sub> values obtained at each substrate concentration can be used to determine the apparent inhibitory constants <i>K</i><sub>i</sub><sup>app</sup> and <i>K</i><sub>i</sub>*<sup>app</sup> defined as the dissociation constant for the initial EI complex and the constant for the overall dissociation from E*I to E + I, respectively (<a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>).<a onclick="showRef(event, 'cit42a cit42b'); return false;" href="javascript:void(0);" class="ref cit42a cit42b">(42a,b)</a> Based on the relationship among <i>k</i><sub>obs</sub>, <i>v</i><sub>i</sub>, and <i>v</i><sub>s</sub> (<i>k</i><sub>6</sub> = <i>k</i><sub>obs</sub> × <i>v</i><sub>i</sub>/<i>v</i><sub>s</sub>) at all of the trypanothione disulfide (TS<sub>2</sub>) and <b>19a</b> concentrations assayed, <i>k</i><sub>6</sub> varies between 3.9 × 10<sup>–6</sup> and 6.5 × 10<sup>–5</sup> s<sup>–1</sup>. Taking into consideration the extremely slow process of recovery of the enzymatic activity after complete inactivation of <i>Li</i>TryR (400 nM) upon incubation with 25 μM <b>19a</b> for 16 h and subsequent 2500-fold dilution (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S13</a>), a value of 3 × 10<sup>–5</sup> s<sup>–1</sup> was selected as a conservative upper value for <i>k</i><sub>6</sub>. Fixing this value for <i>k</i><sub>6</sub> rendered very good estimations of <i>K</i><sub>i</sub><sup>app</sup> and <i>K</i><sub>i</sub>*<sup>app</sup> after the fitting process for all of the substrate concentrations assayed (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration dependence of the observed rate constants of <i>Li</i>TryR (0.8 nM) inactivation by <b>19a</b> at different TS<sub>2</sub> concentrations. Plot of the <i>k</i><sub>obs</sub> values (±standard errors) as a function of <b>19a</b> concentration at six different TS<sub>2</sub> concentrations (3.1, 6.2, 12.5, 25, 50, and 100 μM) (<i>k</i><sub>obs</sub> determinations for every <b>19a</b> concentration at the different fixed TS<sub>2</sub> concentrations assayed are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Supporting Information</a>). Curves were fitted using <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>, and the results of the fits are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Apparent Inhibition Constants for <i>Li</i>TryR Time-Dependent Inhibition by <b>19a</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>[TS</b><sub><b>2</b></sub><b>] (μM)</b></th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub><sup>app</sup> (<b>μM</b>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub>*<sup>app</sup> (<b>μM</b>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="char" char="±">8.9 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="char" char="±">8.3 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char="±">9.3 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub>i</sub><sup>app</sup> and <i>K</i><sub>i</sub>*<sup>app</sup> values at different TS<sub>2</sub> concentrations were obtained by fitting to <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a> the <i>k</i><sub>obs</sub> values for every <b>19a</b> concentration at the different fixed TS<sub>2</sub> concentrations assayed. Results are the estimated values of the nonlinear regression ± associated standard errors.</p></div></div></div><div class="NLM_p">The relationships between the different <i>K</i><sub>i</sub><sup>app</sup> and <i>K</i><sub>i</sub> values in slow-binding inhibitors are the same as those for classical linear reversible inhibitors.<a onclick="showRef(event, 'cit42a cit42b'); return false;" href="javascript:void(0);" class="ref cit42a cit42b">(42a,b)</a> By applying <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a> to fit the <i>K</i><sub>i</sub><sup>app</sup> values obtained at the six different TS<sub>2</sub> concentrations assayed (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S8A</a>), we could estimate the values of α (0.8 ± 0.4) and <i>K</i><sub>i</sub> (7.8 ± 1.7 μM). A similar approach (<a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S8B</a>) was followed to estimate the values of α* (5.5 ± 2.9) and <i>K</i><sub>i</sub>* (0.5 ± 0.1 μM) for the two-step global process of enzyme inhibition. According to these results, formation of the initial EI complex is not affected by the presence of substrate, a behavior that is characteristic of a pure noncompetitive process (α ∼ 1). The isomerization step from EI to E*I strongly enhances the inhibitory activity of <b>19a</b>, which is characterized by an overall <i>K</i><sub>i</sub>* value of 0.5 μM. This isomerization process is, as expected, slightly impaired by the presence of substrate (α = 5.5) because of the generation of the enzyme–substrate–inhibitor complex, which decreases the concentration of the EI complex and thereafter the rate of E*I generation. Despite this small substrate effect, an α value of 5.5 for the overall process is still in the range of α values characteristic of noncompetitive (mixed) inhibitors. The overall inhibitory process is depicted in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Scheme S5</a>. Because of the ability of <b>19a</b> to cause enzyme dissociation, the characteristic isomerization of the enzyme in this mechanism of slow-binding inhibition is expected to be related to homodimer disruption.</div><div class="NLM_p last">Interestingly, compounds <b>12b</b> and <b>12q</b> have similar IC<sub>50</sub> values in the reductase assay but only <b>12b</b> interferes with dimerization. The kinetic analyses reveal that both compounds are time-dependent inhibitors but only inhibition caused by <b>12b</b> follows a two-step process of enzyme isomerization (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S11 and Table S3</a>). Plots of <i>k</i><sub>obs</sub><i>vs</i> inhibitor concentration for <b>12q</b> fit to a straight line that is indicative of a single-step binding mechanism (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S12, Table S4, and Scheme S4</a>), which agrees with its inability to disrupt the homodimer.</div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Computational Studies</h3><div class="NLM_p">Despite numerous attempts to form cocrystals with <i>Li</i>TryR or soak crystals of the enzyme with moderately or highly potent triazole-based dimerization disruptors <b>12a</b>, <b>12b</b>, and the heteroaromatic <b>12r</b>, no diffraction-quality crystal containing an enzyme/drug complex could be obtained. Of note, similar problems were encountered in previous cocrystallization efforts with the predecessor imidazoles <b>2</b> and <b>3</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Because of these so-far insurmountable hurdles, we had to rely on molecular modeling tools to try and shed light on the atomistic details of the binding process. Docking the most potent triazoles <b>12b</b>, <b>12c</b> into the cavity of one <i>Li</i>TryR monomer that lodges the <sup>435</sup>Pro–Met<sup>447</sup> α-helix of the other monomer, while feasible, failed to account for the SAR results discussed above. Indeed, the biologically essential naphthyl or biphenyl R<sub>3</sub> substituents could not be properly accommodated unless the ligand folded onto itself in an unrealistic fashion due to lack of room. Therefore, we sought alternative binding sites in <i>Li</i>TryR, as found in Protein Data Bank (PDB) entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JK6">2JK6</a><a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a> using the FTMap web server.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This procedure highlighted the existence of a large, hydrophobic, and putatively druggable cavity right at the center of the dimer that is lined by residues from both monomers and located very close to the interfacial helices that were mimicked by the original peptides and peptidomimetics (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>Li</i>TryR dimer structure. FTMap identified the central interfacial cavity and the two adjacent sites where the two FAD cofactors are lodged as putative ligand-binding sites (circled by yellow lines).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, this central cavity at the <i>Li</i>TryR dimer interface is reminiscent of that present in <i>Plasmodium falciparum</i> GR<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> or hGR and is shown to bind some noncompetitive or uncompetitive inhibitors such as safranin, menadione,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> xanthenes,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> or <i>N</i>-arylisoalloxazines.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Ligand accessibility to this site was assessed by means of the CAVER web server,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> which identified several tunnels connecting this intermonomer cavity to the bulk solvent (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Visualization of the potential access routes from the bulk solvent to the interfacial cavity (2.808 Å<sup>3</sup>, 0.77 “druggability”) as determined by the CAVER Web server using default parameters.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In comparison, each nicotinamide adenine dinucleotide phosphate (NADP) binding site occupies 1.343 Å<sup>3</sup> and its druggability is 0.63. The tunnels are depicted as a continuous semitransparent gray surface. The central vertical α-helices encompass the amino acid residues originally identified as hotspots for dimerization. The FAD prosthetic groups are displayed as stick models for reference purposes only.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next performed docking studies with the most potent triazole dimerization inhibitors <b>12b</b>, <b>12c</b> and the disubstituted thiazole analogue <b>19a</b> centering the search within the proposed interfacial cavity of the <i>Li</i>TryR homodimer (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The best ligand poses had in common the positioning of the (hetero)aromatic scaffold inside the connection tunnel and the terminal ammonium group of the R<sub>1</sub> substituent at the hydrogen-bonding distance from the carboxylate of Glu466′ (<i>d</i>(N<sub><b>12b</b></sub>···O<sub>Glu466′</sub>) = 2.2 Å, <i>d</i>(N<sub><b>12c</b></sub>···O <sub>Glu466′</sub>) = 3.4 Å).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proposed ligand-binding modes within <i>Li</i>TryR. (a) Cartoon representation of dimeric <i>Li</i>TryR showing the two FAD prosthetic groups (sticks, C atoms in gray) close to the active sites and a docked <b>19a</b> molecule (C atoms in pink) filling half of the central interfacial hydrophobic cavity and part of the tunnel connecting it to the bulk solvent. (b) Details of the best-scoring binding pose for <b>12b</b> (C atoms in green). (c) Details of the best-scoring binding pose for <b>12c</b> (C atoms in cyan). (d) Details of the best-scoring binding pose for <b>19a</b> (C atoms in pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The proposed binding modes also revealed the potential of the imidazolidinone group of the R<sub>2</sub> substituent to act as a hydrogen bond acceptor from the hydroxyl group of either Thr65 (<i>d</i>(N<sub><b>12b</b></sub>···O<sub>Thr65</sub>) = 2.9 Å), for the naphthyl compound <b>12b</b>, or Ser433′ (<i>d</i>(N<sub><b>12c</b></sub>···O<sub>Ser433′</sub>) = 2.5 Å), for biphenyl compounds <b>12c</b> and <b>19b</b>. The unhindered rotation of the central benzene ring of the scaffold seems to play a fundamental role to distinctly orient the R<sub>2</sub> substituent in each complex. Regarding the R<sub>3</sub> hydrophobic substituents at the thiazole, the bulky naphthyl and biphenyl aromatic groups for compounds <b>12b</b>, <b>12c</b> could be accommodated in one of the hydrophobic subpockets of the interfacial cavity that is mainly defined by Pro435′ and Phe367′, in good accord with the previous FTMap results. In addition, for the R<sub>3</sub> and R<sub>4</sub> disubstituted phenyl-thiazole analogue <b>19a</b>, one of the phenyl groups attached to the thiazole ring was found to point directly toward the second hydrophobic subpocket Leu72–Leu72′ at the bottom of the cavity, another location pinpointed by FTMap. This binding mode nicely accounts for the above-mentioned dramatic improvement of inhibitory potency relative to the monosubstituted phenyl-thiazole <b>12n</b>.</div><div class="NLM_p">Our molecular dynamics simulations and binding energy decomposition results using <b>19a</b> as a representative inhibitor point to Glu436 as one of the major contributors to ligand binding (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S16</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_003.avi" class="ext-link">Movie S1</a> in the Supporting Information). We have previously shown that this residue is a hotspot for <i>Li</i>TryR dimerization.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, in all X-ray crystal structures of TryR, this glutamate’s carboxylate from one monomer is involved in two short hydrogen bonds with the peptide backbone of Ser464 and Ala465 from the other monomer. Inhibitor binding appears to promote the loss of these interdimer hydrogen-bonding interactions (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S17</a>) due to a wedge effect brought about by hydrophobic interactions involving the phenyl rings on the one side of the molecule and strong electrostatic interactions on the other side, which involve not only the free amino group but also the triazole ring. Indeed, the negative electrostatic potential generated by the two unsubstituted ring nitrogens faces the positive dipole of the short <sup>400</sup>MetGly<sup>405</sup> α-helix. Taken together, the theoretical calculations provide a rationale for the observed SAR results. Furthermore, the residue in hGR (PDB id: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XAN">1XAN</a>) that is positionally equivalent to Leu72 in <i>Li</i>TryR is Phe78, whose aromatic side chain provides a flat platform for the stacking of ligands such as safranin or xanthene<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> but prevents the binding of our novel compounds, hence their remarkable selectivity. The central cavity putatively targeted by <b>19a</b> and analogues is lined by the residues listed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Table S5</a>, which also shows the positionally equivalent residues in hGR. The overall lack of identity in several crucial regions is in consonance with the observed marked selectivity for TryR.</div><div class="NLM_p">To further support the feasibility of the proposed binding mode and improve the binding affinity for the putative target site, a new <i>C</i><sub>2</sub>-symmetric compound <b>22</b> was rationally designed with a view to exploiting the <i>C</i>-2 symmetry of this homodimeric enzyme and simultaneously occupy both entrance/exit tunnels (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The putative <i>Li</i>TryR/<b>19a</b> complex provided the starting point for the structure-based design. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, reproducing the binding mode of <b>19a</b> within one monomer on the other monomer immediately reveals the possibility of merging both single molecular entities into one by making use of a suitable linker bonded to the R<sub>3</sub> substituent. To this end, a 1,3-disubstituted phenyl was selected as an appropriate spacer to yield the <i>C</i><sub>2</sub>-symmetric compound <b>22</b>, which was also docked into the putative binding site (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Rationale for the design of the <i>C</i><sub>2</sub>-symmetric compound <b>22</b>. (A) Best docking pose for <b>19a</b> (C atoms in pink) with the tail extended into one <i>Li</i>TryR monomer reproduced for the other monomer (C atoms in white). Note how the propylamino group is extended and oriented toward the carboxylate of Glu466 in both cases. (B) Best-scoring result provided by the automated docking program<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> for <b>22</b> (CPK model) inside the central interfacial cavity and connecting tunnels. The side chains of Glu466 and Glu466′ are displayed as sticks with C atoms colored in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The good agreement found between the intended binding mode for <b>22</b> and that found by the automated docking program<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) is noteworthy. In addition to the hydrophobic contacts between the aromatic rings and the walls of the cavity, the two terminal R<sub>1</sub> butylammonium groups of <b>22</b> are presumed to establish simultaneous salt bridges with Glu466/Glu467 and Glu466′/Glu467′, whereas the carbonyl groups of the two imidazolidinone moieties can establish hydrogen bonds with the protonated nitrogens of Lys61/Lys61′, the side-chain carboxamide of Gln68, and the backbone NH of Ser433/Ser433′.</div><div class="NLM_p last">The activity of the new symmetric compound <b>22</b> was evaluated in the two enzymatic assays. Encouragingly, the compound emerged not only as the most effective <i>Li</i>TryR inhibitor of the entire series, with an IC<sub class="stack">50</sub><sup class="stack">act</sup> value of 0.4 ± 0.03 μM, but also as a very potent dimerization disruptor (IC<sub class="stack">50</sub><sup class="stack">dim</sup> = 8.0 ± 0.2 μM). In comparison with the corresponding monomeric triazole ligand <b>12n</b> (substituted with an R<sub>3</sub> phenyl group), <b>22</b> was 28- and 4-fold more potent, respectively, in both assays (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Taken together, these experimental results support the proposed binding mode of the monomeric and symmetric triazole-based compounds at this interfacial site.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Inhibitory Activity on Other TryR Enzymes from the <i>Trypanosoma</i> Genus</h3><div class="NLM_p">TryR is an essential enzyme not only for <i>Leishmania</i> but also for <i>Trypanosoma</i> parasites. Given the high degree of identity/similarity among the amino acid sequences of TryRs from these two genera, some degree of activity against so closely related enzymes would not be unexpected for our compounds. To test this hypothesis, the most active members of these series were tested as inhibitors of the oxidoreductase activity of TryRs from <i>T. brucei</i> (<i>Tb</i>TryR) and <i>Trypanosoma congolense</i> (<i>Tco</i>TryR), the causative agents of sleep sickness and nagana, respectively. The results shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> demonstrate, in fact, very similar activities for <b>12a</b>–<b>c</b>, <b>12n</b>, <b>12r</b>, <b>19a</b>, and <b>22</b> as inhibitors of the three enzymes.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> ± SE Values (μM) for Selected Triazole Analogues <b>12a</b>–<b>c</b>, <b>12n</b>, <b>12r</b>, <b>19a</b>, and <b>22</b> in the Oxidoreductase Activity of TryR from <i>L. infantum</i>, <i>T. brucei</i>, and <i>T. congolense</i></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±"><i>Li</i>TryR</th><th class="colsep0 rowsep0" align="center" char="±"><i>Tb</i>TryR</th><th class="colsep0 rowsep0" align="center" char="±"><i>Tco</i>TryR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char="±">14.6 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">13.3 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">11.0 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">9.7 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char="±">10.9 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">10.0 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="char" char="±">9.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">12.5 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">9.3 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="char" char="±">11.9 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">15.0 ± 2.9</td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>In Vitro</i> Antileishmanial Evaluation and Cytotoxicity</h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Compound Internalization into the Parasites</h4><div class="NLM_p">Our earlier attempts to develop <i>Li</i>TryR dimerization disruptors as leishmanicidal molecules were hampered by the poor ability of previously synthesized compounds to cross the parasite plasma membrane. The peptidomimetics herein described, endowed with fluorescent properties, no longer suffer from this limitation. <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> shows the intense blue fluorescence emitted by promastigotes incubated for 1 h with compound <b>12a</b>. Strong fluorescent spots can be observed in the apical region of some parasites, just opposite the flagellar pocket that is expected to be the main entry region for these compounds.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Fluorescence microscopy images of <i>L. infantum</i> promastigotes treated with 25 μM compound <b>12a</b> for 1 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Activity on Extracellular Parasites and Human Cells</h4><div class="NLM_p">Representative examples of triazole-based <i>Li</i>TryR enzyme inhibitors were tested <i>in vitro</i> against <i>L. infantum</i> axenic promastigotes and amastigotes. Cytotoxicity was assessed employing the human liver cancer cell line HepG2. Miltefosine, the R<sub>9</sub> conjugate of the prototype peptide <b>1</b>, and imidazole-based compounds <b>2</b> and <b>3</b> were included as reference drugs. According to the data shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, among the 18 triazole compounds tested, 9 showed half-maximal effective concentration (EC<sub>50</sub>) values below 10 μM against <i>Leishmania</i> promastigotes or amastigotes (<b>12b</b>, <b>12c</b>, <b>12i–k</b>, <b>12n</b>, <b>19b</b>, <b>19d</b>, and <b>19e</b>) that are similar to those observed for the reference compounds.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In Vitro</i> Activity on <i>L. infantum</i> Parasites and Cytotoxic Activity of Representative Triazole Compounds<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="/" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM) promastigotes<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM) amastigotes<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM) HepG2<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="/">SI<sub>p</sub>/SI<sub>a</sub><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">16.4 ± 0.9</td><td class="colsep0 rowsep0" align="left">13.9 ± 0.6</td><td class="colsep0 rowsep0" align="left">20.3 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="/">1.2/1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">8.4 ± 0.3</td><td class="colsep0 rowsep0" align="left">15.3 ± 1.7</td><td class="colsep0 rowsep0" align="left">33.3 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="/">4.0/2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">4.9 ± 0.4</td><td class="colsep0 rowsep0" align="left">11.6 ± 0.8</td><td class="colsep0 rowsep0" align="left">43.1 ± 2.6</td><td class="colsep0 rowsep0" align="char" char="/">8.8/3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">12.7 ± 0.3</td><td class="colsep0 rowsep0" align="left">31.6 ± 5.8</td><td class="colsep0 rowsep0" align="left">25.7 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="/">2.0/<1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">5.8 ± 0.7</td><td class="colsep0 rowsep0" align="left">5.2 ± 0.3</td><td class="colsep0 rowsep0" align="left">60.4 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="/">10.4/11.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">8.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.7</td><td class="colsep0 rowsep0" align="left">12.4 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="/">1.8/1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">4.0 ± 0.2</td><td class="colsep0 rowsep0" align="left">7.4 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="/">ND/1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left">42.6 ± 3.9</td><td class="colsep0 rowsep0" align="left">25.2 ± 0.5</td><td class="colsep0 rowsep0" align="left">44.9 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="/">1.0/1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left">5.4 ± 0.08</td><td class="colsep0 rowsep0" align="left">11.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">16.4 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="/">3.0/1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12o</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">67.9 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="/"><1.0/<1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">27.0 ± 2.8</td><td class="colsep0 rowsep0" align="left">43.3 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="/">ND/1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="left">23.8 ± 0.5</td><td class="colsep0 rowsep0" align="left">22.3± 0.6</td><td class="colsep0 rowsep0" align="left">29.4 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="/">1.2/1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12s</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">68.8 ± 3.2</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="char" char="/">ND/>1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">10.7 ± 1.3</td><td class="colsep0 rowsep0" align="left">15.6 ± 3.0</td><td class="colsep0 rowsep0" align="left">26.5 ± 4.1</td><td class="colsep0 rowsep0" align="char" char="/">2.5/1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">9.4 ± 0.5</td><td class="colsep0 rowsep0" align="left">17.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="/">ND/1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">22.6 ± 5.7</td><td class="colsep0 rowsep0" align="left">≥ 75</td><td class="colsep0 rowsep0" align="char" char="/">ND/≥3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">9.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">12.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="/">ND/1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">8.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">6.6 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="/">ND/<1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">3.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">4.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">30.5 ± 4.1</td><td class="colsep0 rowsep0" align="char" char="/">8.0/6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">miltefosine</td><td class="colsep0 rowsep0" align="left">47.6 ± 0.6</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.1</td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="char" char="/">>1.6/>37.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>9</sub>-peptide <b>1</b></td><td class="colsep0 rowsep0" align="left">3.1 ± 0.6</td><td class="colsep0 rowsep0" align="left">3.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">61.7 ± 6.1</td><td class="colsep0 rowsep0" align="char" char="/">19.9/18.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">12.8 ± 0.7</td><td class="colsep0 rowsep0" align="left">12.8 ± 1.3</td><td class="colsep0 rowsep0" align="left">27.1 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="/">2.1/2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">5.3 ± 0.3</td><td class="colsep0 rowsep0" align="left">5.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">14.2 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="/">2.7/2.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Miltefosine, linear peptide <b>1</b> conjugated to R<sub>9</sub>, and imidazole-containing compounds <b>2</b> and <b>3</b> were included as in-house reference compounds.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Results are representative of three independent experiments, each performed in triplicate. EC<sub>50</sub> ± SE values are indicated.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">The half-maximal effective concentration (EC<sub>50</sub>) is defined as that causing a 50% reduction of proliferation in <i>L. infantum</i> promastigotes (EC<sub>50p</sub>) and amastigotes (EC<sub>50a</sub>) or human hepatocellular carcinoma (HepG2) cells. Dead parasites were identified by their increased permeability to propidium iodide (PI).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Cytotoxicity in HepG2 cells was measured using the crystal violet method.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">The selectivity index (SI) is the ratio of EC<sub>50</sub> against human cells to EC<sub>50</sub> against <i>L. infantum</i> promastigotes (SI<sub>p</sub>) and amastigotes (SI<sub>a</sub>).</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">Of all the compounds bearing a butylamine at R<sub>1</sub>, an imidazolidinone at R<sub>2</sub>, and different R<sub>3</sub> substituents (<b>12a</b>–<b>c</b>), the biphenylethyl analogue <b>12c</b> displayed better activity against both promastigotes and amastigotes than those containing naphthyl or phenylethyl substituents (<b>12c</b> > <b>12b</b> > <b>12a</b>) and also lower cytotoxicity. This results in an improved selectivity index (SI) of 8.8 for promastigotes (SI<sub>p</sub>) and 3.7 for amastigotes (SI<sub>a</sub>) in comparison with the SIs of the corresponding biphenyl imidazole analogue <b>3</b> (SI<sub>p</sub> = SI<sub>a</sub> = 2.7). On the other hand, a combination of a shorter propyl spacer at R<sub>1</sub> and the biphenyl group at R<sub>3</sub> gave <b>12i</b>, the most potent and selective compound of the entire series, with EC<sub>50</sub> values of 5.8 against promastigotes (EC<sub>50p</sub>) and 5.2 μM against amastigotes (EC<sub>50a</sub>) and the highest SIs (SI<sub>p</sub> = 10.4 and SI<sub>a</sub> = 11.6). The imidazolidinone moiety at R<sub>2</sub> could be eliminated without compromising the leishmanicidal activity (<b>12j</b>, <b>12k</b>), but a significant increase in cytotoxicity was detected, which suggests a positive effect of the imidazolidinone on reducing the cytotoxicity. As regards R<sub>3</sub>, the biphenylethyl substituent could be replaced by a phenyl resulting in an equipotent leishmanicidal analogue (<b>12c</b><i>vs</i><b>12n</b>), in contrast to the higher IC<sub>50</sub> values observed for <b>12n</b> in the enzymatic assays. However, the SI for <b>12n</b> was low due to an increase in toxicity. The introduction of polyheteroaromatic rings gave rise to a significant reduction of the leishmanicidal activity (<b>12q</b>–<b>s</b><i>vs</i><b>12c</b>) in contrast to the high potency observed for these analogues in the enzymatic assays. Disubstituted thiazole analogues <b>19a</b>–<b>e</b> also showed high leishmanicidal activities against amastigotes with EC<sub>50</sub> values in the 8.4−22.6 μM range but, with the exception of <b>19c</b>, low SIs (SI < 2.5) due to higher toxicities. Remarkably, the symmetrical triazole analogue <b>22</b> turned out to be one of the most potent and selective agents against <i>L. infantum</i> amastigotes with an EC<sub>50a</sub> value of 4.9 μM and a SI<sub>a</sub> of 6.2.</div><div class="NLM_p last">It should be noted that a direct correlation between <i>in vitro</i> TryR inhibitory activity and <i>in cellulo</i> effects is not to be expected due to differences in cellular permeability or the possibility that this enzyme is not the only target for these compounds. Therefore, among the newly tested triazole-based analogues, the propylamine biphenyl derivative <b>12i</b> and the <i>C</i>-2 symmetric <b>22</b> displayed the best leishmanicidal activity and the lowest <i>in cellulo</i> cytotoxicity with SI values that exceeded those obtained for the imidazoles <b>2</b> and <b>3</b> by 5–6-fold. It is interesting to point out that, despite the relatively poor IC<sub>50</sub> value obtained for <b>12i</b> in the oxidoreductase activity assay, its behavior in the dimerization assay is similar to that of the most potent compounds from these series. This finding suggests that their ability to disrupt the dimer may be largely responsible for the leishmanicidal activity of these compounds. As IC<sub>50</sub> values were calculated taking into consideration only the initial velocities of the reactions and because of the time-dependent behavior of these molecules, compounds such as <b>12i</b> may show good activities in the dimerization assay while displaying poor IC<sub>50</sub> values.</div></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Leishmanicidal Activity in Intracellular Amastigotes</h4><div class="NLM_p">The most potent and selective compounds were further tested for their leishmanicidal activity in amastigote-infected THP-1 cells. The EC<sub>50</sub> values obtained are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Miltefosine, edelfosine, amphotericin B, the R<sub>9</sub>-conjugate of the prototype peptide <b>1</b>, and compounds <b>2</b> and <b>3</b> from the precursor imidazole series were included as reference compounds. In our view, the fact that the EC<sub>50</sub> values cover a range from 22 to >75 μM indicates that not all of the compounds are able to cross the plasma and phagolysosomal membranes in the macrophages. Among the monomeric triazole-based compounds, only the phenyl derivative <b>12a</b>, with an EC<sub>50</sub> value of 32.4 μM, and the biphenyl derivatives <b>12c</b>, <b>12i</b>, with EC<sub>50</sub> values of 46.5 and 54.5 μM, respectively, displayed moderate effectiveness against intracellular amastigotes. Interestingly, the symmetric triazole molecule <b>22</b> emerged, once again, as the most potent and selective leishmanicidal compound of all of the triazole-based series (EC<sub>50</sub> = 22 μM), showing a SI of 2.2, better than that obtained for edelfosine (SI = 1.4). Accordingly, derivatives <b>12a</b>, <b>12c</b>, <b>12i</b>, and <b>22</b> constitute the first analogues designed against the dimerization interface of TryR that show leishmanicidal activity toward intracellular amastigotes. These results confirm the interest and potential of both monomeric and symmetric triazole-based compounds as antileishmanial agents.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>In Vitro</i> Antileishmanial Activity for the Most Representative Triazole-Based Compounds in Amastigote-Infected THP-1 Monocyte-Derived Macrophages<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM) intracellular amastigotes<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM) THP-1<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">32.4 ± 6.7</td><td class="colsep0 rowsep0" align="left">45 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">46.5 ± 1.5</td><td class="colsep0 rowsep0" align="left">>75 (100% at 75 μM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">54.4 ± 15.5</td><td class="colsep0 rowsep0" align="left">>75 (100% at 75 μM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75 (67% at 75 μM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">>75 (63% at 75 μM)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">22.2 ± 6.4</td><td class="colsep0 rowsep0" align="left">48.4 ± 14.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mdelfosine</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.02</td><td class="colsep0 rowsep0" align="left">3.5 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">miltefosine</td><td class="colsep0 rowsep0" align="left">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amphotericin B</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sub>9</sub>-peptide <b>1</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">14.5 ± 2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">27.9 ± 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">>75</td><td class="colsep0 rowsep0" align="left">15.5 ± 1.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Edelfosine, miltefosine, and amphotericin B were included as reference leishmanicidal drugs. The R<sub>9</sub>-peptide <b>1</b> and the imidazole-containing compounds <b>2</b> and <b>3</b> were included as in-house reference compounds for structure–activity comparisons.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">The half-maximal effective concentration (EC<sub>50</sub>) is defined as that causing a 50% reduction in the number of <i>L. infantum</i> amastigotes per cell in the culture or amastigote-infected THP-1 monocyte-derived macrophages. Living intracellular amastigotes were identified by their green fluorescence due to green fluorescent protein (GFP) expression and their lack of permeability to propidium iodide; EC<sub>50</sub> ± SE values are indicated.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Cytotoxicity was assessed in THP-1 monocyte-derived macrophages by measuring lactate dehydrogenase (LDH) activity.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Cell viability of amastigote-infected THP-1 monocyte-derived macrophages at 75 μM (maximum concentration assayed). Results are representative of three independent experiments.</p></div></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The development of new and more efficient antileishmanial drugs is a priority in the field of neglected tropical diseases. From a small library of 26 triazole-phenyl-thiazole compounds, we have identified the most potent small-molecule dimerization disruptors of <i>Li</i>TryR described to date. Similar to prototype peptide <b>1</b>, they behave as slow-binding, noncompetitive inhibitors with overall <i>K</i><sub>i</sub>* values of 0.5 μM (<b>19a</b>). These molecules are also endowed with high antileishmanial activity against both extracellular and intracellular parasites and improved selectivity indexes when compared to those obtained for previous in-house imidazole-based compounds.</div><div class="NLM_p">Molecular modeling studies carried out for the most potent <i>Li</i>TryR triazole-containing dimerization inhibitors <b>12b</b>, <b>12c</b>, and <b>19a</b> identified a previously unexplored but apparently druggable binding site consisting of a large central cavity at the dimer interface of the enzyme. In the absence of crystallographic evidence, despite extensive efforts, this putative binding mode provided a rationale for the observed SAR and a basis for the subsequent structure-based design of a new symmetrical triazole analogue <b>22</b> that displays improved <i>Li</i>TryR inhibitory activities over those of its parental monomeric triazole. This rationally designed compound shows a dramatic enhancement in leishmanicidal potency, in particular against intracellular amastigotes.</div><div class="NLM_p last">All in all, our results provide the first evidence for ligand binding to a so-far unexplored region of <i>Li</i>TryR and lay the ground for further design of innovative TryR inhibitors that may become valuable candidates in the process of discovering new drugs against leishmaniasis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53353" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53353" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemical Procedures</h3><div class="NLM_p">Experiments dealing with air- and water-sensitive reagents/compounds were performed in an argon atmosphere. Hygroscopic species were previously dried under vacuum for 24 h by P<sub>2</sub>O<sub>5</sub> as the drying agent. Unless otherwise noted, analytical-grade solvents and commercially available reagents were used without further purification. Anhydrous CH<sub>2</sub>Cl<sub>2</sub> was dried by refluxing over CaH<sub>2</sub>. EtOH was dried with 4 Å molecular sieves previously activated in a microwave oven. THF was dried by reflux over sodium/benzophenone. Pressured reactions were carried out on a Sigma-Aldrich Ace Glass flask (50 or 100 mL) supplied with a Teflon cap. Microwave-assisted experiments were performed on a Biotage Initiator 2.0 single-mode cavity instrument from Biotage (Uppsala). Experiments were carried out in sealed microwave reaction vials at the standard absorbance level (400 W maximum power). Lyophilizations were carried out on a Telstar 6-80 lyophilizer.</div><div class="NLM_p">Monitoring of the reactions was performed by analytical thin-layer chromatography (TLC) on silica gel 60 F<sub>254</sub> (Merck) or by high-performance liquid chromatography coupled to mass spectrometry (HPLC–MS) using a Waters Alliance 2695 Separation Module with a Waters Micromass ZQ Detector.</div><div class="NLM_p">Compounds were purified by (a) flash column chromatography (Merck) with silica gel 60 (230–400 mesh); (b) high-performance flash column chromatography (HPFC) on a Biotage Isolera One using cartridges of Claricep i-Series, Silica, 40 g (40–60 μm, 60 Å) for normal phase chromatography, and KP-C18-HS 12g (21 × 55 mm<sup>2</sup>) for the reverse phase; (c) centrifugal circular thin-layer chromatography (CCTLC) on a Chromatotron (Kiesegel 60 PF<sub>254</sub> gipshaltig, Merck), with layer thicknesses of 1 and 2 mm and flow rates of 2 and 3 mL/min; or (d) semipreparative HPLC purifications on a Waters 2695 HPLC system equipped with a Photodiode Array 2998 coupled to a 3100 Mass Detector mass spectrometer using a C18 Sunfire column (19 mm × 150 mm).</div><div class="NLM_p">The purity of the compounds was checked by analytical HPLC on a Waters 600 system equipped with a C18 Sunfire column (4.6 mm × 150 mm, 3.5 μm) and a selectable wavelength UV detector. Alternatively, an Agilent Technologies 1120 Compact LC provided with a reverse-phase column ACE 5 C18-300 (4.6 mm × 150 mm, 3.5 μm) and integrated diode detector PDA 996 was used. As the mobile phase, mixtures of A (CH<sub>3</sub>CN) and B (H<sub>2</sub>O) (0.05% TFA) on isocratic or gradient mode with a flow rate of 1 mL/min were used. The following gradients were used: from 10% A to 100% A in 10 min (gradient A) and from 1% A to 100% A in 10 min (gradient B). The purity of the final compounds was also determined to be >95% by elemental analysis with a LECO CHNS-932 apparatus. Deviations of the elemental analysis results from the calculated value were within ±0.4%.</div><div class="NLM_p">Melting points (m.p.) were measured on a Mettler Toledo M170 apparatus and are uncorrected. Infrared (IR) spectra were recorded on a PerkinElmer Spectrum One instrument and KBr pellet as a sample support. Mass spectrum (MS) on electrospray ionization (ESI) mode was recorded on a Hewlett-Packard 1100SD in positive mode. High-resolution mass spectra (HRMS) were obtained on an Agilent 6520 Accurate-Mass Q-TOF LC-MS equipped with an HP-1200 (Agilent) liquid chromatograph coupled to a mass spectrometer with a Q-TOF 6520 hybrid mass analyzer. Usually, an error equal to or lower than 5 ppm was allowed. Nuclear magnetic resonance (NMR) spectra were recorded on a Varian INNOVA-300 operating at 300 MHz (<sup>1</sup>H) and 75 MHz (<sup>13</sup>C), a Varian INNOVA-400 operating at 400 MHz (<sup>1</sup>H) and 100 MHz (<sup>13</sup>C), a Varian MERCURY-400 operating at 400 MHz (<sup>1</sup>H) and 100 MHz (<sup>13</sup>C), and a Varian SYSTEM-500 operating at 500 MHz (<sup>1</sup>H) and 125 MHz (<sup>13</sup>C). The assignments were performed by means of different standard homonuclear and heteronuclear correlation experiments (gradient heteronuclear single quantum coherence (gHSQC), gradient heteronuclear multiple bond coherence (gHMBC), and nuclear Overhauser enhancement spectroscopy (NOESY)) when required.</div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-Azido-2-(2-(2-oxoimidazolidin-1-yl)ethoxy)benzo-nitrile (<b>5a</b>)</h4><div class="NLM_p last">A solution of bromoarene <b>4a</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (500 mg, 1.61 mmol) and NaN<sub>3</sub> (1.57 g, 24.2 mmol) in anhydrous DMSO (30 mL) in the presence of 4 Å molecular sieves, and under an argon atmosphere, was heated at 100 °C for 72 h. The reaction was allowed to cool to room temperature and diluted with H<sub>2</sub>O (60 mL), and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, evaporated to dryness, and lyophilized. The residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:3) to give 372 mg (85%) of <b>5a</b> as a yellow solid; m.p.: 158–161 °C; IR (KBr), ν (cm<sup>–1</sup>): 3230 (NH-st), 3090 (C<sub>sp</sub>–H st), 2223 (C≡N st), 2125 (N═N═N st), 1702 (C═O st); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ (ppm): 7.53 (d, <i>J</i> = 8.3 Hz, 1H, Ar), 6.70 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H, Ar), 6.53 (d, <i>J</i> = 1.8 Hz, 1H, Ar), 4.71 (bs, 1H, NHCON), 4.20 (t, <i>J</i> = 4.7 Hz, 2H, OCH<sub>2</sub>), 3.81–3.76 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.64 (t, <i>J</i> = 4.9 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.44 (t, <i>J</i> = 8.1 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.8 (NHCON), 161.8 (OC<sub>Ar</sub>), 146.8 (C<sub>Ar</sub>), 134.9 (CH<sub>Ar</sub>), 116.2 (CN), 111.8 (CH<sub>Ar</sub>), 103.2 (CH<sub>Ar</sub>), 98.3 (C<sub>Ar</sub>), 69.4 (OCH<sub>2</sub>), 47.8 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 43.2 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 38.6 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON); MS (ESI, positive mode) <i>m</i>/<i>z</i>: 567.2 [2M + Na]<sup>+</sup>, 295.0 [M + Na]<sup>+</sup>, 273.0 [M + H]<sup>+</sup>. NaN<sub>3</sub> may be toxic and explosive. Thus, for safety precautions, a polycarbonate safety screen in a properly functioning fume hood was always used to perform this reaction.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Benzyl-4-(1-(4-cyano-3-((1-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>8</b>)</h4><div class="NLM_p last">To a solution of azide <b>5a</b> (450 mg, 1.65 mmol), commercially available benzyl-5-hexynylcarbamate (523 mg, 2.15 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (42 mg, 0.17 mmol) in EtOH (25 mL) were added sodium ascorbate (131 mg, 0.66 mmol) and H<sub>2</sub>O (25 mL). The reaction mixture was stirred at room temperature in the dark overnight. The mixture was evaporated to dryness, and the residue dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was washed with H<sub>2</sub>O (3 × 50 mL), dryed (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated under reduced pressure. The residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:3) to provide <b>8</b> (573 mg, 69%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 7.86 (s, 1H, Ar), 7.61 (d, <i>J</i> = 8.3 Hz, 1H, Ar), 7.49 (s, 1H, Ar), 7.34 (d, <i>J</i> = 7.1 Hz, 1H, Ar), 7.32–7.17 (m, 5H, Ar), 5.05 (bs, 1H, NHCbz), 5.02 (s, 2H, NHCOOC<u class="uu">H</u><sub>2</sub>), 4.68 (bs, 1H, NHCON), 4.26 (t, <i>J</i> = 5.2 Hz, 2H, OCH<sub>2</sub>), 3.66 (t, <i>J</i> = 7.9 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.57 (t, <i>J</i> = 5.2 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.33 (t, <i>J</i> = 8.3 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.18 (q, <i>J</i> = 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.76 (t, <i>J</i> = 7.3 Hz, 2H, TrizCH<sub>2</sub>), 1.71 (quin, <i>J</i> = 7.4 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.52 (quin, <i>J</i> = 7.2 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.8 (NHCON), 161.5 (OC<sub>Ar</sub>), 156.6 (NHCOO), 149.2 (C<sub>Ar</sub>), 141.5 (C<sub>Ar</sub>), 136.6 (CH<sub>Ar</sub>), 135.1 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 119.1 (CH<sub>Ar</sub>), 115.7 (CN), 112.1 (CH<sub>Ar</sub>), 104.1 (CH<sub>Ar</sub>), 101.5 (C<sub>Ar</sub>), 69.0 (OCH<sub>2</sub>), 66.7 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 47.3 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.8 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.8 (CH<sub>2</sub>NHCbz), 38.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.1 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.1 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>29</sub>N<sub>7</sub>O<sub>4</sub> 503.2281; found 503.2279 (−0.33 ppm).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Benzyl-4-(1-(4-carbamothioyl-3-((1-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>9</b>)</h4><div class="NLM_p last">To a solution of benzonitrile <b>8</b> (400 mg, 0.79 mmol) in DMF (25 mL), 20% aq (NH<sub>4</sub>)<sub>2</sub>S (3.78 mL, 55.6 mmol) was added and then heated to 80 °C for 4 h. The reaction mixture was allowed to cool to room temperature, and then, CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added. The mixture was successively washed with HCl 0.1 N (2 × 50 mL), H<sub>2</sub>O (1 × 50 mL), and brine (1 × 50 mL). The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness. The crude was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:5) to give <b>9</b> (354 mg, 74%) as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 9.63 (bs, 1H, SCNH<sub>2</sub>), 9.50 (bs, 1H, SCNH<sub>2</sub>), 8.71 (d, <i>J</i> = 8.7 Hz, 1H, Ar), 7.78 (s, 1H, Ar), 7.45 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.36–7.17 (m, 5H, Ar), 7.10 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H, Ar), 5.96 (bs, 1H, NHCbz), 5.02 (s, 2H, NHCOOC<u class="uu">H</u><sub>2</sub>), 4.98 (bs, 1H, NHCON), 4.16 (t, <i>J</i> = 4.4 Hz, 2H, OCH<sub>2</sub>), 3.64 (t, <i>J</i> = 4.4 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.50 (dd, <i>J</i> = 9.7, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.40 (dd, <i>J</i> = 9.1, 6.2 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.17 (q, <i>J</i> = 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.73 (t, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>), 1.70 (quin, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.53 (quin, <i>J</i> = 7.5 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 196.5 (SCNH<sub>2</sub>), 163.5 (NHCON), 156.3 (NHCOO), 149.1 (C<sub>Ar</sub>), 140.3 (C<sub>Ar</sub>), 138.4 (CH<sub>Ar</sub>), 136.7 (CH<sub>Ar</sub>), 128.7 (CH<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 125.1 (C<sub>Ar</sub>), 119.1 (CH<sub>Ar</sub>), 111.3 (CH<sub>Ar</sub>), 104.0 (CH<sub>Ar</sub>), 66.8 (OCH<sub>2</sub>), 66.6 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 45.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 43.2 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.9 (CH<sub>2</sub>NHCbz), 38.3 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.8 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.4 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.3 (Triz<u class="uu">C</u>H<sub>2</sub>); MS (ESI, positive mode) <i>m</i>/<i>z</i>: 538.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedure for the Synthesis of Thiazoles <b>11a</b>–<b>c</b> by Hantzsch Cyclization</h4><div class="NLM_p">A solution of thioamide <b>9</b> (1 equiv) in <sup><i>i</i></sup>PrOH (15 mL) was treated with the appropriated α-haloketone (<b>10a</b>–<b>c</b>) (1 equiv). The reaction mixture was stirred at 70 °C for 3–6 h in a pressure flask, and then, it was allowed to cool to room temperature and concentrated to dryness under reduced pressure. The residue was purified by flash column chromatography or CCTLC on a Chromatotron (eluents are specified in each case).</div><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Benzyl-(4-(1-(3-(2-(2-oxoimidazolidin-1-yl)ethoxy)-4-(4-phenethylthiazol-2-yl)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>11a</b>)</h5><div class="NLM_p last">Following the general procedure, thioamide <b>9</b> (100 mg, 0.19 mmol) and the commercially available 1-bromo-4-phenylbutan-2-one (<b>10a</b> 42 mg, 0.19 mmol) in <sup><i>i</i></sup>PrOH (15 mL) reacted at 70 °C for 4 h. After the workup, the residue was purified by CCTLC on the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:3) to yield 108 mg (87%) of <b>11a</b> as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.46 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.81 (s, 1H, Ar), 7.51 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.38–7.06 (m, 11H, Ar), 6.86 (s, 1H, Ar), 5.06 (t, <i>J</i> = 6.0 Hz, 1H, NHCbz), 5.01 (s, 2H, NHCOOC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 4.34 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.69 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.50 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.26 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.18 (q, <i>J</i> = 7.4 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 3.12–2.97 (m, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>Ph), 2.76 (t, <i>J</i> = 7.4 Hz, 2H, TrizCH<sub>2</sub>), 1.71 (quin, <i>J</i> = 7.4 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.59 (quin, <i>J</i> = 7.1 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.8 (NHCON), 160.3 (OC<sub>Ar</sub>), 156.6 (C<sub>Ar</sub>), 156.0 (C<sub>Ar</sub>), 155.9 (C<sub>Ar</sub>), 148.7 (C<sub>Ar</sub>), 141.7 (C<sub>Ar</sub>), 138.3 (C<sub>Ar</sub>), 136.7 (C<sub>Ar</sub>), 130.0 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.4 (CH<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 126.1 (CH<sub>Ar</sub>), 122.7 (C<sub>Ar</sub>), 119.1 (CH<sub>Ar</sub>), 115.1 (CH<sub>Ar</sub>), 112.4 (CH<sub>Ar</sub>), 104.5 (CH<sub>Ar</sub>), 67.8 (OCH<sub>2</sub>), 66.7 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 46.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 43.0 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.8 (CH<sub>2</sub>NHCbz), 38.4 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 35.6 (CH<sub>2</sub>CH<sub>2</sub>Ph), 33.4 (CH<sub>2</sub>CH<sub>2</sub>Ph), 29.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.4 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.2 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>36</sub>H<sub>39</sub>N<sub>7</sub>O<sub>4</sub>S 665.2784; found 665.2791 (1.00 ppm).</div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Benzyl-(<i>E</i>)-(4-(1-(4-(4-(2-(naphthalen-2-yl)vinyl)thiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>11b</b>)</h5><div class="NLM_p last">According to the general procedure, thioamide <b>9</b> (520 mg, 0.97 mmol) and α-bromoketone <b>10b</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (267 mg, 0.97 mmol) were reacted at 70 °C for 5 h in <i><sup>i</sup></i>PrOH. After the workup, the residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:4) to give <b>11b</b> (365 mg, 51%) as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.61 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.90–7.64 (m, 7H, Ar, ThiazCH═C<u class="uu">H</u>), 7.55 (s, 1H, Ar), 7.45–7.36 (m, 3H, Ar), 7.30–7.14 (m, 7H, Ar, ThiazC<u class="uu">H</u>═CH), 5.03 (s, 2H, NHCOOC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 4.97 (bs, 1H, NHCON), 4.48 (bs, 1H, NHCbz), 4.39 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.73 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.52 (dd, <i>J</i> = 9.0, 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.28 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.20 (q, <i>J</i> = 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.78 (t, <i>J</i> = 7.3 Hz, 2H, TrizCH<sub>2</sub>), 1.74 (quin, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.59–1.51 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.7 (NHCON), 161.0 (OC<sub>Ar</sub>), 156.6 (C<sub>Ar</sub>), 156.2 (C<sub>Ar</sub>), 153.5 (C<sub>Ar</sub>), 148.8 (C<sub>Ar</sub>), 138.6 (C<sub>Ar</sub>), 136.7 (C<sub>Ar</sub>), 134.7 (CH<sub>Ar</sub>), 133.8 (C<sub>Ar</sub>), 133.3 (C<sub>Ar</sub>), 131.5 (CH<sub>Ar</sub>), 130.3 (CH<sub>Ar</sub>), 128.7 (CH<sub>Ar</sub>), 128.4 (CH<sub>Ar</sub>), 128.3 (CH<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 127.8 (CH<sub>Ar</sub>), 127.2 (C<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 126.1 (CH<sub>Ar</sub>), 123.6 (CH<sub>Ar</sub>), 121.8 (CH<sub>Ar</sub>), 119.2 (CH<sub>Ar</sub>), 117.1 (CH<sub>Ar</sub>), 112.5 (CH<sub>Ar</sub>), 104.5 (CH<sub>Ar</sub>), 67.7 (OCH<sub>2</sub>), 66.8 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 46.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 43.0 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.9 (CH<sub>2</sub>NHCbz), 38.4 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.4 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.2 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>39</sub>N<sub>7</sub>O<sub>4</sub>S 713.2784; found 713.2779 (−0.72 ppm).</div></div><div id="sec4_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Benzyl-(<i>E</i>)-(4-(1-(4-(4-(2-([1,1′-biphenyl]-4-yl)vinyl) thiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>11c</b>)</h5><div class="NLM_p last">Following the general Hantzsch synthesis, <b>9</b> (200 mg, 0.37 mmol) reacted with α-bromoketone <b>10c</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (112 mg, 0.37 mmol) for 5 h. After the workup, the residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 100:3) to give 174 mg (63%) of <b>11c</b> as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.57 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.81 (s, 1H, Ar), 7.61–7.45 (m, 8H, Ar, ThiazCH═C<u class="uu">H</u>), 7.40–7.31 (m, 3H, Ar), 7.31–7.16 (m, 7H, Ar), 7.12 (d, <i>J</i> = 16.0 Hz, 1H, ThiazC<u class="uu">H</u>═CH), 5.02 (s, 2H, NHCOOC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 4.68 (bs, 1H, NHCON), 4.36 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.70 (t, <i>J</i> = 5.8 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.50 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.26 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.16 (q, <i>J</i> = 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.76 (t, <i>J</i> = 7.3 Hz, 2H, TrizCH<sub>2</sub>), 1.75 (quin, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.55 (quin, <i>J</i> = 7.3 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.7 (NHCON), 160.9 (OC<sub>Ar</sub>), 156.6 (C<sub>Ar</sub>), 156.2 (C<sub>Ar</sub>), 153.4 (C<sub>Ar</sub>), 148.8 (C<sub>Ar</sub>), 140.7 (C<sub>Ar</sub>), 140.6 (C<sub>Ar</sub>), 138.6 (CH<sub>Ar</sub>), 136.7 (C<sub>Ar</sub>), 136.2 (CH<sub>Ar</sub>), 130.9 (CH<sub>Ar</sub>), 130.3 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.3 (CH<sub>Ar</sub>), 127.5 (CH<sub>Ar</sub>), 127.0 (CH<sub>Ar</sub>), 122.4 (C<sub>Ar</sub>), 121.5 (CH<sub>Ar</sub>), 119.1 (CH<sub>Ar</sub>), 117.4 (CH<sub>Ar</sub>), 112.4 (CH<sub>Ar</sub>), 104.4 (CH<sub>Ar</sub>), 67.7 (OCH<sub>2</sub>), 66.8 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 46.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.9 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.9 (CH<sub>2</sub>NHCbz), 38.4 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.4 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.2 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>42</sub>H<sub>41</sub>N<sub>7</sub>O<sub>4</sub>S 739.2941; found 739.2972 (4.21 ppm).</div></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> General Procedure for N-Cbz Deprotection</h4><div class="NLM_p last">A solution of the corresponding Cbz-protected compound (1 equiv) in a 1:1 mixture of THF/MeOH (20 mL) containing Pd/C (10%) (20% w/w) and TFA (0.5–1.5 mL) was hydrogenated at room temperature for 2 h under atmospheric pressure using a balloon filled with hydrogen gas (three cycles of vacuum + hydrogen). The Pd/C was filtered through Whatman poly(tetrafluoroethylene) (PTFE) filter paper, and the solvent was removed under reduced pressure and co-evaporated with mixtures of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (5 × 10 mL). The residue was purified by HPFC on an SP1 Isolera Biotage using reverse-phase columns (from 0% of CH<sub>3</sub>CN to 100% of CH<sub>3</sub>CN in 45 min) to afford to give the final deprotected compounds as trifluoroacetate salts.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(2-(5-(4-(4-Ammoniumbutyl)-1<i>H</i>-1,2,3-triazol-1-yl)-2-(4-phenethylthiazol-2-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>12a</b>)</h4><div class="NLM_p last">According to the general hydrogenolysis procedure, a solution of <b>11a</b> (55 mg, 0.08 mmol), in 1:1 THF/MeOH (20 mL) containing Pd/C (10%) (20% w/w) (18 mg) and TFA (0.5 mL), was hydrogenated. The residue was purified by HPFC on the SP1 Isolera Biotage using reverse-phase columns (from 0% of CH<sub>3</sub>CN to 100% of CH<sub>3</sub>CN in 45 min) to afford <b>12a (</b>19 mg, 35%) as a colorless oil. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ (ppm): 8.47 (s, 1H, Ar), 8.46 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.70 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.58 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H, Ar), 7.33–7.17 (m, 5H, Ar), 7.15 (s, 1H, Ar), 4.48 (t, <i>J</i> = 5.5 Hz, 2H, OCH<sub>2</sub>), 3.74 (t, <i>J</i> = 5.5 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.60 (dd, <i>J</i> = 9.3, 6.9 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.36 (dd, <i>J</i> = 9.3, 6.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.15–3.03 (m, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>Ph), 3.00 (t, <i>J</i> = 7.4 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.87 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.89–1.81 (m, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.81–1.70 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ (ppm): 165.1 (NHCON), 162.0 (OC<sub>Ar</sub>), 157.4 (C<sub>Ar</sub>), 157.1 (C<sub>Ar</sub>), 149.3 (C<sub>Ar</sub>), 142.8 (C<sub>Ar</sub>), 139.7 (C<sub>Ar</sub>), 130.8 (CH<sub>Ar</sub>), 129.5 (CH<sub>Ar</sub>), 129.4 (CH<sub>Ar</sub>), 127.0 (CH<sub>Ar</sub>), 123.8 (C<sub>Ar</sub>), 121.6 (CH<sub>Ar</sub>), 116.9 (CH<sub>Ar</sub>), 113.6 (CH<sub>Ar</sub>), 105.7 (CH<sub>Ar</sub>), 68.4 (OCH<sub>2</sub>), 47.0 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 43.9 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.4 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 39.3 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 36.7 (CH<sub>2</sub>CH<sub>2</sub>Ph), 34.3 (CH<sub>2</sub>CH<sub>2</sub>Ph), 28.0 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 27.1 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.6 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 7.1 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S 531.2416; found 531.2424 (1.35 ppm); anal. calcd for C<sub>28</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S·TFA: C, 55.80; H, 5.31; N, 15.18; S, 4.97; found: C, 55.94; H, 5.50; N, 15.08; S, 4.51.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(2-(5-(4-(4-Ammoniumbutyl)-1<i>H</i>-1,2,3-triazol-1-yl)-2-(4-(2-(naphthalen-2-yl)ethyl)thiazol-2-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>12b</b>)</h4><div class="NLM_p last">Following the deprotection procedure, compound <b>11b</b> (218 mg, 0.31 mmol), Pd/C (10%) (20% w/w) (44 mg), and TFA (1.3 mL) in a 1:1 mixture of THF/MeOH (30 mL) were hydrogenated. After the workup, the residue was purified by reverse phase on the Biotage to yield 51 mg (24%) of <b>12b</b> as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.77 (s, 1H, Ar), 8.49 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.89–7.66 (m, 8H, Ar, NH<sub>3</sub><sup>+</sup>), 7.52–7.34 (m, 3H, Ar), 7.34 (s, 1H, Ar), 4.47 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.63 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.48 (dd, <i>J</i> = 8.9 Hz, <i>J</i> = 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.33–3.04 (m, 6H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>, ThiazC<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 2.93–2.86 (m, 2H, ThiazCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 2.77 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.84–1.71 (m, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.67–1.56 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75 MHz) δ (ppm): 162.1 (NHCON), 159.4 (OC<sub>Ar</sub>), 155.6 (C<sub>Ar</sub>), 155.3 (C<sub>Ar</sub>), 147.7 (C<sub>Ar</sub>), 139.0 (C<sub>Ar</sub>), 137.9 (C<sub>Ar</sub>), 133.2 (CH<sub>Ar</sub>), 131.6 (C<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 127.7 (CH<sub>Ar</sub>), 127.4 (CH<sub>Ar</sub>), 127.3 (C<sub>Ar</sub>), 126.2 (CH<sub>Ar</sub>), 125.9 (CH<sub>Ar</sub>), 125.2 (CH<sub>Ar</sub>), 121.4 (CH<sub>Ar</sub>), 120.4 (CH<sub>Ar</sub>), 116.1 (CH<sub>Ar</sub>), 112.0 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.6 (OCH<sub>2</sub>), 45.3 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 34.9 (Thiaz<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 32.5 (ThiazCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 26.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.7 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.8 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 7.8 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O<sub>2</sub>S 581.2573; found 581.2572 (−0.13 ppm); anal. calcd for C<sub>32</sub>H<sub>35</sub>N<sub>7</sub>O<sub>2</sub>S·TFA: C, 58.69; H, 5.22; N, 14.09; S, 4.61; found: C, 58.20; H, 5.01; N, 14.09; S, 4.12.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(2-(2-(4-(2-([1,1′-Biphenyl]-4-yl)ethyl)thiazol-2-yl)-5-(4-(4-ammoniumbutyl)-1<i>H</i>-1,2,3-triazol-1-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>12c</b>)</h4><div class="NLM_p last">Following the hydrogenolysis procedure, compound <b>11c</b> (50 mg, 0.07 mmol), Pd/C (10%) (20% w/w) (10 mg), and TFA (0.5 mL) in a 1:1 mixture of THF/MeOH (20 mL) were hydrogenated. After the workup, the residue was purified by reverse phase on the Biotage to give <b>12c (</b>17 mg, 35%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ (ppm): 8.77 (s, 1H, Ar), 8.47 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.75 (d, <i>J</i> = 2.1 Hz, 1H, Ar), 7.69 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H, Ar), 7.66–7.62 (m, 2H, Ar), 7.60–7.56 (m, 2H, Ar), 7.48–7.39 (m, 3H, Ar), 7.38–7.29 (m, 3H, Ar), 6.41 (bs, 1H, NHCON), 4.47 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.63 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.49 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.21 (dd, <i>J</i> = 9.3, 6.5 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.17–2.96 (m, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>, ThiazC<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 2.74 (t, <i>J</i> = 7.4 Hz, 2H, TrizCH<sub>2</sub>), 2.69 (t, <i>J</i> = 7.2 Hz, 2H, ThiazCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.72 (quin, <i>J</i> = 7.6 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.58–1.42 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 159.4 (OC<sub>Ar</sub>), 155.6 (C<sub>Ar</sub>), 155.3 (C<sub>Ar</sub>), 148.1 (C<sub>Ar</sub>), 140.7 (C<sub>Ar</sub>), 140.0 (C<sub>Ar</sub>), 138.0 (C<sub>Ar</sub>), 137.8 (C<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 127.2 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 121.3 (C<sub>Ar</sub>), 120.3 (CH<sub>Ar</sub>), 116.0 (CH<sub>Ar</sub>), 112.0 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.6 (OCH<sub>2</sub>), 45.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 37.7 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 34.3 (Thiaz<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 32.5 (ThiazCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 30.1 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.9 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.7 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 8.4 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>34</sub>H<sub>37</sub>N<sub>7</sub>O<sub>2</sub>S 607.2729; found 607.2740 (1.73 ppm); anal. calcd for C<sub>34</sub>H<sub>37</sub>N<sub>7</sub>O<sub>2</sub>S·TFA: C, 59.91; H, 5.31; N, 13.58; S, 4.44; found: C, 60.08; H, 5.09; N, 13.18; S, 4.20.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Phosphonium (2-Oxo-3-phenylpropyl)triphenyl Chloride (<b>15</b>)</h4><div class="NLM_p last">A solution of 1-chloro-3-phenylpropan-2-one (250 mg, 1.48 mmol) and triphenylphosphine (583 mg, 2.22 mmol) in anhydrous toluene (8 mL) and under an argon atmosphere was heated to 110 °C for 6 h in a pressure tube. After cooling to room temperature, the white solid was filtered and washed with cooled diethyl ether (3 × 10 mL) to give <b>15</b> (498 mg, 78%) as a white solid;<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> m.p.: 200–202 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 7.93–7.64 (m, 15H, Ar), 7.31–7.20 (m, 3H, Ar), 7.12 (d, <i>J</i> = 6.7 Hz, 2H, Ar), 5.91 (d, <i>J</i> = 12.7 Hz, 2H, Ar), 4.14 (s, 2H, CH<sub>2</sub>CO).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>E</i>)-4-([1,1′-Biphenyl]-4-yl)-1-phenylbut-3-en-2-one (<b>16c</b>)</h4><div class="NLM_p last">A stirred solution of <b>15</b> (250 mg, 0.58 mmol) and KOH (130 mg, 2.37 mmol) in dry toluene (15 mL) was heated at 110 °C in a pressure flask for 3 h. After cooling to room temperature, [1,1′-biphenyl]-4-carboxaldehyde (158 mg, 0.87 mmol) was added dropwise. The reaction mixture was stirred at 110 °C for 3 additional hours, cooled, and evaporated under reduced pressure. The residue was dissolved in EtOAc (30 mL), washed with H<sub>2</sub>O (2 × 30 mL) and brine (1 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness. The residue was purified by flash column chromatography (hexane/EtOAc, 95:5) to yield <b>16c</b> (107 mg, 62%) as a white solid; m.p.: 121–126 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 7.59 (d, <i>J</i> = 16.1 Hz, 1H, C<u class="uu">H</u>═CHCO), 7.56–7.48 (m, 6H, Ar), 7.37 (t, <i>J</i> = 7.4 Hz, 2H, Ar), 7.34–7.25 (m, 3H, Ar), 7.24–7.15 (m, 3H, Ar), 6.74 (d, <i>J</i> = 16.0 Hz, 1H, CH═C<u class="uu">H</u>CO), 3.88 (s, 2H, CH<sub>2</sub>CO); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 197.4 (CO), 143.5 (Ar<u class="uu">C</u>H═CH), 143.1 (C<sub>Ar</sub>), 140.2 (CH<sub>Ar</sub>), 134.6 (C<sub>Ar</sub>), 133.5 (C<sub>Ar</sub>), 129.6 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.1 (C<sub>Ar</sub>), 127.7 (ArCH═<u class="uu">C</u>H), 127.2 (CH<sub>Ar</sub>), 127.1 (CH<sub>Ar</sub>), 125.1 (CH<sub>Ar</sub>), 48.6 (<u class="uu">C</u>H<sub>2</sub>CO); MS (ESI, positive mode) <i>m</i>/<i>z</i>: 321.0 [M + Na]<sup>+</sup>, 299.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-4-(4-Phenyloxyphenyl)-1-phenylbut-3-en-2-one (<b>16d</b>)</h4><div class="NLM_p last">Following a procedure similar to that described for <b>16c</b>, a solution of phosphonium salt <b>15</b> (700 mg, 1.62 mmol), KOH (728 mg, 13 mmol), and 4-phenoxybenzaldehyde (0.34 mL, 1.95 mmol) in dry toluene (20 mL) was reacted in a pressure flask. After the workup, the residue was purified by flash column chromatography (hexane/EtOAc, 95:5) to give 241 mg (47%) of <b>16d</b> as a white solid; m.p.: 95–97 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 7.51 (d, <i>J</i> = 16.0 Hz, 1H, C<u class="uu">H</u>═CHCO), 7.47–7.33 (m, 2H, Ar), 7.30–7.21 (m, 4H, Ar), 7.19–7.13 (m, 3H, Ar), 7.06 (tt, <i>J</i> = 7.4, 1.1 Hz, 1H, Ar), 6.97–6.90 (m, 2H, Ar), 6.89–6.83 (m, 2H, Ar), 6.60 (d, <i>J</i> = 16.0 Hz, 1H, CH═C<u class="uu">H</u>CO), 3.83 (s, 2H, CH<sub>2</sub>CO); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 197.3 (CO), 159.9 (OC<sub>Ar</sub>), 156.1 (OC<sub>Ar</sub>), 142.8 (Ar<u class="uu">C</u>H═CH), 134.7 (C<sub>Ar</sub>), 130.2 (CH<sub>Ar</sub>), 130.0 (CH<sub>Ar</sub>), 129.6 (CH<sub>Ar</sub>), 129.2 (C<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 127.1 (ArCH═<u class="uu">C</u>H), 124.3 (CH<sub>Ar</sub>), 124.0 (CH<sub>Ar</sub>), 119.8 (CH<sub>Ar</sub>), 118.5 (CH<sub>Ar</sub>), 48.5 (<u class="uu">C</u>H<sub>2</sub>CO); MS (ESI, positive mode) <i>m</i>/<i>z</i>: 337.0 [M + Na]<sup>+</sup>, 315.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> General Procedure for the Synthesis of α-Bromomethylketones <b>17a</b>–<b>d</b></h4><div class="NLM_p">To a solution of the corresponding ketone (1 equiv) in CH<sub>3</sub>CN, <i>p-</i>TsOH (1.3–2.6 equiv) and NBS (1.3–2.6 equiv) were successively added at room temperature and the mixture was stirred for 6 h/overnight. After quenching with H<sub>2</sub>O (30 mL), the reaction mixture was carefully concentrated under reduced pressure without heating. The aqueous crude was extracted with EtOAc (3 × 30 mL), and the organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to dryness. The residue was purified by flash column chromatography or CCTLC on the Chromatotron (the eluents are specified in each case) to give the desired α-bromoketones <b>17a</b>–<b>d</b>.</div><div id="sec4_1_13_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 2-([1,1′-Biphenyl]-4-yl)-1-bromo-1-phenylethan-2-one (<b>17a</b>)</h5><div class="NLM_p last">Following the general bromination procedure, <i>p-</i>TsOH (173 mg, 0.92 mmol) and NBS (165 mg, 0.92 mmol) were successively added to a solution of the commercially available <b>16a</b> (50 mg, 0.18 mmol) in CH<sub>3</sub>CN (15 mL). The reaction was stirred at room temperature overnight. After the workup, the residue was purified by CCTLC on the Chromatotron (hexane/EtOAc, 80:20) to give 62 mg (98%) of <b>17a</b> as a white solid; m.p.: decompose without melting; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.08 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 7.67 (d, <i>J</i> = 8.4 Hz, 2H, Ar), 7.63–7.54 (m, 4H, Ar), 7.47 (t, <i>J</i> = 7.5 Hz, 2H, Ar), 7.43–7.29 (m, 4H, Ar), 6.43 (s, 1H, BrCHCO).</div></div><div id="sec4_1_13_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 2-(4-Phenyloxyphenyl)-1-bromo-1-phenylethan-2-one (<b>17b</b>)</h5><div class="NLM_p last">The general bromination procedure was followed with the commercially available <b>16b</b> (150 mg, 0.52 mmol), <i>p-</i>TsOH (297 mg, 1.56 mmol), and NBS (278 mg, 1.56 mmol) in CH<sub>3</sub>CN (22 mL) at room temperature overnight. The residue was purified by CCTLC on the Chromatotron (hexane/CH<sub>2</sub>Cl<sub>2</sub>, 70:30) to afford <b>17b</b> (140 mg, 73%) as a white solid; m.p.: 116-118 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 7.97 (d, <i>J</i> = 8.9 Hz, 2H, Ar), 7.53 (dd, <i>J</i> = 8.1, 1.6 Hz, 2H, Ar), 7.44–7.29 (m, 5H, Ar), 7.22 (tt, <i>J</i> = 7.3, 1.0 Hz, 1H, Ar), 7.06 (dd, <i>J</i> = 7.9, 1.6 Hz, 2H, Ar), 6.96 (d, <i>J</i> = 8.9 Hz, 2H, Ar), 6.34 (s, 1H, BrCHCO); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 189.7 (CO), 162.7 (OC<sub>Ar</sub>), 155.1 (OC<sub>Ar</sub>), 136.2 (C<sub>Ar</sub>), 131.7 (CH<sub>Ar</sub>), 130.3 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 128.5 (C<sub>Ar</sub>), 125.1 (CH<sub>Ar</sub>), 120.6 (CH<sub>Ar</sub>), 117.4 (CH<sub>Ar</sub>), 51.2 (Br<u class="uu">C</u>HCO); MS (ESI, positive mode) <i>m</i>/<i>z</i>: 389 [M + Na]<sup>+</sup> with a Br isotopic pattern.</div></div><div id="sec4_1_13_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>E</i>)-4-([1,1′-Biphenyl]-4-yl)-1-bromo-1-phenylbut-3-en-2-one (<b>17c</b>)</h5><div class="NLM_p last">Following the general procedure, compound <b>16c</b> (200 mg, 0.67 mmol) dissolved in CH<sub>3</sub>CN (25 mL) was sequentially treated with <i>p-</i>TsOH (191 mg, 1.00 mmol) and NBS (179 mg, 1.00 mmol) at room temperature for 4 h. After the workup, the residue was purified by flash column chromatography (hexane/EtOAc, 90:10) to give <b>17c</b> (253 mg, 79%) as a white solid; m.p.: 118–120 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 7.71 (d, <i>J</i> = 15.8 Hz, 1H, C<u class="uu">H</u>═CHCO), 7.56–7.49 (m, 6H, Ar), 7.47–7.42 (m, 2H, Ar), 7.41–7.34 (m, 2H, Ar), 7.35–7.24 (m, 4H, Ar), 6.94 (d, <i>J</i> = 15.8 Hz, 1H, CH═C<u class="uu">H</u>CO), 5.61 (s, 1H, BrCHCO); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 190.4 (CO), 145.0 (Ar<u class="uu">C</u>H═CH), 143.9 (C<sub>Ar</sub>), 140.1 (CH<sub>Ar</sub>), 135.4 (C<sub>Ar</sub>), 133.2 (C<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 128.1 (C<sub>Ar</sub>), 127.7 (ArCH═<u class="uu">C</u>H), 127.2 (CH<sub>Ar</sub>), 127.1 (CH<sub>Ar</sub>), 121.4 (CH<sub>Ar</sub>), 55.5 (Br<u class="uu">C</u>HCO).</div></div><div id="sec4_1_13_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (<i>E</i>)-4-(4-Phenyloxyphenyl)-1-phenylbut-3-en-2-one (<b>17d</b>)</h5><div class="NLM_p last">According to the general bromination procedure, the α,β-unsaturated compound <b>16d</b> (211 mg, 0.67 mmol), <i>p-</i>TsOH (140 mg, 0.74 mmol), and NBS (131 mg, 0.74 mmol) dissolved in CH<sub>3</sub>CN (25 mL) were reacted at room temperature for 4 h. After the workup, the crude was purified by flash column chromatography (hexane/EtOAc, 97:3) to give <b>17d</b> (150 mg, 39%) as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 7.72 (d, <i>J</i> = 15.7 Hz, 1H, C<u class="uu">H</u>═CHCO), 7.56–7.47 (m, 4H, Ar), 7.43–7.32 (m, 5H, Ar), 7.18 (tt, <i>J</i> = 7.4, 1.1 Hz, 1H, Ar), 7.10–7.01 (m, 2H, Ar), 6.97 (d, <i>J</i> = 8.8 Hz, 2H, Ar), 6.89 (d, <i>J</i> = 15.7 Hz, 1H, CH═C<u class="uu">H</u>CO), 5.66 (s, 1H, BrCHCO); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 190.4 (CO), 160.4 (OC<sub>Ar</sub>), 156.0 (OC<sub>Ar</sub>), 144.8 (Ar<u class="uu">C</u>H═CH), 135.5 (C<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 130.1 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.1 (C<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 128.9 (ArCH═<u class="uu">C</u>H), 124.5 (CH<sub>Ar</sub>), 120.2 (CH<sub>Ar</sub>), 120.0 (CH<sub>Ar</sub>), 118.5 (CH<sub>Ar</sub>), 55.5 (Br<u class="uu">C</u>HCO); MS (ESI, positive mode) <i>m</i>/<i>z</i>: 417.0 [M + Na]<sup>+</sup>, 393.0 [M + H]<sup>+</sup> with a Br isotopic pattern.</div></div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Benzyl-(4-(1-(4-(4,5-diphenylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>18a</b>)</h4><div class="NLM_p last">Following the general procedure of Hantzsch synthesis, the thioamide <b>9</b> (150 mg, 0.28 mmol) and the commercially available 1-bromo-1,2-diphenylethan-2-one <b>17e</b> (77 mg, 0.28 mmol) reacted in <i><sup>i</sup></i>PrOH (20 mL). After the workup, the final residue was purified by CCTLC in the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 97:3) to provide 191 mg (94%) of <b>18a</b> as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.62 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.89 (s, 1H, Ar), 7.64–7.57 (m, 3H, Ar), 7.44–7.23 (m, 14H, Ar), 5.19 (t, <i>J</i> = 6.0 Hz, 1H, NHCbz), 5.08 (s, 2H, NHCOOC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 4.87 (bs, 1H, NHCON), 4.44 (t, <i>J</i> = 5.9 Hz, 2H, OCH<sub>2</sub>), 3.75 (t, <i>J</i> = 5.8 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.57 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.29 (t, <i>J</i> = 8.0 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.25 (q, <i>J</i> = 6.9 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.82 (t, <i>J</i> = 7.4 Hz, 2H, TrizCH<sub>2</sub>), 1.84–1.71 (m, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.62 (quin, <i>J</i> = 6.2 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.2 (NHCON), 158.3 (OC<sub>Ar</sub>), 156.6 (C<sub>Ar</sub>), 155.9 (C<sub>Ar</sub>), 149.3 (C<sub>Ar</sub>), 148.7 (C<sub>Ar</sub>), 138.4 (C<sub>Ar</sub>), 136.7 (C<sub>Ar</sub>), 135.1 (C<sub>Ar</sub>), 134.3 (C<sub>Ar</sub>), 132.2 (CH<sub>Ar</sub>), 129.7 (CH<sub>Ar</sub>), 129.6 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 128.8 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.4 (CH<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 127.9 (C<sub>Ar</sub>), 122.5 (CH<sub>Ar</sub>), 119.1 (CH<sub>Ar</sub>), 112.4 (CH<sub>Ar</sub>), 104.4 (CH<sub>Ar</sub>), 67.7 (OCH<sub>2</sub>), 66.7 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 46.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.9 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.8 (CH<sub>2</sub>NHCbz), 38.4 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.3 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.2 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>39</sub>N<sub>7</sub>O<sub>4</sub>S 713.2784; found 713.2786 (0.23 ppm).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Benzyl-(4-(1-(3-(2-(2-oxoimidazolidin-1-yl)ethoxy)-4-(4-([1,1′-biphenyl]-4-yl)-5-phenylthiazol-2-yl)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>18b</b>)</h4><div class="NLM_p last">Following the general procedure for the synthesis of thiazoles by Hantzsch cyclization, thioamide <b>9</b> (194 mg, 0.36 mmol) reacted with α-bromoketone <b>17a</b> (127 mg, 0.36 mmol) in <i><sup>i</sup></i>PrOH (20 mL). After the workup, the residue was purified by CCTLC on the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5) to give <b>18b</b> (244 mg, 84%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.66 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.60 (s, 1H, Ar), 7.71 (d, <i>J</i> = 8.1 Hz, 2H, Ar), 7.65–7.51 (m, 3H, Ar), 7.56 (d, <i>J</i> = 8.1 Hz, 2H, Ar), 7.52–7.18 (m, 14H, Ar), 5.13 (bs, 1H, NHCON), 5.10 (s, 2H, NCOOCH<sub>2</sub>), 4.67 (bs, 1H, NHCbz), 4.47 (t, <i>J</i> = 5.9 Hz, 2H, OCH<sub>2</sub>), 3.78 (t, <i>J</i> = 5.9 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.59 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.37–3.22 (m, 4H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.84 (t, <i>J</i> = 7.3 Hz, 2H, TrizCH<sub>2</sub>), 1.86–1.74 (m, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.64 (quin, <i>J</i> = 7.2 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.7 (NHCON), 158.4 (OC<sub>Ar</sub>), 156.6 (C<sub>Ar</sub>), 156.0 (NHCOO), 149.0 (C<sub>Ar</sub>), 148.8 (C<sub>Ar</sub>), 140.8 (C<sub>Ar</sub>), 140.5 (C<sub>Ar</sub>), 138.5 (C<sub>Ar</sub>), 136.7 (C<sub>Ar</sub>), 134.4 (C<sub>Ar</sub>), 134.1 (CH<sub>Ar</sub>), 132.3 (C<sub>Ar</sub>), 129.8 (CH<sub>Ar</sub>), 129.5 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.3 (CH<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 127.5 (C<sub>Ar</sub>), 127.1 (CH<sub>Ar</sub>), 122.5 (CH<sub>Ar</sub>), 119.2 (C<sub>Ar</sub>), 112.5 (CH<sub>Ar</sub>), 104.5 (CH<sub>Ar</sub>), 67.7 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 66.8 (OCH<sub>2</sub>), 46.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.9 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.9 (CH<sub>2</sub>NHCbz), 38.4 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.4 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.2 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>46</sub>H<sub>43</sub>N<sub>7</sub>O<sub>4</sub>S 789.3097; found 789.3063 (−4.31 ppm).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Benzyl-(4-(1-(3-(2-(2-oxoimidazolidin-1-yl)ethoxy)-4-(4-(4-phenyloxyphenyl-1-yl)-5-phenylthiazol-2-yl)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>18c</b>)</h4><div class="NLM_p last">Following the general procedure for the synthesis of thiazoles by Hantzsch cyclization, thioamide <b>9</b> (190 mg, 0.35 mmol) and α-bromoketone <b>17b</b> (130 mg, 0.35 mmol) reacted in <i><sup>i</sup></i>PrOH (20 mL). The final residue was purified by CCTLC in the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5) to yield 235 mg (81%) of <b>18c</b> a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.63 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.90 (s, 1H, Ar), 7.65–7.55 (m, 3H, Ar), 7.47–7.24 (m, 13H, Ar), 7.11 (t, <i>J</i> = 7.4 Hz, 1H, Ar), 7.04 (d, <i>J</i> = 8.0 Hz, 2H, Ar), 6.95 (d, <i>J</i> = 8.3 Hz, 2H, Ar), 5.14 (bs, 1H, NHCON), 5.09 (s, 2H, NCOOCH<sub>2</sub>), 4.73 (bs, 1H, NHCbz), 4.46 (t, <i>J</i> = 5.9 Hz, 2H, OCH<sub>2</sub>), 3.77 (t, <i>J</i> = 5.9 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.59 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.37–3.21 (m, 4H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.84 (t, <i>J</i> = 7.3 Hz, 2H, TrizCH<sub>2</sub>), 1.84–1.74 (m, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.63 (quin, <i>J</i> = 7.2 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 75 MHz) δ (ppm): 162.7 (NHCON), 158.3 (OC<sub>Ar</sub>), 157.2 (C<sub>Ar</sub>), 157.0 (OC<sub>Ar</sub>), 156.6 (OC<sub>Ar</sub>), 156.0 (NHCOO), 148.8 (C<sub>Ar</sub>), 138.5 (C<sub>Ar</sub>), 136.7 (C<sub>Ar</sub>), 133.7 (C<sub>Ar</sub>), 132.3 (C<sub>Ar</sub>), 130.7 (CH<sub>Ar</sub>), 130.1 (C<sub>Ar</sub>), 129.9 (CH<sub>Ar</sub>), 129.7 (CH<sub>Ar</sub>), 129.7 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.2 (C<sub>Ar</sub>), 128.2 (CH<sub>Ar</sub>), 123.6 (CH<sub>Ar</sub>), 122.5 (C<sub>Ar</sub>), 119.3 (CH<sub>Ar</sub>), 119.1 (C<sub>Ar</sub>), 118.6 (CH<sub>Ar</sub>), 112.5 (CH<sub>Ar</sub>), 104.5 (CH<sub>Ar</sub>), 67.7 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 66.8 (OCH<sub>2</sub>), 46.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.9 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.9 (CH<sub>2</sub>NHCbz), 38.4 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 29.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.3 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.2 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>46</sub>H<sub>43</sub>N<sub>7</sub>O<sub>5</sub>S 805.3046; found 805.3054 (0.92 ppm).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Benzyl-(<i>E</i>)-(4-(1-(4-(4-(2-([1,1′-biphenyl]-4-yl)vinyl)-5-phenylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy) phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>18d</b>)</h4><div class="NLM_p last">Following the general Hantzsch cyclization procedure, thioamide <b>9</b> (200 mg, 0.37 mmol) and α-bromoketone <b>17c</b> (140 mg, 0.37 mmol) reacted in <i><sup>i</sup></i>PrOH (20 mL). After the workup, the residue was purified by CCTLC on the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 95:5) to give <b>18d</b> (183 mg, 59%) as a yellow oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.72 (s, 1H, Ar), 8.61 (d, <i>J</i> = 8.4 Hz, 1H, Ar), 7.80–7.71 (m, 3H, Ar, ThiazCH═C<u class="uu">H</u>), 7.70–7.53 (m, 10H, Ar), 7.51–7.42 (m, 3H, Ar), 7.39–7.27 (m, 3H, Ar, NHCbz), 7.24 (d, <i>J</i> = 15.7 Hz, 1H, ThiazC<u class="uu">H</u>═CH), 6.42 (bs, 1H, NHCON), 5.02 (s, 2H, NHCOOCH<sub>2</sub>), 4.48 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.66 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.49 (dd, <i>J</i> = 9.0, 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.23 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.08 (q, <i>J</i> = 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.72 (t, <i>J</i> = 7.1 Hz, 2H, TrizCH<sub>2</sub>), 1.70 (quin, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.52 (quin, <i>J</i> = 7.2 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75 MHz) δ (ppm): 161.8 (NHCON), 158.0 (OC<sub>Ar</sub>), 155.8 (NHCOO), 147.9 (C<sub>Ar</sub>), 146.6 (C<sub>Ar</sub>), 139.4 (C<sub>Ar</sub>), 139.3 (C<sub>Ar</sub>), 138.3 (C<sub>Ar</sub>), 137.1 (C<sub>Ar</sub>), 135.8 (C<sub>Ar</sub>), 135.0 (C<sub>Ar</sub>), 131.6 (C<sub>Ar</sub>), 130.9 (CH<sub>Ar</sub>), 129.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.6 (CH<sub>Ar</sub>), 128.0 (C<sub>Ar</sub>), 128.0 (CH<sub>Ar</sub>), 127.4 (CH<sub>Ar</sub>), 127.3 (C<sub>Ar</sub>), 127.2 (CH<sub>Ar</sub>), 126.9 (CH<sub>Ar</sub>), 126.7 (C<sub>Ar</sub>), 126.2 (CH<sub>Ar</sub>), 120.9 (CH<sub>Ar</sub>), 119.9 (CH<sub>Ar</sub>), 119.5 (C<sub>Ar</sub>), 112.0 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.3 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 64.9 (OCH<sub>2</sub>), 45.0 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.3 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 39.9 (CH<sub>2</sub>NHCbz), 37.3 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 28.7 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 25.8 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.5 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>48</sub>H<sub>45</sub>N<sub>7</sub>O<sub>4</sub>S 815.3254; found 815.3266 (1.56 ppm).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Benzyl-(<i>E</i>)-(4-(1-(4-(4-(2-([4-phenyloxyphenyl]-1-yl)vinyl)-5-phenylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1<i>H</i>-1,2,3-triazol-4-yl)butyl)carbamate (<b>18e</b>)</h4><div class="NLM_p last">According to the general Hantzsch procedure, thioamide <b>9</b> (183 mg, 0.34 mmol) was reacted with α-bromoketone <b>17d</b> (134 mg, 0.34 mmol) in <i><sup>i</sup></i>PrOH (23 mL). After purification of the residue by CCTLC on the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 96:4), <b>18e</b> (150 mg, 52%) was obtained as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.74 (s, 1H, Ar), 8.61 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.85–7.67 (m, 3H, Ar, ThiazCH═C<u class="uu">H</u>), 7.64–7.51 (m, 5H, Ar), 7.51–7.24 (m, 9H, Ar), 7.20–7.10 (m, 2H, Ar, ThiazC<u class="uu">H</u>═CH), 7.05 (d, <i>J</i> = 7.7 Hz, 2H, Ar), 7.00 (d, <i>J</i> = 8.6 Hz, 2H, Ar), 6.40 (bs, 1H, NHCON), 5.01 (s, 2H, NHCOOCH<sub>2</sub>), 4.49 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.66 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.49 (dd, <i>J</i> = 9.0, 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.22 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.07 (q, <i>J</i> = 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.74 (t, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>), 1.69 (quin, <i>J</i> = 7.5 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.53 (quin, <i>J</i> = 7.2 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 75 MHz) δ (ppm): 162.1 (NHCON), 158.1 (C<sub>Ar</sub>), 156.6 (OC<sub>Ar</sub>), 156.3 (OC<sub>Ar</sub>), 156.1 (OC<sub>Ar</sub>), 156.0 (NHCOO), 148.1 (C<sub>Ar</sub>), 146.7 (OC<sub>Ar</sub>), 138.4 (C<sub>Ar</sub>), 137.3 (C<sub>Ar</sub>), 134.8 (C<sub>Ar</sub>), 132.0 (C<sub>Ar</sub>), 131.6 (C<sub>Ar</sub>), 131.1 (C<sub>Ar</sub>), 130.1 (C<sub>Ar</sub>), 129.4 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 128.4 (CH<sub>Ar</sub>), 128.3 (CH<sub>Ar</sub>), 127.7 (CH<sub>Ar</sub>), 123.7 (CH<sub>Ar</sub>), 120.9 (CH<sub>Ar</sub>), 120.3 (C<sub>Ar</sub>), 118.9 (CH<sub>Ar</sub>), 118.7 (CH<sub>Ar</sub>), 112.0 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.4 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 65.1 (OCH<sub>2</sub>), 45.1 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.0 (CH<sub>2</sub>NHCbz), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 28.9 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.0 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.7 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>48</sub>H<sub>45</sub>N<sub>7</sub>O<sub>5</sub>S 831.3203; found 831.3174 (−3.45 ppm).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(2-(5-(4-(4-Ammoniobutyl)-1<i>H</i>-1,2,3-triazol-1-yl)-2-(4,5-diphenylthiazol-2-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>19a</b>)</h4><div class="NLM_p last">Following the general Cbz removal procedure, <b>18a</b> (100 mg, 0.14 mmol), Pd/C 10% (20 mg) and TFA (1 mL) afforded, after purification, compound <b>19a</b> (25 mg, 26%) as a colorless oil. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ (ppm): 8.56 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 8.46 (s, 1H, Ar), 7.71 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 7.59 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H, Ar), 7.56–7.51 (m, 2H, Ar), 7.44–7.27 (m, 8H, Ar), 4.51 (t, <i>J</i> = 5.5 Hz, 2H, OCH<sub>2</sub>), 3.76 (t, <i>J</i> = 5.5 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.62 (dd, <i>J</i> = 9.3, 6.9 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.32 (dd, <i>J</i> = 9.3, 6.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.00 (q, <i>J</i> = 6.5 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.86 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.95–1.65 (m, 4H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (CD<sub>3</sub>OD, 75 MHz) δ (ppm): 165.0 (NHCON), 159.9 (OC<sub>Ar</sub>), 157.5 (C<sub>Ar</sub>), 150.6 (C<sub>Ar</sub>), 149.3 (C<sub>Ar</sub>), 139.8 (C<sub>Ar</sub>), 136.4 (C<sub>Ar</sub>), 135.8 (C<sub>Ar</sub>), 133.3 (CH<sub>Ar</sub>), 130.6 (CH<sub>Ar</sub>), 130.5 (CH<sub>Ar</sub>), 130.3 (CH<sub>Ar</sub>), 129.9 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 123.7 (CH<sub>Ar</sub>), 121.6 (CH<sub>Ar</sub>), 113.6 (CH<sub>Ar</sub>), 105.6 (CH<sub>Ar</sub>), 68.2 (OCH<sub>2</sub>), 46.9 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 43.9 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 40.4 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 39.3 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 28.0 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 27.1 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 25.6 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 9.3 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>33</sub>N<sub>7</sub>O<sub>2</sub>S 579.2416; found 579.242 (0.61 ppm); anal. calcd for C<sub>32</sub>H<sub>34</sub>N<sub>7</sub>O<sub>2</sub>S·TFA: C, 58.87; H, 4.94; N, 14.13; S, 4.62; found: C, 59.15; H, 5.36 N, 14.62; S, 5.03.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-(2-(5-(4-(4-Ammoniobutyl)-1<i>H</i>-1,2,3-triazol-1-yl)-2-(4-([1,1′-biphenyl]-4-yl)-5-phenylthiazol-2-yl)phenoxy) ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>19b</b>)</h4><div class="NLM_p last">The general N-deprotection procedure described for <b>12a</b>–<b>c</b> was followed with <b>18b</b> (100 mg, 0.13 mmol), Pd/C 10% (20 mg), and TFA (0.8 mL) to give, after workup and purification, compound <b>19b</b> (15 mg, 15%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.79 (s, 1H, Ar), 8.57 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.80 (d, <i>J</i> = 8.1 Hz, 1H, Ar), 7.77–7.60 (m, 10H, Ar, NH<sub>3</sub><sup>+</sup>), 7.54–7.41 (m, 7H, Ar), 7.37 (t, <i>J</i> = 7.5 Hz, 1H, Ar), 6.40 (bs, 1H, NHCON), 4.53 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>), 3.66 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.51 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.23 (t, <i>J</i> = 7.8 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 2.85 (t, <i>J</i> = 7.5 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.78 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.76 (quin, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.63 (quin, <i>J</i> = 7.8 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 157.9 (OC<sub>Ar</sub>), 155.8 (C<sub>Ar</sub>), 148.0 (C<sub>Ar</sub>), 147.7 (C<sub>Ar</sub>), 139.4 (C<sub>Ar</sub>), 139.4 (C<sub>Ar</sub>), 138.3 (C<sub>Ar</sub>), 133.9 (C<sub>Ar</sub>), 133.7 (C<sub>Ar</sub>), 131.5 (CH<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.1 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 128.8 (CH<sub>Ar</sub>), 128.5 (CH<sub>Ar</sub>), 127.6 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 121.1 (CH<sub>Ar</sub>), 120.4 (C<sub>Ar</sub>), 112.1 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.4 (OCH<sub>2</sub>), 45.1 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 38.6 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 26.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.5 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.4 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 9.3 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>38</sub>H<sub>37</sub>N<sub>7</sub>O<sub>2</sub>S 655.2729; found 655.2748 (2.87 ppm); anal. calcd for C<sub>38</sub>H<sub>38</sub>N<sub>7</sub>O<sub>2</sub>S·TFA: C, 62.41; H, 4.98; N, 12.74; S, 4.16; found: C, 62.36; H, 5.06; N, 12.37; S, 4.25.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(2-(5-(4-(4-Ammoniobutyl)-1<i>H</i>-1,2,3-triazol-1-yl)-2-(4-([4-phenyloxyphenyl]-1-yl)-5-phenylthiazol-2-yl) phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>19c</b>)</h4><div class="NLM_p last">Following the general Cbz deprotection procedure, <b>18c</b> (120 mg, 0.15 mmol), Pd/C 10% (24 mg), and TFA (0.9 mL) were reacted. Workup and purification yielded <b>19c</b> (44 mg, 37%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.78 (s, 1H, Ar), 8.53 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.79 (d, <i>J</i> = 2.1 Hz, 1H, Ar), 7.83–7.72 (m, 3H, NH<sub>3</sub><sup>+</sup>), 7.71 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H, Ar), 7.56 (d, <i>J</i> = 8.7 Hz, 2H, Ar), 7.50–7.32 (m, 7H, Ar), 7.17 (t, <i>J</i> = 7.4 Hz, 1H, Ar), 7.06 (d, <i>J</i> = 7.9 Hz, 2H, Ar), 6.98 (d, <i>J</i> = 8.7 Hz, 2H, Ar), 6.39 (bs, 1H, NHCON), 4.51 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>), 3.65 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.50 (dd, <i>J</i> = 9.0, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.22 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 2.91–2.80 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.77 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.76 (quin, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.64 (quin, <i>J</i> = 8.1 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 158.1 (CF<sub>3</sub><u class="uu">C</u>OO<sup>–</sup>), 157.8 (C<sub>Ar</sub>), 156.5 (OC<sub>Ar</sub>), 156.2 (OC<sub>Ar</sub>), 155.5 (OC<sub>Ar</sub>), 147.9 (C<sub>Ar</sub>), 147.7 (C<sub>Ar</sub>), 138.3 (C<sub>Ar</sub>), 133.3 (C<sub>Ar</sub>), 131.5 (C<sub>Ar</sub>), 130.4 (CH<sub>Ar</sub>), 130.1 (CH<sub>Ar</sub>), 129.8 (CH<sub>Ar</sub>), 129.2 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 128.8 (CH<sub>Ar</sub>), 128.3 (C<sub>Ar</sub>), 123.8 (CH<sub>Ar</sub>), 121.1 (C<sub>Ar</sub>), 120.4 (CH<sub>Ar</sub>), 119.0 (CH<sub>Ar</sub>), 118.1 (CH<sub>Ar</sub>), 115.8 (<u class="uu">C</u>F<sub>3</sub>COO<sup>–</sup>), 112.1 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.3 (OCH<sub>2</sub>), 45.1 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 38.6 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 26.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.5 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.4 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 9.8 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>38</sub>H<sub>37</sub>N<sub>7</sub>O<sub>3</sub>S 671.2679; found 671.2673 (−0.81 ppm); anal. calcd for C<sub>38</sub>H<sub>38</sub>N<sub>7</sub>O<sub>3</sub>S·TFA: C, 61.14; H, 4.87; N, 12.48; S, 4.08; found: C, 61.55; H, 4.99; N, 12.12; S, 4.34.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-(2-(2-(4-(2-([1,1′-Biphenyl]-4-yl)ethyl)-5-phenyl-thiazol-2-yl)-5-(4-(4-ammoniobutyl)-1<i>H</i>-1,2,3-triazol-1-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>19d</b>)</h4><div class="NLM_p last">Following the general hydrogenation procedure, a solution of <b>18d</b> (91 mg, 0.11 mmol), Pd/C 10% (18 mg), and TFA (0.7 mL) was reacted to give, after purification, <b>19d</b> (14 mg, 16%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.78 (s, 1H, Ar), 8.54 (d, <i>J</i> = 8.6 Hz, 1H, Ar), 7.78 (d, <i>J</i> = 2.1 Hz, 1H, Ar), 7.72 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H, Ar), 7.73–7.65 (m, 3H, NH<sub>3</sub><sup>+</sup>), 7.62 (d, <i>J</i> = 7.2 Hz, 2H, Ar), 7.54 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 7.49–7.38 (m, 7H, Ar), 7.33 (tt, <i>J</i> = 7.4, 1.3 Hz, 1H, Ar), 7.26 (d, <i>J</i> = 8.2 Hz, 2H, Ar), 6.39 (bs, 1H, NHCON), 4.50 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>), 3.65 (t, <i>J</i> = 5.6 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.49 (dd, <i>J</i> = 8.9, 6.7 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.21 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.16–3.12 (m, 4H, ThiazC<u class="uu">H</u><sub><u class="uu">2</u></sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 2.85 (t, <i>J</i> = 7.5 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.78 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.76 (quin, <i>J</i> = 7.6 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.63 (quin, <i>J</i> = 7.5 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 157.4 (C<sub>Ar</sub>), 155.6 (OC<sub>Ar</sub>), 150.1 (C<sub>Ar</sub>), 147.7 (C<sub>Ar</sub>), 140.7 (C<sub>Ar</sub>), 140.1 (C<sub>Ar</sub>), 138.1 (C<sub>Ar</sub>), 137.9 (C<sub>Ar</sub>), 133.4 (C<sub>Ar</sub>), 131.4 (C<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.8 (CH<sub>Ar</sub>), 128.0 (CH<sub>Ar</sub>), 127.2 (CH<sub>Ar</sub>), 126.6 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 121.3 (C<sub>Ar</sub>), 120.4 (CH<sub>Ar</sub>), 112.1 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.4 (OCH<sub>2</sub>), 45.2 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 38.7 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 34.6 (Thiaz<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 31.2 (ThiazCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 26.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.6 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.4 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 9.8 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>41</sub>N<sub>7</sub>O<sub>2</sub>S 683.3042; found 683.3050 (1.06 ppm); anal. calcd for C<sub>40</sub>H<sub>42</sub>N<sub>7</sub>O<sub>2</sub>S·TFA: C, 63.22; H, 5.31; N, 12.29; S, 4.02; found: C, 63.40; H, 5.64; N, 12.50; S, 3.93.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(2-(2-(4-(2-([4-Phenyloxyphenyl]-1-yl)ethyl)-5-phenyl-thiazol-2-yl)-5-(4-(4-ammoniobutyl)-1<i>H</i>-1,2,3-triazol-1-yl)phenoxy)ethyl)imidazolidin-2-one 2,2,2-Trifluoroacetate (<b>19e</b>)</h4><div class="NLM_p last">Following the general Cbz deprotection procedure, reaction of <b>18e</b> (80 mg, 0.10 mmol), Pd/C 10% (16 mg), and TFA (0.6 mL) afforded <b>19e</b> (20 mg, 26%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.78 (s, 1H, Ar), 8.56–8.50 (m, 1H, Ar), 7.77 (d, <i>J</i> = 2.0 Hz, 1H, Ar), 7.81–7.64 (m, 4H, Ar, NH<sub>3</sub><sup>+</sup>), 7.62 (d, <i>J</i> = 7.2 Hz, 1H, Ar), 7.54 (d, <i>J</i> = 8.1 Hz, 1H, Ar), 7.50–7.31 (m, 7H, Ar), 7.26 (d, <i>J</i> = 7.9 Hz, 1H, Ar), 7.16 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 7.10 (t, <i>J</i> = 7.4 Hz, 1H, Ar), 6.94 (d, <i>J</i> = 8.0 Hz, 1H, Ar), 6.90 (d, <i>J</i> = 8.5 Hz, 1H, Ar), 6.39 (bs, 1H, NHCON), 4.49 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>), 3.64 (t, <i>J</i> = 5.7 Hz, 2H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.48 (dd, <i>J</i> = 9.0, 6.6 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.21 (t, <i>J</i> = 7.9 Hz, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.15–3.06 (m, 4H, ThiazC<u class="uu">H</u><sub><u class="uu">2</u></sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 2.85 (t, <i>J</i> = 7.5 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.78 (t, <i>J</i> = 7.2 Hz, 2H, TrizCH<sub>2</sub>), 1.75 (quin, <i>J</i> = 7.4 Hz, 2H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.64 (quin, <i>J</i> = 7.0 Hz, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 157.3 (C<sub>Ar</sub>), 157.1 (C<sub>Ar</sub>), 155.6 (OC<sub>Ar</sub>), 154.6 (C<sub>Ar</sub>), 150.0 (C<sub>Ar</sub>), 147.7 (C<sub>Ar</sub>), 140.7 (C<sub>Ar</sub>), 138.1 (C<sub>Ar</sub>), 137.9 (C<sub>Ar</sub>), 136.6 (C<sub>Ar</sub>), 133.4 (C<sub>Ar</sub>), 131.4 (CH<sub>Ar</sub>), 129.9 (CH<sub>Ar</sub>), 129.8 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 129.0 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.9 (CH<sub>Ar</sub>), 128.0 (CH<sub>Ar</sub>), 126.6 (CH<sub>Ar</sub>), 126.5 (CH<sub>Ar</sub>), 123.1 (CH<sub>Ar</sub>), 121.3 (C<sub>Ar</sub>), 118.8 (CH<sub>Ar</sub>), 118.1 (CH<sub>Ar</sub>), 112.1 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.4 (OCH<sub>2</sub>), 45.2 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 38.7 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.5 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 34.6 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>PhOPh), 31.2 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>PhOPh), 26.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.6 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.4 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 9.7 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>40</sub>H<sub>41</sub>N<sub>7</sub>O<sub>3</sub>S 699.2992; found 699.2993 (0.17 ppm); anal. calcd for C<sub>40</sub>H<sub>42</sub>N<sub>7</sub>O<sub>3</sub>S·TFA: C, 61.98; H, 5.20; N, 12.05; S, 3.94; found: C, 62.23; H, 5.34; N, 11.68; S, 3.50.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(3-(2-Bromo)acetylphenyl)-2-bromoethan-1-one (<b>20</b>)</h4><div class="NLM_p last">Following the general procedure described for the synthesis α-bromomethylketones <b>17a</b>–<b>e</b>, <i>p</i>-toluensulfonic acid (761 mg, 4.00 mmol) and NBS (713 mg, 4.00 mmol) were successively added to a solution of commercially available diacetyl benzene (250 mg, 1.54 mmol) in CH<sub>3</sub>CN (20 mL) and stirred at room temperature overnight. After the workup, the residue was purified by flash column chromatography (hexane/EtOAc, 90:10) to give <b>20</b> (366 mg, 74%) as a white solid.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> m.p.: 87–88 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ (ppm): 8.55 (t, <i>J</i> = 1.8 Hz, 1H, Ar), 7.20 (dd, <i>J</i> = 7.8, 1.8 Hz, 2H, Ar), 7.64 (t, <i>J</i> = 7.8 Hz, 1H, Ar), 4.78 (s, 4H, BrCH<sub>2</sub>CO).</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Dibenzyl-((((1,3-phenylenebis(thiazole-4,2-diyl))bis(3-(2-(2-oxoimidazolidin-1-yl)ethoxy)-4,1-phenylene))bis(1<i>H</i>-1,2,3-triazole-1,4-diyl))bis(butane-4,1-diyl))dicarbamate (<b>21</b>)</h4><div class="NLM_p last">Following the general procedure of Hantzsch synthesis, <b>9</b> (100 mg, 0.19 mmol) was reacted with α-bromoketone <b>20</b> (30 mg, 0.09 mmol) in <i><sup>i</sup></i>PrOH (15 mL). After the workup, the residue was purified by CCTLC on the Chromatotron (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 96:4) to give <b>21</b> (68 mg, 30%) as a pink oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.75 (s, 2H, Ar), 8.68 (d, <i>J</i> = 8.5 Hz, 2H, Ar), 8.37 (s, 2H, Ar), 8.12 (dd, <i>J</i> = 7.6, 1.7 Hz, 2H, Ar), 7.79 (d, <i>J</i> = 2.0 Hz, 2H, Ar), 7.75 (dd, <i>J</i> = 8.7, 1.8 Hz, 2H, Ar), 7.60 (t, <i>J</i> = 7.7 Hz, 1H, Ar), 7.46–7.10 (m, 12H, Ar, NHCbz), 6.42 (s, 2H, NHCON), 5.01 (s, 4H, NHCOOCH<sub>2</sub>), 4.52 (t, <i>J</i> = 5.6 Hz, 4H, OCH<sub>2</sub>), 3.69 (t, <i>J</i> = 5.6 Hz, 4H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.53 (dd, <i>J</i> = 9.0, 6.7 Hz, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.25 (t, <i>J</i> = 7.9 Hz, 4H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 3.07 (q, <i>J</i> = 6.5 Hz, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCbz), 2.74 (t, <i>J</i> = 7.1 Hz, 4H, TrizCH<sub>2</sub>), 1.70 (quin, <i>J</i> = 7.6 Hz, 4H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.52 (quin, <i>J</i> = 7.2 Hz, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCbz); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 160.2 (C<sub>Ar</sub>), 156.1 (OC<sub>Ar</sub>), 155.9 (NHCOO), 153.3 (C<sub>Ar</sub>), 148.1 (C<sub>Ar</sub>), 138.3 (C<sub>Ar</sub>), 137.3 (CH<sub>Ar</sub>), 134.7 (C<sub>Ar</sub>), 129.3 (CH<sub>Ar</sub>), 128.3 (CH<sub>Ar</sub>), 127.7 (CH<sub>Ar</sub>), 126.0 (C<sub>Ar</sub>), 123.7 (C<sub>Ar</sub>), 121.1 (CH<sub>Ar</sub>), 120.3 (CH<sub>Ar</sub>), 116.4 (CH<sub>Ar</sub>), 112.1 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.6 (OCH<sub>2</sub>), 65.1 (NHCOO<u class="uu">C</u>H<sub>2</sub>), 45.3 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 37.6 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 28.9 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCbz), 26.0 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.7 (Triz<u class="uu">C</u>H<sub>2</sub>); HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>62</sub>H<sub>64</sub>N<sub>14</sub>O<sub>8</sub>S<sub>2</sub> 1196.4473; found 1196.4482 (0.72 ppm).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1,1′-((((1,3-Phenylenebis(thiazole-4,2-diyl))bis(5-(4-(4-ammoniobutyl)-1<i>H</i>-1,2,3-triazol-1-yl)-2,1-phenylene)) bis(oxy))bis(ethane-2,1-diyl))bis(imidazolidin-2-one)bis(2,2,2-trifluoroacetate) (<b>22</b>)</h4><div class="NLM_p last">Following the general Cbz removal procedure, <b>21</b> (120 mg, 0.11 mmol), Pd/C 10% (24 mg), and TFA (1.0 mL) reacted to gave, after workup and purification, compound <b>22</b> (22 mg, 19%) as a colorless oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ (ppm): 8.81 (s, 2H, Ar), 8.75 (s, 1H, Ar), 8.69 (d, <i>J</i> = 8.5 Hz, 2H, Ar), 8.40 (s, 2H, Ar), 8.13 (dd, <i>J</i> = 7.8, 1.7 Hz, 2H, Ar), 7.94–7.67 (m, 10H, Ar, NH<sub>3</sub><sup>+</sup>), 7.62 (t, <i>J</i> = 7.7 Hz, 1H, Ar), 6.42 (bs, 2H, NHCON), 4.54 (t, <i>J</i> = 5.7 Hz, 4H, OCH<sub>2</sub>), 3.69 (t, <i>J</i> = 5.6 Hz, 4H, OCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 3.53 (dd, <i>J</i> = 8.9, 6.7 Hz, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NHCON), 3.25 (t, <i>J</i> = 7.9 Hz, 4H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>NHCON), 2.90–2.80 (m, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>NH<sub>3</sub><sup>+</sup>), 2.78 (t, <i>J</i> = 7.3 Hz, 4H, TrizCH<sub>2</sub>), 1.76 (quin, <i>J</i> = 7.4 Hz, 4H, TrizCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.64 (quin, <i>J</i> = 7.7 Hz, 4H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ (ppm): 162.1 (NHCON), 160.2 (OC<sub>Ar</sub>), 158.0 (CF<sub>3</sub><u class="uu">C</u>OO<sup>–</sup>), 155.9 (C<sub>Ar</sub>), 153.3 (C<sub>Ar</sub>), 147.7 (C<sub>Ar</sub>), 138.2 (C<sub>Ar</sub>), 134.7 (CH<sub>Ar</sub>), 129.4 (CH<sub>Ar</sub>), 126.0 (CH<sub>Ar</sub>), 123.1 (C<sub>Ar</sub>), 121.2 (C<sub>Ar</sub>), 120.5 (CH<sub>Ar</sub>), 116.5 (CH<sub>Ar</sub>), 112.1 (CH<sub>Ar</sub>), 104.3 (CH<sub>Ar</sub>), 67.6 (OCH<sub>2</sub>), 45.3 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NHCON), 42.4 (OCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 38.6 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.6 (CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>NHCON), 26.5 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 25.6 (TrizCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.4 (Triz<u class="uu">C</u>H<sub>2</sub>); HPLC (gradient A, Agilent): <i>R</i><sub>t</sub> = 6.4 min; HRMS (ES, positive mode) <i>m</i>/<i>z</i>: calcd for C<sub>46</sub>H<sub>52</sub>N<sub>14</sub>O<sub>4</sub>S<sub>2</sub> 928.3737; found 928.3740 (0.27 ppm); anal. calcd for C<sub>46</sub>H<sub>52</sub>N<sub>14</sub>O<sub>4</sub>S<sub>2</sub>.2TFA: C, 51.90; H, 4.70; N, 16.95; S, 5.54; found: C, 51.38; H, 5.16; N, 16.98; S, 5.83.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Biological Methods</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Chemical Compounds</h4><div class="NLM_p last">For <i>Li</i>TryR oxidoreductase activity and dimer quantitation assays, stock solutions of synthesized compounds were prepared in anhydrous DMSO at 5 mM. For the leishmanicidal and cytotoxicity assays, stock solutions of synthesized compounds were prepared in anhydrous DMSO at 15 mM. All reagents for the <i>Li</i>TryR activity assay were obtained from Sigma-Aldrich (St. Louis, MO) except for TS<sub>2</sub>, which was purchased from Bachem (Bubendorf, Switzerland).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>Li</i>TryR Purification</h4><div class="NLM_p last">Recombinant <i>L. infantum</i> TryR (<i>Li</i>TryR) HIS-tagged and HIS-FLAG-tagged versions were used for all <i>Li</i>TryR oxidoreductase activity and dimer quantitation assays. These <i>Li</i>TryR versions were purified from <i>Escherichia coli</i> as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Briefly, <i>pRSETA-HIS-LiTryR</i> construct alone or in combination with the <i>pET24a-FLAG-LiTryR</i> construct was transformed into BL21 (DE3) Rossetta <i>E. coli</i> strain. An overnight <i>E. coli</i> culture grown at 37 °C in Luria–Bertani (LB) medium with the appropriate antibiotics and vigorous shaking was diluted (1:100) in the same medium and allowed to grow in the same conditions until the OD<sub>600</sub> was 0.5. Then, <i>Li</i>TryR expression was induced by addition of 1 mM isopropyl-β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (IPTG) for 16 h at 26 °C. The cells were centrifuged for 5 min at 9000<i>g</i> and 4 °C and the wet pellet resuspended in lysis buffer (50 mM Tris, pH 7, 300 mM NaCl, 25 mM imidazole, protease inhibitor cocktail, and 1 mg/mL lysozyme). Following a 30 min incubation on ice, the cell lysate was sonicated on wet ice (50% pulses, potency 7) for 30 min using a Sonifier Cell Disruptor B15 (Branson, Danbury, CT) and centrifuged for 1 h at 50 000<i>g</i> and 4 °C. The supernatant was sonicated again as previously described for 10 min and loaded on a HisTrap column (GE Healthcare, Chicago, IL) for 16 h at 4 °C using a P-1 peristaltic pump (GE Healthcare, Chicago, IL). Once loaded, the HisTrap column was connected to an ÄKTA purifier UPC 10 (GE Healthcare, Chicago, IL) and washed using a 5–10% gradient between buffer A (50 mM Tris, pH 7 and 300 mM NaCl) and B (50 mM Tris, pH 7, 300 mM NaCl, and 500 mM imidazole). <i>Li</i>TryR was eluted using a 40% gradient between buffers A and B. Fractions containing recombinant <i>Li</i>TryR were pooled and loaded into a HiPrep 26/10 Desalting column (GE Healthcare, Chicago, IL) previously equilibrated with buffer A. Finally, <i>Li</i>TryR was concentrated to 2 mg/mL using an Amicon Ultra-15 50K (Merck Millipore, Burlington, MA) and an equal volume of glycerol was added before storing at −20 °C.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>Tb</i>TryR and <i>Tco</i>TryR Purification</h4><div class="NLM_p last">The DNA coding sequences for <i>Homo sapiens</i> GR, <i>T. brucei</i> TryR, and <i>T. congolense</i> TryR were polymerase chain reaction (PCR)-amplified and cloned in the pRSETA plasmid. The DNA coding for hGR (transcript variant 1; NCBI Reference Sequence: <a href="https://NM_000637.5" class="ext-link">NM_000637.5</a>) was purchased from GeneScript. Genomic DNA from <i>T. congolense</i> parasites was kindly provided by Dr. Stefan Magez (University of Vrije, Brussels). Genomic DNA from the <i>T. brucei</i> S16 cell line was kindly provided by José M. Pérez-Victoria. Instituto de Parasitología y Biomedicina “López—Neyra” CSIC. HIS-tagged recombinant <i>T. brucei</i> and <i>T. congolense</i> TryRs (<i>Tb</i>TryR and <i>Tco</i>TryR, respectively) were purified from <i>E. coli</i> as already explained for <i>Li</i>TryR.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> TryR Oxidoreductase Activity</h4><div class="NLM_p">TryR oxidoreductase activity was determined spectrophotometrically using a modified version of the DTNB-coupled assay described by Hamilton et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Briefly, reactions were carried out at 26 °C in 250 μL of <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES) buffer (pH 7.5, 40 mM) containing ethylenediaminetetraacetic acid (EDTA) (1 mM), NADP<sup>+</sup> (30 μM), DTNB (25 μM), TS<sub>2</sub> (1 μM), NADPH (150 μM), glycerol (0.02%), DMSO (1.75%), and recombinant TryR (7 nM). DTNB, glycerol, and DMSO concentrations used in this assay do not have any relevant effect on the kinetics of the enzymatic reaction. Reactions were started by addition of a mixture of NADPH and TS<sub>2.</sub></div><div class="NLM_p last">TryR oxidoreductase activity was monitored at 26 °C by an increase in absorbance at 412 nm in an EnSpire Multimode Plate Reader (PerkinElmer, Waltham, MA). 2-Nitro-5-meta mercaptobenzoic acid (TNB) concentration was obtained by multiplying the absorbance values by 100 (50 μM TNB generates 0.5 arbitrary units of absorbance at 412 nm). In this DTNB-coupled assay, one molecule of T(SH)<sub>2</sub> reduces one molecule of DTNB, producing two TNB molecules. All of the assays were conducted in at least three independent experiments. Data were analyzed using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> hGR Oxidoreductase Activity</h4><div class="NLM_p last">hGR oxidoreductase activity was determined spectrophotometrically using a DTNB-coupled assay. Briefly, reactions were carried out at 37 °C in 250 μL of HEPES buffer (pH 7.5, 40 mM) containing EDTA (1 mM), NADP<sup>+</sup>, (60 μM), DTNB (150 μM), oxidized glutathione (50 μM), NADPH (300 μM), glycerol (0.02%), DMSO (1.75%), and recombinant hGR (7 nM). DTNB, glycerol, and DMSO concentrations used in this assay do not have any relevant effect on the kinetics of the enzymatic reaction. hGR oxidoreductase activity was monitored at 37 °C by an increase in absorbance at 412 nm using an EnSpire Multimode Plate Reader (PerkinElmer, Waltham, MA). TNB concentration was obtained by multiplying the absorbance values by 100 (50 μM TNB generates 0.5 arbitrary units of absorbance at 412 nm). All of the assays were conducted in at least three independent experiments. Data were analyzed using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.).</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Dimer Quantitation Assay</h4><div class="NLM_p last">The stability of the <i>Li</i>TryR dimeric form in the presence of 1,2,3-triazole-phenyl-thiazole-based compounds was evaluated using the novel enzyme-linked immunosorbent assay (ELISA) developed in our laboratory.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Briefly, HIS-FLAG-tagged <i>Li</i>TryR (400 nM) was incubated in dimerization buffer (1 mL of 300 mM NaCl, 50 mM Tris, pH 8.0) for 16 h at 37 °C with agitation and in a humid atmosphere in the presence of the different compounds ranging from 75 to 3.12 μM. Next, the different solutions were centrifuged at 18 000<i>g</i> for 15 min at room temperature. The supernatants (200 μL/well) were added to the α-FLAG-coated plates (Sigma-Aldrich, St. Louis, MO) and incubated for 30 min at 37 °C with agitation in a humid atmosphere. The plates were washed five times with TTBS buffer (2 mM Tris, pH 7.6, 138 mM NaCl, and 0.1% Tween-20) and incubated with diluted monoclonal α-HIS horseradish peroxidase (HRP)-conjugated antibody (200 μL, 1:50 000, Abcam, Cambridge, U.K.) in fatty acid- and essentially globulin-free bovine serum albumin (BSA) (5%) prepared in TTBS buffer for 1 h at room temperature. The plates were washed five times, and <i>o</i>-phenylenediamine dihydrochloride (OPD) substrate prepared according to the manufacturer’s instructions was added. The enzymatic reaction was stopped after 5 min with H<sub>2</sub>SO<sub>4</sub> (100 μL, 0.5 μM), and the absorbances were measured at 490 nm in an EnSpire Multimode Plate Reader (PerkinElmer, Waltham, MA). All of the assays were conducted in triplicate in at least three independent experiments. Data were analyzed using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Determination of <b>19a</b> Inhibitory Constants</h4><div class="NLM_p last">The inhibitory constants <i>K</i><sub>i</sub> and <i>K</i><sub>i</sub>* for <b>19a</b> were calculated following a slightly modified version of the standard DTNB-coupled assay.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> TS<sub>2</sub> was serially diluted (sixfold dilution from 1666 to 52 μM) in a buffer containing 40 mM HEPES (pH 7.5) and 1 mM EDTA. The different TS<sub>2</sub> solutions were dispensed (15 μL) in a 96-well microplate. <b>19a</b> was serially diluted in DMSO (sixfold dilution from 1875 to 445 μM). The different aliquots of <b>19a</b> and the equivalent amount of the vehicle (DMSO) were added to a preassay mixture, yielding different mixtures containing 40 mM HEPES (pH 7.5), 1 mM EDTA, 416.67 μM NADPH, 208.33 μM DTNB, 1.45% DMSO, and different <b>19a</b> concentrations ranging from 6.2 to 26 μM. These mixtures (180 μL) were subsequently added to the appropriate wells previously filled with different TS<sub>2</sub> solutions. The assay was initiated by addition of 55 μL of buffer containing 40 mM HEPES (pH 7.5), 1 mM EDTA, 272.73 μM NADP<sup>+</sup>, 0.01% glycerol, and 3.5 nM recombinant <i>Li</i>TryR using an automated dispensing system (PerkinElmer, Waltham, MA). The order of addition was essential to avoid enzyme preincubation with the inhibitor or the substrates. The final 250 μL assay contained 40 mM HEPES buffer (pH 7.5) 1 mM EDTA, 300 μM NADPH, 60 μM NADP<sup>+</sup>, 150 μM DTNB, 6.25–50 μM TS<sub>2</sub>, 1.04% DMSO, 0.002% glycerol, and 0.8 nM recombinant <i>Li</i>TryR. TryR oxidoreductase activity was monitored at 26 °C by an increase in absorbance at 412 nm in an EnSpire Multimode Plate Reader (PerkinElmer, Waltham, MA). Coupling an automated dispenser module to the spectrophotometer enabled real-time detection of the enzymatic reaction, which was crucial for high-quality nonlinear fits of the experimental data and, especially, to estimate the initial velocity of the progress curves in the presence of <b>19a</b>. To guarantee linearity of the enzyme reaction in the absence of an inhibitor, the analysis was performed with data obtained during the first 20 000 s to avoid TS<sub>2</sub> depletion. Under this condition, all uninhibited reactions followed straight lines until the generation of 230 μM TNB (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S10</a>). This product concentration was never reached in the inhibited reactions during the first 20 000 s. All of the assays were conducted in three independent experiments.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Data and Statistical Analysis</h4><div class="NLM_p">GraFit 6.0 software (Erithacus, Horley, SRY, U.K.) was used to perform linear and nonlinear regressions. All experiments were undertaken in triplicate to ensure the reliability of single values.</div><div class="NLM_p"><i>k</i><sub>obs</sub> values were estimated for every <b>19a</b> concentration at all TS<sub>2</sub> concentrations by fitting the values of the TNB concentration produced during each enzymatic reaction to <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>.<a onclick="showRef(event, 'cit42b ref53'); return false;" href="javascript:void(0);" class="ref cit42b ref53">(42b,53)</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_m001.gif" alt="" id="_i68" /></img><span class="labelSpan">(1)</span></span>where <i>v</i><sub>i</sub> and <i>v</i><sub>s</sub> are the initial and the steady-state velocities, respectively, <i>k</i><sub>obs</sub> is the apparent first-order rate constant for the conversion of <i>v</i><sub>i</sub> into the steady-state velocity (<i>v</i><sub>s</sub>), and <i>d</i> is a parameter that indicates the displacement of the curve on the vertical ordinate and takes into account any nonzero value of the measured signal at time zero caused by some of the reagents. The apparent inhibition constants (<i>K</i><sub>i</sub><sup>app</sup> and <i>K</i><sub>i</sub>*<sup>app</sup>) for each TS<sub>2</sub> concentration were determined by fitting the <i>k</i><sub>obs</sub> values obtained at different <b>19a</b> concentrations to <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_m002.gif" alt="" id="_i69" /></img><span class="labelSpan">(2)</span></span>where <i>K</i><sub>i</sub><sup>app</sup> is the apparent value of the <i>K</i><sub>i</sub> for the initial encounter complex (EI) and <i>K</i><sub>i</sub>*<sup>app</sup> is the apparent value of the overall inhibition constant <i>K</i><sub>i</sub>* to form a higher-affinity complex (E*I). <i>k</i><sub>6</sub> is the first-order rate constant that defines the reverse isomerization step that returns E*I to EI.<a onclick="showRef(event, 'cit42a ref53'); return false;" href="javascript:void(0);" class="ref cit42a ref53">(42a,53)</a></div><div class="NLM_p last">The <i>K</i><sub>i</sub> value for the formation of the EI complex was determined by fitting the <i>K</i><sub>i</sub><sup>app</sup> values obtained at different TS<sub>2</sub> concentrations to <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>. In addition, this graph was used to assess the inhibition modality of <b>19a</b> during the first equilibrium of its two-step binding mechanism. The value obtained for α defines the mode of inhibition (competitive, α → infinite; uncompetitive, α → 0; pure noncompetitive, α = 1; mixed, 1 < α < 10).<a onclick="showRef(event, 'cit42a'); return false;" href="javascript:void(0);" class="ref cit42a">(42a)</a><span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_m003.gif" alt="" id="_i70" /></img><span class="labelSpan">(3)</span></span>The overall inhibition constant <i>K</i><sub>i</sub>* value was determined by fitting the <i>K</i><sub>i</sub>*<sup>app</sup> values obtained at different TS<sub>2</sub> concentrations to <a class="ref internalNav" href="#eq4" aria-label="eq 4">eq 4</a>. In addition, this graph was used to assess the overall inhibition modality of <b>19a</b> during its two-step binding mechanism. As explained above, the value obtained for α defines the mode of inhibition.<a onclick="showRef(event, 'cit42a'); return false;" href="javascript:void(0);" class="ref cit42a">(42a)</a><span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_m004.gif" alt="" id="_i71" /></img><span class="labelSpan">(4)</span></span></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Leishmania Cell Lines and Culture</h4><div class="NLM_p last"><i>L. infantum</i> promastigotes (MCAN/ES/89/IPZ229/1/89) were grown in Roswell Park Memorial Institute (RPMI)-1640 medium (Sigma-Aldrich, St. Louis, MO) supplemented with 10% heat-inactivated fetal calf serum (FCS), antibiotics, and 25 mM HEPES (pH 7.2) at 26 °C. <i>L. infantum</i> axenic amastigotes (MCAN/ES/89/IPZ229/1/89) were grown in M199 medium (Invitrogen, Leiden, The Netherlands) supplemented with 10% heat-inactivated FCS, 1 g/L β-alanine, 100 mg/L <span class="smallcaps smallerCapital">l</span>-asparagine, 200 mg/L sucrose, 50 mg/L sodium pyruvate, 320 mg/L malic acid, 40 mg/L fumaric acid, 70 mg/L succinic acid, 200 mg/L α-ketoglutaric acid, 300 mg/L citric acid, 1.1 g/L sodium bicarbonate, 5 g/L morpholineethanesulfonic acid (MES), 0.4 mg/L hemin, and 10 mg/L gentamicine, pH 5.4, at 37 °C.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Axenization of <i>L. infantum</i> Promastigotes</h4><div class="NLM_p last">Axenization was performed by diluting 0.5 mL of a 7-day stationary phase culture of <i>L. infantum</i> promastigotes (2–3 × 10<sup>7</sup> parasites/mL) in 4.5 mL of amastigotes medium and incubating the culture at 37 °C for 2 or 3 days. <i>L. infantum</i> axenic amastigotes apparition was followed by phase-contrast microscopy using an Eclipse Ti inverted microscope (Nikon, Tokyo, Japan).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Leishmanicidal Activity</h4><div class="NLM_p last">Drug treatment of <i>L. infantum</i> promastigotes was performed during the logarithmic growth phase at a concentration of 2 × 10<sup>6</sup> parasites/mL at 26 °C for 24 h. Drug treatment of <i>L. infantum</i> axenic amastigotes was performed during the logarithmic growth phase at a concentration of 1 × 10<sup>6</sup> parasites/mL at 37 °C for 24 h. EC<sub>50</sub> was evaluated by flow cytometry by the propidium iodide (PI) exclusion method. After selection of the parasite population based on their forward scatter (FSC) and side scatter (SSC) values, live and dead parasite cells were identified by their permeability to PI. All of the assays were conducted in triplicate in at least three independent experiments. Data were analyzed using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Fluorescence Microscopy</h4><div class="NLM_p last">Logarithmic growth phase promastigotes were treated with 25 μM <b>12a</b> for 1 h at 26 °C. Parasites were fixed using a solution containing EDTA (450 mM) and mounted on polylysine slides (Thermo Scientific, Waltham, MA). Images were captured with an Eclipse Ti inverted microscope (Nikon, Tokyo, Japan).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Human Cell Line Culture</h4><div class="NLM_p">THP-1 cells were grown in RPMI-1640 medium (Gibco, Leiden, The Netherlands) supplemented with 10% heat-inactivated FCS, antibiotics, 10 mM HEPES, 2 mM glutamine, and 1 mM sodium pyruvate, pH 7.2, at 37 °C and 5% CO<sub>2</sub>.</div><div class="NLM_p last">Liver hepatocellular carcinoma HepG2 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich, St. Louis, MO) with 10% heat-inactivated FCS, antibiotics, and 10 mM HEPES.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Determination of Cellular Toxicity</h4><div class="NLM_p last">Drug treatment of liver hepatocellular carcinoma HepG2 cells was performed at a concentration of 10<sup>5</sup> cells/mL at 37 °C and 5% CO<sub>2</sub> for 24 h. EC<sub>50</sub> was evaluated by the crystal violet assay. Briefly, cells were washed with phosphate-buffered saline (PBS) and stained with 200 μL of crystal violet solution (0.2% crystal violet, 2% ethanol) for 10 min at room temperature. Next, the plates were washed twice with tap water and allowed to dry. The stained cells were solubilized with 400 μL of 1% sodium dodecyl sulfate (SDS), and the color intensity was quantified at 570 nm using an EnSpire Multimode Plate Reader (PerkinElmer, Waltham, MA). All of the assays were conducted in triplicate in at least three independent experiments. Data were analyzed using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>In Vitro</i> Infection of THP-1-Derived Macrophages with GFP-Expressing <i>L. infantum</i> Axenic Amastigotes</h4><div class="NLM_p">THP-1 monocytes were seeded in a 48-well plate at a concentration of 5 × 10<sup>5</sup> cells/mL (250 μL/well) in RPMI complete medium supplemented with phorbol 12-myristate 13-acetate (PMA) (100 ng/mL). Differentiation of THP-1 monocytes to macrophages was allowed for 24 h at 37 °C and 5% CO<sub>2</sub>. THP-1-derived macrophages were infected with GFP-expressing axenic amastigotes at 5 × 10<sup>6</sup> parasites/mL in RPMI complete medium for 24 h (250 μL/well). Extracellular amastigotes were washed twice with PBS. The remaining extracellular parasites were challenged for 24 h with THP-1 medium supplemented with 10% horse serum (Gibco) instead of FCS. Cells were washed twice with PBS, and treatments were performed in 250 μL of fresh RPMI medium supplemented with 10% horse serum for 72 h at 37 °C and 5% CO<sub>2</sub>. Afterward, treatments were removed by two PBS washes. Lysis of infected cells was performed with 120 μL of SDS 0.005% (w/v) in PBS. After a 30 min incubation at 37 °C, lysis was stopped by adding RPMI complete medium with PI at 20 μg/mL (120 μL/well). The lysates were transferred to a 96-well plate (200 μL/well), and the GFP<sup>+</sup> amastigotes extracted from the infected cells were acquired by a Beckman Coulter FC500 flow cytometer. Each sample (100 μL) was acquired for 20 s.</div><div class="NLM_p">Cytotoxicity of THP-1 infected macrophages was determined using an in-house developed lactate dehydrogenase (LDH) activity assay. LDH activity assays from the remaining cell lysates (100 μL/well) were carried out at 37 °C in 250 μL of Tris/HCl buffer (pH 8.9, 50 mM) containing <span class="smallcaps smallerCapital">dl</span>-lactate (840 mM), NAD<sup>+</sup> (450 μM), 1-methoxyphenazine methosulfate (45 μM), and nitro blue tetrazolium chloride (40 μM). The color intensity of the generated formazan dye was monitored at 570 nm using an EnSpire Multimode Plate Reader (PerkinElmer, Waltham, MA). CC<sub>50</sub> values were calculated using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.).</div><div class="NLM_p last">The relative number of GFP<sup>+</sup> intracellular amastigotes per cell in each sample was estimated after the division of the total number of GFP+ amastigotes by the LDH activity value of the sample. Results were normalized to the vehicle-treated controls. EC<sub>50</sub> values of intracellular amastigotes were calculated using a nonlinear regression model with GraFit 6 software (Erithacus, Horley, Surrey, U.K.). All of the assays were conducted in at least three independent experiments.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Screening for Pan-Assay Interference Compounds (PAINS) and Aggregation</h4><div class="NLM_p last">Screening of all tested compounds for pan-assay interference compounds (PAINS) and aggregation <i>via</i> public tools (<u class="uu">http://zinc15.docking.org/patterns/home/</u> and <u class="uu">https://www.cbligand.org/PAINS/</u>) gave no hits. Dose–response curves for all experiments and compounds were recorded. None of the curves showed Hill slopes that could be a hint for PAINS (curves for representative compounds <b>12b</b> and <b>12c</b> are presented in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S14</a>, Supporting information). Counter-screening against related (glutathione reductase; GR) and unrelated (superoxide dismutase) targets discarded any nonspecific activity of the compounds. Reaction curves for TryR and GR in the presence of compounds <b>12b</b> and <b>12c</b> are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Figure S15</a>. Nifurtimox is included as a well-characterized inhibitor of GR. SAR, considered the most relevant criterion that distinguishes a PAIN from a non-PAIN, is deeply discussed in the manuscript.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Computational Methods</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Automated Ligand Docking</h4><div class="NLM_p last">A three-dimensional cubic grid consisting of 65 × 65 × 65 points with a spacing of 0.375 Å centered midway between the two active sites of <i>Li</i>TryR was defined for ligand docking. Electrostatic, desolvation, and affinity maps for the atom types present in the ligands of this series were calculated using AutoGrid 4.2.6. Then, the Lamarckian genetic algorithm implemented in AutoDock4<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> was used to generate up to 100 feasible binding poses of the ligands studied. The best poses were selected on the basis of results from intra- and intermolecular energy evaluations.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Molecular Dynamics Simulations</h4><div class="NLM_p last">The leaprcff14SB AMBER force field and the graphics processing unit (GPU)-based implementation of the pmemd.cuda module of Amber16 in the single-precision–fixed-precision (SPFP) mode were used, as described before.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The molecular dynamics trajectories were analyzed using the cpptraj module of AmberTools18, and the binding energy analysis was carried out with our in-house tool MM-ISMSA.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The molecular graphics program PyMOL<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> was employed for molecular editing, visualization, and figure preparation.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00206" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00206?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00206</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional synthesis; biological and computational assays; screening of representative compounds for PAINS; <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS spectra and HPLC chromatograms for all of the target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of the prepared compounds and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Movie of <i>Li</i>TryR-<b>19a</b> complex (Movie S1) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_003.avi" class="ext-link">AVI</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf">jm1c00206_si_001.pdf (7.24 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_002.csv">jm1c00206_si_002.csv (3.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_003.avi">jm1c00206_si_003.avi (2.27 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00206" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Jiménez-Ruiz</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Biología de Sistemas, Universidad
de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#badbd4ced5d4d3d594d0d3d7dfd4dfc0facfdbd294dfc9"><span class="__cf_email__" data-cfemail="24454a504b4a4d4b0a4e4d49414a415e6451454c0a4157">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonsoles Velázquez</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica (IQM-CSIC), c/ Juan de la Cierva 3, E-28006 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2209-1751" title="Orcid link">http://orcid.org/0000-0003-2209-1751</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d4bda5b9a7a2e6ed94bda5b9fab7a7bdb7fab1a7"><span class="__cf_email__" data-cfemail="0a637b67797c38334a637b672469796369246f79">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alejandro Revuelto</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica (IQM-CSIC), c/ Juan de la Cierva 3, E-28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Héctor de Lucio</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Biología de Sistemas, Universidad
de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9840-0779" title="Orcid link">http://orcid.org/0000-0002-9840-0779</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Carlos García-Soriano</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Biología de Sistemas, Universidad
de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pedro A. Sánchez-Murcia</span> - <span class="hlFld-Affiliation affiliation">Área
de Farmacología, Departamento de Ciencias Biomédicas,
Unidad Asociada al IQM-CSIC, Universidad
de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</span>; 
    <span>Present Address:
                        Division of Physiological Chemistry, Otto Loewi Research Center, Medical University of Graz, Neue Stiftingstalstraße 6/III, A-8010 Graz, Austria</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8415-870X" title="Orcid link">http://orcid.org/0000-0001-8415-870X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federico Gago</span> - <span class="hlFld-Affiliation affiliation">Área
de Farmacología, Departamento de Ciencias Biomédicas,
Unidad Asociada al IQM-CSIC, Universidad
de Alcalá, E-28805 Alcalá de Henares, Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3071-4878" title="Orcid link">http://orcid.org/0000-0002-3071-4878</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María-José Camarasa</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica (IQM-CSIC), c/ Juan de la Cierva 3, E-28006 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4978-6468" title="Orcid link">http://orcid.org/0000-0002-4978-6468</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.R. and H.d.L. contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>F.G., M.-J.C., A.J.-R., and S.V.: participated in research design. A.R.: carried out the synthesis. H.d.L. and J.C.G.-S.: performed biological evaluations. A.R., P.A.S.-M., and F.G.: conducted computational studies. F.G., A.J.-R., and S.V.: performed data analysis and supervised experiments. A.R., H.d.L., F.G., A.J.-R., M.-J.C., and S.V.: wrote or contributed to the writing of the manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e13213-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work has been supported by the Spanish MICINN (Projects PID2019-104070RB-C21 and PID2019-104070RB-C22), the Spanish Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC, Projects CSIC-PIE-201980E100 and CSIC-PIE-201980E028), and the Comunidad de Madrid (PLATESA2-CM ref S-2018/BAA-4370). The Spanish MEC is also acknowledged for FPU grants to A.R. and J.C.G.-S.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CCTLC</td><td class="NLM_def"><p class="first last">centrifugal circular thin-layer chromatography</p></td></tr><tr><td class="NLM_term">CuAAC</td><td class="NLM_def"><p class="first last">1,3-dipolar copper(I)-catalyzed azide–alkyne cycloaddition</p></td></tr><tr><td class="NLM_term">EC<sub>50a</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration in amastigotes</p></td></tr><tr><td class="NLM_term">EC<sub>50p</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration in promastigotes</p></td></tr><tr><td class="NLM_term">HepG2</td><td class="NLM_def"><p class="first last">liver hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub><sup>act</sup></td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration in the activity assay</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub><sup>dim</sup></td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration in the dimerization assay</p></td></tr><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">glutathione reductase</p></td></tr><tr><td class="NLM_term"><i>Li</i>TryR</td><td class="NLM_def"><p class="first last"><i>Leishmania infantum</i> trypanothione reductase</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrogenase</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">RuAAC</td><td class="NLM_def"><p class="first last">ruthenium-catalyzed azide–alkyne cycloaddition</p></td></tr><tr><td class="NLM_term">SI<sub>a</sub></td><td class="NLM_def"><p class="first last">selectivity index in amastigotes</p></td></tr><tr><td class="NLM_term">SI<sub>p</sub></td><td class="NLM_def"><p class="first last">selectivity index in promastigotes</p></td></tr><tr><td class="NLM_term"><i>Tb</i>TryR</td><td class="NLM_def"><p class="first last"><i>Trypanosoma brucei</i> trypanothione reductase</p></td></tr><tr><td class="NLM_term"><i>Tco</i>TryR</td><td class="NLM_def"><p class="first last"><i>Trypanosoma congolense</i> trypanothione reductase</p></td></tr><tr><td class="NLM_term">Try/TryR</td><td class="NLM_def"><p class="first last">thypanothione/trypanothione reductase</p></td></tr><tr><td class="NLM_term">TS<sub>2</sub></td><td class="NLM_def"><p class="first last">trypanothione disulfide</p></td></tr><tr><td class="NLM_term">VL</td><td class="NLM_def"><p class="first last">visceral leishmaniasis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 56 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>Leishmaniasis</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2020</span>. Available online: <a href="http://http:/www.who.int/gho/neglected_diseases/leishmaniasis/en/" class="extLink">http:/www.who.int/gho/neglected_diseases/leishmaniasis/en/</a> (accessed
Oct, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=WHO&title=Leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DLeishmaniasis%26pub%3DWHO%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ready, P. D.</span></span> <span> </span><span class="NLM_article-title">Epidemiology of visceral leishmaniasis</span>. <i>Clin. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.2147/CLEP.S44267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.2147%2FCLEP.S44267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=24833919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvV2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=147-154&author=P.+D.+Ready&title=Epidemiology+of+visceral+leishmaniasis&doi=10.2147%2FCLEP.S44267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of visceral leishmaniasis</span></div><div class="casAuthors">Ready Paul D</div><div class="citationInfo"><span class="NLM_cas:title">Clinical epidemiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-54</span>
        ISSN:<span class="NLM_cas:issn">1179-1349</span>.
    </div><div class="casAbstract">Leishmania species are the causative agents of leishmaniasis, a neglected tropical disease.  These parasitic protozoans are usually transmitted between vertebrate hosts by the bite of blood sucking female phlebotomine sand flies.  This review focuses on the two parasites causing most human visceral leishmaniasis (VL), which leads to substantial health problems or death for up to 400,000 people per year.  Except for travel cases, Leishmania donovani infections are restricted to the (sub-)tropics of Asia and Africa, where transmission is mostly anthroponotic, while Leishmania infantum occurs in the drier parts of Latin America as well as in the Mediterranean climate regions of the Old World, with the domestic dog serving as the main reservoir host.  The prevalence of VL caused by L. infantum has been declining where living standards have improved.  In contrast, infections of L. donovani continue to cause VL epidemics in rural areas on the Indian subcontinent and in East Africa.  The current review compares and contrasts these continental differences and suggests priorities for basic and applied research that might improve VL control.  Transmission cycles, pathogenesis, diagnosis, treatment and prognosis, prevention (including vector control), surveillance, transmission modeling, and international control efforts are all reviewed.  Most case detection is passive, and so routine surveillance does not usually permit accurate assessments of any changes in the incidence of VL.  Also, it is not usually possible to estimate the human inoculation rate of parasites by the sand fly vectors because of the limitations of survey methods.  Consequently, transmission modeling rarely passes beyond the proof of principle stage, and yet it is required to help develop risk factor analysis for control programs.  Anthroponotic VL should be susceptible to elimination by rapid case detection and treatment combined with local vector control, and one of the most important interventions may well be socioeconomic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnQb3thmCTV0H3Rlp_k91zfW6udTcc2eZx8h2eozOnpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvV2lsA%253D%253D&md5=59b7860c7fca93b3e8574b50275a0ea0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2147%2FCLEP.S44267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCLEP.S44267%26sid%3Dliteratum%253Aachs%26aulast%3DReady%26aufirst%3DP.%2BD.%26atitle%3DEpidemiology%2520of%2520visceral%2520leishmaniasis%26jtitle%3DClin.%2520Epidemiol.%26date%3D2014%26volume%3D6%26spage%3D147%26epage%3D154%26doi%3D10.2147%2FCLEP.S44267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumier, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strych, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottazzi, M. E.</span></span> <span> </span><span class="NLM_article-title">Status of vaccine research and development of vaccines for leishmanisis</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2992</span>– <span class="NLM_lpage">2995</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2015.12.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.vaccine.2015.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26973063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFKitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=2992-2995&author=P.+M.+Gillespieauthor=C.+M.+Beaumierauthor=U.+Strychauthor=T.+Haywardauthor=P.+J.+Hotezauthor=M.+E.+Bottazzi&title=Status+of+vaccine+research+and+development+of+vaccines+for+leishmanisis&doi=10.1016%2Fj.vaccine.2015.12.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Status of vaccine research and development of vaccines for leishmaniasis</span></div><div class="casAuthors">Gillespie, Portia M.; Beaumier, Coreen M.; Strych, Ulrich; Hayward, Tara; Hotez, Peter J.; Bottazzi, Maria Elena</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2992-2995</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A no. of leishmaniasis vaccine candidates are at various stages of pre-clin. and clin. development.  Leishmaniasis is a vector-borne neglected tropical disease (NTD) caused by a protozoan parasite of the genus Leishmania and transmitted to humans by the bite of a sand fly.  Visceral leishmaniasis (VL, kala-azar) is a high mortality NTD found mostly in South Asia and East Africa, while cutaneous leishmaniasis (CL) is a disfiguring NTD highly endemic in the Middle East, Central Asia, North Africa, and the Americas.  Ests. attribute 50,000 annual deaths and 3.3 million disability-adjusted life years to leishmaniasis.  There are only a few approved drug treatments, no prophylactic drug and no vaccine.  Ideally, an effective vaccine against leishmaniasis will elicit long-lasting immunity and protect broadly against VL and CL.  Vaccines such as Leish-F1, F2 and F3, developed at IDRI and designed based on selected Leishmania antigen epitopes, have been in clin. trials.  Other groups, including the Sabin Vaccine Institute in collaboration with the National Institutes of Health are investigating recombinant Leishmania antigens in combination with selected sand fly salivary gland antigens in order to augment host immunity.  To date, both VL and CL vaccines have been shown to be cost-effective in economic modeling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmFFGisHW4j7Vg90H21EOLACvtfcHk0ljyVbDz__xJGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFKitLo%253D&md5=8a6296088fe26a6d298562562db97cd1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2015.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2015.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DP.%2BM.%26aulast%3DBeaumier%26aufirst%3DC.%2BM.%26aulast%3DStrych%26aufirst%3DU.%26aulast%3DHayward%26aufirst%3DT.%26aulast%3DHotez%26aufirst%3DP.%2BJ.%26aulast%3DBottazzi%26aufirst%3DM.%2BE.%26atitle%3DStatus%2520of%2520vaccine%2520research%2520and%2520development%2520of%2520vaccines%2520for%2520leishmanisis%26jtitle%3DVaccine%26date%3D2016%26volume%3D34%26spage%3D2992%26epage%3D2995%26doi%3D10.1016%2Fj.vaccine.2015.12.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span> <span> </span><span class="NLM_article-title">Current and emerging medications for the treatment of leishmaniasis</span>. <i>Exp. Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1080/14656566.2019.1609940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1080%2F14656566.2019.1609940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31063412" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=1251-1265&author=J.+Chakravartyauthor=S.+Sundar&title=Current+and+emerging+medications+for+the+treatment+of+leishmaniasis&doi=10.1080%2F14656566.2019.1609940"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F14656566.2019.1609940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14656566.2019.1609940%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarty%26aufirst%3DJ.%26aulast%3DSundar%26aufirst%3DS.%26atitle%3DCurrent%2520and%2520emerging%2520medications%2520for%2520the%2520treatment%2520of%2520leishmaniasis%26jtitle%3DExp.%2520Opin.%2520Pharmacother.%26date%3D2019%26volume%3D20%26spage%3D1251%26epage%3D1265%26doi%3D10.1080%2F14656566.2019.1609940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blesson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnerat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouattara, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pécoul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub-Wourgaft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasunna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zijlstra, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arana, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvar, J.</span></span> <span> </span><span class="NLM_article-title">Recent developments of visceral leishmaniasis treatments: successes, pitfalls and perspectives</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>, <span class="NLM_elocation-id">e00048-18</span> <span class="refDoi"> DOI: 10.1128/CMR.00048-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1128%2FCMR.00048-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=30158301" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&author=F.+Alvesauthor=G.+Bilbeauthor=S.+Blessonauthor=V.+Goyalauthor=S.+Monneratauthor=C.+Mowbrayauthor=G.+M.+Ouattaraauthor=B.+P%C3%A9coulauthor=S.+Rijalauthor=J.+Rodeauthor=A.+Solomosauthor=N.+Strub-Wourgaftauthor=M.+Wasunnaauthor=S.+Wellsauthor=E.+E.+Zijlstraauthor=B.+Aranaauthor=J.+Alvar&title=Recent+developments+of+visceral+leishmaniasis+treatments%3A+successes%2C+pitfalls+and+perspectives&doi=10.1128%2FCMR.00048-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FCMR.00048-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00048-18%26sid%3Dliteratum%253Aachs%26aulast%3DAlves%26aufirst%3DF.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DMonnerat%26aufirst%3DS.%26aulast%3DMowbray%26aufirst%3DC.%26aulast%3DOuattara%26aufirst%3DG.%2BM.%26aulast%3DP%25C3%25A9coul%26aufirst%3DB.%26aulast%3DRijal%26aufirst%3DS.%26aulast%3DRode%26aufirst%3DJ.%26aulast%3DSolomos%26aufirst%3DA.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26aulast%3DWasunna%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DZijlstra%26aufirst%3DE.%2BE.%26aulast%3DArana%26aufirst%3DB.%26aulast%3DAlvar%26aufirst%3DJ.%26atitle%3DRecent%2520developments%2520of%2520visceral%2520leishmaniasis%2520treatments%253A%2520successes%252C%2520pitfalls%2520and%2520perspectives%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2018%26volume%3D31%26doi%3D10.1128%2FCMR.00048-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponte-Sucre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamarro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dujardin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Vélez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Hernández, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pountain, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwenechanya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, B.</span></span> <span> </span><span class="NLM_article-title">Drug resistance and treatment failure in leishmaniasis: a 21st century challenge</span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0006052</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0006052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1371%2Fjournal.pntd.0006052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29240765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2qsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&author=A.+Ponte-Sucreauthor=F.+Gamarroauthor=J.+C.+Dujardinauthor=M.+P.+Barrettauthor=R.+L%C3%B3pez-V%C3%A9lezauthor=R.+Garc%C3%ADa-Hern%C3%A1ndezauthor=A.+W.+Pountainauthor=R.+Mwenechanyaauthor=B.+Papadopoulou&title=Drug+resistance+and+treatment+failure+in+leishmaniasis%3A+a+21st+century+challenge&doi=10.1371%2Fjournal.pntd.0006052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance and treatment failure in leishmaniasis: a 21st century challenge</span></div><div class="casAuthors">Ponte-Sucre, Alicia; Gamarro, Francisco; Dujardin, Jean-Claude; Barrett, Michael P.; Lopez-Velez, Rogelio; Garcia-Hernandez, Raquel; Pountain, Andrew W.; Mwenechanya, Roy; Papadopoulou, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e0006052/1-e0006052/24</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem.  Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system.  Pentavalent antimonials have been used successfully worldwide for the treatment of leishmaniasis since the first half of the 20th century, but the last 10 to 20 years have witnessed an increase in clin. resistance, e.g., in North Bihar in India.  In this review, we discuss the meaning of "resistance" related to leishmaniasis and discuss its mol. epidemiol., particularly for Leishmania donovani that causes visceral leishmaniasis.  We also discuss how resistance can affect drug combination therapies.  Mol. mechanisms known to contribute to resistance to antimonials, amphotericin B, and miltefosine are also outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6TWUhcg-NibVg90H21EOLACvtfcHk0ljyVbDz__xJGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2qsr7F&md5=37789e9b3b8ef1e82b34fe1b4991421b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0006052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0006052%26sid%3Dliteratum%253Aachs%26aulast%3DPonte-Sucre%26aufirst%3DA.%26aulast%3DGamarro%26aufirst%3DF.%26aulast%3DDujardin%26aufirst%3DJ.%2BC.%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26aulast%3DL%25C3%25B3pez-V%25C3%25A9lez%26aufirst%3DR.%26aulast%3DGarc%25C3%25ADa-Hern%25C3%25A1ndez%26aufirst%3DR.%26aulast%3DPountain%26aufirst%3DA.%2BW.%26aulast%3DMwenechanya%26aufirst%3DR.%26aulast%3DPapadopoulou%26aufirst%3DB.%26atitle%3DDrug%2520resistance%2520and%2520treatment%2520failure%2520in%2520leishmaniasis%253A%2520a%252021st%2520century%2520challenge%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26doi%3D10.1371%2Fjournal.pntd.0006052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, K.</span></span> <span> </span><span class="NLM_article-title">Molecular targets and pathways for the treatment of visceral leishmaniasis</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.drudis.2017.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28919438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFehs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=161-170&author=V.+Jainauthor=K.+Jain&title=Molecular+targets+and+pathways+for+the+treatment+of+visceral+leishmaniasis&doi=10.1016%2Fj.drudis.2017.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular targets and pathways for the treatment of visceral leishmaniasis</span></div><div class="casAuthors">Jain, Vineet; Jain, Keerti</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Visceral leishmaniasis (VL) represents the most severe form of the tropical disease, leishmaniasis.  Treatment of VL is complicated because of the few clin. approved antileishmanial drugs available; emerging resistance to first-line drugs; need for a temp.-controlled 'cold' supply chain; serious toxicity concerns over drugs such as amphotericin B; high cost of medication; and unavailability of clin. approved antileishmanial vaccines.  Attacking potential mol. targets, specific to the parasite, is a vital step in the treatment of this and other infectious diseases.  As we discuss here, comprehensive investigation of these targets could provide a promising strategy for the treatment of visceral leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd71mNaDhkv7Vg90H21EOLACvtfcHk0liOyWdJrC8Ypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFehs73K&md5=82e7714a7c3df52c785dda42faffe19d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DK.%26atitle%3DMolecular%2520targets%2520and%2520pathways%2520for%2520the%2520treatment%2520of%2520visceral%2520leishmaniasis%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D161%26epage%3D170%26doi%3D10.1016%2Fj.drudis.2017.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansuri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diwan, A.</span></span> <span> </span><span class="NLM_article-title">An insight into the current perspective and potential drug targets for visceral leishmaniasis (VL)</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1129</span>, <span class="refDoi"> DOI: 10.2174/1389450121666200422083735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.2174%2F1389450121666200422083735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=32321399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVagtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=1105-1129&author=R.+Mansuriauthor=J.+Singhauthor=A.+Diwan&title=An+insight+into+the+current+perspective+and+potential+drug+targets+for+visceral+leishmaniasis+%28VL%29&doi=10.2174%2F1389450121666200422083735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmaniasis (VL)</span></div><div class="casAuthors">Mansuri, Rani; Singh, Jagbir; Diwan, Anupama</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1105-1129</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Leishmaniasis is one of the six entities on the list of most important diseases of the World Health Organization/Tropical Disease Research (WHO/TDR).  After Malaria, it is one of the most prevalent and lethal parasitic diseases.  VL is the fatal form of this disease, esp. if left untreated.  The drugs that are currently available for the treatment of VL are expensive, toxic, or no longer effective, esp. in endemic regions.  Currently, no vaccine has been developed to immunize humans against VL.  The major problems with the current drugs are the development of resistance and their adverse effects.  Therefore, there is a strong urge to research and design drugs that have better efficacies and low toxicities as compared to current chemotherapeutic drugs.  Leishmania has various enzymes involved in its metabolic pathways, which are unique to either the same genus or trypanosomatids, making them a very suitable, attractive and novel target sites for drug development.  One of the significant pathways unique to trypanosomatids is the thiol metab. pathway, which is involved in the maintenance of redox homeostasis as well as protection of the parasite in the macrophage from oxidative stress-induced damage.  In this review the several pathways, their essential enzymes as well as the proposed changes in the parasites due to drug resistance have been discussed to help to understand the most suitable drug target.  The thiol metab. pathway is discussed in detail, providing evidence of this pathway being the most favorable choice for drug targeting in VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroGF4R4CvM2LVg90H21EOLACvtfcHk0liOyWdJrC8Ypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVagtL7O&md5=0142d719288142ce982de7ab151ac55c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1389450121666200422083735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450121666200422083735%26sid%3Dliteratum%253Aachs%26aulast%3DMansuri%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DDiwan%26aufirst%3DA.%26atitle%3DAn%2520insight%2520into%2520the%2520current%2520perspective%2520and%2520potential%2520drug%2520targets%2520for%2520visceral%2520leishmaniasis%2520%2528VL%2529%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2020%26volume%3D21%26spage%3D1105%26epage%3D1129%26doi%3D10.2174%2F1389450121666200422083735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiering, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H.</span></span> <span> </span><span class="NLM_article-title">The parasite-specific trypanothione metabolism of trypanosoma and leishmania</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1515/BC.2003.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1515%2FBC.2003.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=12751784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVektbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=539-549&author=R.+L.+Krauth-Siegelauthor=S.+K.+Meieringauthor=H.+Schmidt&title=The+parasite-specific+trypanothione+metabolism+of+trypanosoma+and+leishmania&doi=10.1515%2FBC.2003.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania</span></div><div class="casAuthors">Krauth-Siegel, R. Luise; Meiering, Svea K.; Schmidt, Heide</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">539-549</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  The bis(glutathionyl)spermidine trypanothione exclusively occurs in parasitic protozoa of the order Kinetoplastida, such as trypanosomes and leishmania, some of which are the causative agents of several tropical diseases.  The dithiol is kept reduced by the flavoenzyme trypanothione reductase and the trypanothione system replaces in these parasites the nearly ubiquitous glutathione/glutathione reductase couple.  Trypanothione is a reductant of thioredoxin and tryparedoxin, small dithiol proteins, which in turn deliver reducing equiv. for the synthesis of deoxyribonucleotides as well as for the detoxification of hydroperoxides by different peroxidases.  Depending on the individual organism and the developmental state, the parasites also contain significant amts. of glutathione, mono-glutathionylspermidine and ovothiol, whereby all four low mol. mass thiols are directly (trypanothione and mono-glutathionylspermidine) or indirectly (glutathione and ovothiol) maintained in the reduced state by trypanothione reductase.  Thus the trypanothione system is central for any thiol regeneration and trypanothione reductase has been shown to be an essential enzyme in these parasites.  The absence of this pathway from the mammalian host and the sensitivity of trypanosomatids toward oxidative stress render the enzymes of the trypanothione metab. attractive target mols. for the rational development of new drugs against African sleeping sickness, Changas' disease and the different forms of leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRsZG2zf-i77Vg90H21EOLACvtfcHk0liOyWdJrC8Ypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVektbg%253D&md5=e52abde2d7bae69966ea289d26248c4d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.062%26sid%3Dliteratum%253Aachs%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DMeiering%26aufirst%3DS.%2BK.%26aulast%3DSchmidt%26aufirst%3DH.%26atitle%3DThe%2520parasite-specific%2520trypanothione%2520metabolism%2520of%2520trypanosoma%2520and%2520leishmania%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D539%26epage%3D549%26doi%3D10.1515%2FBC.2003.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Target assessment for antiparasitic drug discovery</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2007.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.pt.2007.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=17962072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSktrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=589-595&author=J.+A.+Frearsonauthor=P.+A.+Wyattauthor=I.+H.+Gilbertauthor=A.+H.+Fairlamb&title=Target+assessment+for+antiparasitic+drug+discovery&doi=10.1016%2Fj.pt.2007.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Target assessment for antiparasitic drug discovery</span></div><div class="casAuthors">Frearson, Julie A.; Wyatt, Paul G.; Gilbert, Ian H.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">589-595</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Drug discovery is a high-risk, expensive and lengthy process taking at least 12 years and costing upwards of US$500 million per drug to reach the clinic.  For neglected diseases, the drug discovery process is driven by medical need and guided by pre-defined target product profiles.  Assessment and prioritization of the most promising targets for entry into screening programs is crucial for maximizing the chances of success.  Here, we describe criteria used in our drug discovery unit for target assessment and introduce the 'traffic-light' system as a prioritization and management tool.  We hope this brief review will stimulate basic scientists to acquire addnl. information necessary for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpZsiQ7tE_7Vg90H21EOLACvtfcHk0liOyWdJrC8Ypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSktrzJ&md5=40edb0aa482e5b6155dc653397c1c45d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2007.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2007.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BA.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DTarget%2520assessment%2520for%2520antiparasitic%2520drug%2520discovery%26jtitle%3DTrends%2520Parasitol.%26date%3D2007%26volume%3D23%26spage%3D589%26epage%3D595%26doi%3D10.1016%2Fj.pt.2007.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Thiol redox biology of trypanosomatids and potential targets for chemotherapy</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2015.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.molbiopara.2015.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26592324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2016&pages=67-74&author=A.+E.+Lerouxauthor=R.+L.+Krauth-Siegel&title=Thiol+redox+biology+of+trypanosomatids+and+potential+targets+for+chemotherapy&doi=10.1016%2Fj.molbiopara.2015.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol redox biology of trypanosomatids and potential targets for chemotherapy</span></div><div class="casAuthors">Leroux, Alejandro E.; Krauth-Siegel, R. Luise</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Trypanosomatids are the causative agents of African sleeping sickness, Chagas' disease, and the different forms of leishmaniasis.  This family of protozoan parasite possesses a trypanothione-based redox metab. that provides the reducing equiv. for various vital processes such as the biosynthesis of DNA precursors and the detoxification of hydroperoxides.  Almost all enzymes of the redox pathway proved to be essential and therefore fulfil one crucial prerequisite for a putative drug target.  Trypanothione synthetase and trypanothione reductase are present in all trypanosomatids but absent from the mammalian host which, in addn. to the essentiality, renders them highly specific.  The chemotherapy research on both enzymes is further supported by the availability of high-throughput screening techniques and crystal structures.  In this review we focus on the recent advances and limitations in the development of lead compds. targeting trypanothione synthetase and trypanothione reductase.  We present an overview of the available inhibitors and discuss future perspectives including other components of the parasite-specific redox pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprdJHuvV_b5rVg90H21EOLACvtfcHk0lhT3UcATl5X0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3I&md5=06b997e4dd8a181c654990351956a57a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2015.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DA.%2BE.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26atitle%3DThiol%2520redox%2520biology%2520of%2520trypanosomatids%2520and%2520potential%2520targets%2520for%2520chemotherapy%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2016%26volume%3D206%26spage%3D67%26epage%3D74%26doi%3D10.1016%2Fj.molbiopara.2015.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2016.193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1038%2Fnrmicro.2016.193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28239154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=217-231&author=M.+C.+Fieldauthor=D.+Hornauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+W.+Grayauthor=K.+D.+Readauthor=M.+De+Ryckerauthor=L.+S.+Torrieauthor=P.+G.+Wyattauthor=S.+Wyllieauthor=I.+H.+Gilbert&title=Anti-trypanosomatid+drug+discovery%3A+an+ongoing+challenge+and+a+continuing+need&doi=10.1038%2Fnrmicro.2016.193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span></div><div class="casAuthors">Field, Mark C.; Horn, David; Fairlamb, Alan H.; Ferguson, Michael A. J.; Gray, David W.; Read, Kevin D.; De Rycker, Manu; Torrie, Leah S.; Wyatt, Paul G.; Wyllie, Susan; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-231</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.  These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal.  Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them.  In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled.  In addn., we consider the important challenges to drug discovery strategies and the new technologies that can address them.  The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBpRGL7YaP7Vg90H21EOLACvtfcHk0lhT3UcATl5X0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D&md5=1585d954d6eb695196a6c8921a84e300</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2016.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2016.193%26sid%3Dliteratum%253Aachs%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DAnti-trypanosomatid%2520drug%2520discovery%253A%2520an%2520ongoing%2520challenge%2520and%2520a%2520continuing%2520need%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26spage%3D217%26epage%3D231%26doi%3D10.1038%2Fnrmicro.2016.193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanwar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munde, M.</span></span> <span> </span><span class="NLM_article-title">Molecular insights into trypanothione reductase-inhibitor interaction: A structure-based review</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>351</i></span>, <span class="NLM_elocation-id">1700373</span> <span class="refDoi"> DOI: 10.1002/ardp.201700373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fardp.201700373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2018&author=N.+Tiwariauthor=N.+Tanwarauthor=M.+Munde&title=Molecular+insights+into+trypanothione+reductase-inhibitor+interaction%3A+A+structure-based+review&doi=10.1002%2Fardp.201700373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fardp.201700373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201700373%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DN.%26aulast%3DTanwar%26aufirst%3DN.%26aulast%3DMunde%26aufirst%3DM.%26atitle%3DMolecular%2520insights%2520into%2520trypanothione%2520reductase-inhibitor%2520interaction%253A%2520A%2520structure-based%2520review%26jtitle%3DArch.%2520Pharm.%26date%3D2018%26volume%3D351%26doi%3D10.1002%2Fardp.201700373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battista, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorillo, A.</span></span> <span> </span><span class="NLM_article-title">Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>, <span class="NLM_elocation-id">1924</span> <span class="refDoi"> DOI: 10.3390/molecules25081924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.3390%2Fmolecules25081924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVekur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&author=T.+Battistaauthor=C.+Gianniauthor=A.+Ilariauthor=A.+Fiorillo&title=Targeting+trypanothione+reductase%2C+a+key+enzyme+in+the+redox+trypanosomatid+metabolism%2C+to+develop+new+drugs+against+leishmaniasis+and+trypanosomiases&doi=10.3390%2Fmolecules25081924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases</span></div><div class="casAuthors">Battista, Theo; Colotti, Gianni; Ilari, Andrea; Fiorillo, Annarita</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1924</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The protozoans Leishmania and Trypanosoma, belonging to the same Trypanosomatidae family, are the causative agents of Leishmaniasis, Chagas disease, and human African trypanosomiasis.  Overall, these infections affect millions of people worldwide, posing a serious health issue as well as socio-economical concern.  Current treatments are inadequate, mainly due to poor efficacy, toxicity, and emerging resistance; therefore, there is an urgent need for new drugs.  Among several mol. targets proposed, trypanothione reductase (TR) is of particular interest for its crit. role in controlling the parasite's redox homeostasis and several classes of active compds. that inhibit TR have been proposed so far.  This review provides a comprehensive overview of TR's structural characterization.  In particular, we discuss all the structural features of TR relevant for drug discovery, with a focus on the recent advances made in the understanding of inhibitor binding.  The reported cases show how, on the basis of the detailed structural information provided by the crystallog. anal., it is possible to rationally modify mol. scaffolds to improve their properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop2DZXElUewrVg90H21EOLACvtfcHk0lhT3UcATl5X0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVekur7M&md5=d19e3b7e88240c74ea2d9670ca357ec3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25081924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25081924%26sid%3Dliteratum%253Aachs%26aulast%3DBattista%26aufirst%3DT.%26aulast%3DGianni%26aufirst%3DC.%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DFiorillo%26aufirst%3DA.%26atitle%3DTargeting%2520trypanothione%2520reductase%252C%2520a%2520key%2520enzyme%2520in%2520the%2520redox%2520trypanosomatid%2520metabolism%252C%2520to%2520develop%2520new%2520drugs%2520against%2520leishmaniasis%2520and%2520trypanosomiases%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26doi%3D10.3390%2Fmolecules25081924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saccoliti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, R.</span></span> <span> </span><span class="NLM_article-title">Recent advancement in the search of innovative antiprotozoal agents targeting trypanothione metabolism</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2420</span>– <span class="NLM_lpage">2435</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcmdc.202000325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=32805075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslygtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=2420-2435&author=F.+Saccolitiauthor=R.+Di+Santoauthor=R.+Costi&title=Recent+advancement+in+the+search+of+innovative+antiprotozoal+agents+targeting+trypanothione+metabolism&doi=10.1002%2Fcmdc.202000325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism</span></div><div class="casAuthors">Saccoliti, Francesco; Di Santo, Roberto; Costi, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2420-2435</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Leishmania and Trypanosoma parasites are responsible for the challenging neglected tropical diseases leishmaniasis, Chagas disease, and human African trypanosomiasis, which account for up to 40,000 deaths annually mainly in developing countries.  Current chemotherapy relies on drugs with significant limitations in efficacy and safety, prompting the urgent need to explore innovative approaches to improve the drug discovery pipeline.  The unique trypanothione-based redox pathway, which is absent in human hosts, is vital for all trypanosomatids and offers valuable opportunities to guide the rational development of specific, broad-spectrum and innovative anti-trypanosomatid agents.  Major efforts focused on the key metabolic enzymes trypanothione synthetase-amidase and trypanothione reductase, whose inhibition should affect the entire pathway and, finally, parasite survival.  Herein, we will report and comment on the most recent studies in the search for enzyme inhibitors, underlining the promising opportunities that have emerged so far to drive the exploration of future successful therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoXJ31TxSdz7Vg90H21EOLACvtfcHk0lhdJord-EOCDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslygtLbL&md5=a0afb4a7a5057f38774f1c2be868bcbb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000325%26sid%3Dliteratum%253Aachs%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26atitle%3DRecent%2520advancement%2520in%2520the%2520search%2520of%2520innovative%2520antiprotozoal%2520agents%2520targeting%2520trypanothione%2520metabolism%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D2420%26epage%3D2435%26doi%3D10.1002%2Fcmdc.202000325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alphey, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanks, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Dihydroquinazolines as a novel class of <i>Trypanosoma brucei</i> trypanothione reductase inhibitors: discovery, synthesis and characterization of their binding mode by protein crystallography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6514</span>– <span class="NLM_lpage">6530</span>, <span class="refDoi"> DOI: 10.1021/jm200312v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200312v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWjs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6514-6530&author=S.+Pattersonauthor=M.+S.+Alpheyauthor=D.+C.+Jonesauthor=E.+J.+Shanksauthor=I.+P.+Streetauthor=J.+A.+Frearsonauthor=P.+G.+Wyattauthor=I.+H.+Gilbertauthor=A.+H.+Fairlamb&title=Dihydroquinazolines+as+a+novel+class+of+Trypanosoma+brucei+trypanothione+reductase+inhibitors%3A+discovery%2C+synthesis+and+characterization+of+their+binding+mode+by+protein+crystallography&doi=10.1021%2Fjm200312v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography</span></div><div class="casAuthors">Patterson, Stephen; Alphey, Magnus S.; Jones, Deuan C.; Shanks, Emma J.; Street, Ian P.; Frearson, Julie A.; Wyatt, Paul G.; Gilbert, Ian H.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6514-6530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trypanothione reductase (TryR) is a genetically validated drug target in the parasite Trypanosoma brucei, the causative agent of human African trypanosomiasis.  Here we report the discovery, synthesis, and development of a novel series of TryR inhibitors I (R1 = Me, Et, 4-morpholinylmethyl, Ph, etc.; R2 = Me, MeO2C, Ph, Me2NCH2CH2, etc.; R3 = cyclohexyl, Ph, 3-FC6H4, 3,4-Me2C6H4, PhCH2, etc.; X = H, OH; R4 = H, Cl, Br, I, Ph, 4-pyridyl, 1-naphthyl, etc.; R5 = H, Br, Ph) based on a 3,4-dihydroquinazoline scaffold.  In addn., a high resoln. crystal structure of TryR, alone and in complex with substrates and inhibitors from this series, is presented.  This represents the first report of a high resoln. complex between a noncovalent ligand and this enzyme.  Structural studies revealed that upon ligand binding the enzyme undergoes a conformational change to create a new subpocket which is occupied by an aryl group on the ligand.  Therefore, the inhibitor, in effect, creates its own small binding pocket within the otherwise large, solvent exposed active site.  The TryR-ligand structure was subsequently used to guide the synthesis of inhibitors, including analogs that challenged the induced subpocket.  This resulted in the development of inhibitors, such as I [R1 = Me; R2 = Me2N(CH2)2; R3 = 4-MeC6H4; R4 = Cl; R5 = X = H], with improved potency against both TryR and T. brucei parasites in a whole cell assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Yqr4e6doy7Vg90H21EOLACvtfcHk0lhdJord-EOCDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWjs7zN&md5=88926d1f4b18b350b3736b2770394fad</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm200312v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200312v%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DAlphey%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DShanks%26aufirst%3DE.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DDihydroquinazolines%2520as%2520a%2520novel%2520class%2520of%2520Trypanosoma%2520brucei%2520trypanothione%2520reductase%2520inhibitors%253A%2520discovery%252C%2520synthesis%2520and%2520characterization%2520of%2520their%2520binding%2520mode%2520by%2520protein%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6514%26epage%3D6530%26doi%3D10.1021%2Fjm200312v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span> <span> </span><span class="NLM_article-title">Polyamine-trypanothione pathway: an update</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.4155%2Ffmc-2016-0180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=27957878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=61-77&author=A.+Ilariauthor=A.+Fiorilloauthor=I.+Genoveseauthor=G.+Colotti&title=Polyamine-trypanothione+pathway%3A+an+update&doi=10.4155%2Ffmc-2016-0180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Polyamine-trypanothione pathway: an update</span></div><div class="casAuthors">Ilari, Andrea; Fiorillo, Annarita; Genovese, Ilaria; Colotti, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-77</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In trypanosomatids, polyamine and trypanothione pathways can be considered as a whole unique metab., where most enzymes are essential for parasitic survival and infectivity.  Leishmania parasites and all the other members of the Trypanosomatids family depend on polyamines for growth and survival: the enzymes involved in the synthesis and utilization of spermidine and trypanothione, i.e., arginase, ornithine decarboxylase, S-adenosylmethionine decarboxylase, spermidine synthase, and in particular trypanothione synthetase-amidase, trypanothione reductase and tryparedoxin-dependent peroxidase are promising targets for drug development.  This review deals with recent structure-based studies on these enzymes, aimed at the discovery of inhibitors of this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhWOIln1CS7Vg90H21EOLACvtfcHk0liDVqFblELxqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamsLjL&md5=89194c550293252b618900dabf5cb5b1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0180%26sid%3Dliteratum%253Aachs%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DFiorillo%26aufirst%3DA.%26aulast%3DGenovese%26aufirst%3DI.%26aulast%3DColotti%26aufirst%3DG.%26atitle%3DPolyamine-trypanothione%2520pathway%253A%2520an%2520update%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D61%26epage%3D77%26doi%3D10.4155%2Ffmc-2016-0180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oullette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, B.</span></span> <span> </span><span class="NLM_article-title">Disruption of the trypanothione reductase gene of <i>Leishmania</i> decreases its ability to survive oxidative stress in macrophages</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2590</span>– <span class="NLM_lpage">2598</span>, <span class="refDoi"> DOI: 10.1093/emboj/16.10.2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1093%2Femboj%2F16.10.2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=9184206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaK2sXjsF2hs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=2590-2598&author=C.+Dumasauthor=M.+Oulletteauthor=J.+Tovarauthor=M.+L.+Cunninghamauthor=A.+H.+Fairlambauthor=S.+Tamarauthor=M.+Olivierauthor=B.+Papadopoulou&title=Disruption+of+the+trypanothione+reductase+gene+of+Leishmania+decreases+its+ability+to+survive+oxidative+stress+in+macrophages&doi=10.1093%2Femboj%2F16.10.2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages</span></div><div class="casAuthors">Dumas, Carole; Ouellette, Marc; Tovar, Jorge; Cunningham, Mark L.; Fairlamb, Alan H.; Tamar, Samira; Olivier, Martin; Papadopoulou, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2590-2598</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Parasitic protozoa belonging to the order Kinetoplastida contain trypanothione as their major thiol.  Trypanothione reductase (TR), the enzyme responsible for maintaining trypanothione in its reduced form, is thought to be central to the redox defense systems of trypanosomatids.  To investigate further the physiol. role of TR in Leishmania, we attempted to create TR-knockout mutants by gene disruption in L. donovani and L. major strains using the selectable markable neomycin and hygromycin phosphotransferases.  TR is likely to be an important gene for parasite survival since all our attempts to obtain a TR null mutant in L. donovani failed.  Instead, we obtained mutants with a partial trisomy for the TR locus where, despite the successful disruption of two TR alleles by gene targeting, a third TR copy was generated as a result of genomic rearrangements involving the translocation of a TR-contg. region to a larger chromosome.  Mutants of L. donovani and L. major possessing only one wild-type TR allele express less TR mRNA and have lower TR activity compared with wild-type cells carrying two copies of the TR gene.  Significantly, these mutants show attenuated infectivity with a markedly decreased capacity to survive intracellularly within macrophages, provided that the latter are producing reactive oxygen intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9OoguRHiLiLVg90H21EOLACvtfcHk0liDVqFblELxqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsF2hs7k%253D&md5=741e990c3e3ece2ad9294daa81374712</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.10.2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.10.2590%26sid%3Dliteratum%253Aachs%26aulast%3DDumas%26aufirst%3DC.%26aulast%3DOullette%26aufirst%3DM.%26aulast%3DTovar%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DM.%2BL.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DTamar%26aufirst%3DS.%26aulast%3DOlivier%26aufirst%3DM.%26aulast%3DPapadopoulou%26aufirst%3DB.%26atitle%3DDisruption%2520of%2520the%2520trypanothione%2520reductase%2520gene%2520of%2520Leishmania%2520decreases%2520its%2520ability%2520to%2520survive%2520oxidative%2520stress%2520in%2520macrophages%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D2590%26epage%3D2598%26doi%3D10.1093%2Femboj%2F16.10.2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Gasparo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harangozo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Targeting a large active site: structure-based design of nanomolar inhibitors of <i>Trypanosoma brucei</i> trypanothione reductase</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">11416</span>– <span class="NLM_lpage">11421</span>, <span class="refDoi"> DOI: 10.1002/chem.201901664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fchem.201901664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31407832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjs7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=11416-11421&author=R.+De%0AGasparoauthor=O.+Halgasauthor=D.+Harangozoauthor=M.+Kaiserauthor=E.+F.+Paiauthor=R.+L.+Krauth-Siegelauthor=F.+Diederich&title=Targeting+a+large+active+site%3A+structure-based+design+of+nanomolar+inhibitors+of+Trypanosoma+brucei+trypanothione+reductase&doi=10.1002%2Fchem.201901664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase</span></div><div class="casAuthors">De Gasparo, Raoul; Halgas, Ondrej; Harangozo, Dora; Kaiser, Marcel; Pai, Emil F.; Krauth-Siegel, R. Luise; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">11416-11421</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Trypanothione reductase (TR) plays a key role in the unique redox metab. of trypanosomatids, the causative agents of human African trypanosomiasis (HAT), Chagas' disease, and leishmaniases.  Introduction of a new, lean propargylic vector to a known class of TR inhibitors resulted in the strongest reported competitive inhibitor of Trypanosoma (T.) brucei TR, with an inhibition const. Ki of 73 nM, which is fully selective against human glutathione reductase (hGR).  The best ligands exhibited in vitro IC50 values (half-maximal inhibitory concn.) against the HAT pathogen, T. brucei rhodesiense, in the mid-nanomolar range, reaching down to 50 nM. X-Ray co-crystal structures confirmed the binding mode of the ligands and revealed the presence of a HEPES buffer mol. in the large active site.  Extension of the propargylic vector, guided by structure-based design, to replace the HEPES buffer mol. should give inhibitors with low nanomolar Ki and IC50 values for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBy2IMEKQxW7Vg90H21EOLACvtfcHk0liDVqFblELxqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjs7%252FN&md5=38dd84304eecc21db7f0e080b99cd710</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fchem.201901664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201901664%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DR.%26aulast%3DHalgas%26aufirst%3DO.%26aulast%3DHarangozo%26aufirst%3DD.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DTargeting%2520a%2520large%2520active%2520site%253A%2520structure-based%2520design%2520of%2520nanomolar%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520trypanothione%2520reductase%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2019%26volume%3D25%26spage%3D11416%26epage%3D11421%26doi%3D10.1002%2Fchem.201901664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span>; <span class="NLM_string-name">Ridley, R. G.</span>; <span class="NLM_string-name">Vial, H. J.</span></span> <i>Drugs against Parasitic Diseases: R&D Methodologies and Issues, Discoveries and Drug Development</i>, TDR/PRD/03.1; <span class="NLM_publisher-name">WHO</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">118</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=A.+H.+Fairlamb&author=R.+G.+Ridley&author=H.+J.+Vial&title=Drugs+against+Parasitic+Diseases%3A+R%26D+Methodologies+and+Issues%2C+Discoveries+and+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26jtitle%3DDrugs%2520against%2520Parasitic%2520Diseases%253A%2520R%2526D%2520Methodologies%2520and%2520Issues%252C%2520Discoveries%2520and%2520Drug%2520Development%26pub%3DWHO%26date%3D2003%26spage%3D107%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Dual action of antimonial drugs on thiol redox metabolism in the human pathogen <i>Leishmania donovani</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">39925</span>– <span class="NLM_lpage">39932</span>, <span class="refDoi"> DOI: 10.1074/jbc.M405635200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1074%2Fjbc.M405635200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=15252045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVKku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=39925-39932&author=S.+Wyllieauthor=M.+L.+Cunninghamauthor=A.+H.+Fairlamb&title=Dual+action+of+antimonial+drugs+on+thiol+redox+metabolism+in+the+human+pathogen+Leishmania+donovani&doi=10.1074%2Fjbc.M405635200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani</span></div><div class="casAuthors">Wyllie, Susan; Cunningham, Mark L.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">39925-39932</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Despite extensive use of antimonial compds. in the treatment of leishmaniasis, their mode of action remains uncertain.  Here we show that trivalent antimony (SbIII) interferes with trypanothione metab. in drug-sensitive Leishmania parasites by 2 inherently distinct mechanisms.  First, SbIII decreases thiol buffering capacity by inducing rapid efflux of intracellular trypanothione and glutathione in approx. equimolar amts.  Second, SbIII inhibits trypanothione reductase in intact cells, resulting in accumulation of the disulfide forms of trypanothione and glutathione.  These 2 mechanisms combine to profoundly compromise the thiol redox potential in both amastigote and promastigote stages of the life cycle.  Furthermore, we demonstrate that sodium stibogluconate, a pentavalent antimonial used clin. for the treatment for leishmaniasis, induces similar effects on thiol redox metab. in axenically cultured amastigotes.  These observations suggest ways in which current antimony therapies could be improved, overcoming the growing problem of antimony resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqnMKFh1ixPbVg90H21EOLACvtfcHk0ljnp75POEK8lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVKku7k%253D&md5=ba95437aa1cdac7e923b4edcba77f7c4</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M405635200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M405635200%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DM.%2BL.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DDual%2520action%2520of%2520antimonial%2520drugs%2520on%2520thiol%2520redox%2520metabolism%2520in%2520the%2520human%2520pathogen%2520Leishmania%2520donovani%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D39925%26epage%3D39932%26doi%3D10.1074%2Fjbc.M405635200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyanayagam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, C.</span></span> <span> </span><span class="NLM_article-title">Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2000.01721.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1046%2Fj.1365-2958.2000.01721.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10672177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12iu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=542-552&author=S.+Kriegerauthor=W.+Schwarzauthor=M.+R.+Ariyanayagamauthor=A.+H.+Fairlambauthor=R.+L.+Krauth-Siegelauthor=C.+Clayton&title=Trypanosomes+lacking+trypanothione+reductase+are+avirulent+and+show+increased+sensitivity+to+oxidative+stress&doi=10.1046%2Fj.1365-2958.2000.01721.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress</span></div><div class="casAuthors">Krieger, S.; Schwarz, W.; Ariyanayagam, M. R.; Fairlamb, A. H.; Krauth-Siegel, R. L.; Clayton, C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">542-552</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">In Kinetoplastida, trypanothione and trypanothione reductase (TRYR) provide an intracellular reducing environment, substituting for the glutathione-glutathione reductase system found in most other organisms.  To investigate the physiol. role of TRYR in Trypanosoma brucei, the authors generated cells contg. just one trypanothione reductase gene, TRYR, which was under the control of a tetracycline-inducible promoter.  This enabled them to regulate TRYR activity in the cells from less than 1% to 400% of wild-type levels by adjusting the concn. of added tetracycline.  In normal growth medium (which contains reducing agents), trypanosomes contg. less than 10% of wild-type enzyme activity were unable to grow, although the levels of reduced trypanothione and total thiols remained const.  In media lacking reducing agents, hypersensitivity towards hydrogen peroxide (EC50 = 3.5 μM) was obsd. compared with the wild type (EC50 = 223 μM).  The depletion of TRYR had no effect on susceptibility to melarsen oxide.  The infectivity and virulence of the parasites in mice was dependent upon tetracycline-regulated TRYR activity: if the trypanosomes were injected into mice in the absence of tetracycline, no infection was detectable; and when tetracycline was withdrawn from previously infected animals, the parasitemia was suppressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2EKuT6CV6CrVg90H21EOLACvtfcHk0ljnp75POEK8lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12iu74%253D&md5=29124c2e79d1752607204bbd4274a821</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2000.01721.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2000.01721.x%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DW.%26aulast%3DAriyanayagam%26aufirst%3DM.%2BR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DClayton%26aufirst%3DC.%26atitle%3DTrypanosomes%2520lacking%2520trypanothione%2520reductase%2520are%2520avirulent%2520and%2520show%2520increased%2520sensitivity%2520to%2520oxidative%2520stress%26jtitle%3DMol.%2520Microbiol.%26date%3D2000%26volume%3D35%26spage%3D542%26epage%3D552%26doi%3D10.1046%2Fj.1365-2958.2000.01721.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baiocco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span> <span> </span><span class="NLM_article-title">Trypanothione reductase from <i>Leishmania infantum</i>: cloning, expression, purification, crystallization and preliminary X-ray data analysis</span>. <i>Protein Pept. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.2174/092986609787316306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.2174%2F092986609787316306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=19200044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVequ74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=196-200&author=P.+Baioccoauthor=S.+Franceschiniauthor=A.+Ilariauthor=G.+Colotti&title=Trypanothione+reductase+from+Leishmania+infantum%3A+cloning%2C+expression%2C+purification%2C+crystallization+and+preliminary+X-ray+data+analysis&doi=10.2174%2F092986609787316306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanothione reductase from Leishmania infantum: Cloning, expression, purification, crystallization and preliminary x-ray data analysis</span></div><div class="casAuthors">Baiocco, Paola; Franceschini, Stefano; Ilari, Andrea; Colotti, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-200</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The most promising targets for Leishmania-specific drug design are 2 key enzymes involved in the unique thiol-based metab., common to all parasites of the Trypanosomatidae family: trypanothione synthetase and trypanothione reductase (I).  Recently, new inhibitors of I have been identified such as polyamines and tricyclic compds.  The knowledge of the 3-dimensional structure of Leishmania I will shed light on the mechanism of interaction of these inhibitors with I and will be the starting point to design novel lead candidates to facilitate the development of new effective and affordable drugs.  Here, I of L. infantum was cloned, expressed in Escherichia coli, and purified.  Crystals were obtained at 294 K by the hanging-drop vapor-diffusion method using (NH4)2SO4 as precipitant and diffracted to better than 2.95 Å resoln. using a synchrotron radiation source.  The I crystals exhibited an unusually high solvent content of 74%, and were found to belong to tetragonal space group P41 with unit-cell parameters a = b = 103.45, c = 192.62 Å, and 2 mols. in the asym. unit.  The protein x-ray structure has been solved by mol. replacement and the model is under construction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTnM4ouqhEc7Vg90H21EOLACvtfcHk0ljnp75POEK8lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVequ74%253D&md5=89a106a7bfc63e8a3a2bb48e9161119c</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.2174%2F092986609787316306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986609787316306%26sid%3Dliteratum%253Aachs%26aulast%3DBaiocco%26aufirst%3DP.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DColotti%26aufirst%3DG.%26atitle%3DTrypanothione%2520reductase%2520from%2520Leishmania%2520infantum%253A%2520cloning%252C%2520expression%252C%2520purification%252C%2520crystallization%2520and%2520preliminary%2520X-ray%2520data%2520analysis%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2009%26volume%3D16%26spage%3D196%26epage%3D200%26doi%3D10.2174%2F092986609787316306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baiocco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of antimony treatment in leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2603</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1021/jm900185q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900185q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Glurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2603-2612&author=P.+Baioccoauthor=G.+Colottiauthor=S.+Franceschiniauthor=A.+Ilari&title=Molecular+basis+of+antimony+treatment+in+leishmaniasis&doi=10.1021%2Fjm900185q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Antimony Treatment in Leishmaniasis</span></div><div class="casAuthors">Baiocco, Paola; Colotti, Gianni; Franceschini, Stefano; Ilari, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2603-2612</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Leishmaniasis is a disease that affects 2 million people and kills 70000 persons every year.  It is caused by Leishmania species, which are human protozoan parasites of the trypanosomatidae family.  Trypanosomatidae differ from the other eukaryotes in their specific redox metab. because the glutathione/glutathione reductase system is replaced by the unique trypanothione/trypanothione reductase system.  The current treatment of leishmaniasis relies mainly on antimonial drugs.  The crystal structures of oxidized trypanothione reductase (TR) from Leishmania infantum and of the complex of reduced TR with NADPH and Sb(III), reported in this paper, disclose for the first time the mol. mechanism of action of antimonial drugs against the parasite.  Sb(III), which is coordinated by the two redox-active catalytic cysteine residues (Cys52 and Cys57), one threonine residue (Thr335), and His461' of the 2-fold symmetry related subunit in the dimer, strongly inhibits TR activity.  Because TR is essential for the parasite survival and virulence and it is absent in mammalian cells, these findings provide insights toward the design of new more affordable and less toxic drugs against Leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRjK4eboFKabVg90H21EOLACvtfcHk0ljbQNDAx2kBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Glurc%253D&md5=c5fa0e9358491d5d7f285619eb2fe333</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm900185q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900185q%26sid%3Dliteratum%253Aachs%26aulast%3DBaiocco%26aufirst%3DP.%26aulast%3DColotti%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DIlari%26aufirst%3DA.%26atitle%3DMolecular%2520basis%2520of%2520antimony%2520treatment%2520in%2520leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2603%26epage%3D2612%26doi%3D10.1021%2Fjm900185q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Persch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todoroff, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirdjaja, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derbani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1891</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201402032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcmdc.201402032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=24788386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1880-1891&author=E.+Perschauthor=S.+Brysonauthor=N.+K.+Todoroffauthor=C.+Eberleauthor=J.+Thelemannauthor=N.+Dirdjajaauthor=M.+Kaiserauthor=M.+Weberauthor=H.+Derbaniauthor=R.+Brunauthor=G.+Schneiderauthor=E.+F.+Paiauthor=R.+L.+Krauth-Siegelauthor=F.+Diederich&title=Binding+to+large+enzyme+pockets%3A+small-molecule+inhibitors+of+trypanothione+reductase&doi=10.1002%2Fcmdc.201402032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Binding to Large Enzyme Pockets: Small-Molecule Inhibitors of Trypanothione Reductase</span></div><div class="casAuthors">Persch, Elke; Bryson, Steve; Todoroff, Nickolay K.; Eberle, Christian; Thelemann, Jonas; Dirdjaja, Natalie; Kaiser, Marcel; Weber, Maria; Derbani, Hassan; Brun, Reto; Schneider, Gisbert; Pai, Emil F.; Krauth-Siegel, R. Luise; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1880-1891</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The causative agents of the parasitic disease human African trypanosomiasis belong to the family of trypanosomatids.  These parasitic protozoa exhibit a unique thiol redox metab. that is based on the flavoenzyme trypanothione reductase (TR).  TR was identified as a potential drug target and features a large active site that allows a multitude of possible ligand orientations, which renders rational structure-based inhibitor design highly challenging.  Herein we describe the synthesis, binding properties, and kinetic anal. of a new series of small-mol. inhibitors of TR.  The conjunction of biol. activities, mutation studies, and virtual ligand docking simulations led to the prediction of a binding mode that was confirmed by crystal structure anal.  The crystal structures revealed that the ligands bind to the hydrophobic wall of the so-called "mepacrine binding site".  The binding conformation and potency of the inhibitors varied for TR from Trypanosoma brucei and T. cruzi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvk-DaSeuaBLVg90H21EOLACvtfcHk0ljbQNDAx2kBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGmsbo%253D&md5=494d9a33a79de5eaae0309fe39dd677c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402032%26sid%3Dliteratum%253Aachs%26aulast%3DPersch%26aufirst%3DE.%26aulast%3DBryson%26aufirst%3DS.%26aulast%3DTodoroff%26aufirst%3DN.%2BK.%26aulast%3DEberle%26aufirst%3DC.%26aulast%3DThelemann%26aufirst%3DJ.%26aulast%3DDirdjaja%26aufirst%3DN.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DDerbani%26aufirst%3DH.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBinding%2520to%2520large%2520enzyme%2520pockets%253A%2520small-molecule%2520inhibitors%2520of%2520trypanothione%2520reductase%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1880%26epage%3D1891%26doi%3D10.1002%2Fcmdc.201402032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Gasparo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodbeck-Persch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentzen, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation and X-ray Co-crystal structures of cyclohexylpyrrolidine ligands for trypanothione reductase, an enzyme from the redox metabolism of trypanosoma</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcmdc.201800067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29624890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFaisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=957-967&author=R.+De%0AGasparoauthor=E.+Brodbeck-Perschauthor=S.+Brysonauthor=N.+B.+Hentzenauthor=M.+Kaiserauthor=E.+F.+Paiauthor=R.+L.+Krauth-Siegelauthor=F.+Diederich&title=Biological+evaluation+and+X-ray+Co-crystal+structures+of+cyclohexylpyrrolidine+ligands+for+trypanothione+reductase%2C+an+enzyme+from+the+redox+metabolism+of+trypanosoma&doi=10.1002%2Fcmdc.201800067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma</span></div><div class="casAuthors">De Gasparo, Raoul; Brodbeck-Persch, Elke; Bryson, Steve; Hentzen, Nina B.; Kaiser, Marcel; Pai, Emil F.; Krauth-Siegel, R. Luise; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">957-967</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The tropical diseases human African trypanosomiasis, Chagas disease, and the various forms of leishmaniasis are caused by parasites of the family of trypanosomatids.  These protozoa possess a unique redox metab. based on trypanothione and trypanothione reductase (TR), making TR a promising drug target.  We report the optimization of properties and potency of cyclohexylpyrrolidine inhibitors of TR by structure-based design.  The best inhibitors were freely sol. and showed competitive inhibition consts. (Ki) against Trypanosoma (T.) brucei TR and T. cruzi TR and in vitro activities (half-maximal inhibitory concn., IC50) against these parasites in the low micromolar range, with high selectivity against human glutathione reductase.  X-ray co-crystal structures confirmed the binding of the ligands to the hydrophobic wall of the "mepacrine binding site" with the new, soly.-providing vectors oriented toward the surface of the large active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9ijT5bkmCbVg90H21EOLACvtfcHk0ljbQNDAx2kBkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFaisrk%253D&md5=a94783c83362cb70fdfef0a77bcf91ec</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800067%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DR.%26aulast%3DBrodbeck-Persch%26aufirst%3DE.%26aulast%3DBryson%26aufirst%3DS.%26aulast%3DHentzen%26aufirst%3DN.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBiological%2520evaluation%2520and%2520X-ray%2520Co-crystal%2520structures%2520of%2520cyclohexylpyrrolidine%2520ligands%2520for%2520trypanothione%2520reductase%252C%2520an%2520enzyme%2520from%2520the%2520redox%2520metabolism%2520of%2520trypanosoma%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D957%26epage%3D967%26doi%3D10.1002%2Fcmdc.201800067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzate, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span> <span> </span><span class="NLM_article-title">Probing the dimerization interface of <i>Leishmania infantum</i> trypanothione reductase with site-directed mutagenesis and short peptides</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1212</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcbic.201200744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=23744811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1212-1217&author=M.+A.+Toroauthor=P.+A.+S%C3%A1nchez-Murciaauthor=D.+Morenoauthor=M.+Ruiz-Santaquiteriaauthor=J.+F.+Alzateauthor=A.+Negriauthor=M.+J.+Camarasaauthor=F.+Gagoauthor=S.+Vel%C3%A1zquezauthor=A.+Jim%C3%A9nez-Ruiz&title=Probing+the+dimerization+interface+of+Leishmania+infantum+trypanothione+reductase+with+site-directed+mutagenesis+and+short+peptides&doi=10.1002%2Fcbic.201200744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Dimerization Interface of Leishmania infantum Trypanothione Reductase with Site-Directed Mutagenesis and Short Peptides</span></div><div class="casAuthors">Toro, Miguel A.; Sanchez-Murcia, Pedro A.; Moreno, David; Ruiz-Santaquiteria, Marta; Alzate, Juan Fernando; Negri, Ana; Camarasa, Maria-Jose; Gago, Federico; Velazquez, Sonsoles; Jimenez-Ruiz, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1212-1217</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The inhibitory activity was tested of a set of peptide sequences derived from an α-helix of the dimeric trypanothione reductase from Leishmania infantum.  Replacement of a glutamic acid residue with a lysine promoted monomer dissocn. and enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhsufkT7uGFbVg90H21EOLACvtfcHk0li-Z-ORajTk5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFarurw%253D&md5=5b883d783bdbc6ac5ce640c51653cacc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200744%26sid%3Dliteratum%253Aachs%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DAlzate%26aufirst%3DJ.%2BF.%26aulast%3DNegri%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26atitle%3DProbing%2520the%2520dimerization%2520interface%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%2520with%2520site-directed%2520mutagenesis%2520and%2520short%2520peptides%26jtitle%3DChemBioChem%26date%3D2013%26volume%3D14%26spage%3D1212%26epage%3D1217%26doi%3D10.1002%2Fcbic.201200744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Comparison of hydrocarbon- and lactam-bridged cyclic peptides as dimerization inhibitors of <i>Leishmania infantum</i> trypanothione reductase</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">55784</span>– <span class="NLM_lpage">55794</span>, <span class="refDoi"> DOI: 10.1039/C5RA06853C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FC5RA06853C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=55784-55794&author=P.+A.+S%C3%A1nchez-Murciaauthor=M.+Ruiz-Santaquiteriaauthor=M.+A.+Toroauthor=H.+De+Lucioauthor=M.+A.+Jim%C3%A9nezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=Comparison+of+hydrocarbon-+and+lactam-bridged+cyclic+peptides+as+dimerization+inhibitors+of+Leishmania+infantum+trypanothione+reductase&doi=10.1039%2FC5RA06853C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of hydrocarbon-and lactam-bridged cyclic peptides as dimerization inhibitors of Leishmania infantum trypanothione reductase</span></div><div class="casAuthors">Sanchez-Murcia, Pedro A.; Ruiz-Santaquiteria, Marta; Toro, Miguel A.; de Lucio, Hector; Jimenez, Maria Angeles; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">69</span>),
    <span class="NLM_cas:pages">55784-55794</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">All-hydrocarbon and lactam-bridged staples linking amino acid side-chains have been used to stabilize the α-helical motif in short 13-mer peptides that target crit. protein-protein interactions at the dimerization interface of Leishmania infantum trypanothione reductase (Li-TryR).  The design of the best positions for covalent hydrocarbon closure relied on a theor. prediction of the degree of helicity of the corresponding cyclic peptides in water.  Selected (i, i + 4) and (i, i + 7) hydrocarbon-stapled peptides were prepd. by using solid-phase synthesis protocols and optimized ring-closing metathesis reactions under microwave conditions.  Structural anal. by NMR spectroscopy confirmed high helical contents in aq. TFE solns. for both types of helix-constrained cyclic peptides.  Remarkably, the ability to prevent Li-TryR dimerization was reduced in both (i, i + 4) and (i, i + 7) hydrocarbon stapled peptides but was retained in the corresponding (i, i + 4) Glu-Lys lactam-bridged analog, which also showed a higher resistance to proteolytic degrdn. by proteinase K relative to the linear peptide prototype.  In silico studies indicated that the introduction of a hydrocarbon staple vs. a lactam bridge likely perturbs crit. interactions required for proper binding of the peptide to the Li-TryR monomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzL_ModJCzbrVg90H21EOLACvtfcHk0li-Z-ORajTk5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltbrK&md5=ef9bb8be43e2042a614ddaa15ba8e2df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC5RA06853C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA06853C%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DM.%2BA.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DComparison%2520of%2520hydrocarbon-%2520and%2520lactam-bridged%2520cyclic%2520peptides%2520as%2520dimerization%2520inhibitors%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D55784%26epage%3D55794%26doi%3D10.1039%2FC5RA06853C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled -helical peptides with improved proteolytic stability</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.02.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2018.02.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29501944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVCgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2018&pages=238-247&author=M.+Ruiz-Santaquiteriaauthor=S.+De+Castroauthor=M.+A.+Toroauthor=H.+De+Lucioauthor=K.+J.+Guti%C3%A9rrezauthor=P.+A.+S%C3%A1nchez-Murciaauthor=M.+A.+Jim%C3%A9nezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=Trypanothione+reductase+inhibition+and+anti-leishmanial+activity+of+all-hydrocarbon+stapled+-helical+peptides+with+improved+proteolytic+stability&doi=10.1016%2Fj.ejmech.2018.02.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability</span></div><div class="casAuthors">Ruiz-Santaquiteria, Marta; de Castro, Sonia; Toro, Miguel A.; de Lucio, Hector; Gutierrez, Kilian Jesus; Sanchez-Murcia, Pedro A.; Jimenez, Maria Angeles; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">238-247</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Trypanothione reductase (TryR) is a well-established target in the search for novel antitrypanosomal and antileishmanial agents.  The authors have previously identified linear and lactam-bridged 13-residue peptides derived from an α-helical region making up part of the dimeric interface of Leishmania infantum TryR (Li-TryR) which prevent trypanothione redn. by disrupting enzyme dimerization.  The authors now show that i,i + 4 side-chain crosslinking with an all-hydrocarbon staple stabilizes the helical structure of these peptides and significantly improves their resistance to protease cleavage relative to previous linear and cyclic lactam analogs.  Interestingly, replacement of the amide bridge by the hydrocarbon staple at the same cyclization positions generates derivs. (2 and 3) that similarly inhibit oxidoreductase activity of the enzyme but unexpectedly stabilize the TryR homodimer.  The most proteolytically stable peptide 2 covalently linked to oligoarginines displayed potent in vitro leishmanicidal activity against L. infantum parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHlkUhyIXErVg90H21EOLACvtfcHk0li-Z-ORajTk5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVCgsbg%253D&md5=b52ee080f76842c1bafac149f4a4c64e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.02.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.02.071%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DDe%2BCastro%26aufirst%3DS.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DM.%2BA.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DTrypanothione%2520reductase%2520inhibition%2520and%2520anti-leishmanial%2520activity%2520of%2520all-hydrocarbon%2520stapled%2520-helical%2520peptides%2520with%2520improved%2520proteolytic%2520stability%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D149%26spage%3D238%26epage%3D247%26doi%3D10.1016%2Fj.ejmech.2018.02.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Improved proteolytic stability and potent activity against <i>Leishmania infantum</i> trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2017.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29017116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=615-623&author=H.+De%0ALucioauthor=A.+M.+Gamoauthor=M.+Ruiz-Santaquiteriaauthor=S.+De+Castroauthor=P.+A.+S%C3%A1nchez-Murciaauthor=M.+A.+Toroauthor=K.+J.+Guti%C3%A9rrezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=Improved+proteolytic+stability+and+potent+activity+against+Leishmania+infantum+trypanothione+reductase+of+%CE%B1%2F%CE%B2-peptide+foldamers+conjugated+to+cell-penetrating+peptides&doi=10.1016%2Fj.ejmech.2017.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides</span></div><div class="casAuthors">de Lucio, Hector; Gamo, Ana Maria; Ruiz-Santaquiteria, Marta; de Castro, Sonia; Sanchez-Murcia, Pedro A.; Toro, Miguel A.; Gutierrez, Kilian Jesus; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">615-623</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The objective of the current study was to enhance the proteolytic stability of peptide-based inhibitors that target crit. protein-protein interactions at the dimerization interface of Leishmania infantum trypanothione reductase (Li-TryR) using a backbone modification strategy.  To achieve this goal we carried out the synthesis, proteolytic stability studies and biol. evaluation of a small library of α/β3-peptide foldamers of different length (from 9-mers to 13-mers) and different α→β substitution patterns related to prototype linear α-peptides.  We show that several 13-residue α/β3-peptide foldamers retain inhibitory potency against the enzyme (in both activity and dimerization assays) while they are far less susceptible to proteolytic degrdn. than an analogous α-peptide.  The strong dependence of the binding affinities for Li-TryR on the length of the α,β-peptides is supported by theor. calcns. on conformational ensembles of the resulting complexes.  The conjugation of the most proteolytically stable α/β-peptide with oligoarginines results in a mol. with potent activity against L. infantum promastigotes and amastigotes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQjnGz46wXPLVg90H21EOLACvtfcHk0lhz893Hns1Zkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egt7%252FL&md5=5b9336bc6bd284339386234a79430221</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGamo%26aufirst%3DA.%2BM.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DDe%2BCastro%26aufirst%3DS.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DImproved%2520proteolytic%2520stability%2520and%2520potent%2520activity%2520against%2520Leishmania%2520infantum%2520trypanothione%2520reductase%2520of%2520%25CE%25B1%252F%25CE%25B2-peptide%2520foldamers%2520conjugated%2520to%2520cell-penetrating%2520peptides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D140%26spage%3D615%26epage%3D623%26doi%3D10.1016%2Fj.ejmech.2017.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, F. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">First example of peptides targeting the dimer interface of <i>Leishmania infantum</i> trypanothione reductase with potent in vitro antileishmanial activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2017.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28431354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVertbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=49-59&author=M.+Ruiz-Santaquiteriaauthor=P.+A.+S%C3%A1nchez-Murciaauthor=M.+A.+Toroauthor=H.+De+Lucioauthor=K.+J.+Guti%C3%A9rrezauthor=S.+De+Castroauthor=F.+A.+C.+Carneiroauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=First+example+of+peptides+targeting+the+dimer+interface+of+Leishmania+infantum+trypanothione+reductase+with+potent+in+vitro+antileishmanial+activity&doi=10.1016%2Fj.ejmech.2017.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity#</span></div><div class="casAuthors">Ruiz-Santaquiteria, Marta; Sanchez-Murcia, Pedro A.; Toro, Miguel A.; de Lucio, Hector; Gutierrez, Kilian Jesus; de Castro, Sonia; Carneiro, Filipa A. C.; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-59</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 9-mer and 13-mer amide-bridged cyclic peptides derived from the linear prototype Ac-PKIIQSVGIS-Nle-K-Nle-NH2 (Toro et al. ChemBioChem2013) has been designed and synthesized by introduction of the lactam between amino acid side chains that are sepd. by one helical turn (i, i+4).  All of these compds. were tested in vitro as both dimerization and enzyme inhibitors of Leishmania infantum trypanothione reductase (Li-TryR).  Three of the 13-mer cyclic peptide derivs. inhibited the oxidoreductase activity of Li-TryR in the low micromolar range and they also disrupted enzyme dimerization.  Cyclic analogs were more resistant to proteases than was the linear prototype.  Furthermore, the most potent TryR inhibitors in the linear and cyclic series displayed potent in vitro activity against Leishmania infantum upon conjugation with cationic cell-penetrating peptides.  To date, these conjugated peptides can be considered the first example of TryR dimerization inhibitors that are active in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZnJx3mnsk7Vg90H21EOLACvtfcHk0lhz893Hns1Zkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVertbo%253D&md5=62be4b235d84b14f717be07ba09eb500</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DDe%2BCastro%26aufirst%3DS.%26aulast%3DCarneiro%26aufirst%3DF.%2BA.%2BC.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DFirst%2520example%2520of%2520peptides%2520targeting%2520the%2520dimer%2520interface%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%2520with%2520potent%2520in%2520vitro%2520antileishmanial%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D49%26epage%3D59%26doi%3D10.1016%2Fj.ejmech.2017.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Revuelto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carriles, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermoso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in nonpeptidic dimerization inhibitors of <i>Leishmania infantum</i> trypanothione reductase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00355</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00355" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnt1emt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=873-891&author=A.+Revueltoauthor=M.+Ruiz-Santaquiteriaauthor=H.+De+Lucioauthor=A.+Gamoauthor=A.+A.+Carrilesauthor=K.+J.+Guti%C3%A9rrezauthor=P.+A.+S%C3%A1nchez-Murciaauthor=J.+A.+Hermosoauthor=F.+Gagoauthor=M.+J.+Camarasaauthor=A.+Jim%C3%A9nez-Ruizauthor=S.+Vel%C3%A1zquez&title=Pyrrolopyrimidine+vs+imidazole-phenyl-thiazole+scaffolds+in+nonpeptidic+dimerization+inhibitors+of+Leishmania+infantum+trypanothione+reductase&doi=10.1021%2Facsinfecdis.8b00355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolopyrimidine vs. Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase</span></div><div class="casAuthors">Revuelto, Alejandro; Ruiz-Santaquiteria, Marta; de Lucio, Hector; Gamo, Ana; Carriles, Alejandra A.; Gutierrez, Kilian Jesus; Sanchez-Murcia, Pedro A.; Hermoso, Juan A.; Gago, Federico; Camarasa, Maria-Jose; Jimenez-Ruiz, Antonio; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-891</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Disruption of protein-protein interactions of essential oligomeric enzymes by small mols. represents a significant challenge.  We recently reported some linear and cyclic peptides derived from an α-helical region present in the homodimeric interface of Leishmania infantum trypanothione reductase (Li-TryR) that showed potent effects on both dimerization and redox activity of this essential enzyme.  Here, we describe our first steps toward the design of nonpeptidic small-mol. Li-TryR dimerization disruptors using a proteomimetic approach.  The pyrrolopyrimidine and the 5-6-5 imidazole-phenyl-thiazole α-helix-mimetic scaffolds were suitably decorated with substituents that could mimic three key residues (K, Q, and I) of the linear peptide prototype (PKIIQSVGIS-Nle-K-Nle).  Extensive optimization of previously described synthetic methodologies was required.  A library of 15 compds. bearing different hydrophobic alkyl and arom. substituents was synthesized.  The imidazole-phenyl-thiazole-based analogs outperformed the pyrrolopyrimidine-based derivs. in both inhibiting the enzyme and killing extracellular and intracellular parasites in cell culture.  The most active imidazole-phenyl-thiazole compds. 3e and 3f inhibit Li-TryR and prevent growth of the parasites at low micromolar concns. similar to those required by the peptide prototype.  The intrinsic fluorescence of these compds. inside the parasites visually demonstrates their good permeability in comparison with previous peptide-based Li-TryR dimerization disruptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDSWj0L14SLVg90H21EOLACvtfcHk0lhz893Hns1Zkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnt1emt7o%253D&md5=6575b500e29b9ccdfe13e3686a02da3b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00355%26sid%3Dliteratum%253Aachs%26aulast%3DRevuelto%26aufirst%3DA.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGamo%26aufirst%3DA.%26aulast%3DCarriles%26aufirst%3DA.%2BA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DHermoso%26aufirst%3DJ.%2BA.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DPyrrolopyrimidine%2520vs%2520imidazole-phenyl-thiazole%2520scaffolds%2520in%2520nonpeptidic%2520dimerization%2520inhibitors%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D873%26epage%3D891%26doi%3D10.1021%2Facsinfecdis.8b00355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span> <span> </span><span class="NLM_article-title">Synthetic non-peptide mimetics of α-helices</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1039/B608043J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FB608043J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=17264933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=326-334&author=J.+M.+Davisauthor=L.+K.+Tsouauthor=A.+D.+Hamilton&title=Synthetic+non-peptide+mimetics+of+%CE%B1-helices&doi=10.1039%2FB608043J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic non-peptide mimetics of α-helices</span></div><div class="casAuthors">Davis, Jessica M.; Tsou, Lun K.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">326-334</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Proteins in nature fold into native conformations in which combinations of peripherally projected aliph., arom. and ionic functionalities direct a wide range of properties. α-Helixes, one of the most common protein secondary structures, serve as important recognition regions on protein surfaces for numerous protein-protein, protein-DNA and protein-RNA interactions.  These interactions are characterized by conserved structural features within the α-helical domain.  Rational design of structural mimetics of these domains with synthetic small mols. has proven an effective means to modulate such protein functions.  In this tutorial review the authors discuss strategies that utilize synthetic small-mol. antagonists to selectively target essential protein-protein interactions involved in certain diseases.  The authors also evaluate some of the protein-protein interactions that have been or are potential targets for α-helix mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVaarT0w-MSbVg90H21EOLACvtfcHk0lgLAd5yLN5XJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKlurg%253D&md5=762376cfbf797ff5f642a4256706a1d9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FB608043J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB608043J%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DSynthetic%2520non-peptide%2520mimetics%2520of%2520%25CE%25B1-helices%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2007%26volume%3D36%26spage%3D326%26epage%3D334%26doi%3D10.1039%2FB608043J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azzarito, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of -helix-mediated protein-protein interactions using designed molecules</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1038/nchem.1568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1038%2Fnchem.1568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=23422557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislWms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=161-173&author=V.+Azzaritoauthor=K.+Longauthor=N.+S.+Murphyauthor=A.+J.+Wilson&title=Inhibition+of+-helix-mediated+protein-protein+interactions+using+designed+molecules&doi=10.1038%2Fnchem.1568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of α-helix-mediated protein-protein interactions using designed molecules</span></div><div class="casAuthors">Azzarito, Valeria; Long, Kerya; Murphy, Natasha S.; Wilson, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-173</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inhibition of protein-protein interactions (PPIs) represents a significant challenge because it is unclear how they can be effectively and selectively targeted using small mols.  Achieving this goal is crit. given the defining role of these interactions in biol. processes.  A rational approach to inhibitor design based on the secondary structure at the interface is the focus of much research, and different classes of designed ligands have emerged, some of which effectively and selectively disrupt targeted PPIs.  This Review discusses the relevance of PPIs and, in particular, the importance of α-helix-mediated PPIs to chem. biol. and drug discovery with a focus on designing inhibitors, including constrained peptides, foldamers and proteomimetic-derived ligands.  In doing so, key challenges and major advances in developing generic approaches for the elaboration of PPI inhibitors are highlighted.  The challenges faced in developing such ligands as drug leads - and how criteria applied to these may differ from conventional small-mol. drugs - are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpsQAFaEkKq7Vg90H21EOLACvtfcHk0lgLAd5yLN5XJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislWms7c%253D&md5=161f88aa1c745dee9a95b1fab340b9fe</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1568%26sid%3Dliteratum%253Aachs%26aulast%3DAzzarito%26aufirst%3DV.%26aulast%3DLong%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DN.%2BS.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26atitle%3DInhibition%2520of%2520-helix-mediated%2520protein-protein%2520interactions%2520using%2520designed%2520molecules%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D161%26epage%3D173%26doi%3D10.1038%2Fnchem.1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span> <span> </span><span class="NLM_article-title">Helix mimetics: recent developments</span>. <i>Prog. Biophys. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.pbiomolbio.2015.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.pbiomolbio.2015.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26048776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2015&pages=33-40&author=A.+J.+Wilson&title=Helix+mimetics%3A+recent+developments&doi=10.1016%2Fj.pbiomolbio.2015.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Helix mimetics: Recent developments</span></div><div class="casAuthors">Wilson, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of protein-protein interaction (PPIs) inhibitors represents a challenging goal in chem. biol. and drug discovery.  PPIs are problematic targets because they involve large surfaces with less well defined features and recognition motifs that are less amenable to conventional exptl. and computational ligand discovery methodologies.  α-Helix mediated PPIs represent a sub group with a clearly defined interface and thus may be more amenable to the development of generic ligand discovery methods.  Indeed, this is borne out in numerous studies using peptides covalently constrained into a helical conformation resulting in improvement of myriad biophys. and cellular properties.  It is however desirable to have small mol. alternatives: a helix mimetic (proteomimetic) is a generic small mol. scaffold that projects functional groups in a similar spatial orientation so as to mimic the presentation of key amino acid side chains from the helix that mediates the PPI.  The first true example of a helix mimetic was described over a decade ago however this approach has not yet been elaborated to the extent that it receives similar levels of attention to constrained peptides.  This review explores recent significant developments in the area of small mol. α-helix mimetics and provides a crit. overview of success stories, potential limitations of the approach, and areas for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpwEmuwmbN7LVg90H21EOLACvtfcHk0lgLAd5yLN5XJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFehsb8%253D&md5=c075ab454b3b8b0e7f9a2712667a7aa4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2015.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26atitle%3DHelix%2520mimetics%253A%2520recent%2520developments%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D119%26spage%3D33%26epage%3D40%26doi%3D10.1016%2Fj.pbiomolbio.2015.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CHai, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-S.</span></span> <span> </span><span class="NLM_article-title">Novel pyrrolopyrimidine-based -helix mimetics: cell-permeable inhibitors of protein-protein interactions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1021/ja108230s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja108230s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=676-679&author=J.+H.+Leeauthor=Q.+Zhangauthor=S.+Joauthor=S.+C.+CHaiauthor=M.+Ohauthor=W.+Imauthor=H.+Luauthor=H.-S.+Lim&title=Novel+pyrrolopyrimidine-based+-helix+mimetics%3A+cell-permeable+inhibitors+of+protein-protein+interactions&doi=10.1021%2Fja108230s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Pyrrolopyrimidine-Based α-Helix Mimetics: Cell-Permeable Inhibitors of Protein-Protein Interactions</span></div><div class="casAuthors">Lee, Ji Hoon; Zhang, Qi; Jo, Sunhwan; Chai, Sergio C.; Oh, Misook; Im, Wonpil; Lu, Hua; Lim, Hyun-Suk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">676-679</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is considerable interest in developing non-peptidic, small-mol. α-helix mimetics to disrupt α-helix-mediated protein-protein interactions.  The design of a novel pyrrolopyrimidine-based scaffold, e.g. I, for such α-helix mimetics with increased conformational rigidity is reported.  A facile solid-phase synthetic route that is amenable to divergent synthesis of a large library was also developed.  Using a fluorescence polarization-based assay, cell-permeable, dual MDMX/MDM2 inhibitors were identified, demonstrating that the designed mols. can act as α-helix mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv4W7ktDH-wbVg90H21EOLACvtfcHk0lhQon7kY4rvwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylt7%252FM&md5=b39bcfe478f7f745a332167800eb9531</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja108230s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja108230s%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJo%26aufirst%3DS.%26aulast%3DCHai%26aufirst%3DS.%2BC.%26aulast%3DOh%26aufirst%3DM.%26aulast%3DIm%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DH.-S.%26atitle%3DNovel%2520pyrrolopyrimidine-based%2520-helix%2520mimetics%253A%2520cell-permeable%2520inhibitors%2520of%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D676%26epage%3D679%26doi%3D10.1021%2Fja108230s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a 5-6-5 imidazole-phenyl-thiazole based -helix mimetic</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1021/ol8022962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8022962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVequ7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=25-28&author=C.+G.+Cummingsauthor=N.+T.+Rossauthor=W.+P.+Kattauthor=A.+D.+Hamilton&title=Synthesis+and+biological+evaluation+of+a+5-6-5+imidazole-phenyl-thiazole+based+-helix+mimetic&doi=10.1021%2Fol8022962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of a 5-6-5 Imidazole-Phenyl-Thiazole Based α-Helix Mimetic</span></div><div class="casAuthors">Cummings, Christopher G.; Ross, Nathan T.; Katt, William P.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-28</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of small mols. that disrupt protein-protein interactions is a key goal in addressing a no. of disease states.  The α-helix is commonly found at protein interaction interfaces and has been the focus of substantial small mol. mimetic efforts.  One of the primary drawbacks of many small mol. α-helix mimetics is their hydrophobic core structures.  To address this problem we have developed a novel scaffold based on a more water sol. 5-6-5 imidazole-phenyl-thiazole core.  An inhibitor I of this class has been shown to disrupt the Cdc42/Dbs protein-protein interaction at micromolar concns. and may be useful in overcoming Cdc42-induced tumor resistance to anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSgWLc1YG2AbVg90H21EOLACvtfcHk0lhQon7kY4rvwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVequ7zO&md5=6788c1c8955381382442ae21f376b869</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol8022962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8022962%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DC.%2BG.%26aulast%3DRoss%26aufirst%3DN.%2BT.%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%25205-6-5%2520imidazole-phenyl-thiazole%2520based%2520-helix%2520mimetic%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D25%26epage%3D28%26doi%3D10.1021%2Fol8022962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharb, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chander, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yar, M. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacological significance of triazole scaffold</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.3109/14756360903524304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.3109%2F14756360903524304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=20583859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1-21&author=R.+Kharbauthor=P.+Chanderauthor=M.+S.+Yar&title=Pharmacological+significance+of+triazole+scaffold&doi=10.3109%2F14756360903524304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological significance of triazole scaffold</span></div><div class="casAuthors">Kharb, Rajeev; Sharma, Prabodh Chander; Yar, Mohammed Shahar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The triazole nucleus is one of the most important and well known heterocycles which is a common and integral feature of a variety of natural products and medicinal agents.  Triazole nucleus is present as a core structural component in an array of drug categories such as antimicrobial, anti-inflammatory, analgesic, antiepileptic, antiviral, antineoplastic, antihypertensive, antimalarial, local anesthetic, antianxiety, antidepressant, antihistaminic, antioxidant, antitubercular, anti-Parkinson's, antidiabetic, antiobesity and immunomodulatory agents, etc.  The broad and potent activity of triazole and their derivs. has established them as pharmacol. significant scaffolds.  The basic heterocyclic rings present in the various medicinal agents are 1,2,3-triazole and 1,2,4-triazole.  A large vol. of research has been carried out on triazole and their derivs., which has proved the pharmacol. importance of this heterocyclic nucleus.  The present paper is an attempt to review the pharmacol. activities reported for triazole derivs. in the current literature with an update of recent research findings on this nuclei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOA5JZn2bgv7Vg90H21EOLACvtfcHk0lhQon7kY4rvwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyrs7o%253D&md5=d99a3098d011fbc334349f06865ac3db</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3109%2F14756360903524304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756360903524304%26sid%3Dliteratum%253Aachs%26aulast%3DKharb%26aufirst%3DR.%26aulast%3DChander%26aufirst%3DP.%26aulast%3DYar%26aufirst%3DM.%2BS.%26atitle%3DPharmacological%2520significance%2520of%2520triazole%2520scaffold%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2011%26volume%3D26%26spage%3D1%26epage%3D21%26doi%3D10.3109%2F14756360903524304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delisi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingoia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terenzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martorana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almerico, A. M.</span></span> <span> </span><span class="NLM_article-title">1,2,3-triazole in heterocyclic compounds, endowed with biological activity through 1,3-dipolar cycloadditions</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">3289</span>– <span class="NLM_lpage">3306</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201301695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fejoc.201301695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=3289-3306&author=A.+Lauriaauthor=R.+Delisiauthor=F.+Mingoiaauthor=A.+Terenziauthor=A.+Martoranaauthor=G.+Baroneauthor=A.+M.+Almerico&title=1%2C2%2C3-triazole+in+heterocyclic+compounds%2C+endowed+with+biological+activity+through+1%2C3-dipolar+cycloadditions&doi=10.1002%2Fejoc.201301695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,3-Triazole in heterocyclic compounds, endowed with biological activity, through 1,3-dipolar cycloadditions</span></div><div class="casAuthors">Lauria, Antonino; Delisi, Riccardo; Mingoia, Francesco; Terenzi, Alessio; Martorana, Annamaria; Barone, Giampaolo; Almerico, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3289-3306</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  1,3-Dipolar cycloaddn. reactions can be considered a powerful synthetic tool in the building of heterocyclic rings, with applications in different fields.  This review focused the synthesis of biol. active compds. possessing the 1,2,3-triazole core through 1,3-dipolar cycloaddn. reactions.  The 1,2,3-triazole skeleton was presented as a single disubstituted ring, as a linker between two mols., or embedded in a polyheterocycle.  The cycloaddn. reactions are usually catalyzed by copper or ruthenium.  Domino reactions were achieved through dipolarophile anion formation, generally followed by cyclization.  The variety of attainable heterocyclic structures gave an illustration of the importance of the 1,2,3-triazole core in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq03KuVyNiHbVg90H21EOLACvtfcHk0lj4uB-WH22RUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKksrk%253D&md5=e40a607da9bc933b1e77094961d5099f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201301695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201301695%26sid%3Dliteratum%253Aachs%26aulast%3DLauria%26aufirst%3DA.%26aulast%3DDelisi%26aufirst%3DR.%26aulast%3DMingoia%26aufirst%3DF.%26aulast%3DTerenzi%26aufirst%3DA.%26aulast%3DMartorana%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DG.%26aulast%3DAlmerico%26aufirst%3DA.%2BM.%26atitle%3D1%252C2%252C3-triazole%2520in%2520heterocyclic%2520compounds%252C%2520endowed%2520with%2520biological%2520activity%2520through%25201%252C3-dipolar%2520cycloadditions%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26volume%3D2014%26spage%3D3289%26epage%3D3306%26doi%3D10.1002%2Fejoc.201301695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dheer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, R.</span></span> <span> </span><span class="NLM_article-title">Medicinal attributes of 1,2,3-triazoles: current developments</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.bioorg.2017.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28126288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2017&pages=30-54&author=D.+Dheerauthor=V.+Singhauthor=R.+Shankar&title=Medicinal+attributes+of+1%2C2%2C3-triazoles%3A+current+developments&doi=10.1016%2Fj.bioorg.2017.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal attributes of 1,2,3-triazoles: Current developments</span></div><div class="casAuthors">Dheer, Divya; Singh, Virender; Shankar, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-54</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1,2,3-Triazoles are important five-membered heterocyclic scaffold due to their extensive biol. activities.  This framework can be readily obtained in good to excellent yields on the multigram scale through click chem. via reaction of aryl/alkyl halides, alkynes and NaN3 under ambient conditions.  It has been an emerging area of interest for many researchers throughout the globe owing to its immense pharmacol. scope.  The present work aims to summarize the current approaches adopted for the synthesis of the 1,2,3-triazole and medicinal significance of these architectures as a lead structure for the discovery of drug mols. such as COX-1/COX-2 inhibitors (celecoxib, pyrazofurin), HIV protease inhibitors, CB1 cannabinoid receptor antagonist and much more which are in the pipeline of clin. trials.  The emphasis has been given on the major advancements in the medicinal prospectus of this pharmacophore for the period during 2008-2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocxJdPU28FUbVg90H21EOLACvtfcHk0lh5yTnAqZn2Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGku7c%253D&md5=538daa02d12a4beb205ee8ec9c8c8754</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DDheer%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DShankar%26aufirst%3DR.%26atitle%3DMedicinal%2520attributes%2520of%25201%252C2%252C3-triazoles%253A%2520current%2520developments%26jtitle%3DBioorg.%2520Chem.%26date%3D2017%26volume%3D71%26spage%3D30%26epage%3D54%26doi%3D10.1016%2Fj.bioorg.2017.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bozorov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisa, H. A.</span></span> <span> </span><span class="NLM_article-title">1,2,3-triazole-containing hybrids as leads in medicinal chemistry: a recent overview</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3511</span>– <span class="NLM_lpage">3531</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.bmc.2019.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31300317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlChtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=3511-3531&author=K.+Bozorovauthor=J.+Zhaoauthor=H.+A.+Aisa&title=1%2C2%2C3-triazole-containing+hybrids+as+leads+in+medicinal+chemistry%3A+a+recent+overview&doi=10.1016%2Fj.bmc.2019.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview</span></div><div class="casAuthors">Bozorov, Khurshed; Zhao, Jiangyu; Aisa, Haji A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3511-3531</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The 1,2,3-triazole ring is a major pharmacophore system among nitrogen-contg. heterocycles.  These five-membered heterocyclic motifs with three nitrogen heteroatoms can be prepd. easily using 'click' chem. with copper- or ruthenium-catalyzed azide-alkyne cycloaddn. reactions.  Recently, the 'linker' property of 1,2,3-triazoles was demonstrated, and a novel class of 1,2,3-triazole-contg. hybrids and conjugates was synthesized and evaluated as lead compds. for diverse biol. targets.  These lead compds. have been demonstrated as anticancer, antimicrobial, anti-tubercular, antiviral, antidiabetic, antimalarial, anti-leishmanial, and neuroprotective agents.  The present review summarises advances in lead compds. of 1,2,3-triazole-contg. hybrids, conjugates, and their related heterocycles in medicinal chem. published in 2018.  This review will be useful to scientists in research fields of org. synthesis, medicinal chem., phytochem., and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUam33GCV_hbVg90H21EOLACvtfcHk0lg5Cios-d1wRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlChtLbM&md5=0f7aa003e525a20a2b344f93a2357c20</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DBozorov%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DAisa%26aufirst%3DH.%2BA.%26atitle%3D1%252C2%252C3-triazole-containing%2520hybrids%2520as%2520leads%2520in%2520medicinal%2520chemistry%253A%2520a%2520recent%2520overview%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D3511%26epage%3D3531%26doi%3D10.1016%2Fj.bmc.2019.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">See for example</p></div><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues
Gazolla, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves Borsodi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado Ferreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gontijo Vaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasconcelos, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, W. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2018.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29407957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFems7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2018&pages=274-286&author=R.+R.+Teixeiraauthor=P.+A.+Rodrigues%0AGazollaauthor=A.+M.+Da+Silvaauthor=M.+P.+Goncalves+Borsodiauthor=B.+R.+Bergmannauthor=R.+Salgado+Ferreiraauthor=B.+Gontijo+Vazauthor=G.+A.+Vasconcelosauthor=W.+P.+Lima&title=Synthesis+and+leishmanicidal+activity+of+eugenol+derivatives+bearing+1%2C2%2C3-triazole+functionalities&doi=10.1016%2Fj.ejmech.2018.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities</span></div><div class="casAuthors">Teixeira, Robson Ricardo; Gazolla, Poliana Aparecida Rodrigues; Manoel da Silva, Adalberto; Borsodi, Maria Paula Goncalves; Bergmann, Bartira Rossi; Ferreira, Rafaela Salgado; Vaz, Boniek Gontijo; Vasconcelos, Gessica Adriana; Lima, Wallace Pacienza</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">274-286</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this paper, it is described the synthesis and the evaluation of the leishmanicidal activity of twenty-six eugenol derivs. bearing 1,2,3-triazole functionalities.  The evaluation of the compds. on promastigotes of Leishmania amazonensis (WHOM/BR/75/Josefa) showed that eugenol derivs. present leishmanicidal activities with varying degrees of effectiveness.  The most active compd., namely 4-(3-(4-allyl-2-methoxyphenoxy)propyl)-1-(4-methylbenzyl)-1H-1,2,3-triazole (I) (IC50 = 7.4 ± 0.8 μmol L-1), also targeted Leishmania parasites inside peritoneal macrophages (IC50 = 1.6 μmol L-1) without interfering with cell viability.  The cytotoxicity of I against macrophage cells presented IC50 of 211.9 μmol L-1 and the selective index was equal to 132.5.  Under similar conditions, compd. I was more effective than glucantime and pentamidine, two drugs currently in the clinic.  In addn., theor. calcns. showed that this compd. also presents most physicochem. and pharmacokinetic properties within the ranges expected for orally available drugs.  It is believed that eugenol bearing 1,2,3-triazole functionalities may represent a scaffold to be explored toward the development of new agents to treat leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0klLlhYfJerVg90H21EOLACvtfcHk0lixTRh-Js0Dcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFems7s%253D&md5=b84837c5a3a6be8d1d7d6b454d58bc85</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DTeixeira%26aufirst%3DR.%2BR.%26aulast%3DRodrigues%2BGazolla%26aufirst%3DP.%2BA.%26aulast%3DDa%2BSilva%26aufirst%3DA.%2BM.%26aulast%3DGoncalves%2BBorsodi%26aufirst%3DM.%2BP.%26aulast%3DBergmann%26aufirst%3DB.%2BR.%26aulast%3DSalgado%2BFerreira%26aufirst%3DR.%26aulast%3DGontijo%2BVaz%26aufirst%3DB.%26aulast%3DVasconcelos%26aufirst%3DG.%2BA.%26aulast%3DLima%26aufirst%3DW.%2BP.%26atitle%3DSynthesis%2520and%2520leishmanicidal%2520activity%2520of%2520eugenol%2520derivatives%2520bearing%25201%252C2%252C3-triazole%2520functionalities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D146%26spage%3D274%26epage%3D286%26doi%3D10.1016%2Fj.ejmech.2018.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, D.</span></span> <span> </span><span class="NLM_article-title">Potential antileishmanial activity of a triazole-based hybrid peptide against <i>Leishmania major</i></span>. <i>ChemistrySelect</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">10220</span>– <span class="NLM_lpage">10225</span>, <span class="refDoi"> DOI: 10.1002/slct.201802002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fslct.201802002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=10220-10225&author=K.+Majiauthor=M.+Abbasiauthor=D.+Podderauthor=R.+Dattaauthor=D.+Haldar&title=Potential+antileishmanial+activity+of+a+triazole-based+hybrid+peptide+against+Leishmania+major&doi=10.1002%2Fslct.201802002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential antileishmanial activity of a triazole-based hybrid peptide against leishmania major</span></div><div class="casAuthors">Maji, Krishnendu; Abbasi, Mazharul; Podder, Debasish; Datta, Rupak; Haldar, Debasish</div><div class="citationInfo"><span class="NLM_cas:title">ChemistrySelect</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">10220-10225</span>CODEN:
                <span class="NLM_cas:coden">CHEMUD</span>;
        ISSN:<span class="NLM_cas:issn">2365-6549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The dipeptides (I) (R1 = iso-Bu, CH2C6H5, iso-Pr, H) with a triazole contg. synthetic amino acid and Leu/ Phe/ Val/ Gly have been designed and synthesized as a potent antileishmanial agent.  The 1-(2-Amino-phenyl)-1H-[1, 2,3] triazole-4-carboxylic acid was synthesized using click chem. approach.  From X-ray crystallog., the peptide I (R1 = i-Bu) contg. a Leu residue at C-terminus adopts kink like structure but there is no intramol. hydrogen bond.  So, the hydrogen bonding sites are free and allowed for intermol. interaction with the guests.  The phenylalanine analog I (R1 = CH2C6H5) where the Ph and triazole rings are perpendicular to each other also form supramol. column-like structure through π-π stacking interaction.  The incorporation of a triazole contg. synthetic amino acid at the N-terminus enhances its anti-parasites activity.  The properties such as lipophilicity and cytotoxicity, are relevant factors for the design of new antileishmanial agent.  IC50 value were calcd. for dipeptides I (R1 is defined above) using normal growth inhibition strategy.  For dipeptide I (R1 = i-Bu), IC50 value is 11μg/mL and the Phe contg. dipeptide I (R1 = CH2C6H5) exhibits IC50 21.17μg/mL on Leishmania major promastigotes.  But the Val and Gly contg. dipeptides 3 I (R1 = i-Pr) and 4 have IC50 values 138.23μg/mL and 21.75μg/mL resp.  The higher lipophilicity of dipeptide I (R1 = i-Bu) is likely to improve the chances of reaching this intracellular parasite.  The exptl. result show that the triazole-based dipeptide I (R1 = i-Bu) is promising as antileishmanial agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvNL3mHm_DXbVg90H21EOLACvtfcHk0ljr8iKzgWF43g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7bF&md5=b4e643677764f768a7818dcc3728e3ac</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1002%2Fslct.201802002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fslct.201802002%26sid%3Dliteratum%253Aachs%26aulast%3DMaji%26aufirst%3DK.%26aulast%3DAbbasi%26aufirst%3DM.%26aulast%3DPodder%26aufirst%3DD.%26aulast%3DDatta%26aufirst%3DR.%26aulast%3DHaldar%26aufirst%3DD.%26atitle%3DPotential%2520antileishmanial%2520activity%2520of%2520a%2520triazole-based%2520hybrid%2520peptide%2520against%2520Leishmania%2520major%26jtitle%3DChemistrySelect%26date%3D2018%26volume%3D3%26spage%3D10220%26epage%3D10225%26doi%3D10.1002%2Fslct.201802002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">See for example reviews</p></div><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Haldón, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicasio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, P. J.</span></span> <span> </span><span class="NLM_article-title">Copper-catalyzed azide-alkyne cycloadditions (CuAAC): an update</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">9528</span>– <span class="NLM_lpage">9550</span>, <span class="refDoi"> DOI: 10.1039/C5OB01457C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FC5OB01457C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26284434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=9528-9550&author=E.+Hald%C3%B3nauthor=M.+C.+Nicasioauthor=P.+J.+P%C3%A9rez&title=Copper-catalyzed+azide-alkyne+cycloadditions+%28CuAAC%29%3A+an+update&doi=10.1039%2FC5OB01457C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-catalysed azide-alkyne cycloadditions (CuAAC): an update</span></div><div class="casAuthors">Haldon, Estela; Nicasio, M. Carmen; Perez, Pedro J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9528-9550</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The reactions of org. azides and alkynes catalyzed by copper species represent the prototypical examples of click chem were discussed in detailed.  The so-called CuAAC reaction (copper-catalyzed azide-alkyne cycloaddn.), discovered in 2002, has been expanded since then to become an excellent tool in org synthesis.  In this contribution the recent results described in the literature since 2010 were reviewed, classified according to the nature of the catalyst precursor: copper(I) or copper(II) salts or complexes, metallic or nano-particulated copper and several solid-supported copper systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrTQSw3c0uv7Vg90H21EOLACvtfcHk0liOQ5aGVBIDCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmtbrE&md5=829bd0ca7fcb535afde89f531f5e3f1f</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1039%2FC5OB01457C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB01457C%26sid%3Dliteratum%253Aachs%26aulast%3DHald%25C3%25B3n%26aufirst%3DE.%26aulast%3DNicasio%26aufirst%3DM.%2BC.%26aulast%3DP%25C3%25A9rez%26aufirst%3DP.%2BJ.%26atitle%3DCopper-catalyzed%2520azide-alkyne%2520cycloadditions%2520%2528CuAAC%2529%253A%2520an%2520update%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D9528%26epage%3D9550%26doi%3D10.1039%2FC5OB01457C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beke-Somfai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalsmeden, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kann, N.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed azide alkyne cycloaddition reaction: scope, mechanism and applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">14726</span>– <span class="NLM_lpage">14768</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00466</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00466" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVOjtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=14726-14768&author=J.+R.+Johanssonauthor=T.+Beke-Somfaiauthor=A.+S.+Stalsmedenauthor=N.+Kann&title=Ruthenium-catalyzed+azide+alkyne+cycloaddition+reaction%3A+scope%2C+mechanism+and+applications&doi=10.1021%2Facs.chemrev.6b00466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications</span></div><div class="casAuthors">Johansson, Johan R.; Beke-Somfai, Tamas; Said Staalsmeden, Anna; Kann, Nina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">14726-14768</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The ruthenium-catalyzed azide alkyne cycloaddn. (RuAAC) affords 1,5-disubstituted 1,2,3-triazoles in one step and complements the more established copper-catalyzed reaction providing the 1,4-isomer.  The RuAAC reaction has quickly found its way into the org. chem. toolbox and found applications in many different areas, such as medicinal chem., polymer synthesis, organocatalysis, supramol. chem. and the construction of electronic devices.  This review discusses the mechanism, scope and applications of the RuAAC reaction, covering the literature from the last 10 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6MPHm8oo-m7Vg90H21EOLACvtfcHk0lgmp312gWCuBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVOjtLnM&md5=ed7e3b2927255710c1fd9148974027aa</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00466%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DJ.%2BR.%26aulast%3DBeke-Somfai%26aufirst%3DT.%26aulast%3DStalsmeden%26aufirst%3DA.%2BS.%26aulast%3DKann%26aufirst%3DN.%26atitle%3DRuthenium-catalyzed%2520azide%2520alkyne%2520cycloaddition%2520reaction%253A%2520scope%252C%2520mechanism%2520and%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D14726%26epage%3D14768%26doi%3D10.1021%2Facs.chemrev.6b00466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span> <span> </span><span class="NLM_article-title">Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">5163</span>– <span class="NLM_lpage">5176</span>, <span class="refDoi"> DOI: 10.1111/bph.15250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1111%2Fbph.15250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=32888319" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2020&pages=5163-5176&author=H.+Lucioauthor=M.+A.+Toroauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruiz&title=Pseudoirreversible+slow-binding+inhibition+of+trypanothione+reductase+by+a+protein-protein+interaction+disruptor&doi=10.1111%2Fbph.15250"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fbph.15250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.15250%26sid%3Dliteratum%253Aachs%26aulast%3DLucio%26aufirst%3DH.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26atitle%3DPseudoirreversible%2520slow-binding%2520inhibition%2520of%2520trypanothione%2520reductase%2520by%2520a%2520protein-protein%2520interaction%2520disruptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D177%26spage%3D5163%26epage%3D5176%26doi%3D10.1111%2Fbph.15250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Enzymes: A Practical Introduction to Structure</span>.  <i>Mechanism and Data Analysis</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2F0471220639" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+A.+Copeland&title=Mechanism+and+Data+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1002%2F0471220639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEnzymes%253A%2520A%2520Practical%2520Introduction%2520to%2520Structure%26btitle%3DMechanism%2520and%2520Data%2520Analysis%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <i>Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2F9781118540398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery%3A+A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1002%2F9781118540398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%253A%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grove, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnuud, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottarella, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span> <span> </span><span class="NLM_article-title">The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1038/nprot.2015.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1038%2Fnprot.2015.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=25855957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Smt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=733-755&author=D.+Kozakovauthor=L.+E.+Groveauthor=D.+R.+Hallauthor=T.+Bohnuudauthor=S.+E.+Mottarellaauthor=L.+Luoauthor=B.+Xiaauthor=D.+Beglovauthor=S.+Vajda&title=The+FTMap+family+of+web+servers+for+determining+and+characterizing+ligand-binding+hot+spots+of+proteins&doi=10.1038%2Fnprot.2015.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins</span></div><div class="casAuthors">Kozakov, Dima; Grove, Laurie E.; Hall, David R.; Bohnuud, Tanggis; Mottarella, Scott E.; Luo, Lingqi; Xia, Bing; Beglov, Dmitri; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">733-755</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">FTMap is a computational mapping server that identifies binding hot spots of macromols., i.e., regions of the surface with major contributions to the ligand-binding free energy.  To use FTMap, users submit a protein, DNA or RNA structure in PDB (Protein Data Bank) format.  FTMap samples billions of positions of small org. mols. used as probes, and it scores the probe poses using a detailed energy expression.  Regions that bind clusters of multiple probe types identify the binding hot spots in good agreement with exptl. data.  FTMap serves as the basis for other servers, namely FTSite, which was used to predict ligand-binding sites, FTFlex, which was used to account for side chain flexibility, FTMap/param, used to parameterize addnl. probes and FTDyn, for mapping ensembles of protein structures.  Applications include detg. the druggability of proteins, identifying ligand moieties that are most important for binding, finding the most bound-like conformation in ensembles of unliganded protein structures and providing input for fragment-based drug design.  FTMap is more accurate than classical mapping methods such as GRID and MCSS, and it is much faster than the more-recent approaches to protein mapping based on mixed mol. dynamics.  By using 16 probe mols., the FTMap server finds the hot spots of an av.-size protein in <1 h.  As FTFlex performs mapping for all low-energy conformers of side chains in the binding site, its completion time is proportionately longer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnH27-sNtGLVg90H21EOLACvtfcHk0lgmp312gWCuBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Smt74%253D&md5=dbc729e9ffb47989f0df8baebaf032fa</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2015.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2015.043%26sid%3Dliteratum%253Aachs%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DGrove%26aufirst%3DL.%2BE.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DBohnuud%26aufirst%3DT.%26aulast%3DMottarella%26aufirst%3DS.%2BE.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DB.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DThe%2520FTMap%2520family%2520of%2520web%2520servers%2520for%2520determining%2520and%2520characterizing%2520ligand-binding%2520hot%2520spots%2520of%2520proteins%26jtitle%3DNat.%2520Protoc.%26date%3D2015%26volume%3D10%26spage%3D733%26epage%3D755%26doi%3D10.1038%2Fnprot.2015.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarma, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span> <span> </span><span class="NLM_article-title">Glutathione reductase of the malarial parasite <i>Plasmodium falciparum</i>: crystal structure and inhibitor development</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>328</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(03)00347-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2FS0022-2836%2803%2900347-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=12729762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ojtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2003&pages=893-907&author=G.+N.+Sarmaauthor=N.+Savvidesauthor=K.+Beckerauthor=M.+Schirmerauthor=R.+H.+Schirmerauthor=P.+A.+Karplus&title=Glutathione+reductase+of+the+malarial+parasite+Plasmodium+falciparum%3A+crystal+structure+and+inhibitor+development&doi=10.1016%2FS0022-2836%2803%2900347-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione Reductase of the Malarial Parasite Plasmodium falciparum: Crystal Structure and Inhibitor Development</span></div><div class="casAuthors">Sarma, G. N.; Savvides, S. N.; Becker, K.; Schirmer, M.; Schirmer, R. H.; Karplus, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">893-907</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The malarial parasite Plasmodium falciparum is known to be sensitive to oxidative stress, and thus the antioxidant enzyme glutathione reductase (GR; NADPH+GSSG+H+↔NADP++2 GSH) has become an attractive drug target for antimalarial drug development.  Here, we report the 2.6 A resoln. crystal structure of P. falciparum GR.  The homodimeric flavoenzyme is compared to the related human GR with focus on structural aspects relevant for drug design.  The most pronounced differences between the two enzymes concern the shape and electrostatics of a large (450 A3) cavity at the dimer interface.  This cavity binds numerous non-competitive inhibitors and is a target for selective drug design.  A 34-residue insertion specific for the GRs of malarial parasites shows no d., implying that it is disordered.  The precise location of this insertion along the sequence allows us to explain the deleterious effects of a mutant in this region and suggests new functional studies.  To complement the structural comparisons, we report the relative susceptibility of human and plasmodial GRs to a series of tricyclic inhibitors as well as to peptides designed to interfere with protein folding and dimerization.  Enzyme-kinetic studies on GRs from chloroquine-resistant and chloroquine-sensitive parasite strains were performed and indicate that the structure reported here represents GR of P. falciparum strains in general and thus is a highly relevant target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTrsi3sZmurVg90H21EOLACvtfcHk0ljb5rB-zjnkPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ojtrg%253D&md5=bf64be2ea683df5a769ee24f0d1bd9db</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2803%2900347-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252803%252900347-4%26sid%3Dliteratum%253Aachs%26aulast%3DSarma%26aufirst%3DG.%2BN.%26aulast%3DSavvides%26aufirst%3DN.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DSchirmer%26aufirst%3DM.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26atitle%3DGlutathione%2520reductase%2520of%2520the%2520malarial%2520parasite%2520Plasmodium%2520falciparum%253A%2520crystal%2520structure%2520and%2520inhibitor%2520development%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D328%26spage%3D893%26epage%3D907%26doi%3D10.1016%2FS0022-2836%2803%2900347-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, G. E.</span></span> <span> </span><span class="NLM_article-title">A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1989.tb14500.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1111%2Fj.1432-1033.1989.tb14500.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=2912729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaL1MXhtFSktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=1989&pages=693-703&author=P.+A.+Karplusauthor=E.+F.+Paiauthor=G.+E.+Schulz&title=A+crystallographic+study+of+the+glutathione+binding+site+of+glutathione+reductase+at+0.3-nm+resolution&doi=10.1111%2Fj.1432-1033.1989.tb14500.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution</span></div><div class="casAuthors">Karplus, P. Andrew; Pai, Emil F.; Schulz, Georg E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-703</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The binding of glutathione, some related mols., and 2 redox compds. to crystals of human erythrocyte glutathione reductase was investigated by x-ray crystallog. at 0.3-nm resoln.  Models for several bound ligands were built and subjected to crystallog. refinement.  The results clearly showed the residues involved in glutathione binding as well as the geometry of the disulfide exchange.  Glutathione-I was bound in a V-shaped conformation, whereas glutathione-II was extended.  The zwitterionic glutamyl end of glutathione-II appeared to be the most tightly bound part of the substrate.  All glutathione conjugates and derivs. studied showed binding dominated by the interactions at this site.  In the reduced enzyme, glutathione-I formed a mixed disulfide intermediate with cysteine (Cys)-58.  Other structural changes were obsd. on redn. of the enzyme, and it was demonstrated that the carboxamidomethylated enzyme is a good model for the reduced species.  Lipoate, a weak substrate of the enzyme, assumed a defined binding site where its disulfide was available for being attacked by Cys-58-Sγ.  A 2nd region with affinity for a no. of compds. was found in a large cavity at the dimer interface of the enzyme.  No functional role of this site is known.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXh-H0cDa23bVg90H21EOLACvtfcHk0ljb5rB-zjnkPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtFSktbw%253D&md5=dec7f50864096d6ff6ad42e42a860831</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1989.tb14500.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1989.tb14500.x%26sid%3Dliteratum%253Aachs%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DA%2520crystallographic%2520study%2520of%2520the%2520glutathione%2520binding%2520site%2520of%2520glutathione%2520reductase%2520at%25200.3-nm%2520resolution%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1989%26volume%3D178%26spage%3D693%26epage%3D703%26doi%3D10.1111%2Fj.1432-1033.1989.tb14500.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span> <span> </span><span class="NLM_article-title">Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">8101</span>– <span class="NLM_lpage">8107</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.14.8101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1074%2Fjbc.271.14.8101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=8626496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaK28XitFart7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=8101-8107&author=S.+N.+Savvidesauthor=P.+A.+Karplus&title=Kinetics+and+crystallographic+analysis+of+human+glutathione+reductase+in+complex+with+a+xanthene+inhibitor&doi=10.1074%2Fjbc.271.14.8101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor</span></div><div class="casAuthors">Savvides, Savvas N.; Karplus, P. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">8101-7</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of a complex between the noncompetitive inhibitor (Kis = 27 μM, Kii = 48 μM with respect to oxidized glutathione (GSSG) and Kis = 144 μM, Kii = 176 μM with respect to NADPH) 6-hydroxy-3-oxo-3H-xanthene-9-propionic acid (XAN) and human glutathione reductase (hGR).  The structure, refined to an R-factor of 0.158 at 2.0 Å resoln., reveals XAN bound in the large cavity present at the hGR dimer interface where it does not overlap the glutathione binding site.  The inhibitor binding causes extensive local structural changes that primarily involve amino acid residues from a 30-residue α-helix that lines the cavity and contributes to the active site of hGR.  Despite the lack of phys. overlap of XAN with the GSSG binding site, no GSSG binding is seen in soaks carried out with high XAN and GSSG concns., suggesting that some subtle interaction between the sites exists.  An earlier crystallog. anal. on the complex between hGR and 3,7-diamino-2,8-dimethyl-5-phenyl-phenazinium chloride (safranin) showed that safranin bound at this same site.  We have found that safranin also inhibits hGR in a noncompetitive fashion, but it binds about 16 times less tightly (Kis - 453 μM, Kii - 586 μM with respect to GSSG) than XAN and does not preclude the binding of GSSG in the crystal.  Although in structure-based drug design competitive inhibitors are usually targeted, Xan's binding to a well defined site that is unique to glutathione reductase suggests that noncompetitive inhibitors could also serve as lead compds. for structure-based drug design, in particular as components of chimeric inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz-HcLLeopLrVg90H21EOLACvtfcHk0ljSODvZ_-DSVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFart7w%253D&md5=94eb7ec01fc8a81bffac961a89a40cb5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.14.8101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.14.8101%26sid%3Dliteratum%253Aachs%26aulast%3DSavvides%26aufirst%3DS.%2BN.%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26atitle%3DKinetics%2520and%2520crystallographic%2520analysis%2520of%2520human%2520glutathione%2520reductase%2520in%2520complex%2520with%2520a%2520xanthene%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D8101%26epage%3D8107%26doi%3D10.1074%2Fjbc.271.14.8101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schönleben-Janas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittl, P. R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystallographic, kinetic and electrochemical studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1021/jm950511+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm950511%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A280%3ADyaK287pslyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1549-1554&author=A.+Sch%C3%B6nleben-Janasauthor=P.+Kirschauthor=P.+R.+E.+Mittlauthor=R.+H.+Schirmerauthor=R.+L.+Krauth-Siegel&title=Inhibition+of+human+glutathione+reductase+by+10-arylisoalloxazines%3A+crystallographic%2C+kinetic+and+electrochemical+studies&doi=10.1021%2Fjm950511%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies</span></div><div class="casAuthors">Schonleben-Janas A; Kirsch P; Mittl P R; Schirmer R H; Krauth-Siegel R L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1549-54</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of newly synthesized N(10)-arylisoalloxazines--some of which are known to be antimalarial agents--were studied as inhibitors of human glutathione reductase (GR;NADPH + GSSG + H(+) <==> NADP(+) + 2GSH).  The flavoenzyme was inhibited with IC(50) values between </- 1 and 100 microM in the presence of 100 microM NADPH.  The isoalloxazines and N(3)-methylisoalloxazines with a 4'-chlorophenyl or a 3',5'-dichlorophenyl group at N10 were found to be the most promising inhibitors of GR, although even the bulkier 10-naphthyl and -anthryl derivatives were also effective inhibitors.  In contrast, at position N3 of the isoalloxazine ring, the size of the substituent was found to strongly influence the inhibitory effect.  Introduction of a carboxymethyl group at N3--which markedly increased the solubility of the derivative in aqueous solutions-- caused a rise in the IC(50) values by 1 order of magnitude. 8-Fluoro- and 8-azido-10-arylisoalloxazines were potent inhibitors of GR; consequently position C8 of the benzenoid subnucleus instead of N3 should be considered for introducing substituents.  No correlation was observed between the inhibitory strength of several isoalloxazines and their redox potential as measured by cyclovoltammetry.  The crystallographic analysis of GR complexed with 10-(4'-chlorophenyl)-3-(carboxymethyl)isoalloxazine and 10-(3',5'-dichlorophenyl)-3-(carboxymethyl)isoalloxazine, respectively, revealed the presence of one inhibitor molecule bound at the 2-fold axis of the homodimeric protein.  This location is consistent with fluorescence titration measurements and enzyme kinetic studies in solution which gave no indication for binding at the substrate sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1gt6RrGDwBD0SWnHPWbmmfW6udTcc2eatbqiO3Lg34Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287pslyrtw%253D%253D&md5=2bf9dd1a81169d5061fce3c69e8c4a12</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm950511%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950511%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nleben-Janas%26aufirst%3DA.%26aulast%3DKirsch%26aufirst%3DP.%26aulast%3DMittl%26aufirst%3DP.%2BR.%2BE.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520human%2520glutathione%2520reductase%2520by%252010-arylisoalloxazines%253A%2520crystallographic%252C%2520kinetic%2520and%2520electrochemical%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1549%26epage%3D1554%26doi%3D10.1021%2Fjm950511%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stourac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavra, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brezovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damborsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, D.</span></span> <span> </span><span class="NLM_article-title">Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">W414</span>– <span class="NLM_lpage">W422</span>, <span class="refDoi"> DOI: 10.1093/nar/gkz378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1093%2Fnar%2Fgkz378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31114897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktVyitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=W414-W422&author=J.+Stouracauthor=O.+Vavraauthor=P.+Kokkonenauthor=J.+Filipovicauthor=G.+Pintoauthor=J.+Brezovskyauthor=J.+Damborskyauthor=D.+Bednar&title=Caver+Web+1.0%3A+identification+of+tunnels+and+channels+in+proteins+and+analysis+of+ligand+transport&doi=10.1093%2Fnar%2Fgkz378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport</span></div><div class="casAuthors">Stourac, Jan; Vavra, Ondrej; Kokkonen, Piia; Filipovic, Jiri; Pinto, Gaspar; Brezovsky, Jan; Damborsky, Jiri; Bednar, David</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W414-W422</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Caver Web 1.0 is a web server for comprehensive anal. of protein tunnels and channels, and study of the ligands' transport through these transport pathways.  Caver Web is the first interactive tool allowing both the analyses within a single graphical user interface.  The server is built on top of the abundantly used tunnel detection tool Caver 3.02 and CaverDock 1.0 enabling the study of the ligand transport.  The program is easy-to-use as the only required inputs are a protein structure for a tunnel identification and a list of ligands for the transport anal.  The automated guidance procedures assist the users to set up the calcn. in a way to obtain biol. relevant results.  The identified tunnels, their properties, energy profiles and trajectories for ligands' passages can be calcd. and visualized.  The tool is very fast (2-20 min per job) and is applicable even for virtual screening purposes.  Its simple setup and comprehensive graphical user interface make the tool accessible for a broad scientific community.  The server is freely available at https://loschmidt.chemi.muni.cz/caverweb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprFB8ybCscXrVg90H21EOLACvtfcHk0lhzmDcGavA2gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktVyitb4%253D&md5=46f31538c8da65018274d664803ac512</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkz378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkz378%26sid%3Dliteratum%253Aachs%26aulast%3DStourac%26aufirst%3DJ.%26aulast%3DVavra%26aufirst%3DO.%26aulast%3DKokkonen%26aufirst%3DP.%26aulast%3DFilipovic%26aufirst%3DJ.%26aulast%3DPinto%26aufirst%3DG.%26aulast%3DBrezovsky%26aufirst%3DJ.%26aulast%3DDamborsky%26aufirst%3DJ.%26aulast%3DBednar%26aufirst%3DD.%26atitle%3DCaver%2520Web%25201.0%253A%2520identification%2520of%2520tunnels%2520and%2520channels%2520in%2520proteins%2520and%2520analysis%2520of%2520ligand%2520transport%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2019%26volume%3D47%26spage%3DW414%26epage%3DW422%26doi%3D10.1093%2Fnar%2Fgkz378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0li5m29iRyqZlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">House, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, G. A.</span></span> <span> </span><span class="NLM_article-title">The chemistry of carbanions. VI. Stereochemistry of the Wittig reaction with stabilized ylids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3327</span>– <span class="NLM_lpage">3333</span>, <span class="refDoi"> DOI: 10.1021/jo01034a049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01034a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaF2MXjtFyq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1964&pages=3327-3333&author=H.+O.+Houseauthor=V.+K.+Jonesauthor=G.+A.+Frank&title=The+chemistry+of+carbanions.+VI.+Stereochemistry+of+the+Wittig+reaction+with+stabilized+ylids&doi=10.1021%2Fjo01034a049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry of carbanions. VI. Stereochemistry of the Wittig reaction with stabilized ylides</span></div><div class="casAuthors">House, Herbert O.; Jones, Vera K.; Frank, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3327-33</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">cf. ibid. 28(12), 3362-79(1963); CA 58, 7959e.  The effect of various reaction conditions on the proportions of cis and trans olefinic products obtained from the Wittig reaction of stabilized ylides [Ph3P:CHCO2Me and (EtO)2P(ONa):CHCO2Me] with acetaldehyde and chloroacetaldehyde was studied.  The highest proportion of cis isomer was obtained by the use of the protonic solvent methanol.  Solns. of lithium salts were less effective and suspensions of lithium salts were without effect in enhancing the proportion of cis olefin in these cases.  This study of the Wittig reaction of the benzylidenephosphorane (Ph3P:CHPh) with EtCHO does not support the previous reports that the proportion of the cis isomer may be markedly enhanced by the presence of a suspension or a soln. of LiBr or LiI in the reaction mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolD-nxB1O1KLVg90H21EOLACvtfcHk0li5m29iRyqZlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXjtFyq&md5=48fccb1c4f4c33d0298911000f968fdb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo01034a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01034a049%26sid%3Dliteratum%253Aachs%26aulast%3DHouse%26aufirst%3DH.%2BO.%26aulast%3DJones%26aufirst%3DV.%2BK.%26aulast%3DFrank%26aufirst%3DG.%2BA.%26atitle%3DThe%2520chemistry%2520of%2520carbanions.%2520VI.%2520Stereochemistry%2520of%2520the%2520Wittig%2520reaction%2520with%2520stabilized%2520ylids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1964%26volume%3D29%26spage%3D3327%26epage%3D3333%26doi%3D10.1021%2Fjo01034a049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitzler-Kunkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bialas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brixner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würthner, F.</span></span> <span> </span><span class="NLM_article-title">Unraveling the structure and exciton coupling for multichromophoric merocyanine dye molecules</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6368</span>– <span class="NLM_lpage">6378</span>, <span class="refDoi"> DOI: 10.1039/C7CP00115K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FC7CP00115K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28197618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1yktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=6368-6378&author=F.+Kochauthor=M.+Stolteauthor=A.+Zitzler-Kunkelauthor=D.+Bialasauthor=A.+Steinbacherauthor=T.+Brixnerauthor=F.+W%C3%BCrthner&title=Unraveling+the+structure+and+exciton+coupling+for+multichromophoric+merocyanine+dye+molecules&doi=10.1039%2FC7CP00115K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the structure and exciton coupling for multichromophoric merocyanine dye molecules</span></div><div class="casAuthors">Koch, Federico; Stolte, Matthias; Zitzler-Kunkel, Andre; Bialas, David; Steinbacher, Andreas; Brixner, Tobias; Wuerthner, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6368-6378</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The relative orientation of chromophores is a key factor in detg. the relationship between the structure and the functionality in mol. multichromophore ensembles.  In the case of structurally flexible mol. systems in soln., the task to clarify the relevant effects of accessible chromophore orientations with spectroscopic observations is very demanding.  In this study, we address this issue by investigating a series of differently connected multichromophoric systems composed of highly dipolar merocyanine dyes that are systematically varied in their substitution pattern and the no. of chromophores attached to a bridging benzene ring.  Combining electro-optical absorption (EOA) and UV/Vis spectroscopy with d. functional theory (DFT) as well as exciton theory discloses conformational preferences and rationalizes the optical properties of the interacting chromophores.  Our findings suggest for all multichromophoric systems there is a relative orientation of the chromophores which compensates for the individual dipole moments of the merocyanine dyes by pointing preferably in opposing directions.  These orientations furthermore rationalize the obsd. spectral properties by partly excitonically-coupled subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOB0GilePfP7Vg90H21EOLACvtfcHk0lhbvXP2C4fvnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1yktbg%253D&md5=4e3ac58c8cf4cf954116959f6ce8088f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1039%2FC7CP00115K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CP00115K%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DF.%26aulast%3DStolte%26aufirst%3DM.%26aulast%3DZitzler-Kunkel%26aufirst%3DA.%26aulast%3DBialas%26aufirst%3DD.%26aulast%3DSteinbacher%26aufirst%3DA.%26aulast%3DBrixner%26aufirst%3DT.%26aulast%3DW%25C3%25BCrthner%26aufirst%3DF.%26atitle%3DUnraveling%2520the%2520structure%2520and%2520exciton%2520coupling%2520for%2520multichromophoric%2520merocyanine%2520dye%2520molecules%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2017%26volume%3D19%26spage%3D6368%26epage%3D6378%26doi%3D10.1039%2FC7CP00115K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravanamuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Ellman’s-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1042/bj20021298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1042%2Fbj20021298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=12416994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1aqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2003&pages=529-537&author=C.+J.+Hamiltonauthor=A.+Saravanamuthuauthor=I.+M.+Egglestonauthor=A.+H.+Fairlamb&title=Ellman%E2%80%99s-reagent-mediated+regeneration+of+trypanothione+in+situ%3A+substrate-economical+microplate+and+time-dependent+inhibition+assays+for+trypanothione+reductase&doi=10.1042%2Fbj20021298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Ellman's-reagent-mediated regeneration of trypanothione in situ: Substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase</span></div><div class="casAuthors">Hamilton, Chris J.; Saravanamuthu, Ahilan; Eggleston, Ian M.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Trypanothione reductase (TryR) is a key enzyme involved in the oxidative stress management of the Trypanosoma and Leishmania parasites, which helps to maintain an intracellular reducing environment by redn. of the small-mol.-mass disulfide trypanothione (T[S]2) to its di-thiol deriv. dihydrotrypanothione (T[SH]2).  TryR inhibition studies are currently impaired by the prohibitive costs of the native enzyme substrate T[S]2.  Such costs are particularly notable in time-dependent and high-throughput inhibition assays.  In the present study we report a protocol that greatly decreases the substrate quantities needed for such assays.  This is achieved by coupling the assay with the chem. oxidant 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), which can rapidly re-oxidize the T[SH]2 product back into the disulfide substrate T[S]2, thereby maintaining const. substrate concns. and avoiding deviations from rate linearity due to substrate depletion.  This has enabled the development of a continuous microplate assay for both classical and time-dependent TryR inhibition in which linear reaction rates can be maintained for 60 min or more using minimal substrate concns. (< 1 μM, compared with a substrate Km value of 30 μM) that would normally be completely consumed within seconds.  In this manner, substrate requirements are decreased by orders of magnitude.  The characterization of a novel time-dependent inhibitor, cis-3-oxo-8,9b-bis-(N1-acrylamidospermidyl)-1,2,3,4,4a,9b-hexahydrobenzofuran (PK43), is also described using these procedures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT5qEv1mf2k7Vg90H21EOLACvtfcHk0lhbvXP2C4fvnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1aqurc%253D&md5=813cc4af4076132e4d8f74f81ea669b4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1042%2Fbj20021298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021298%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DC.%2BJ.%26aulast%3DSaravanamuthu%26aufirst%3DA.%26aulast%3DEggleston%26aufirst%3DI.%2BM.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DEllman%25E2%2580%2599s-reagent-mediated%2520regeneration%2520of%2520trypanothione%2520in%2520situ%253A%2520substrate-economical%2520microplate%2520and%2520time-dependent%2520inhibition%2520assays%2520for%2520trypanothione%2520reductase%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D369%26spage%3D529%26epage%3D537%26doi%3D10.1042%2Fbj20021298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baici, A.</span></span> <span> </span><span class="NLM_article-title">Kinetics of Enzyme-Modifier Interactions</span>.  <i>Selected Topics in the Theory and Diagnosis of Inhibition and Activation Mechanisms</i>; <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Vienna, Austria</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1007%2F978-3-7091-1402-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Baici&title=Selected+Topics+in+the+Theory+and+Diagnosis+of+Inhibition+and+Activation+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1402-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-7091-1402-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaici%26aufirst%3DA.%26atitle%3DKinetics%2520of%2520Enzyme-Modifier%2520Interactions%26btitle%3DSelected%2520Topics%2520in%2520the%2520Theory%2520and%2520Diagnosis%2520of%2520Inhibition%2520and%2520Activation%2520Mechanisms%26pub%3DSpringer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepartz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2168</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2165-2168&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facs.jmedchem.7b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis; Merz, Kenneth M.; Schepartz, Alanna; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2165-2168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecstasy of discovering a new hit from screening can lead to a highly productive research effort to discover new bioactive compds.  However, in too many cases this ecstasy is followed by the agony of realizing that the compds. are not active against the desired target.  Many of these false hits are Pan Assay INterference compds. (PAINS) 1 or colloidal aggregators.  Whether the screen is conducted in silico or in the lab. and whether screening libraries, natural products, or drugs are used, all discovery efforts that rely on some form of screening to identify bioactivity are susceptible to this phenomenon.  Studies that omit crit. controls against exptl. artifacts caused by PAINS may waste years of research effort as useless compds. are progressed.  The American Chem. Society (ACS) is eager to alert the scientific community to this problem and to recommend protocols that will eliminate the publication of research articles based on compds. with artificial activity.  This editorial aims to summarize relevant concepts and to set the framework by which relevant ACS journals will address this issue going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUf5u51VEpbVg90H21EOLACvtfcHk0lhbvXP2C4fvnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D&md5=64bf087659a47fe7769208217ef8c989</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00229%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2165%26epage%3D2168%26doi%3D10.1021%2Facs.jmedchem.7b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez-Salgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortés-Cabrera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perona, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Redondo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morreale, A.</span></span> <span> </span><span class="NLM_article-title">MM-ISMSA: an ultrafast and accurate scoring function for protein-protein docking</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3395</span>– <span class="NLM_lpage">3408</span>, <span class="refDoi"> DOI: 10.1021/ct300497z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300497z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=3395-3408&author=J.+Klettauthor=A.+N%C3%BA%C3%B1ez-Salgadoauthor=H.+G.+Dos+Santosauthor=A.+Cort%C3%A9s-Cabreraauthor=A.+Peronaauthor=R.+Gil-Redondoauthor=D.+Abiaauthor=F.+Gagoauthor=A.+Morreale&title=MM-ISMSA%3A+an+ultrafast+and+accurate+scoring+function+for+protein-protein+docking&doi=10.1021%2Fct300497z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">MM-ISMSA: An Ultrafast and Accurate Scoring Function for Protein-Protein Docking</span></div><div class="casAuthors">Klett, Javier; Nunez-Salgado, Alfonso; Dos Santos, Helena G.; Cortes-Cabrera, Alvaro; Perona, Almudena; Gil-Redondo, Ruben; Abia, David; Gago, Federico; Morreale, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3395-3408</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An ultrafast and accurate scoring function for protein-protein docking is presented.  It includes (1) a mol. mechanics (MM) part based on a 12-6 Lennard-Jones potential; (2) an electrostatic component based on an implicit solvent model (ISM) with individual desolvation penalties for each partner in the protein-protein complex plus a hydrogen bonding term; and (3) a surface area (SA) contribution to account for the loss of water contacts upon protein-protein complex formation.  The accuracy and performance of the scoring function, termed MM-ISMSA, have been assessed by (1) comparing the total binding energies, the electrostatic term, and its components (charge-charge and individual desolvation energies), as well as the per residue contributions, to results obtained with well-established methods such as APBSA or MM-PB(GB)SA for a set of 1242 decoy protein-protein complexes and (2) testing its ability to recognize the docking soln. closest to the exptl. structure as that providing the most favorable total binding energy.  For this purpose, a test set consisting of 15 protein-protein complexes with known 3D structure mixed with 10 decoys for each complex was used.  The correlation between the values afforded by MM-ISMSA and those from the other methods is quite remarkable (r2 ∼ 0.9), and only 0.2-5.0 s (depending on the no. of residues) are spent on a single calcn. including an all vs all pairwise energy decompn.  On the other hand, MM-ISMSA correctly identifies the best docking soln. as that closest to the exptl. structure in 80% of the cases.  Finally, MM-ISMSA can process mol. dynamics trajectories and reports the results as averaged values with their std. deviations.  MM-ISMSA has been implemented as a plug-in to the widely used mol. graphics program PyMOL, although it can also be executed in command-line mode.  MM-ISMSA is distributed free of charge to nonprofit organizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru35V4Q0Syu7Vg90H21EOLACvtfcHk0liky9JaY_u6DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCht7bI&md5=3f00ad1a76c3a7eece4c75df533a122a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fct300497z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300497z%26sid%3Dliteratum%253Aachs%26aulast%3DKlett%26aufirst%3DJ.%26aulast%3DN%25C3%25BA%25C3%25B1ez-Salgado%26aufirst%3DA.%26aulast%3DDos%2BSantos%26aufirst%3DH.%2BG.%26aulast%3DCort%25C3%25A9s-Cabrera%26aufirst%3DA.%26aulast%3DPerona%26aufirst%3DA.%26aulast%3DGil-Redondo%26aufirst%3DR.%26aulast%3DAbia%26aufirst%3DD.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DMorreale%26aufirst%3DA.%26atitle%3DMM-ISMSA%253A%2520an%2520ultrafast%2520and%2520accurate%2520scoring%2520function%2520for%2520protein-protein%2520docking%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D3395%26epage%3D3408%26doi%3D10.1021%2Fct300497z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="ref56_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schrodinger, L. L. C.</span></span> <i>The PyMOL Molecular Graphics System, Version 1.8</i>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+L.+C.+Schrodinger&title=The+PyMOL+Molecular+Graphics+System%2C+Version+1.8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref56_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSchrodinger%26aufirst%3DL.%2BL.%2BC.%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%252C%2520Version%25201.8%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38a','cit38b'],'ref39':['cit39a','cit39b'],'ref40':['cit40a','cit40b'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['ref56_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. From a peptide dimerization disruptor of <i>Li</i>TryR (<b>1</b>) and in-house imidazoles <b>2</b> and <b>3</b> to the newly designed triazole-phenyl-thiazole scaffold <b>I</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the First Series of 1,4-Disubstituted 1,2,3-Triazole Compounds <b>12a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaN<sub>3</sub>, DMSO, molecular sieves 4 Å, 100 °C, 72 h; (b) Cp*RuCI(PPh<sub>3</sub>)<sub>2</sub> (5 or 10 mol %), DMF, rt to 100 °C; (c) CuSO<sub>4</sub>·5H<sub>2</sub>O, sodium ascorbate, H<sub>2</sub>O/EtOH 1:1, rt, 8 h; (d) (NH<sub>4</sub>)<sub>2</sub>S 20% aq, DMF, 80 °C, 4 h; (e) α-bromomethylketones <b>10a</b>–<b>c</b>, <sup><i>i</i></sup>PrOH, 70 °C, 5 h; (f) H<sub>2</sub>, Pd/C 10%, TFA, THF/MeOH 1:1, rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Triazoles Disubstituted at the Thiazole Ring (<b>19a</b>–<b>e</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PPh<sub>3</sub>, dry toluene, 110 °C, 6 h; (b) KOH, dry toluene, 110 °C, 3 h; (c) RCHO, 110 °C, 3 h; (d) NBS, <i>p</i>-TsOH, CH<sub>3</sub>CN, rt, 14 h; (e) thioamide <b>9</b>, <b>17a</b>–<b>e</b>, <sup><i>i</i></sup>PrOH, 70 °C, 5 h; (f) H<sub>2</sub>, Pd/C 10%, TFA, THF/MeOH 1:1, rt, 2 h. *Commercially available reagents.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Newly Designed Symmetrical Analogue 22<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, <i>p</i>-TsOH, acetonitrile, rt, 14 h; (b) thioamide <b>9</b>, <sup><i>i</i></sup>PrOH, 70 °C, 5 h; (c) H<sub>2</sub> Pd/C 10%, TFA, THF/MeOH, 1:1, rt, 2 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time-dependent inhibition of <i>Li</i>TryR. Reaction progress curves of <i>Li</i>TryR in the absence (◆) and presence of 25 μM mepacrine (<b>□</b>), 10 μM peptide <b>1</b> (▲), 10 μM <b>12c</b> (<b>○</b>), 10 μM <b>12b</b> (●), 10 μM <b>12r</b> (◊), 10 μM <b>12s</b> (■), or 10 μM <b>19a</b> (<b>△</b>). [DTNB] = 100 μM. [NADPH] = 150 μM. Data represent the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Two-Step Mechanism of Time-Dependent Inhibition of <i>Li</i>TryR<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>The first step is a rapid equilibrium that generates the enzyme–inhibitor (EI) complex. This process is governed by the association rate (<i>k</i><sub>3</sub>) and the dissociation rate (<i>k</i><sub>4</sub>) constants. The second step consists of slow and reversible inactivation of the enzyme that is governed by the forward isomerization rate constant (<i>k</i><sub>5</sub>) and the much smaller reverse rate constant (<i>k</i><sub>6</sub>).</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration dependence of the observed rate constants of <i>Li</i>TryR (0.8 nM) inactivation by <b>19a</b> at different TS<sub>2</sub> concentrations. Plot of the <i>k</i><sub>obs</sub> values (±standard errors) as a function of <b>19a</b> concentration at six different TS<sub>2</sub> concentrations (3.1, 6.2, 12.5, 25, 50, and 100 μM) (<i>k</i><sub>obs</sub> determinations for every <b>19a</b> concentration at the different fixed TS<sub>2</sub> concentrations assayed are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf" class="ext-link">Supporting Information</a>). Curves were fitted using <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>, and the results of the fits are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>Li</i>TryR dimer structure. FTMap identified the central interfacial cavity and the two adjacent sites where the two FAD cofactors are lodged as putative ligand-binding sites (circled by yellow lines).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Visualization of the potential access routes from the bulk solvent to the interfacial cavity (2.808 Å<sup>3</sup>, 0.77 “druggability”) as determined by the CAVER Web server using default parameters.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In comparison, each nicotinamide adenine dinucleotide phosphate (NADP) binding site occupies 1.343 Å<sup>3</sup> and its druggability is 0.63. The tunnels are depicted as a continuous semitransparent gray surface. The central vertical α-helices encompass the amino acid residues originally identified as hotspots for dimerization. The FAD prosthetic groups are displayed as stick models for reference purposes only.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proposed ligand-binding modes within <i>Li</i>TryR. (a) Cartoon representation of dimeric <i>Li</i>TryR showing the two FAD prosthetic groups (sticks, C atoms in gray) close to the active sites and a docked <b>19a</b> molecule (C atoms in pink) filling half of the central interfacial hydrophobic cavity and part of the tunnel connecting it to the bulk solvent. (b) Details of the best-scoring binding pose for <b>12b</b> (C atoms in green). (c) Details of the best-scoring binding pose for <b>12c</b> (C atoms in cyan). (d) Details of the best-scoring binding pose for <b>19a</b> (C atoms in pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Rationale for the design of the <i>C</i><sub>2</sub>-symmetric compound <b>22</b>. (A) Best docking pose for <b>19a</b> (C atoms in pink) with the tail extended into one <i>Li</i>TryR monomer reproduced for the other monomer (C atoms in white). Note how the propylamino group is extended and oriented toward the carboxylate of Glu466 in both cases. (B) Best-scoring result provided by the automated docking program<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> for <b>22</b> (CPK model) inside the central interfacial cavity and connecting tunnels. The side chains of Glu466 and Glu466′ are displayed as sticks with C atoms colored in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/medium/jm1c00206_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Fluorescence microscopy images of <i>L. infantum</i> promastigotes treated with 25 μM compound <b>12a</b> for 1 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00206/20210506/images/large/jm1c00206_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00206&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 56 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>Leishmaniasis</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2020</span>. Available online: <a href="http://http:/www.who.int/gho/neglected_diseases/leishmaniasis/en/" class="extLink">http:/www.who.int/gho/neglected_diseases/leishmaniasis/en/</a> (accessed
Oct, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=WHO&title=Leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DLeishmaniasis%26pub%3DWHO%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ready, P. D.</span></span> <span> </span><span class="NLM_article-title">Epidemiology of visceral leishmaniasis</span>. <i>Clin. Epidemiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.2147/CLEP.S44267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.2147%2FCLEP.S44267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=24833919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A280%3ADC%252BC2cflvV2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=147-154&author=P.+D.+Ready&title=Epidemiology+of+visceral+leishmaniasis&doi=10.2147%2FCLEP.S44267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of visceral leishmaniasis</span></div><div class="casAuthors">Ready Paul D</div><div class="citationInfo"><span class="NLM_cas:title">Clinical epidemiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-54</span>
        ISSN:<span class="NLM_cas:issn">1179-1349</span>.
    </div><div class="casAbstract">Leishmania species are the causative agents of leishmaniasis, a neglected tropical disease.  These parasitic protozoans are usually transmitted between vertebrate hosts by the bite of blood sucking female phlebotomine sand flies.  This review focuses on the two parasites causing most human visceral leishmaniasis (VL), which leads to substantial health problems or death for up to 400,000 people per year.  Except for travel cases, Leishmania donovani infections are restricted to the (sub-)tropics of Asia and Africa, where transmission is mostly anthroponotic, while Leishmania infantum occurs in the drier parts of Latin America as well as in the Mediterranean climate regions of the Old World, with the domestic dog serving as the main reservoir host.  The prevalence of VL caused by L. infantum has been declining where living standards have improved.  In contrast, infections of L. donovani continue to cause VL epidemics in rural areas on the Indian subcontinent and in East Africa.  The current review compares and contrasts these continental differences and suggests priorities for basic and applied research that might improve VL control.  Transmission cycles, pathogenesis, diagnosis, treatment and prognosis, prevention (including vector control), surveillance, transmission modeling, and international control efforts are all reviewed.  Most case detection is passive, and so routine surveillance does not usually permit accurate assessments of any changes in the incidence of VL.  Also, it is not usually possible to estimate the human inoculation rate of parasites by the sand fly vectors because of the limitations of survey methods.  Consequently, transmission modeling rarely passes beyond the proof of principle stage, and yet it is required to help develop risk factor analysis for control programs.  Anthroponotic VL should be susceptible to elimination by rapid case detection and treatment combined with local vector control, and one of the most important interventions may well be socioeconomic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnQb3thmCTV0H3Rlp_k91zfW6udTcc2eZ9HWVvWGzPOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflvV2lsA%253D%253D&md5=59b7860c7fca93b3e8574b50275a0ea0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2147%2FCLEP.S44267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCLEP.S44267%26sid%3Dliteratum%253Aachs%26aulast%3DReady%26aufirst%3DP.%2BD.%26atitle%3DEpidemiology%2520of%2520visceral%2520leishmaniasis%26jtitle%3DClin.%2520Epidemiol.%26date%3D2014%26volume%3D6%26spage%3D147%26epage%3D154%26doi%3D10.2147%2FCLEP.S44267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumier, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strych, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottazzi, M. E.</span></span> <span> </span><span class="NLM_article-title">Status of vaccine research and development of vaccines for leishmanisis</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2992</span>– <span class="NLM_lpage">2995</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2015.12.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.vaccine.2015.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26973063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFKitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=2992-2995&author=P.+M.+Gillespieauthor=C.+M.+Beaumierauthor=U.+Strychauthor=T.+Haywardauthor=P.+J.+Hotezauthor=M.+E.+Bottazzi&title=Status+of+vaccine+research+and+development+of+vaccines+for+leishmanisis&doi=10.1016%2Fj.vaccine.2015.12.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Status of vaccine research and development of vaccines for leishmaniasis</span></div><div class="casAuthors">Gillespie, Portia M.; Beaumier, Coreen M.; Strych, Ulrich; Hayward, Tara; Hotez, Peter J.; Bottazzi, Maria Elena</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2992-2995</span>CODEN:
                <span class="NLM_cas:coden">VACCDE</span>;
        ISSN:<span class="NLM_cas:issn">0264-410X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A no. of leishmaniasis vaccine candidates are at various stages of pre-clin. and clin. development.  Leishmaniasis is a vector-borne neglected tropical disease (NTD) caused by a protozoan parasite of the genus Leishmania and transmitted to humans by the bite of a sand fly.  Visceral leishmaniasis (VL, kala-azar) is a high mortality NTD found mostly in South Asia and East Africa, while cutaneous leishmaniasis (CL) is a disfiguring NTD highly endemic in the Middle East, Central Asia, North Africa, and the Americas.  Ests. attribute 50,000 annual deaths and 3.3 million disability-adjusted life years to leishmaniasis.  There are only a few approved drug treatments, no prophylactic drug and no vaccine.  Ideally, an effective vaccine against leishmaniasis will elicit long-lasting immunity and protect broadly against VL and CL.  Vaccines such as Leish-F1, F2 and F3, developed at IDRI and designed based on selected Leishmania antigen epitopes, have been in clin. trials.  Other groups, including the Sabin Vaccine Institute in collaboration with the National Institutes of Health are investigating recombinant Leishmania antigens in combination with selected sand fly salivary gland antigens in order to augment host immunity.  To date, both VL and CL vaccines have been shown to be cost-effective in economic modeling studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmFFGisHW4j7Vg90H21EOLACvtfcHk0liUDEAQeoLgWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFKitLo%253D&md5=8a6296088fe26a6d298562562db97cd1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2015.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2015.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DP.%2BM.%26aulast%3DBeaumier%26aufirst%3DC.%2BM.%26aulast%3DStrych%26aufirst%3DU.%26aulast%3DHayward%26aufirst%3DT.%26aulast%3DHotez%26aufirst%3DP.%2BJ.%26aulast%3DBottazzi%26aufirst%3DM.%2BE.%26atitle%3DStatus%2520of%2520vaccine%2520research%2520and%2520development%2520of%2520vaccines%2520for%2520leishmanisis%26jtitle%3DVaccine%26date%3D2016%26volume%3D34%26spage%3D2992%26epage%3D2995%26doi%3D10.1016%2Fj.vaccine.2015.12.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span> <span> </span><span class="NLM_article-title">Current and emerging medications for the treatment of leishmaniasis</span>. <i>Exp. Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1080/14656566.2019.1609940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1080%2F14656566.2019.1609940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31063412" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=1251-1265&author=J.+Chakravartyauthor=S.+Sundar&title=Current+and+emerging+medications+for+the+treatment+of+leishmaniasis&doi=10.1080%2F14656566.2019.1609940"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1080%2F14656566.2019.1609940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14656566.2019.1609940%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarty%26aufirst%3DJ.%26aulast%3DSundar%26aufirst%3DS.%26atitle%3DCurrent%2520and%2520emerging%2520medications%2520for%2520the%2520treatment%2520of%2520leishmaniasis%26jtitle%3DExp.%2520Opin.%2520Pharmacother.%26date%3D2019%26volume%3D20%26spage%3D1251%26epage%3D1265%26doi%3D10.1080%2F14656566.2019.1609940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blesson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnerat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouattara, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pécoul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub-Wourgaft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasunna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zijlstra, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arana, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvar, J.</span></span> <span> </span><span class="NLM_article-title">Recent developments of visceral leishmaniasis treatments: successes, pitfalls and perspectives</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>, <span class="NLM_elocation-id">e00048-18</span> <span class="refDoi"> DOI: 10.1128/CMR.00048-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1128%2FCMR.00048-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=30158301" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&author=F.+Alvesauthor=G.+Bilbeauthor=S.+Blessonauthor=V.+Goyalauthor=S.+Monneratauthor=C.+Mowbrayauthor=G.+M.+Ouattaraauthor=B.+P%C3%A9coulauthor=S.+Rijalauthor=J.+Rodeauthor=A.+Solomosauthor=N.+Strub-Wourgaftauthor=M.+Wasunnaauthor=S.+Wellsauthor=E.+E.+Zijlstraauthor=B.+Aranaauthor=J.+Alvar&title=Recent+developments+of+visceral+leishmaniasis+treatments%3A+successes%2C+pitfalls+and+perspectives&doi=10.1128%2FCMR.00048-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FCMR.00048-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00048-18%26sid%3Dliteratum%253Aachs%26aulast%3DAlves%26aufirst%3DF.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DMonnerat%26aufirst%3DS.%26aulast%3DMowbray%26aufirst%3DC.%26aulast%3DOuattara%26aufirst%3DG.%2BM.%26aulast%3DP%25C3%25A9coul%26aufirst%3DB.%26aulast%3DRijal%26aufirst%3DS.%26aulast%3DRode%26aufirst%3DJ.%26aulast%3DSolomos%26aufirst%3DA.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26aulast%3DWasunna%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DZijlstra%26aufirst%3DE.%2BE.%26aulast%3DArana%26aufirst%3DB.%26aulast%3DAlvar%26aufirst%3DJ.%26atitle%3DRecent%2520developments%2520of%2520visceral%2520leishmaniasis%2520treatments%253A%2520successes%252C%2520pitfalls%2520and%2520perspectives%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2018%26volume%3D31%26doi%3D10.1128%2FCMR.00048-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponte-Sucre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamarro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dujardin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Vélez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Hernández, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pountain, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwenechanya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, B.</span></span> <span> </span><span class="NLM_article-title">Drug resistance and treatment failure in leishmaniasis: a 21st century challenge</span>. <i>PLoS Negl. Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0006052</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0006052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1371%2Fjournal.pntd.0006052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29240765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisV2qsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&author=A.+Ponte-Sucreauthor=F.+Gamarroauthor=J.+C.+Dujardinauthor=M.+P.+Barrettauthor=R.+L%C3%B3pez-V%C3%A9lezauthor=R.+Garc%C3%ADa-Hern%C3%A1ndezauthor=A.+W.+Pountainauthor=R.+Mwenechanyaauthor=B.+Papadopoulou&title=Drug+resistance+and+treatment+failure+in+leishmaniasis%3A+a+21st+century+challenge&doi=10.1371%2Fjournal.pntd.0006052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance and treatment failure in leishmaniasis: a 21st century challenge</span></div><div class="casAuthors">Ponte-Sucre, Alicia; Gamarro, Francisco; Dujardin, Jean-Claude; Barrett, Michael P.; Lopez-Velez, Rogelio; Garcia-Hernandez, Raquel; Pountain, Andrew W.; Mwenechanya, Roy; Papadopoulou, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e0006052/1-e0006052/24</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem.  Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system.  Pentavalent antimonials have been used successfully worldwide for the treatment of leishmaniasis since the first half of the 20th century, but the last 10 to 20 years have witnessed an increase in clin. resistance, e.g., in North Bihar in India.  In this review, we discuss the meaning of "resistance" related to leishmaniasis and discuss its mol. epidemiol., particularly for Leishmania donovani that causes visceral leishmaniasis.  We also discuss how resistance can affect drug combination therapies.  Mol. mechanisms known to contribute to resistance to antimonials, amphotericin B, and miltefosine are also outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6TWUhcg-NibVg90H21EOLACvtfcHk0ljVOsuLbJG79g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisV2qsr7F&md5=37789e9b3b8ef1e82b34fe1b4991421b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0006052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0006052%26sid%3Dliteratum%253Aachs%26aulast%3DPonte-Sucre%26aufirst%3DA.%26aulast%3DGamarro%26aufirst%3DF.%26aulast%3DDujardin%26aufirst%3DJ.%2BC.%26aulast%3DBarrett%26aufirst%3DM.%2BP.%26aulast%3DL%25C3%25B3pez-V%25C3%25A9lez%26aufirst%3DR.%26aulast%3DGarc%25C3%25ADa-Hern%25C3%25A1ndez%26aufirst%3DR.%26aulast%3DPountain%26aufirst%3DA.%2BW.%26aulast%3DMwenechanya%26aufirst%3DR.%26aulast%3DPapadopoulou%26aufirst%3DB.%26atitle%3DDrug%2520resistance%2520and%2520treatment%2520failure%2520in%2520leishmaniasis%253A%2520a%252021st%2520century%2520challenge%26jtitle%3DPLoS%2520Negl.%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26doi%3D10.1371%2Fjournal.pntd.0006052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, K.</span></span> <span> </span><span class="NLM_article-title">Molecular targets and pathways for the treatment of visceral leishmaniasis</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.drudis.2017.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28919438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFehs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=161-170&author=V.+Jainauthor=K.+Jain&title=Molecular+targets+and+pathways+for+the+treatment+of+visceral+leishmaniasis&doi=10.1016%2Fj.drudis.2017.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular targets and pathways for the treatment of visceral leishmaniasis</span></div><div class="casAuthors">Jain, Vineet; Jain, Keerti</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Visceral leishmaniasis (VL) represents the most severe form of the tropical disease, leishmaniasis.  Treatment of VL is complicated because of the few clin. approved antileishmanial drugs available; emerging resistance to first-line drugs; need for a temp.-controlled 'cold' supply chain; serious toxicity concerns over drugs such as amphotericin B; high cost of medication; and unavailability of clin. approved antileishmanial vaccines.  Attacking potential mol. targets, specific to the parasite, is a vital step in the treatment of this and other infectious diseases.  As we discuss here, comprehensive investigation of these targets could provide a promising strategy for the treatment of visceral leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd71mNaDhkv7Vg90H21EOLACvtfcHk0ljVOsuLbJG79g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFehs73K&md5=82e7714a7c3df52c785dda42faffe19d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DV.%26aulast%3DJain%26aufirst%3DK.%26atitle%3DMolecular%2520targets%2520and%2520pathways%2520for%2520the%2520treatment%2520of%2520visceral%2520leishmaniasis%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D161%26epage%3D170%26doi%3D10.1016%2Fj.drudis.2017.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansuri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diwan, A.</span></span> <span> </span><span class="NLM_article-title">An insight into the current perspective and potential drug targets for visceral leishmaniasis (VL)</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1129</span>, <span class="refDoi"> DOI: 10.2174/1389450121666200422083735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.2174%2F1389450121666200422083735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=32321399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVagtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=1105-1129&author=R.+Mansuriauthor=J.+Singhauthor=A.+Diwan&title=An+insight+into+the+current+perspective+and+potential+drug+targets+for+visceral+leishmaniasis+%28VL%29&doi=10.2174%2F1389450121666200422083735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmaniasis (VL)</span></div><div class="casAuthors">Mansuri, Rani; Singh, Jagbir; Diwan, Anupama</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1105-1129</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Leishmaniasis is one of the six entities on the list of most important diseases of the World Health Organization/Tropical Disease Research (WHO/TDR).  After Malaria, it is one of the most prevalent and lethal parasitic diseases.  VL is the fatal form of this disease, esp. if left untreated.  The drugs that are currently available for the treatment of VL are expensive, toxic, or no longer effective, esp. in endemic regions.  Currently, no vaccine has been developed to immunize humans against VL.  The major problems with the current drugs are the development of resistance and their adverse effects.  Therefore, there is a strong urge to research and design drugs that have better efficacies and low toxicities as compared to current chemotherapeutic drugs.  Leishmania has various enzymes involved in its metabolic pathways, which are unique to either the same genus or trypanosomatids, making them a very suitable, attractive and novel target sites for drug development.  One of the significant pathways unique to trypanosomatids is the thiol metab. pathway, which is involved in the maintenance of redox homeostasis as well as protection of the parasite in the macrophage from oxidative stress-induced damage.  In this review the several pathways, their essential enzymes as well as the proposed changes in the parasites due to drug resistance have been discussed to help to understand the most suitable drug target.  The thiol metab. pathway is discussed in detail, providing evidence of this pathway being the most favorable choice for drug targeting in VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroGF4R4CvM2LVg90H21EOLACvtfcHk0ljVOsuLbJG79g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVagtL7O&md5=0142d719288142ce982de7ab151ac55c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1389450121666200422083735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450121666200422083735%26sid%3Dliteratum%253Aachs%26aulast%3DMansuri%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DDiwan%26aufirst%3DA.%26atitle%3DAn%2520insight%2520into%2520the%2520current%2520perspective%2520and%2520potential%2520drug%2520targets%2520for%2520visceral%2520leishmaniasis%2520%2528VL%2529%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2020%26volume%3D21%26spage%3D1105%26epage%3D1129%26doi%3D10.2174%2F1389450121666200422083735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiering, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, H.</span></span> <span> </span><span class="NLM_article-title">The parasite-specific trypanothione metabolism of trypanosoma and leishmania</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1515/BC.2003.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1515%2FBC.2003.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=12751784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVektbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=539-549&author=R.+L.+Krauth-Siegelauthor=S.+K.+Meieringauthor=H.+Schmidt&title=The+parasite-specific+trypanothione+metabolism+of+trypanosoma+and+leishmania&doi=10.1515%2FBC.2003.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The parasite-specific trypanothione metabolism of Trypanosoma and Leishmania</span></div><div class="casAuthors">Krauth-Siegel, R. Luise; Meiering, Svea K.; Schmidt, Heide</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">539-549</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  The bis(glutathionyl)spermidine trypanothione exclusively occurs in parasitic protozoa of the order Kinetoplastida, such as trypanosomes and leishmania, some of which are the causative agents of several tropical diseases.  The dithiol is kept reduced by the flavoenzyme trypanothione reductase and the trypanothione system replaces in these parasites the nearly ubiquitous glutathione/glutathione reductase couple.  Trypanothione is a reductant of thioredoxin and tryparedoxin, small dithiol proteins, which in turn deliver reducing equiv. for the synthesis of deoxyribonucleotides as well as for the detoxification of hydroperoxides by different peroxidases.  Depending on the individual organism and the developmental state, the parasites also contain significant amts. of glutathione, mono-glutathionylspermidine and ovothiol, whereby all four low mol. mass thiols are directly (trypanothione and mono-glutathionylspermidine) or indirectly (glutathione and ovothiol) maintained in the reduced state by trypanothione reductase.  Thus the trypanothione system is central for any thiol regeneration and trypanothione reductase has been shown to be an essential enzyme in these parasites.  The absence of this pathway from the mammalian host and the sensitivity of trypanosomatids toward oxidative stress render the enzymes of the trypanothione metab. attractive target mols. for the rational development of new drugs against African sleeping sickness, Changas' disease and the different forms of leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRsZG2zf-i77Vg90H21EOLACvtfcHk0ljVOsuLbJG79g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVektbg%253D&md5=e52abde2d7bae69966ea289d26248c4d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.062%26sid%3Dliteratum%253Aachs%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DMeiering%26aufirst%3DS.%2BK.%26aulast%3DSchmidt%26aufirst%3DH.%26atitle%3DThe%2520parasite-specific%2520trypanothione%2520metabolism%2520of%2520trypanosoma%2520and%2520leishmania%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D539%26epage%3D549%26doi%3D10.1515%2FBC.2003.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Target assessment for antiparasitic drug discovery</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">589</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2007.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.pt.2007.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=17962072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSktrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=589-595&author=J.+A.+Frearsonauthor=P.+A.+Wyattauthor=I.+H.+Gilbertauthor=A.+H.+Fairlamb&title=Target+assessment+for+antiparasitic+drug+discovery&doi=10.1016%2Fj.pt.2007.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Target assessment for antiparasitic drug discovery</span></div><div class="casAuthors">Frearson, Julie A.; Wyatt, Paul G.; Gilbert, Ian H.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">589-595</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Drug discovery is a high-risk, expensive and lengthy process taking at least 12 years and costing upwards of US$500 million per drug to reach the clinic.  For neglected diseases, the drug discovery process is driven by medical need and guided by pre-defined target product profiles.  Assessment and prioritization of the most promising targets for entry into screening programs is crucial for maximizing the chances of success.  Here, we describe criteria used in our drug discovery unit for target assessment and introduce the 'traffic-light' system as a prioritization and management tool.  We hope this brief review will stimulate basic scientists to acquire addnl. information necessary for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpZsiQ7tE_7Vg90H21EOLACvtfcHk0ljCjMUZry6-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSktrzJ&md5=40edb0aa482e5b6155dc653397c1c45d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2007.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2007.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BA.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DTarget%2520assessment%2520for%2520antiparasitic%2520drug%2520discovery%26jtitle%3DTrends%2520Parasitol.%26date%3D2007%26volume%3D23%26spage%3D589%26epage%3D595%26doi%3D10.1016%2Fj.pt.2007.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Thiol redox biology of trypanosomatids and potential targets for chemotherapy</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.molbiopara.2015.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.molbiopara.2015.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26592324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2016&pages=67-74&author=A.+E.+Lerouxauthor=R.+L.+Krauth-Siegel&title=Thiol+redox+biology+of+trypanosomatids+and+potential+targets+for+chemotherapy&doi=10.1016%2Fj.molbiopara.2015.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol redox biology of trypanosomatids and potential targets for chemotherapy</span></div><div class="casAuthors">Leroux, Alejandro E.; Krauth-Siegel, R. Luise</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Trypanosomatids are the causative agents of African sleeping sickness, Chagas' disease, and the different forms of leishmaniasis.  This family of protozoan parasite possesses a trypanothione-based redox metab. that provides the reducing equiv. for various vital processes such as the biosynthesis of DNA precursors and the detoxification of hydroperoxides.  Almost all enzymes of the redox pathway proved to be essential and therefore fulfil one crucial prerequisite for a putative drug target.  Trypanothione synthetase and trypanothione reductase are present in all trypanosomatids but absent from the mammalian host which, in addn. to the essentiality, renders them highly specific.  The chemotherapy research on both enzymes is further supported by the availability of high-throughput screening techniques and crystal structures.  In this review we focus on the recent advances and limitations in the development of lead compds. targeting trypanothione synthetase and trypanothione reductase.  We present an overview of the available inhibitors and discuss future perspectives including other components of the parasite-specific redox pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprdJHuvV_b5rVg90H21EOLACvtfcHk0ljCjMUZry6-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFerur3I&md5=06b997e4dd8a181c654990351956a57a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2015.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLeroux%26aufirst%3DA.%2BE.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26atitle%3DThiol%2520redox%2520biology%2520of%2520trypanosomatids%2520and%2520potential%2520targets%2520for%2520chemotherapy%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2016%26volume%3D206%26spage%3D67%26epage%3D74%26doi%3D10.1016%2Fj.molbiopara.2015.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2016.193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1038%2Fnrmicro.2016.193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28239154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=217-231&author=M.+C.+Fieldauthor=D.+Hornauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+W.+Grayauthor=K.+D.+Readauthor=M.+De+Ryckerauthor=L.+S.+Torrieauthor=P.+G.+Wyattauthor=S.+Wyllieauthor=I.+H.+Gilbert&title=Anti-trypanosomatid+drug+discovery%3A+an+ongoing+challenge+and+a+continuing+need&doi=10.1038%2Fnrmicro.2016.193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span></div><div class="casAuthors">Field, Mark C.; Horn, David; Fairlamb, Alan H.; Ferguson, Michael A. J.; Gray, David W.; Read, Kevin D.; De Rycker, Manu; Torrie, Leah S.; Wyatt, Paul G.; Wyllie, Susan; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-231</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.  These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal.  Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them.  In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled.  In addn., we consider the important challenges to drug discovery strategies and the new technologies that can address them.  The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBpRGL7YaP7Vg90H21EOLACvtfcHk0ljCjMUZry6-lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D&md5=1585d954d6eb695196a6c8921a84e300</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2016.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2016.193%26sid%3Dliteratum%253Aachs%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DAnti-trypanosomatid%2520drug%2520discovery%253A%2520an%2520ongoing%2520challenge%2520and%2520a%2520continuing%2520need%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26spage%3D217%26epage%3D231%26doi%3D10.1038%2Fnrmicro.2016.193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanwar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munde, M.</span></span> <span> </span><span class="NLM_article-title">Molecular insights into trypanothione reductase-inhibitor interaction: A structure-based review</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>351</i></span>, <span class="NLM_elocation-id">1700373</span> <span class="refDoi"> DOI: 10.1002/ardp.201700373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fardp.201700373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2018&author=N.+Tiwariauthor=N.+Tanwarauthor=M.+Munde&title=Molecular+insights+into+trypanothione+reductase-inhibitor+interaction%3A+A+structure-based+review&doi=10.1002%2Fardp.201700373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fardp.201700373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201700373%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DN.%26aulast%3DTanwar%26aufirst%3DN.%26aulast%3DMunde%26aufirst%3DM.%26atitle%3DMolecular%2520insights%2520into%2520trypanothione%2520reductase-inhibitor%2520interaction%253A%2520A%2520structure-based%2520review%26jtitle%3DArch.%2520Pharm.%26date%3D2018%26volume%3D351%26doi%3D10.1002%2Fardp.201700373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battista, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorillo, A.</span></span> <span> </span><span class="NLM_article-title">Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>, <span class="NLM_elocation-id">1924</span> <span class="refDoi"> DOI: 10.3390/molecules25081924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.3390%2Fmolecules25081924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVekur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&author=T.+Battistaauthor=C.+Gianniauthor=A.+Ilariauthor=A.+Fiorillo&title=Targeting+trypanothione+reductase%2C+a+key+enzyme+in+the+redox+trypanosomatid+metabolism%2C+to+develop+new+drugs+against+leishmaniasis+and+trypanosomiases&doi=10.3390%2Fmolecules25081924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases</span></div><div class="casAuthors">Battista, Theo; Colotti, Gianni; Ilari, Andrea; Fiorillo, Annarita</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1924</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The protozoans Leishmania and Trypanosoma, belonging to the same Trypanosomatidae family, are the causative agents of Leishmaniasis, Chagas disease, and human African trypanosomiasis.  Overall, these infections affect millions of people worldwide, posing a serious health issue as well as socio-economical concern.  Current treatments are inadequate, mainly due to poor efficacy, toxicity, and emerging resistance; therefore, there is an urgent need for new drugs.  Among several mol. targets proposed, trypanothione reductase (TR) is of particular interest for its crit. role in controlling the parasite's redox homeostasis and several classes of active compds. that inhibit TR have been proposed so far.  This review provides a comprehensive overview of TR's structural characterization.  In particular, we discuss all the structural features of TR relevant for drug discovery, with a focus on the recent advances made in the understanding of inhibitor binding.  The reported cases show how, on the basis of the detailed structural information provided by the crystallog. anal., it is possible to rationally modify mol. scaffolds to improve their properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop2DZXElUewrVg90H21EOLACvtfcHk0lhfgzdPgvagzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVekur7M&md5=d19e3b7e88240c74ea2d9670ca357ec3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25081924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25081924%26sid%3Dliteratum%253Aachs%26aulast%3DBattista%26aufirst%3DT.%26aulast%3DGianni%26aufirst%3DC.%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DFiorillo%26aufirst%3DA.%26atitle%3DTargeting%2520trypanothione%2520reductase%252C%2520a%2520key%2520enzyme%2520in%2520the%2520redox%2520trypanosomatid%2520metabolism%252C%2520to%2520develop%2520new%2520drugs%2520against%2520leishmaniasis%2520and%2520trypanosomiases%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26doi%3D10.3390%2Fmolecules25081924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saccoliti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Santo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, R.</span></span> <span> </span><span class="NLM_article-title">Recent advancement in the search of innovative antiprotozoal agents targeting trypanothione metabolism</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2420</span>– <span class="NLM_lpage">2435</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcmdc.202000325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=32805075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslygtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=2420-2435&author=F.+Saccolitiauthor=R.+Di+Santoauthor=R.+Costi&title=Recent+advancement+in+the+search+of+innovative+antiprotozoal+agents+targeting+trypanothione+metabolism&doi=10.1002%2Fcmdc.202000325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism</span></div><div class="casAuthors">Saccoliti, Francesco; Di Santo, Roberto; Costi, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2420-2435</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Leishmania and Trypanosoma parasites are responsible for the challenging neglected tropical diseases leishmaniasis, Chagas disease, and human African trypanosomiasis, which account for up to 40,000 deaths annually mainly in developing countries.  Current chemotherapy relies on drugs with significant limitations in efficacy and safety, prompting the urgent need to explore innovative approaches to improve the drug discovery pipeline.  The unique trypanothione-based redox pathway, which is absent in human hosts, is vital for all trypanosomatids and offers valuable opportunities to guide the rational development of specific, broad-spectrum and innovative anti-trypanosomatid agents.  Major efforts focused on the key metabolic enzymes trypanothione synthetase-amidase and trypanothione reductase, whose inhibition should affect the entire pathway and, finally, parasite survival.  Herein, we will report and comment on the most recent studies in the search for enzyme inhibitors, underlining the promising opportunities that have emerged so far to drive the exploration of future successful therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoXJ31TxSdz7Vg90H21EOLACvtfcHk0lhfgzdPgvagzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslygtLbL&md5=a0afb4a7a5057f38774f1c2be868bcbb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000325%26sid%3Dliteratum%253Aachs%26aulast%3DSaccoliti%26aufirst%3DF.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DR.%26atitle%3DRecent%2520advancement%2520in%2520the%2520search%2520of%2520innovative%2520antiprotozoal%2520agents%2520targeting%2520trypanothione%2520metabolism%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D2420%26epage%3D2435%26doi%3D10.1002%2Fcmdc.202000325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alphey, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanks, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Dihydroquinazolines as a novel class of <i>Trypanosoma brucei</i> trypanothione reductase inhibitors: discovery, synthesis and characterization of their binding mode by protein crystallography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6514</span>– <span class="NLM_lpage">6530</span>, <span class="refDoi"> DOI: 10.1021/jm200312v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200312v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWjs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6514-6530&author=S.+Pattersonauthor=M.+S.+Alpheyauthor=D.+C.+Jonesauthor=E.+J.+Shanksauthor=I.+P.+Streetauthor=J.+A.+Frearsonauthor=P.+G.+Wyattauthor=I.+H.+Gilbertauthor=A.+H.+Fairlamb&title=Dihydroquinazolines+as+a+novel+class+of+Trypanosoma+brucei+trypanothione+reductase+inhibitors%3A+discovery%2C+synthesis+and+characterization+of+their+binding+mode+by+protein+crystallography&doi=10.1021%2Fjm200312v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography</span></div><div class="casAuthors">Patterson, Stephen; Alphey, Magnus S.; Jones, Deuan C.; Shanks, Emma J.; Street, Ian P.; Frearson, Julie A.; Wyatt, Paul G.; Gilbert, Ian H.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6514-6530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trypanothione reductase (TryR) is a genetically validated drug target in the parasite Trypanosoma brucei, the causative agent of human African trypanosomiasis.  Here we report the discovery, synthesis, and development of a novel series of TryR inhibitors I (R1 = Me, Et, 4-morpholinylmethyl, Ph, etc.; R2 = Me, MeO2C, Ph, Me2NCH2CH2, etc.; R3 = cyclohexyl, Ph, 3-FC6H4, 3,4-Me2C6H4, PhCH2, etc.; X = H, OH; R4 = H, Cl, Br, I, Ph, 4-pyridyl, 1-naphthyl, etc.; R5 = H, Br, Ph) based on a 3,4-dihydroquinazoline scaffold.  In addn., a high resoln. crystal structure of TryR, alone and in complex with substrates and inhibitors from this series, is presented.  This represents the first report of a high resoln. complex between a noncovalent ligand and this enzyme.  Structural studies revealed that upon ligand binding the enzyme undergoes a conformational change to create a new subpocket which is occupied by an aryl group on the ligand.  Therefore, the inhibitor, in effect, creates its own small binding pocket within the otherwise large, solvent exposed active site.  The TryR-ligand structure was subsequently used to guide the synthesis of inhibitors, including analogs that challenged the induced subpocket.  This resulted in the development of inhibitors, such as I [R1 = Me; R2 = Me2N(CH2)2; R3 = 4-MeC6H4; R4 = Cl; R5 = X = H], with improved potency against both TryR and T. brucei parasites in a whole cell assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-Yqr4e6doy7Vg90H21EOLACvtfcHk0lhfgzdPgvagzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWjs7zN&md5=88926d1f4b18b350b3736b2770394fad</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm200312v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200312v%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DAlphey%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DShanks%26aufirst%3DE.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DDihydroquinazolines%2520as%2520a%2520novel%2520class%2520of%2520Trypanosoma%2520brucei%2520trypanothione%2520reductase%2520inhibitors%253A%2520discovery%252C%2520synthesis%2520and%2520characterization%2520of%2520their%2520binding%2520mode%2520by%2520protein%2520crystallography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6514%26epage%3D6530%26doi%3D10.1021%2Fjm200312v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span> <span> </span><span class="NLM_article-title">Polyamine-trypanothione pathway: an update</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.4155%2Ffmc-2016-0180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=27957878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=61-77&author=A.+Ilariauthor=A.+Fiorilloauthor=I.+Genoveseauthor=G.+Colotti&title=Polyamine-trypanothione+pathway%3A+an+update&doi=10.4155%2Ffmc-2016-0180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Polyamine-trypanothione pathway: an update</span></div><div class="casAuthors">Ilari, Andrea; Fiorillo, Annarita; Genovese, Ilaria; Colotti, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-77</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In trypanosomatids, polyamine and trypanothione pathways can be considered as a whole unique metab., where most enzymes are essential for parasitic survival and infectivity.  Leishmania parasites and all the other members of the Trypanosomatids family depend on polyamines for growth and survival: the enzymes involved in the synthesis and utilization of spermidine and trypanothione, i.e., arginase, ornithine decarboxylase, S-adenosylmethionine decarboxylase, spermidine synthase, and in particular trypanothione synthetase-amidase, trypanothione reductase and tryparedoxin-dependent peroxidase are promising targets for drug development.  This review deals with recent structure-based studies on these enzymes, aimed at the discovery of inhibitors of this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhWOIln1CS7Vg90H21EOLACvtfcHk0lgh-onGO3Ul2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamsLjL&md5=89194c550293252b618900dabf5cb5b1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0180%26sid%3Dliteratum%253Aachs%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DFiorillo%26aufirst%3DA.%26aulast%3DGenovese%26aufirst%3DI.%26aulast%3DColotti%26aufirst%3DG.%26atitle%3DPolyamine-trypanothione%2520pathway%253A%2520an%2520update%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D61%26epage%3D77%26doi%3D10.4155%2Ffmc-2016-0180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oullette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tovar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, B.</span></span> <span> </span><span class="NLM_article-title">Disruption of the trypanothione reductase gene of <i>Leishmania</i> decreases its ability to survive oxidative stress in macrophages</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2590</span>– <span class="NLM_lpage">2598</span>, <span class="refDoi"> DOI: 10.1093/emboj/16.10.2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1093%2Femboj%2F16.10.2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=9184206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaK2sXjsF2hs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=2590-2598&author=C.+Dumasauthor=M.+Oulletteauthor=J.+Tovarauthor=M.+L.+Cunninghamauthor=A.+H.+Fairlambauthor=S.+Tamarauthor=M.+Olivierauthor=B.+Papadopoulou&title=Disruption+of+the+trypanothione+reductase+gene+of+Leishmania+decreases+its+ability+to+survive+oxidative+stress+in+macrophages&doi=10.1093%2Femboj%2F16.10.2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages</span></div><div class="casAuthors">Dumas, Carole; Ouellette, Marc; Tovar, Jorge; Cunningham, Mark L.; Fairlamb, Alan H.; Tamar, Samira; Olivier, Martin; Papadopoulou, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2590-2598</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Parasitic protozoa belonging to the order Kinetoplastida contain trypanothione as their major thiol.  Trypanothione reductase (TR), the enzyme responsible for maintaining trypanothione in its reduced form, is thought to be central to the redox defense systems of trypanosomatids.  To investigate further the physiol. role of TR in Leishmania, we attempted to create TR-knockout mutants by gene disruption in L. donovani and L. major strains using the selectable markable neomycin and hygromycin phosphotransferases.  TR is likely to be an important gene for parasite survival since all our attempts to obtain a TR null mutant in L. donovani failed.  Instead, we obtained mutants with a partial trisomy for the TR locus where, despite the successful disruption of two TR alleles by gene targeting, a third TR copy was generated as a result of genomic rearrangements involving the translocation of a TR-contg. region to a larger chromosome.  Mutants of L. donovani and L. major possessing only one wild-type TR allele express less TR mRNA and have lower TR activity compared with wild-type cells carrying two copies of the TR gene.  Significantly, these mutants show attenuated infectivity with a markedly decreased capacity to survive intracellularly within macrophages, provided that the latter are producing reactive oxygen intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9OoguRHiLiLVg90H21EOLACvtfcHk0lgh-onGO3Ul2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsF2hs7k%253D&md5=741e990c3e3ece2ad9294daa81374712</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.10.2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.10.2590%26sid%3Dliteratum%253Aachs%26aulast%3DDumas%26aufirst%3DC.%26aulast%3DOullette%26aufirst%3DM.%26aulast%3DTovar%26aufirst%3DJ.%26aulast%3DCunningham%26aufirst%3DM.%2BL.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DTamar%26aufirst%3DS.%26aulast%3DOlivier%26aufirst%3DM.%26aulast%3DPapadopoulou%26aufirst%3DB.%26atitle%3DDisruption%2520of%2520the%2520trypanothione%2520reductase%2520gene%2520of%2520Leishmania%2520decreases%2520its%2520ability%2520to%2520survive%2520oxidative%2520stress%2520in%2520macrophages%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D2590%26epage%3D2598%26doi%3D10.1093%2Femboj%2F16.10.2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Gasparo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harangozo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Targeting a large active site: structure-based design of nanomolar inhibitors of <i>Trypanosoma brucei</i> trypanothione reductase</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">11416</span>– <span class="NLM_lpage">11421</span>, <span class="refDoi"> DOI: 10.1002/chem.201901664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fchem.201901664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31407832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjs7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=11416-11421&author=R.+De%0AGasparoauthor=O.+Halgasauthor=D.+Harangozoauthor=M.+Kaiserauthor=E.+F.+Paiauthor=R.+L.+Krauth-Siegelauthor=F.+Diederich&title=Targeting+a+large+active+site%3A+structure-based+design+of+nanomolar+inhibitors+of+Trypanosoma+brucei+trypanothione+reductase&doi=10.1002%2Fchem.201901664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase</span></div><div class="casAuthors">De Gasparo, Raoul; Halgas, Ondrej; Harangozo, Dora; Kaiser, Marcel; Pai, Emil F.; Krauth-Siegel, R. Luise; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">11416-11421</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Trypanothione reductase (TR) plays a key role in the unique redox metab. of trypanosomatids, the causative agents of human African trypanosomiasis (HAT), Chagas' disease, and leishmaniases.  Introduction of a new, lean propargylic vector to a known class of TR inhibitors resulted in the strongest reported competitive inhibitor of Trypanosoma (T.) brucei TR, with an inhibition const. Ki of 73 nM, which is fully selective against human glutathione reductase (hGR).  The best ligands exhibited in vitro IC50 values (half-maximal inhibitory concn.) against the HAT pathogen, T. brucei rhodesiense, in the mid-nanomolar range, reaching down to 50 nM. X-Ray co-crystal structures confirmed the binding mode of the ligands and revealed the presence of a HEPES buffer mol. in the large active site.  Extension of the propargylic vector, guided by structure-based design, to replace the HEPES buffer mol. should give inhibitors with low nanomolar Ki and IC50 values for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBy2IMEKQxW7Vg90H21EOLACvtfcHk0lgh-onGO3Ul2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjs7%252FN&md5=38dd84304eecc21db7f0e080b99cd710</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fchem.201901664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201901664%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DR.%26aulast%3DHalgas%26aufirst%3DO.%26aulast%3DHarangozo%26aufirst%3DD.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DTargeting%2520a%2520large%2520active%2520site%253A%2520structure-based%2520design%2520of%2520nanomolar%2520inhibitors%2520of%2520Trypanosoma%2520brucei%2520trypanothione%2520reductase%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2019%26volume%3D25%26spage%3D11416%26epage%3D11421%26doi%3D10.1002%2Fchem.201901664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span>; <span class="NLM_string-name">Ridley, R. G.</span>; <span class="NLM_string-name">Vial, H. J.</span></span> <i>Drugs against Parasitic Diseases: R&D Methodologies and Issues, Discoveries and Drug Development</i>, TDR/PRD/03.1; <span class="NLM_publisher-name">WHO</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">118</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=A.+H.+Fairlamb&author=R.+G.+Ridley&author=H.+J.+Vial&title=Drugs+against+Parasitic+Diseases%3A+R%26D+Methodologies+and+Issues%2C+Discoveries+and+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26jtitle%3DDrugs%2520against%2520Parasitic%2520Diseases%253A%2520R%2526D%2520Methodologies%2520and%2520Issues%252C%2520Discoveries%2520and%2520Drug%2520Development%26pub%3DWHO%26date%3D2003%26spage%3D107%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Dual action of antimonial drugs on thiol redox metabolism in the human pathogen <i>Leishmania donovani</i></span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">39925</span>– <span class="NLM_lpage">39932</span>, <span class="refDoi"> DOI: 10.1074/jbc.M405635200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1074%2Fjbc.M405635200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=15252045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVKku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=39925-39932&author=S.+Wyllieauthor=M.+L.+Cunninghamauthor=A.+H.+Fairlamb&title=Dual+action+of+antimonial+drugs+on+thiol+redox+metabolism+in+the+human+pathogen+Leishmania+donovani&doi=10.1074%2Fjbc.M405635200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani</span></div><div class="casAuthors">Wyllie, Susan; Cunningham, Mark L.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">39925-39932</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Despite extensive use of antimonial compds. in the treatment of leishmaniasis, their mode of action remains uncertain.  Here we show that trivalent antimony (SbIII) interferes with trypanothione metab. in drug-sensitive Leishmania parasites by 2 inherently distinct mechanisms.  First, SbIII decreases thiol buffering capacity by inducing rapid efflux of intracellular trypanothione and glutathione in approx. equimolar amts.  Second, SbIII inhibits trypanothione reductase in intact cells, resulting in accumulation of the disulfide forms of trypanothione and glutathione.  These 2 mechanisms combine to profoundly compromise the thiol redox potential in both amastigote and promastigote stages of the life cycle.  Furthermore, we demonstrate that sodium stibogluconate, a pentavalent antimonial used clin. for the treatment for leishmaniasis, induces similar effects on thiol redox metab. in axenically cultured amastigotes.  These observations suggest ways in which current antimony therapies could be improved, overcoming the growing problem of antimony resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqnMKFh1ixPbVg90H21EOLACvtfcHk0lgV-kwEts1_-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVKku7k%253D&md5=ba95437aa1cdac7e923b4edcba77f7c4</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M405635200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M405635200%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DM.%2BL.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DDual%2520action%2520of%2520antimonial%2520drugs%2520on%2520thiol%2520redox%2520metabolism%2520in%2520the%2520human%2520pathogen%2520Leishmania%2520donovani%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D39925%26epage%3D39932%26doi%3D10.1074%2Fjbc.M405635200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krieger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ariyanayagam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, C.</span></span> <span> </span><span class="NLM_article-title">Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2000.01721.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1046%2Fj.1365-2958.2000.01721.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10672177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12iu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=542-552&author=S.+Kriegerauthor=W.+Schwarzauthor=M.+R.+Ariyanayagamauthor=A.+H.+Fairlambauthor=R.+L.+Krauth-Siegelauthor=C.+Clayton&title=Trypanosomes+lacking+trypanothione+reductase+are+avirulent+and+show+increased+sensitivity+to+oxidative+stress&doi=10.1046%2Fj.1365-2958.2000.01721.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress</span></div><div class="casAuthors">Krieger, S.; Schwarz, W.; Ariyanayagam, M. R.; Fairlamb, A. H.; Krauth-Siegel, R. L.; Clayton, C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">542-552</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">In Kinetoplastida, trypanothione and trypanothione reductase (TRYR) provide an intracellular reducing environment, substituting for the glutathione-glutathione reductase system found in most other organisms.  To investigate the physiol. role of TRYR in Trypanosoma brucei, the authors generated cells contg. just one trypanothione reductase gene, TRYR, which was under the control of a tetracycline-inducible promoter.  This enabled them to regulate TRYR activity in the cells from less than 1% to 400% of wild-type levels by adjusting the concn. of added tetracycline.  In normal growth medium (which contains reducing agents), trypanosomes contg. less than 10% of wild-type enzyme activity were unable to grow, although the levels of reduced trypanothione and total thiols remained const.  In media lacking reducing agents, hypersensitivity towards hydrogen peroxide (EC50 = 3.5 μM) was obsd. compared with the wild type (EC50 = 223 μM).  The depletion of TRYR had no effect on susceptibility to melarsen oxide.  The infectivity and virulence of the parasites in mice was dependent upon tetracycline-regulated TRYR activity: if the trypanosomes were injected into mice in the absence of tetracycline, no infection was detectable; and when tetracycline was withdrawn from previously infected animals, the parasitemia was suppressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2EKuT6CV6CrVg90H21EOLACvtfcHk0lgV-kwEts1_-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12iu74%253D&md5=29124c2e79d1752607204bbd4274a821</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2000.01721.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2000.01721.x%26sid%3Dliteratum%253Aachs%26aulast%3DKrieger%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DW.%26aulast%3DAriyanayagam%26aufirst%3DM.%2BR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DClayton%26aufirst%3DC.%26atitle%3DTrypanosomes%2520lacking%2520trypanothione%2520reductase%2520are%2520avirulent%2520and%2520show%2520increased%2520sensitivity%2520to%2520oxidative%2520stress%26jtitle%3DMol.%2520Microbiol.%26date%3D2000%26volume%3D35%26spage%3D542%26epage%3D552%26doi%3D10.1046%2Fj.1365-2958.2000.01721.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baiocco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span> <span> </span><span class="NLM_article-title">Trypanothione reductase from <i>Leishmania infantum</i>: cloning, expression, purification, crystallization and preliminary X-ray data analysis</span>. <i>Protein Pept. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.2174/092986609787316306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.2174%2F092986609787316306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=19200044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVequ74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=196-200&author=P.+Baioccoauthor=S.+Franceschiniauthor=A.+Ilariauthor=G.+Colotti&title=Trypanothione+reductase+from+Leishmania+infantum%3A+cloning%2C+expression%2C+purification%2C+crystallization+and+preliminary+X-ray+data+analysis&doi=10.2174%2F092986609787316306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanothione reductase from Leishmania infantum: Cloning, expression, purification, crystallization and preliminary x-ray data analysis</span></div><div class="casAuthors">Baiocco, Paola; Franceschini, Stefano; Ilari, Andrea; Colotti, Gianni</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-200</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The most promising targets for Leishmania-specific drug design are 2 key enzymes involved in the unique thiol-based metab., common to all parasites of the Trypanosomatidae family: trypanothione synthetase and trypanothione reductase (I).  Recently, new inhibitors of I have been identified such as polyamines and tricyclic compds.  The knowledge of the 3-dimensional structure of Leishmania I will shed light on the mechanism of interaction of these inhibitors with I and will be the starting point to design novel lead candidates to facilitate the development of new effective and affordable drugs.  Here, I of L. infantum was cloned, expressed in Escherichia coli, and purified.  Crystals were obtained at 294 K by the hanging-drop vapor-diffusion method using (NH4)2SO4 as precipitant and diffracted to better than 2.95 Å resoln. using a synchrotron radiation source.  The I crystals exhibited an unusually high solvent content of 74%, and were found to belong to tetragonal space group P41 with unit-cell parameters a = b = 103.45, c = 192.62 Å, and 2 mols. in the asym. unit.  The protein x-ray structure has been solved by mol. replacement and the model is under construction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTnM4ouqhEc7Vg90H21EOLACvtfcHk0lgV-kwEts1_-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVequ74%253D&md5=89a106a7bfc63e8a3a2bb48e9161119c</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.2174%2F092986609787316306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986609787316306%26sid%3Dliteratum%253Aachs%26aulast%3DBaiocco%26aufirst%3DP.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DIlari%26aufirst%3DA.%26aulast%3DColotti%26aufirst%3DG.%26atitle%3DTrypanothione%2520reductase%2520from%2520Leishmania%2520infantum%253A%2520cloning%252C%2520expression%252C%2520purification%252C%2520crystallization%2520and%2520preliminary%2520X-ray%2520data%2520analysis%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2009%26volume%3D16%26spage%3D196%26epage%3D200%26doi%3D10.2174%2F092986609787316306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Baiocco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franceschini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilari, A.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of antimony treatment in leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2603</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1021/jm900185q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900185q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Glurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2603-2612&author=P.+Baioccoauthor=G.+Colottiauthor=S.+Franceschiniauthor=A.+Ilari&title=Molecular+basis+of+antimony+treatment+in+leishmaniasis&doi=10.1021%2Fjm900185q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of Antimony Treatment in Leishmaniasis</span></div><div class="casAuthors">Baiocco, Paola; Colotti, Gianni; Franceschini, Stefano; Ilari, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2603-2612</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Leishmaniasis is a disease that affects 2 million people and kills 70000 persons every year.  It is caused by Leishmania species, which are human protozoan parasites of the trypanosomatidae family.  Trypanosomatidae differ from the other eukaryotes in their specific redox metab. because the glutathione/glutathione reductase system is replaced by the unique trypanothione/trypanothione reductase system.  The current treatment of leishmaniasis relies mainly on antimonial drugs.  The crystal structures of oxidized trypanothione reductase (TR) from Leishmania infantum and of the complex of reduced TR with NADPH and Sb(III), reported in this paper, disclose for the first time the mol. mechanism of action of antimonial drugs against the parasite.  Sb(III), which is coordinated by the two redox-active catalytic cysteine residues (Cys52 and Cys57), one threonine residue (Thr335), and His461' of the 2-fold symmetry related subunit in the dimer, strongly inhibits TR activity.  Because TR is essential for the parasite survival and virulence and it is absent in mammalian cells, these findings provide insights toward the design of new more affordable and less toxic drugs against Leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRjK4eboFKabVg90H21EOLACvtfcHk0lg2Nv9rNsVQdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Glurc%253D&md5=c5fa0e9358491d5d7f285619eb2fe333</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fjm900185q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900185q%26sid%3Dliteratum%253Aachs%26aulast%3DBaiocco%26aufirst%3DP.%26aulast%3DColotti%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DIlari%26aufirst%3DA.%26atitle%3DMolecular%2520basis%2520of%2520antimony%2520treatment%2520in%2520leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2603%26epage%3D2612%26doi%3D10.1021%2Fjm900185q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Persch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todoroff, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thelemann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirdjaja, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derbani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1891</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201402032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcmdc.201402032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=24788386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFGmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1880-1891&author=E.+Perschauthor=S.+Brysonauthor=N.+K.+Todoroffauthor=C.+Eberleauthor=J.+Thelemannauthor=N.+Dirdjajaauthor=M.+Kaiserauthor=M.+Weberauthor=H.+Derbaniauthor=R.+Brunauthor=G.+Schneiderauthor=E.+F.+Paiauthor=R.+L.+Krauth-Siegelauthor=F.+Diederich&title=Binding+to+large+enzyme+pockets%3A+small-molecule+inhibitors+of+trypanothione+reductase&doi=10.1002%2Fcmdc.201402032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Binding to Large Enzyme Pockets: Small-Molecule Inhibitors of Trypanothione Reductase</span></div><div class="casAuthors">Persch, Elke; Bryson, Steve; Todoroff, Nickolay K.; Eberle, Christian; Thelemann, Jonas; Dirdjaja, Natalie; Kaiser, Marcel; Weber, Maria; Derbani, Hassan; Brun, Reto; Schneider, Gisbert; Pai, Emil F.; Krauth-Siegel, R. Luise; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1880-1891</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The causative agents of the parasitic disease human African trypanosomiasis belong to the family of trypanosomatids.  These parasitic protozoa exhibit a unique thiol redox metab. that is based on the flavoenzyme trypanothione reductase (TR).  TR was identified as a potential drug target and features a large active site that allows a multitude of possible ligand orientations, which renders rational structure-based inhibitor design highly challenging.  Herein we describe the synthesis, binding properties, and kinetic anal. of a new series of small-mol. inhibitors of TR.  The conjunction of biol. activities, mutation studies, and virtual ligand docking simulations led to the prediction of a binding mode that was confirmed by crystal structure anal.  The crystal structures revealed that the ligands bind to the hydrophobic wall of the so-called "mepacrine binding site".  The binding conformation and potency of the inhibitors varied for TR from Trypanosoma brucei and T. cruzi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvk-DaSeuaBLVg90H21EOLACvtfcHk0lg2Nv9rNsVQdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFGmsbo%253D&md5=494d9a33a79de5eaae0309fe39dd677c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402032%26sid%3Dliteratum%253Aachs%26aulast%3DPersch%26aufirst%3DE.%26aulast%3DBryson%26aufirst%3DS.%26aulast%3DTodoroff%26aufirst%3DN.%2BK.%26aulast%3DEberle%26aufirst%3DC.%26aulast%3DThelemann%26aufirst%3DJ.%26aulast%3DDirdjaja%26aufirst%3DN.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DDerbani%26aufirst%3DH.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBinding%2520to%2520large%2520enzyme%2520pockets%253A%2520small-molecule%2520inhibitors%2520of%2520trypanothione%2520reductase%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1880%26epage%3D1891%26doi%3D10.1002%2Fcmdc.201402032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Gasparo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodbeck-Persch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentzen, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation and X-ray Co-crystal structures of cyclohexylpyrrolidine ligands for trypanothione reductase, an enzyme from the redox metabolism of trypanosoma</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcmdc.201800067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29624890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFaisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=957-967&author=R.+De%0AGasparoauthor=E.+Brodbeck-Perschauthor=S.+Brysonauthor=N.+B.+Hentzenauthor=M.+Kaiserauthor=E.+F.+Paiauthor=R.+L.+Krauth-Siegelauthor=F.+Diederich&title=Biological+evaluation+and+X-ray+Co-crystal+structures+of+cyclohexylpyrrolidine+ligands+for+trypanothione+reductase%2C+an+enzyme+from+the+redox+metabolism+of+trypanosoma&doi=10.1002%2Fcmdc.201800067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma</span></div><div class="casAuthors">De Gasparo, Raoul; Brodbeck-Persch, Elke; Bryson, Steve; Hentzen, Nina B.; Kaiser, Marcel; Pai, Emil F.; Krauth-Siegel, R. Luise; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">957-967</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The tropical diseases human African trypanosomiasis, Chagas disease, and the various forms of leishmaniasis are caused by parasites of the family of trypanosomatids.  These protozoa possess a unique redox metab. based on trypanothione and trypanothione reductase (TR), making TR a promising drug target.  We report the optimization of properties and potency of cyclohexylpyrrolidine inhibitors of TR by structure-based design.  The best inhibitors were freely sol. and showed competitive inhibition consts. (Ki) against Trypanosoma (T.) brucei TR and T. cruzi TR and in vitro activities (half-maximal inhibitory concn., IC50) against these parasites in the low micromolar range, with high selectivity against human glutathione reductase.  X-ray co-crystal structures confirmed the binding of the ligands to the hydrophobic wall of the "mepacrine binding site" with the new, soly.-providing vectors oriented toward the surface of the large active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9ijT5bkmCbVg90H21EOLACvtfcHk0lg2Nv9rNsVQdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFaisrk%253D&md5=a94783c83362cb70fdfef0a77bcf91ec</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800067%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DR.%26aulast%3DBrodbeck-Persch%26aufirst%3DE.%26aulast%3DBryson%26aufirst%3DS.%26aulast%3DHentzen%26aufirst%3DN.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DBiological%2520evaluation%2520and%2520X-ray%2520Co-crystal%2520structures%2520of%2520cyclohexylpyrrolidine%2520ligands%2520for%2520trypanothione%2520reductase%252C%2520an%2520enzyme%2520from%2520the%2520redox%2520metabolism%2520of%2520trypanosoma%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D957%26epage%3D967%26doi%3D10.1002%2Fcmdc.201800067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzate, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span> <span> </span><span class="NLM_article-title">Probing the dimerization interface of <i>Leishmania infantum</i> trypanothione reductase with site-directed mutagenesis and short peptides</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1212</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1002/cbic.201200744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fcbic.201200744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=23744811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1212-1217&author=M.+A.+Toroauthor=P.+A.+S%C3%A1nchez-Murciaauthor=D.+Morenoauthor=M.+Ruiz-Santaquiteriaauthor=J.+F.+Alzateauthor=A.+Negriauthor=M.+J.+Camarasaauthor=F.+Gagoauthor=S.+Vel%C3%A1zquezauthor=A.+Jim%C3%A9nez-Ruiz&title=Probing+the+dimerization+interface+of+Leishmania+infantum+trypanothione+reductase+with+site-directed+mutagenesis+and+short+peptides&doi=10.1002%2Fcbic.201200744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the Dimerization Interface of Leishmania infantum Trypanothione Reductase with Site-Directed Mutagenesis and Short Peptides</span></div><div class="casAuthors">Toro, Miguel A.; Sanchez-Murcia, Pedro A.; Moreno, David; Ruiz-Santaquiteria, Marta; Alzate, Juan Fernando; Negri, Ana; Camarasa, Maria-Jose; Gago, Federico; Velazquez, Sonsoles; Jimenez-Ruiz, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1212-1217</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The inhibitory activity was tested of a set of peptide sequences derived from an α-helix of the dimeric trypanothione reductase from Leishmania infantum.  Replacement of a glutamic acid residue with a lysine promoted monomer dissocn. and enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhsufkT7uGFbVg90H21EOLACvtfcHk0lgcbo_ntWkS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFarurw%253D&md5=5b883d783bdbc6ac5ce640c51653cacc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200744%26sid%3Dliteratum%253Aachs%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DAlzate%26aufirst%3DJ.%2BF.%26aulast%3DNegri%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26atitle%3DProbing%2520the%2520dimerization%2520interface%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%2520with%2520site-directed%2520mutagenesis%2520and%2520short%2520peptides%26jtitle%3DChemBioChem%26date%3D2013%26volume%3D14%26spage%3D1212%26epage%3D1217%26doi%3D10.1002%2Fcbic.201200744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Comparison of hydrocarbon- and lactam-bridged cyclic peptides as dimerization inhibitors of <i>Leishmania infantum</i> trypanothione reductase</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">55784</span>– <span class="NLM_lpage">55794</span>, <span class="refDoi"> DOI: 10.1039/C5RA06853C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FC5RA06853C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=55784-55794&author=P.+A.+S%C3%A1nchez-Murciaauthor=M.+Ruiz-Santaquiteriaauthor=M.+A.+Toroauthor=H.+De+Lucioauthor=M.+A.+Jim%C3%A9nezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=Comparison+of+hydrocarbon-+and+lactam-bridged+cyclic+peptides+as+dimerization+inhibitors+of+Leishmania+infantum+trypanothione+reductase&doi=10.1039%2FC5RA06853C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of hydrocarbon-and lactam-bridged cyclic peptides as dimerization inhibitors of Leishmania infantum trypanothione reductase</span></div><div class="casAuthors">Sanchez-Murcia, Pedro A.; Ruiz-Santaquiteria, Marta; Toro, Miguel A.; de Lucio, Hector; Jimenez, Maria Angeles; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">69</span>),
    <span class="NLM_cas:pages">55784-55794</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">All-hydrocarbon and lactam-bridged staples linking amino acid side-chains have been used to stabilize the α-helical motif in short 13-mer peptides that target crit. protein-protein interactions at the dimerization interface of Leishmania infantum trypanothione reductase (Li-TryR).  The design of the best positions for covalent hydrocarbon closure relied on a theor. prediction of the degree of helicity of the corresponding cyclic peptides in water.  Selected (i, i + 4) and (i, i + 7) hydrocarbon-stapled peptides were prepd. by using solid-phase synthesis protocols and optimized ring-closing metathesis reactions under microwave conditions.  Structural anal. by NMR spectroscopy confirmed high helical contents in aq. TFE solns. for both types of helix-constrained cyclic peptides.  Remarkably, the ability to prevent Li-TryR dimerization was reduced in both (i, i + 4) and (i, i + 7) hydrocarbon stapled peptides but was retained in the corresponding (i, i + 4) Glu-Lys lactam-bridged analog, which also showed a higher resistance to proteolytic degrdn. by proteinase K relative to the linear peptide prototype.  In silico studies indicated that the introduction of a hydrocarbon staple vs. a lactam bridge likely perturbs crit. interactions required for proper binding of the peptide to the Li-TryR monomer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzL_ModJCzbrVg90H21EOLACvtfcHk0lgcbo_ntWkS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltbrK&md5=ef9bb8be43e2042a614ddaa15ba8e2df</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC5RA06853C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA06853C%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DM.%2BA.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DComparison%2520of%2520hydrocarbon-%2520and%2520lactam-bridged%2520cyclic%2520peptides%2520as%2520dimerization%2520inhibitors%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D55784%26epage%3D55794%26doi%3D10.1039%2FC5RA06853C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled -helical peptides with improved proteolytic stability</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.02.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2018.02.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29501944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVCgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2018&pages=238-247&author=M.+Ruiz-Santaquiteriaauthor=S.+De+Castroauthor=M.+A.+Toroauthor=H.+De+Lucioauthor=K.+J.+Guti%C3%A9rrezauthor=P.+A.+S%C3%A1nchez-Murciaauthor=M.+A.+Jim%C3%A9nezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=Trypanothione+reductase+inhibition+and+anti-leishmanial+activity+of+all-hydrocarbon+stapled+-helical+peptides+with+improved+proteolytic+stability&doi=10.1016%2Fj.ejmech.2018.02.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability</span></div><div class="casAuthors">Ruiz-Santaquiteria, Marta; de Castro, Sonia; Toro, Miguel A.; de Lucio, Hector; Gutierrez, Kilian Jesus; Sanchez-Murcia, Pedro A.; Jimenez, Maria Angeles; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">238-247</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Trypanothione reductase (TryR) is a well-established target in the search for novel antitrypanosomal and antileishmanial agents.  The authors have previously identified linear and lactam-bridged 13-residue peptides derived from an α-helical region making up part of the dimeric interface of Leishmania infantum TryR (Li-TryR) which prevent trypanothione redn. by disrupting enzyme dimerization.  The authors now show that i,i + 4 side-chain crosslinking with an all-hydrocarbon staple stabilizes the helical structure of these peptides and significantly improves their resistance to protease cleavage relative to previous linear and cyclic lactam analogs.  Interestingly, replacement of the amide bridge by the hydrocarbon staple at the same cyclization positions generates derivs. (2 and 3) that similarly inhibit oxidoreductase activity of the enzyme but unexpectedly stabilize the TryR homodimer.  The most proteolytically stable peptide 2 covalently linked to oligoarginines displayed potent in vitro leishmanicidal activity against L. infantum parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCHlkUhyIXErVg90H21EOLACvtfcHk0lgcbo_ntWkS7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVCgsbg%253D&md5=b52ee080f76842c1bafac149f4a4c64e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.02.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.02.071%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DDe%2BCastro%26aufirst%3DS.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DM.%2BA.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DTrypanothione%2520reductase%2520inhibition%2520and%2520anti-leishmanial%2520activity%2520of%2520all-hydrocarbon%2520stapled%2520-helical%2520peptides%2520with%2520improved%2520proteolytic%2520stability%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D149%26spage%3D238%26epage%3D247%26doi%3D10.1016%2Fj.ejmech.2018.02.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Improved proteolytic stability and potent activity against <i>Leishmania infantum</i> trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2017.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29017116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=615-623&author=H.+De%0ALucioauthor=A.+M.+Gamoauthor=M.+Ruiz-Santaquiteriaauthor=S.+De+Castroauthor=P.+A.+S%C3%A1nchez-Murciaauthor=M.+A.+Toroauthor=K.+J.+Guti%C3%A9rrezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=Improved+proteolytic+stability+and+potent+activity+against+Leishmania+infantum+trypanothione+reductase+of+%CE%B1%2F%CE%B2-peptide+foldamers+conjugated+to+cell-penetrating+peptides&doi=10.1016%2Fj.ejmech.2017.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides</span></div><div class="casAuthors">de Lucio, Hector; Gamo, Ana Maria; Ruiz-Santaquiteria, Marta; de Castro, Sonia; Sanchez-Murcia, Pedro A.; Toro, Miguel A.; Gutierrez, Kilian Jesus; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">615-623</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The objective of the current study was to enhance the proteolytic stability of peptide-based inhibitors that target crit. protein-protein interactions at the dimerization interface of Leishmania infantum trypanothione reductase (Li-TryR) using a backbone modification strategy.  To achieve this goal we carried out the synthesis, proteolytic stability studies and biol. evaluation of a small library of α/β3-peptide foldamers of different length (from 9-mers to 13-mers) and different α→β substitution patterns related to prototype linear α-peptides.  We show that several 13-residue α/β3-peptide foldamers retain inhibitory potency against the enzyme (in both activity and dimerization assays) while they are far less susceptible to proteolytic degrdn. than an analogous α-peptide.  The strong dependence of the binding affinities for Li-TryR on the length of the α,β-peptides is supported by theor. calcns. on conformational ensembles of the resulting complexes.  The conjugation of the most proteolytically stable α/β-peptide with oligoarginines results in a mol. with potent activity against L. infantum promastigotes and amastigotes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQjnGz46wXPLVg90H21EOLACvtfcHk0lisOoKu2Nbn5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egt7%252FL&md5=5b9336bc6bd284339386234a79430221</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGamo%26aufirst%3DA.%2BM.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DDe%2BCastro%26aufirst%3DS.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DImproved%2520proteolytic%2520stability%2520and%2520potent%2520activity%2520against%2520Leishmania%2520infantum%2520trypanothione%2520reductase%2520of%2520%25CE%25B1%252F%25CE%25B2-peptide%2520foldamers%2520conjugated%2520to%2520cell-penetrating%2520peptides%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D140%26spage%3D615%26epage%3D623%26doi%3D10.1016%2Fj.ejmech.2017.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Castro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carneiro, F. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">First example of peptides targeting the dimer interface of <i>Leishmania infantum</i> trypanothione reductase with potent in vitro antileishmanial activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2017.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28431354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVertbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=49-59&author=M.+Ruiz-Santaquiteriaauthor=P.+A.+S%C3%A1nchez-Murciaauthor=M.+A.+Toroauthor=H.+De+Lucioauthor=K.+J.+Guti%C3%A9rrezauthor=S.+De+Castroauthor=F.+A.+C.+Carneiroauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruizauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquez&title=First+example+of+peptides+targeting+the+dimer+interface+of+Leishmania+infantum+trypanothione+reductase+with+potent+in+vitro+antileishmanial+activity&doi=10.1016%2Fj.ejmech.2017.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity#</span></div><div class="casAuthors">Ruiz-Santaquiteria, Marta; Sanchez-Murcia, Pedro A.; Toro, Miguel A.; de Lucio, Hector; Gutierrez, Kilian Jesus; de Castro, Sonia; Carneiro, Filipa A. C.; Gago, Federico; Jimenez-Ruiz, Antonio; Camarasa, Maria-Jose; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-59</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 9-mer and 13-mer amide-bridged cyclic peptides derived from the linear prototype Ac-PKIIQSVGIS-Nle-K-Nle-NH2 (Toro et al. ChemBioChem2013) has been designed and synthesized by introduction of the lactam between amino acid side chains that are sepd. by one helical turn (i, i+4).  All of these compds. were tested in vitro as both dimerization and enzyme inhibitors of Leishmania infantum trypanothione reductase (Li-TryR).  Three of the 13-mer cyclic peptide derivs. inhibited the oxidoreductase activity of Li-TryR in the low micromolar range and they also disrupted enzyme dimerization.  Cyclic analogs were more resistant to proteases than was the linear prototype.  Furthermore, the most potent TryR inhibitors in the linear and cyclic series displayed potent in vitro activity against Leishmania infantum upon conjugation with cationic cell-penetrating peptides.  To date, these conjugated peptides can be considered the first example of TryR dimerization inhibitors that are active in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZnJx3mnsk7Vg90H21EOLACvtfcHk0lisOoKu2Nbn5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVertbo%253D&md5=62be4b235d84b14f717be07ba09eb500</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DDe%2BCastro%26aufirst%3DS.%26aulast%3DCarneiro%26aufirst%3DF.%2BA.%2BC.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DFirst%2520example%2520of%2520peptides%2520targeting%2520the%2520dimer%2520interface%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%2520with%2520potent%2520in%2520vitro%2520antileishmanial%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D49%26epage%3D59%26doi%3D10.1016%2Fj.ejmech.2017.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Revuelto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Santaquiteria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carriles, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Murcia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermoso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span> <span> </span><span class="NLM_article-title">Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in nonpeptidic dimerization inhibitors of <i>Leishmania infantum</i> trypanothione reductase</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.8b00355</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.8b00355" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnt1emt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=873-891&author=A.+Revueltoauthor=M.+Ruiz-Santaquiteriaauthor=H.+De+Lucioauthor=A.+Gamoauthor=A.+A.+Carrilesauthor=K.+J.+Guti%C3%A9rrezauthor=P.+A.+S%C3%A1nchez-Murciaauthor=J.+A.+Hermosoauthor=F.+Gagoauthor=M.+J.+Camarasaauthor=A.+Jim%C3%A9nez-Ruizauthor=S.+Vel%C3%A1zquez&title=Pyrrolopyrimidine+vs+imidazole-phenyl-thiazole+scaffolds+in+nonpeptidic+dimerization+inhibitors+of+Leishmania+infantum+trypanothione+reductase&doi=10.1021%2Facsinfecdis.8b00355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolopyrimidine vs. Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase</span></div><div class="casAuthors">Revuelto, Alejandro; Ruiz-Santaquiteria, Marta; de Lucio, Hector; Gamo, Ana; Carriles, Alejandra A.; Gutierrez, Kilian Jesus; Sanchez-Murcia, Pedro A.; Hermoso, Juan A.; Gago, Federico; Camarasa, Maria-Jose; Jimenez-Ruiz, Antonio; Velazquez, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">873-891</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Disruption of protein-protein interactions of essential oligomeric enzymes by small mols. represents a significant challenge.  We recently reported some linear and cyclic peptides derived from an α-helical region present in the homodimeric interface of Leishmania infantum trypanothione reductase (Li-TryR) that showed potent effects on both dimerization and redox activity of this essential enzyme.  Here, we describe our first steps toward the design of nonpeptidic small-mol. Li-TryR dimerization disruptors using a proteomimetic approach.  The pyrrolopyrimidine and the 5-6-5 imidazole-phenyl-thiazole α-helix-mimetic scaffolds were suitably decorated with substituents that could mimic three key residues (K, Q, and I) of the linear peptide prototype (PKIIQSVGIS-Nle-K-Nle).  Extensive optimization of previously described synthetic methodologies was required.  A library of 15 compds. bearing different hydrophobic alkyl and arom. substituents was synthesized.  The imidazole-phenyl-thiazole-based analogs outperformed the pyrrolopyrimidine-based derivs. in both inhibiting the enzyme and killing extracellular and intracellular parasites in cell culture.  The most active imidazole-phenyl-thiazole compds. 3e and 3f inhibit Li-TryR and prevent growth of the parasites at low micromolar concns. similar to those required by the peptide prototype.  The intrinsic fluorescence of these compds. inside the parasites visually demonstrates their good permeability in comparison with previous peptide-based Li-TryR dimerization disruptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDSWj0L14SLVg90H21EOLACvtfcHk0lisOoKu2Nbn5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnt1emt7o%253D&md5=6575b500e29b9ccdfe13e3686a02da3b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.8b00355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.8b00355%26sid%3Dliteratum%253Aachs%26aulast%3DRevuelto%26aufirst%3DA.%26aulast%3DRuiz-Santaquiteria%26aufirst%3DM.%26aulast%3DDe%2BLucio%26aufirst%3DH.%26aulast%3DGamo%26aufirst%3DA.%26aulast%3DCarriles%26aufirst%3DA.%2BA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DK.%2BJ.%26aulast%3DS%25C3%25A1nchez-Murcia%26aufirst%3DP.%2BA.%26aulast%3DHermoso%26aufirst%3DJ.%2BA.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26atitle%3DPyrrolopyrimidine%2520vs%2520imidazole-phenyl-thiazole%2520scaffolds%2520in%2520nonpeptidic%2520dimerization%2520inhibitors%2520of%2520Leishmania%2520infantum%2520trypanothione%2520reductase%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D873%26epage%3D891%26doi%3D10.1021%2Facsinfecdis.8b00355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsou, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span> <span> </span><span class="NLM_article-title">Synthetic non-peptide mimetics of α-helices</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1039/B608043J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FB608043J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=17264933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=326-334&author=J.+M.+Davisauthor=L.+K.+Tsouauthor=A.+D.+Hamilton&title=Synthetic+non-peptide+mimetics+of+%CE%B1-helices&doi=10.1039%2FB608043J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic non-peptide mimetics of α-helices</span></div><div class="casAuthors">Davis, Jessica M.; Tsou, Lun K.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">326-334</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Proteins in nature fold into native conformations in which combinations of peripherally projected aliph., arom. and ionic functionalities direct a wide range of properties. α-Helixes, one of the most common protein secondary structures, serve as important recognition regions on protein surfaces for numerous protein-protein, protein-DNA and protein-RNA interactions.  These interactions are characterized by conserved structural features within the α-helical domain.  Rational design of structural mimetics of these domains with synthetic small mols. has proven an effective means to modulate such protein functions.  In this tutorial review the authors discuss strategies that utilize synthetic small-mol. antagonists to selectively target essential protein-protein interactions involved in certain diseases.  The authors also evaluate some of the protein-protein interactions that have been or are potential targets for α-helix mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVaarT0w-MSbVg90H21EOLACvtfcHk0ljYATFx3luAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKlurg%253D&md5=762376cfbf797ff5f642a4256706a1d9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2FB608043J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB608043J%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DTsou%26aufirst%3DL.%2BK.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DSynthetic%2520non-peptide%2520mimetics%2520of%2520%25CE%25B1-helices%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2007%26volume%3D36%26spage%3D326%26epage%3D334%26doi%3D10.1039%2FB608043J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azzarito, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of -helix-mediated protein-protein interactions using designed molecules</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1038/nchem.1568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1038%2Fnchem.1568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=23422557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislWms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=161-173&author=V.+Azzaritoauthor=K.+Longauthor=N.+S.+Murphyauthor=A.+J.+Wilson&title=Inhibition+of+-helix-mediated+protein-protein+interactions+using+designed+molecules&doi=10.1038%2Fnchem.1568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of α-helix-mediated protein-protein interactions using designed molecules</span></div><div class="casAuthors">Azzarito, Valeria; Long, Kerya; Murphy, Natasha S.; Wilson, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-173</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inhibition of protein-protein interactions (PPIs) represents a significant challenge because it is unclear how they can be effectively and selectively targeted using small mols.  Achieving this goal is crit. given the defining role of these interactions in biol. processes.  A rational approach to inhibitor design based on the secondary structure at the interface is the focus of much research, and different classes of designed ligands have emerged, some of which effectively and selectively disrupt targeted PPIs.  This Review discusses the relevance of PPIs and, in particular, the importance of α-helix-mediated PPIs to chem. biol. and drug discovery with a focus on designing inhibitors, including constrained peptides, foldamers and proteomimetic-derived ligands.  In doing so, key challenges and major advances in developing generic approaches for the elaboration of PPI inhibitors are highlighted.  The challenges faced in developing such ligands as drug leads - and how criteria applied to these may differ from conventional small-mol. drugs - are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpsQAFaEkKq7Vg90H21EOLACvtfcHk0ljYATFx3luAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislWms7c%253D&md5=161f88aa1c745dee9a95b1fab340b9fe</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1568%26sid%3Dliteratum%253Aachs%26aulast%3DAzzarito%26aufirst%3DV.%26aulast%3DLong%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DN.%2BS.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26atitle%3DInhibition%2520of%2520-helix-mediated%2520protein-protein%2520interactions%2520using%2520designed%2520molecules%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D161%26epage%3D173%26doi%3D10.1038%2Fnchem.1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span> <span> </span><span class="NLM_article-title">Helix mimetics: recent developments</span>. <i>Prog. Biophys. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.pbiomolbio.2015.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.pbiomolbio.2015.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26048776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2015&pages=33-40&author=A.+J.+Wilson&title=Helix+mimetics%3A+recent+developments&doi=10.1016%2Fj.pbiomolbio.2015.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Helix mimetics: Recent developments</span></div><div class="casAuthors">Wilson, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Biophysics & Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">PBIMAC</span>;
        ISSN:<span class="NLM_cas:issn">0079-6107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The development of protein-protein interaction (PPIs) inhibitors represents a challenging goal in chem. biol. and drug discovery.  PPIs are problematic targets because they involve large surfaces with less well defined features and recognition motifs that are less amenable to conventional exptl. and computational ligand discovery methodologies.  α-Helix mediated PPIs represent a sub group with a clearly defined interface and thus may be more amenable to the development of generic ligand discovery methods.  Indeed, this is borne out in numerous studies using peptides covalently constrained into a helical conformation resulting in improvement of myriad biophys. and cellular properties.  It is however desirable to have small mol. alternatives: a helix mimetic (proteomimetic) is a generic small mol. scaffold that projects functional groups in a similar spatial orientation so as to mimic the presentation of key amino acid side chains from the helix that mediates the PPI.  The first true example of a helix mimetic was described over a decade ago however this approach has not yet been elaborated to the extent that it receives similar levels of attention to constrained peptides.  This review explores recent significant developments in the area of small mol. α-helix mimetics and provides a crit. overview of success stories, potential limitations of the approach, and areas for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpwEmuwmbN7LVg90H21EOLACvtfcHk0ljYATFx3luAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFehsb8%253D&md5=c075ab454b3b8b0e7f9a2712667a7aa4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.pbiomolbio.2015.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbiomolbio.2015.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26atitle%3DHelix%2520mimetics%253A%2520recent%2520developments%26jtitle%3DProg.%2520Biophys.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D119%26spage%3D33%26epage%3D40%26doi%3D10.1016%2Fj.pbiomolbio.2015.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CHai, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H.-S.</span></span> <span> </span><span class="NLM_article-title">Novel pyrrolopyrimidine-based -helix mimetics: cell-permeable inhibitors of protein-protein interactions</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1021/ja108230s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja108230s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=676-679&author=J.+H.+Leeauthor=Q.+Zhangauthor=S.+Joauthor=S.+C.+CHaiauthor=M.+Ohauthor=W.+Imauthor=H.+Luauthor=H.-S.+Lim&title=Novel+pyrrolopyrimidine-based+-helix+mimetics%3A+cell-permeable+inhibitors+of+protein-protein+interactions&doi=10.1021%2Fja108230s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Pyrrolopyrimidine-Based α-Helix Mimetics: Cell-Permeable Inhibitors of Protein-Protein Interactions</span></div><div class="casAuthors">Lee, Ji Hoon; Zhang, Qi; Jo, Sunhwan; Chai, Sergio C.; Oh, Misook; Im, Wonpil; Lu, Hua; Lim, Hyun-Suk</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">676-679</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is considerable interest in developing non-peptidic, small-mol. α-helix mimetics to disrupt α-helix-mediated protein-protein interactions.  The design of a novel pyrrolopyrimidine-based scaffold, e.g. I, for such α-helix mimetics with increased conformational rigidity is reported.  A facile solid-phase synthetic route that is amenable to divergent synthesis of a large library was also developed.  Using a fluorescence polarization-based assay, cell-permeable, dual MDMX/MDM2 inhibitors were identified, demonstrating that the designed mols. can act as α-helix mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv4W7ktDH-wbVg90H21EOLACvtfcHk0ljYATFx3luAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylt7%252FM&md5=b39bcfe478f7f745a332167800eb9531</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fja108230s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja108230s%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJo%26aufirst%3DS.%26aulast%3DCHai%26aufirst%3DS.%2BC.%26aulast%3DOh%26aufirst%3DM.%26aulast%3DIm%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DH.-S.%26atitle%3DNovel%2520pyrrolopyrimidine-based%2520-helix%2520mimetics%253A%2520cell-permeable%2520inhibitors%2520of%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D676%26epage%3D679%26doi%3D10.1021%2Fja108230s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katt, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a 5-6-5 imidazole-phenyl-thiazole based -helix mimetic</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1021/ol8022962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol8022962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVequ7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=25-28&author=C.+G.+Cummingsauthor=N.+T.+Rossauthor=W.+P.+Kattauthor=A.+D.+Hamilton&title=Synthesis+and+biological+evaluation+of+a+5-6-5+imidazole-phenyl-thiazole+based+-helix+mimetic&doi=10.1021%2Fol8022962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of a 5-6-5 Imidazole-Phenyl-Thiazole Based α-Helix Mimetic</span></div><div class="casAuthors">Cummings, Christopher G.; Ross, Nathan T.; Katt, William P.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-28</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of small mols. that disrupt protein-protein interactions is a key goal in addressing a no. of disease states.  The α-helix is commonly found at protein interaction interfaces and has been the focus of substantial small mol. mimetic efforts.  One of the primary drawbacks of many small mol. α-helix mimetics is their hydrophobic core structures.  To address this problem we have developed a novel scaffold based on a more water sol. 5-6-5 imidazole-phenyl-thiazole core.  An inhibitor I of this class has been shown to disrupt the Cdc42/Dbs protein-protein interaction at micromolar concns. and may be useful in overcoming Cdc42-induced tumor resistance to anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSgWLc1YG2AbVg90H21EOLACvtfcHk0ljb2qLeQnuuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVequ7zO&md5=6788c1c8955381382442ae21f376b869</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol8022962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol8022962%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DC.%2BG.%26aulast%3DRoss%26aufirst%3DN.%2BT.%26aulast%3DKatt%26aufirst%3DW.%2BP.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%25205-6-5%2520imidazole-phenyl-thiazole%2520based%2520-helix%2520mimetic%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D25%26epage%3D28%26doi%3D10.1021%2Fol8022962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kharb, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chander, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yar, M. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacological significance of triazole scaffold</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.3109/14756360903524304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.3109%2F14756360903524304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=20583859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyrs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1-21&author=R.+Kharbauthor=P.+Chanderauthor=M.+S.+Yar&title=Pharmacological+significance+of+triazole+scaffold&doi=10.3109%2F14756360903524304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological significance of triazole scaffold</span></div><div class="casAuthors">Kharb, Rajeev; Sharma, Prabodh Chander; Yar, Mohammed Shahar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-21</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The triazole nucleus is one of the most important and well known heterocycles which is a common and integral feature of a variety of natural products and medicinal agents.  Triazole nucleus is present as a core structural component in an array of drug categories such as antimicrobial, anti-inflammatory, analgesic, antiepileptic, antiviral, antineoplastic, antihypertensive, antimalarial, local anesthetic, antianxiety, antidepressant, antihistaminic, antioxidant, antitubercular, anti-Parkinson's, antidiabetic, antiobesity and immunomodulatory agents, etc.  The broad and potent activity of triazole and their derivs. has established them as pharmacol. significant scaffolds.  The basic heterocyclic rings present in the various medicinal agents are 1,2,3-triazole and 1,2,4-triazole.  A large vol. of research has been carried out on triazole and their derivs., which has proved the pharmacol. importance of this heterocyclic nucleus.  The present paper is an attempt to review the pharmacol. activities reported for triazole derivs. in the current literature with an update of recent research findings on this nuclei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOA5JZn2bgv7Vg90H21EOLACvtfcHk0ljb2qLeQnuuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyrs7o%253D&md5=d99a3098d011fbc334349f06865ac3db</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3109%2F14756360903524304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756360903524304%26sid%3Dliteratum%253Aachs%26aulast%3DKharb%26aufirst%3DR.%26aulast%3DChander%26aufirst%3DP.%26aulast%3DYar%26aufirst%3DM.%2BS.%26atitle%3DPharmacological%2520significance%2520of%2520triazole%2520scaffold%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2011%26volume%3D26%26spage%3D1%26epage%3D21%26doi%3D10.3109%2F14756360903524304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delisi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingoia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terenzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martorana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almerico, A. M.</span></span> <span> </span><span class="NLM_article-title">1,2,3-triazole in heterocyclic compounds, endowed with biological activity through 1,3-dipolar cycloadditions</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">3289</span>– <span class="NLM_lpage">3306</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201301695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fejoc.201301695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=3289-3306&author=A.+Lauriaauthor=R.+Delisiauthor=F.+Mingoiaauthor=A.+Terenziauthor=A.+Martoranaauthor=G.+Baroneauthor=A.+M.+Almerico&title=1%2C2%2C3-triazole+in+heterocyclic+compounds%2C+endowed+with+biological+activity+through+1%2C3-dipolar+cycloadditions&doi=10.1002%2Fejoc.201301695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,3-Triazole in heterocyclic compounds, endowed with biological activity, through 1,3-dipolar cycloadditions</span></div><div class="casAuthors">Lauria, Antonino; Delisi, Riccardo; Mingoia, Francesco; Terenzi, Alessio; Martorana, Annamaria; Barone, Giampaolo; Almerico, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3289-3306</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  1,3-Dipolar cycloaddn. reactions can be considered a powerful synthetic tool in the building of heterocyclic rings, with applications in different fields.  This review focused the synthesis of biol. active compds. possessing the 1,2,3-triazole core through 1,3-dipolar cycloaddn. reactions.  The 1,2,3-triazole skeleton was presented as a single disubstituted ring, as a linker between two mols., or embedded in a polyheterocycle.  The cycloaddn. reactions are usually catalyzed by copper or ruthenium.  Domino reactions were achieved through dipolarophile anion formation, generally followed by cyclization.  The variety of attainable heterocyclic structures gave an illustration of the importance of the 1,2,3-triazole core in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq03KuVyNiHbVg90H21EOLACvtfcHk0ljb2qLeQnuuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFKksrk%253D&md5=e40a607da9bc933b1e77094961d5099f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201301695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201301695%26sid%3Dliteratum%253Aachs%26aulast%3DLauria%26aufirst%3DA.%26aulast%3DDelisi%26aufirst%3DR.%26aulast%3DMingoia%26aufirst%3DF.%26aulast%3DTerenzi%26aufirst%3DA.%26aulast%3DMartorana%26aufirst%3DA.%26aulast%3DBarone%26aufirst%3DG.%26aulast%3DAlmerico%26aufirst%3DA.%2BM.%26atitle%3D1%252C2%252C3-triazole%2520in%2520heterocyclic%2520compounds%252C%2520endowed%2520with%2520biological%2520activity%2520through%25201%252C3-dipolar%2520cycloadditions%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26volume%3D2014%26spage%3D3289%26epage%3D3306%26doi%3D10.1002%2Fejoc.201301695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dheer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, R.</span></span> <span> </span><span class="NLM_article-title">Medicinal attributes of 1,2,3-triazoles: current developments</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2017.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.bioorg.2017.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28126288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2017&pages=30-54&author=D.+Dheerauthor=V.+Singhauthor=R.+Shankar&title=Medicinal+attributes+of+1%2C2%2C3-triazoles%3A+current+developments&doi=10.1016%2Fj.bioorg.2017.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal attributes of 1,2,3-triazoles: Current developments</span></div><div class="casAuthors">Dheer, Divya; Singh, Virender; Shankar, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-54</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">1,2,3-Triazoles are important five-membered heterocyclic scaffold due to their extensive biol. activities.  This framework can be readily obtained in good to excellent yields on the multigram scale through click chem. via reaction of aryl/alkyl halides, alkynes and NaN3 under ambient conditions.  It has been an emerging area of interest for many researchers throughout the globe owing to its immense pharmacol. scope.  The present work aims to summarize the current approaches adopted for the synthesis of the 1,2,3-triazole and medicinal significance of these architectures as a lead structure for the discovery of drug mols. such as COX-1/COX-2 inhibitors (celecoxib, pyrazofurin), HIV protease inhibitors, CB1 cannabinoid receptor antagonist and much more which are in the pipeline of clin. trials.  The emphasis has been given on the major advancements in the medicinal prospectus of this pharmacophore for the period during 2008-2016.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocxJdPU28FUbVg90H21EOLACvtfcHk0ljb2qLeQnuuhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGku7c%253D&md5=538daa02d12a4beb205ee8ec9c8c8754</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2017.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2017.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DDheer%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DShankar%26aufirst%3DR.%26atitle%3DMedicinal%2520attributes%2520of%25201%252C2%252C3-triazoles%253A%2520current%2520developments%26jtitle%3DBioorg.%2520Chem.%26date%3D2017%26volume%3D71%26spage%3D30%26epage%3D54%26doi%3D10.1016%2Fj.bioorg.2017.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bozorov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisa, H. A.</span></span> <span> </span><span class="NLM_article-title">1,2,3-triazole-containing hybrids as leads in medicinal chemistry: a recent overview</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3511</span>– <span class="NLM_lpage">3531</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.bmc.2019.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31300317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlChtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=3511-3531&author=K.+Bozorovauthor=J.+Zhaoauthor=H.+A.+Aisa&title=1%2C2%2C3-triazole-containing+hybrids+as+leads+in+medicinal+chemistry%3A+a+recent+overview&doi=10.1016%2Fj.bmc.2019.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview</span></div><div class="casAuthors">Bozorov, Khurshed; Zhao, Jiangyu; Aisa, Haji A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3511-3531</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The 1,2,3-triazole ring is a major pharmacophore system among nitrogen-contg. heterocycles.  These five-membered heterocyclic motifs with three nitrogen heteroatoms can be prepd. easily using 'click' chem. with copper- or ruthenium-catalyzed azide-alkyne cycloaddn. reactions.  Recently, the 'linker' property of 1,2,3-triazoles was demonstrated, and a novel class of 1,2,3-triazole-contg. hybrids and conjugates was synthesized and evaluated as lead compds. for diverse biol. targets.  These lead compds. have been demonstrated as anticancer, antimicrobial, anti-tubercular, antiviral, antidiabetic, antimalarial, anti-leishmanial, and neuroprotective agents.  The present review summarises advances in lead compds. of 1,2,3-triazole-contg. hybrids, conjugates, and their related heterocycles in medicinal chem. published in 2018.  This review will be useful to scientists in research fields of org. synthesis, medicinal chem., phytochem., and pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUam33GCV_hbVg90H21EOLACvtfcHk0lgOm3VSHeCUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlChtLbM&md5=0f7aa003e525a20a2b344f93a2357c20</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DBozorov%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DAisa%26aufirst%3DH.%2BA.%26atitle%3D1%252C2%252C3-triazole-containing%2520hybrids%2520as%2520leads%2520in%2520medicinal%2520chemistry%253A%2520a%2520recent%2520overview%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D3511%26epage%3D3531%26doi%3D10.1016%2Fj.bmc.2019.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">See for example</p></div><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues
Gazolla, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Silva, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves Borsodi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado Ferreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gontijo Vaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasconcelos, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, W. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2Fj.ejmech.2018.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=29407957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFems7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2018&pages=274-286&author=R.+R.+Teixeiraauthor=P.+A.+Rodrigues%0AGazollaauthor=A.+M.+Da+Silvaauthor=M.+P.+Goncalves+Borsodiauthor=B.+R.+Bergmannauthor=R.+Salgado+Ferreiraauthor=B.+Gontijo+Vazauthor=G.+A.+Vasconcelosauthor=W.+P.+Lima&title=Synthesis+and+leishmanicidal+activity+of+eugenol+derivatives+bearing+1%2C2%2C3-triazole+functionalities&doi=10.1016%2Fj.ejmech.2018.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities</span></div><div class="casAuthors">Teixeira, Robson Ricardo; Gazolla, Poliana Aparecida Rodrigues; Manoel da Silva, Adalberto; Borsodi, Maria Paula Goncalves; Bergmann, Bartira Rossi; Ferreira, Rafaela Salgado; Vaz, Boniek Gontijo; Vasconcelos, Gessica Adriana; Lima, Wallace Pacienza</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">274-286</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this paper, it is described the synthesis and the evaluation of the leishmanicidal activity of twenty-six eugenol derivs. bearing 1,2,3-triazole functionalities.  The evaluation of the compds. on promastigotes of Leishmania amazonensis (WHOM/BR/75/Josefa) showed that eugenol derivs. present leishmanicidal activities with varying degrees of effectiveness.  The most active compd., namely 4-(3-(4-allyl-2-methoxyphenoxy)propyl)-1-(4-methylbenzyl)-1H-1,2,3-triazole (I) (IC50 = 7.4 ± 0.8 μmol L-1), also targeted Leishmania parasites inside peritoneal macrophages (IC50 = 1.6 μmol L-1) without interfering with cell viability.  The cytotoxicity of I against macrophage cells presented IC50 of 211.9 μmol L-1 and the selective index was equal to 132.5.  Under similar conditions, compd. I was more effective than glucantime and pentamidine, two drugs currently in the clinic.  In addn., theor. calcns. showed that this compd. also presents most physicochem. and pharmacokinetic properties within the ranges expected for orally available drugs.  It is believed that eugenol bearing 1,2,3-triazole functionalities may represent a scaffold to be explored toward the development of new agents to treat leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0klLlhYfJerVg90H21EOLACvtfcHk0lgOm3VSHeCUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFems7s%253D&md5=b84837c5a3a6be8d1d7d6b454d58bc85</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DTeixeira%26aufirst%3DR.%2BR.%26aulast%3DRodrigues%2BGazolla%26aufirst%3DP.%2BA.%26aulast%3DDa%2BSilva%26aufirst%3DA.%2BM.%26aulast%3DGoncalves%2BBorsodi%26aufirst%3DM.%2BP.%26aulast%3DBergmann%26aufirst%3DB.%2BR.%26aulast%3DSalgado%2BFerreira%26aufirst%3DR.%26aulast%3DGontijo%2BVaz%26aufirst%3DB.%26aulast%3DVasconcelos%26aufirst%3DG.%2BA.%26aulast%3DLima%26aufirst%3DW.%2BP.%26atitle%3DSynthesis%2520and%2520leishmanicidal%2520activity%2520of%2520eugenol%2520derivatives%2520bearing%25201%252C2%252C3-triazole%2520functionalities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D146%26spage%3D274%26epage%3D286%26doi%3D10.1016%2Fj.ejmech.2018.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, D.</span></span> <span> </span><span class="NLM_article-title">Potential antileishmanial activity of a triazole-based hybrid peptide against <i>Leishmania major</i></span>. <i>ChemistrySelect</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">10220</span>– <span class="NLM_lpage">10225</span>, <span class="refDoi"> DOI: 10.1002/slct.201802002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fslct.201802002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=10220-10225&author=K.+Majiauthor=M.+Abbasiauthor=D.+Podderauthor=R.+Dattaauthor=D.+Haldar&title=Potential+antileishmanial+activity+of+a+triazole-based+hybrid+peptide+against+Leishmania+major&doi=10.1002%2Fslct.201802002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Potential antileishmanial activity of a triazole-based hybrid peptide against leishmania major</span></div><div class="casAuthors">Maji, Krishnendu; Abbasi, Mazharul; Podder, Debasish; Datta, Rupak; Haldar, Debasish</div><div class="citationInfo"><span class="NLM_cas:title">ChemistrySelect</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">10220-10225</span>CODEN:
                <span class="NLM_cas:coden">CHEMUD</span>;
        ISSN:<span class="NLM_cas:issn">2365-6549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The dipeptides (I) (R1 = iso-Bu, CH2C6H5, iso-Pr, H) with a triazole contg. synthetic amino acid and Leu/ Phe/ Val/ Gly have been designed and synthesized as a potent antileishmanial agent.  The 1-(2-Amino-phenyl)-1H-[1, 2,3] triazole-4-carboxylic acid was synthesized using click chem. approach.  From X-ray crystallog., the peptide I (R1 = i-Bu) contg. a Leu residue at C-terminus adopts kink like structure but there is no intramol. hydrogen bond.  So, the hydrogen bonding sites are free and allowed for intermol. interaction with the guests.  The phenylalanine analog I (R1 = CH2C6H5) where the Ph and triazole rings are perpendicular to each other also form supramol. column-like structure through π-π stacking interaction.  The incorporation of a triazole contg. synthetic amino acid at the N-terminus enhances its anti-parasites activity.  The properties such as lipophilicity and cytotoxicity, are relevant factors for the design of new antileishmanial agent.  IC50 value were calcd. for dipeptides I (R1 is defined above) using normal growth inhibition strategy.  For dipeptide I (R1 = i-Bu), IC50 value is 11μg/mL and the Phe contg. dipeptide I (R1 = CH2C6H5) exhibits IC50 21.17μg/mL on Leishmania major promastigotes.  But the Val and Gly contg. dipeptides 3 I (R1 = i-Pr) and 4 have IC50 values 138.23μg/mL and 21.75μg/mL resp.  The higher lipophilicity of dipeptide I (R1 = i-Bu) is likely to improve the chances of reaching this intracellular parasite.  The exptl. result show that the triazole-based dipeptide I (R1 = i-Bu) is promising as antileishmanial agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvNL3mHm_DXbVg90H21EOLACvtfcHk0lgOm3VSHeCUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7bF&md5=b4e643677764f768a7818dcc3728e3ac</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1002%2Fslct.201802002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fslct.201802002%26sid%3Dliteratum%253Aachs%26aulast%3DMaji%26aufirst%3DK.%26aulast%3DAbbasi%26aufirst%3DM.%26aulast%3DPodder%26aufirst%3DD.%26aulast%3DDatta%26aufirst%3DR.%26aulast%3DHaldar%26aufirst%3DD.%26atitle%3DPotential%2520antileishmanial%2520activity%2520of%2520a%2520triazole-based%2520hybrid%2520peptide%2520against%2520Leishmania%2520major%26jtitle%3DChemistrySelect%26date%3D2018%26volume%3D3%26spage%3D10220%26epage%3D10225%26doi%3D10.1002%2Fslct.201802002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">See for example reviews</p></div><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Haldón, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicasio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, P. J.</span></span> <span> </span><span class="NLM_article-title">Copper-catalyzed azide-alkyne cycloadditions (CuAAC): an update</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">9528</span>– <span class="NLM_lpage">9550</span>, <span class="refDoi"> DOI: 10.1039/C5OB01457C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FC5OB01457C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=26284434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=9528-9550&author=E.+Hald%C3%B3nauthor=M.+C.+Nicasioauthor=P.+J.+P%C3%A9rez&title=Copper-catalyzed+azide-alkyne+cycloadditions+%28CuAAC%29%3A+an+update&doi=10.1039%2FC5OB01457C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40aR"><div class="casContent"><span class="casTitleNuber">40a</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-catalysed azide-alkyne cycloadditions (CuAAC): an update</span></div><div class="casAuthors">Haldon, Estela; Nicasio, M. Carmen; Perez, Pedro J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9528-9550</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The reactions of org. azides and alkynes catalyzed by copper species represent the prototypical examples of click chem were discussed in detailed.  The so-called CuAAC reaction (copper-catalyzed azide-alkyne cycloaddn.), discovered in 2002, has been expanded since then to become an excellent tool in org synthesis.  In this contribution the recent results described in the literature since 2010 were reviewed, classified according to the nature of the catalyst precursor: copper(I) or copper(II) salts or complexes, metallic or nano-particulated copper and several solid-supported copper systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrTQSw3c0uv7Vg90H21EOLACvtfcHk0liUU9xwrgtwXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmtbrE&md5=829bd0ca7fcb535afde89f531f5e3f1f</span></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=10.1039%2FC5OB01457C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB01457C%26sid%3Dliteratum%253Aachs%26aulast%3DHald%25C3%25B3n%26aufirst%3DE.%26aulast%3DNicasio%26aufirst%3DM.%2BC.%26aulast%3DP%25C3%25A9rez%26aufirst%3DP.%2BJ.%26atitle%3DCopper-catalyzed%2520azide-alkyne%2520cycloadditions%2520%2528CuAAC%2529%253A%2520an%2520update%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D9528%26epage%3D9550%26doi%3D10.1039%2FC5OB01457C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beke-Somfai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalsmeden, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kann, N.</span></span> <span> </span><span class="NLM_article-title">Ruthenium-catalyzed azide alkyne cycloaddition reaction: scope, mechanism and applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">14726</span>– <span class="NLM_lpage">14768</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00466</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00466" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVOjtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=14726-14768&author=J.+R.+Johanssonauthor=T.+Beke-Somfaiauthor=A.+S.+Stalsmedenauthor=N.+Kann&title=Ruthenium-catalyzed+azide+alkyne+cycloaddition+reaction%3A+scope%2C+mechanism+and+applications&doi=10.1021%2Facs.chemrev.6b00466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40bR"><div class="casContent"><span class="casTitleNuber">40b</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications</span></div><div class="casAuthors">Johansson, Johan R.; Beke-Somfai, Tamas; Said Staalsmeden, Anna; Kann, Nina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">14726-14768</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The ruthenium-catalyzed azide alkyne cycloaddn. (RuAAC) affords 1,5-disubstituted 1,2,3-triazoles in one step and complements the more established copper-catalyzed reaction providing the 1,4-isomer.  The RuAAC reaction has quickly found its way into the org. chem. toolbox and found applications in many different areas, such as medicinal chem., polymer synthesis, organocatalysis, supramol. chem. and the construction of electronic devices.  This review discusses the mechanism, scope and applications of the RuAAC reaction, covering the literature from the last 10 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6MPHm8oo-m7Vg90H21EOLACvtfcHk0liUU9xwrgtwXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVOjtLnM&md5=ed7e3b2927255710c1fd9148974027aa</span></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00466%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DJ.%2BR.%26aulast%3DBeke-Somfai%26aufirst%3DT.%26aulast%3DStalsmeden%26aufirst%3DA.%2BS.%26aulast%3DKann%26aufirst%3DN.%26atitle%3DRuthenium-catalyzed%2520azide%2520alkyne%2520cycloaddition%2520reaction%253A%2520scope%252C%2520mechanism%2520and%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D14726%26epage%3D14768%26doi%3D10.1021%2Facs.chemrev.6b00466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toro, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span> <span> </span><span class="NLM_article-title">Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">5163</span>– <span class="NLM_lpage">5176</span>, <span class="refDoi"> DOI: 10.1111/bph.15250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1111%2Fbph.15250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=32888319" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2020&pages=5163-5176&author=H.+Lucioauthor=M.+A.+Toroauthor=M.+J.+Camarasaauthor=S.+Vel%C3%A1zquezauthor=F.+Gagoauthor=A.+Jim%C3%A9nez-Ruiz&title=Pseudoirreversible+slow-binding+inhibition+of+trypanothione+reductase+by+a+protein-protein+interaction+disruptor&doi=10.1111%2Fbph.15250"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fbph.15250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.15250%26sid%3Dliteratum%253Aachs%26aulast%3DLucio%26aufirst%3DH.%26aulast%3DToro%26aufirst%3DM.%2BA.%26aulast%3DCamarasa%26aufirst%3DM.%2BJ.%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26atitle%3DPseudoirreversible%2520slow-binding%2520inhibition%2520of%2520trypanothione%2520reductase%2520by%2520a%2520protein-protein%2520interaction%2520disruptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D177%26spage%3D5163%26epage%3D5176%26doi%3D10.1111%2Fbph.15250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Enzymes: A Practical Introduction to Structure</span>.  <i>Mechanism and Data Analysis</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2F0471220639" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+A.+Copeland&title=Mechanism+and+Data+Analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1002%2F0471220639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471220639%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEnzymes%253A%2520A%2520Practical%2520Introduction%2520to%2520Structure%26btitle%3DMechanism%2520and%2520Data%2520Analysis%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <i>Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2F9781118540398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery%3A+A+Guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1002%2F9781118540398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery%253A%2520A%2520Guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozakov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grove, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnuud, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottarella, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span> <span> </span><span class="NLM_article-title">The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1038/nprot.2015.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1038%2Fnprot.2015.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=25855957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Smt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=733-755&author=D.+Kozakovauthor=L.+E.+Groveauthor=D.+R.+Hallauthor=T.+Bohnuudauthor=S.+E.+Mottarellaauthor=L.+Luoauthor=B.+Xiaauthor=D.+Beglovauthor=S.+Vajda&title=The+FTMap+family+of+web+servers+for+determining+and+characterizing+ligand-binding+hot+spots+of+proteins&doi=10.1038%2Fnprot.2015.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins</span></div><div class="casAuthors">Kozakov, Dima; Grove, Laurie E.; Hall, David R.; Bohnuud, Tanggis; Mottarella, Scott E.; Luo, Lingqi; Xia, Bing; Beglov, Dmitri; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">733-755</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">FTMap is a computational mapping server that identifies binding hot spots of macromols., i.e., regions of the surface with major contributions to the ligand-binding free energy.  To use FTMap, users submit a protein, DNA or RNA structure in PDB (Protein Data Bank) format.  FTMap samples billions of positions of small org. mols. used as probes, and it scores the probe poses using a detailed energy expression.  Regions that bind clusters of multiple probe types identify the binding hot spots in good agreement with exptl. data.  FTMap serves as the basis for other servers, namely FTSite, which was used to predict ligand-binding sites, FTFlex, which was used to account for side chain flexibility, FTMap/param, used to parameterize addnl. probes and FTDyn, for mapping ensembles of protein structures.  Applications include detg. the druggability of proteins, identifying ligand moieties that are most important for binding, finding the most bound-like conformation in ensembles of unliganded protein structures and providing input for fragment-based drug design.  FTMap is more accurate than classical mapping methods such as GRID and MCSS, and it is much faster than the more-recent approaches to protein mapping based on mixed mol. dynamics.  By using 16 probe mols., the FTMap server finds the hot spots of an av.-size protein in <1 h.  As FTFlex performs mapping for all low-energy conformers of side chains in the binding site, its completion time is proportionately longer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnH27-sNtGLVg90H21EOLACvtfcHk0liUU9xwrgtwXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Smt74%253D&md5=dbc729e9ffb47989f0df8baebaf032fa</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2015.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2015.043%26sid%3Dliteratum%253Aachs%26aulast%3DKozakov%26aufirst%3DD.%26aulast%3DGrove%26aufirst%3DL.%2BE.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DBohnuud%26aufirst%3DT.%26aulast%3DMottarella%26aufirst%3DS.%2BE.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DB.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DThe%2520FTMap%2520family%2520of%2520web%2520servers%2520for%2520determining%2520and%2520characterizing%2520ligand-binding%2520hot%2520spots%2520of%2520proteins%26jtitle%3DNat.%2520Protoc.%26date%3D2015%26volume%3D10%26spage%3D733%26epage%3D755%26doi%3D10.1038%2Fnprot.2015.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarma, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span> <span> </span><span class="NLM_article-title">Glutathione reductase of the malarial parasite <i>Plasmodium falciparum</i>: crystal structure and inhibitor development</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>328</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(03)00347-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1016%2FS0022-2836%2803%2900347-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=12729762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Ojtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2003&pages=893-907&author=G.+N.+Sarmaauthor=N.+Savvidesauthor=K.+Beckerauthor=M.+Schirmerauthor=R.+H.+Schirmerauthor=P.+A.+Karplus&title=Glutathione+reductase+of+the+malarial+parasite+Plasmodium+falciparum%3A+crystal+structure+and+inhibitor+development&doi=10.1016%2FS0022-2836%2803%2900347-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione Reductase of the Malarial Parasite Plasmodium falciparum: Crystal Structure and Inhibitor Development</span></div><div class="casAuthors">Sarma, G. N.; Savvides, S. N.; Becker, K.; Schirmer, M.; Schirmer, R. H.; Karplus, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">893-907</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The malarial parasite Plasmodium falciparum is known to be sensitive to oxidative stress, and thus the antioxidant enzyme glutathione reductase (GR; NADPH+GSSG+H+↔NADP++2 GSH) has become an attractive drug target for antimalarial drug development.  Here, we report the 2.6 A resoln. crystal structure of P. falciparum GR.  The homodimeric flavoenzyme is compared to the related human GR with focus on structural aspects relevant for drug design.  The most pronounced differences between the two enzymes concern the shape and electrostatics of a large (450 A3) cavity at the dimer interface.  This cavity binds numerous non-competitive inhibitors and is a target for selective drug design.  A 34-residue insertion specific for the GRs of malarial parasites shows no d., implying that it is disordered.  The precise location of this insertion along the sequence allows us to explain the deleterious effects of a mutant in this region and suggests new functional studies.  To complement the structural comparisons, we report the relative susceptibility of human and plasmodial GRs to a series of tricyclic inhibitors as well as to peptides designed to interfere with protein folding and dimerization.  Enzyme-kinetic studies on GRs from chloroquine-resistant and chloroquine-sensitive parasite strains were performed and indicate that the structure reported here represents GR of P. falciparum strains in general and thus is a highly relevant target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTrsi3sZmurVg90H21EOLACvtfcHk0lg_yn8dtAb8uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Ojtrg%253D&md5=bf64be2ea683df5a769ee24f0d1bd9db</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2803%2900347-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252803%252900347-4%26sid%3Dliteratum%253Aachs%26aulast%3DSarma%26aufirst%3DG.%2BN.%26aulast%3DSavvides%26aufirst%3DN.%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DSchirmer%26aufirst%3DM.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26atitle%3DGlutathione%2520reductase%2520of%2520the%2520malarial%2520parasite%2520Plasmodium%2520falciparum%253A%2520crystal%2520structure%2520and%2520inhibitor%2520development%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D328%26spage%3D893%26epage%3D907%26doi%3D10.1016%2FS0022-2836%2803%2900347-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, G. E.</span></span> <span> </span><span class="NLM_article-title">A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1989.tb14500.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1111%2Fj.1432-1033.1989.tb14500.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=2912729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaL1MXhtFSktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=1989&pages=693-703&author=P.+A.+Karplusauthor=E.+F.+Paiauthor=G.+E.+Schulz&title=A+crystallographic+study+of+the+glutathione+binding+site+of+glutathione+reductase+at+0.3-nm+resolution&doi=10.1111%2Fj.1432-1033.1989.tb14500.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution</span></div><div class="casAuthors">Karplus, P. Andrew; Pai, Emil F.; Schulz, Georg E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-703</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The binding of glutathione, some related mols., and 2 redox compds. to crystals of human erythrocyte glutathione reductase was investigated by x-ray crystallog. at 0.3-nm resoln.  Models for several bound ligands were built and subjected to crystallog. refinement.  The results clearly showed the residues involved in glutathione binding as well as the geometry of the disulfide exchange.  Glutathione-I was bound in a V-shaped conformation, whereas glutathione-II was extended.  The zwitterionic glutamyl end of glutathione-II appeared to be the most tightly bound part of the substrate.  All glutathione conjugates and derivs. studied showed binding dominated by the interactions at this site.  In the reduced enzyme, glutathione-I formed a mixed disulfide intermediate with cysteine (Cys)-58.  Other structural changes were obsd. on redn. of the enzyme, and it was demonstrated that the carboxamidomethylated enzyme is a good model for the reduced species.  Lipoate, a weak substrate of the enzyme, assumed a defined binding site where its disulfide was available for being attacked by Cys-58-Sγ.  A 2nd region with affinity for a no. of compds. was found in a large cavity at the dimer interface of the enzyme.  No functional role of this site is known.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXh-H0cDa23bVg90H21EOLACvtfcHk0lg_yn8dtAb8uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtFSktbw%253D&md5=dec7f50864096d6ff6ad42e42a860831</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1989.tb14500.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1989.tb14500.x%26sid%3Dliteratum%253Aachs%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26aulast%3DPai%26aufirst%3DE.%2BF.%26aulast%3DSchulz%26aufirst%3DG.%2BE.%26atitle%3DA%2520crystallographic%2520study%2520of%2520the%2520glutathione%2520binding%2520site%2520of%2520glutathione%2520reductase%2520at%25200.3-nm%2520resolution%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1989%26volume%3D178%26spage%3D693%26epage%3D703%26doi%3D10.1111%2Fj.1432-1033.1989.tb14500.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span> <span> </span><span class="NLM_article-title">Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">8101</span>– <span class="NLM_lpage">8107</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.14.8101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1074%2Fjbc.271.14.8101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=8626496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaK28XitFart7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=8101-8107&author=S.+N.+Savvidesauthor=P.+A.+Karplus&title=Kinetics+and+crystallographic+analysis+of+human+glutathione+reductase+in+complex+with+a+xanthene+inhibitor&doi=10.1074%2Fjbc.271.14.8101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor</span></div><div class="casAuthors">Savvides, Savvas N.; Karplus, P. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">8101-7</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of a complex between the noncompetitive inhibitor (Kis = 27 μM, Kii = 48 μM with respect to oxidized glutathione (GSSG) and Kis = 144 μM, Kii = 176 μM with respect to NADPH) 6-hydroxy-3-oxo-3H-xanthene-9-propionic acid (XAN) and human glutathione reductase (hGR).  The structure, refined to an R-factor of 0.158 at 2.0 Å resoln., reveals XAN bound in the large cavity present at the hGR dimer interface where it does not overlap the glutathione binding site.  The inhibitor binding causes extensive local structural changes that primarily involve amino acid residues from a 30-residue α-helix that lines the cavity and contributes to the active site of hGR.  Despite the lack of phys. overlap of XAN with the GSSG binding site, no GSSG binding is seen in soaks carried out with high XAN and GSSG concns., suggesting that some subtle interaction between the sites exists.  An earlier crystallog. anal. on the complex between hGR and 3,7-diamino-2,8-dimethyl-5-phenyl-phenazinium chloride (safranin) showed that safranin bound at this same site.  We have found that safranin also inhibits hGR in a noncompetitive fashion, but it binds about 16 times less tightly (Kis - 453 μM, Kii - 586 μM with respect to GSSG) than XAN and does not preclude the binding of GSSG in the crystal.  Although in structure-based drug design competitive inhibitors are usually targeted, Xan's binding to a well defined site that is unique to glutathione reductase suggests that noncompetitive inhibitors could also serve as lead compds. for structure-based drug design, in particular as components of chimeric inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz-HcLLeopLrVg90H21EOLACvtfcHk0lg_yn8dtAb8uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFart7w%253D&md5=94eb7ec01fc8a81bffac961a89a40cb5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.14.8101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.14.8101%26sid%3Dliteratum%253Aachs%26aulast%3DSavvides%26aufirst%3DS.%2BN.%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26atitle%3DKinetics%2520and%2520crystallographic%2520analysis%2520of%2520human%2520glutathione%2520reductase%2520in%2520complex%2520with%2520a%2520xanthene%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D8101%26epage%3D8107%26doi%3D10.1074%2Fjbc.271.14.8101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schönleben-Janas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittl, P. R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauth-Siegel, R. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystallographic, kinetic and electrochemical studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1021/jm950511+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm950511%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A280%3ADyaK287pslyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1549-1554&author=A.+Sch%C3%B6nleben-Janasauthor=P.+Kirschauthor=P.+R.+E.+Mittlauthor=R.+H.+Schirmerauthor=R.+L.+Krauth-Siegel&title=Inhibition+of+human+glutathione+reductase+by+10-arylisoalloxazines%3A+crystallographic%2C+kinetic+and+electrochemical+studies&doi=10.1021%2Fjm950511%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies</span></div><div class="casAuthors">Schonleben-Janas A; Kirsch P; Mittl P R; Schirmer R H; Krauth-Siegel R L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1549-54</span>
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of newly synthesized N(10)-arylisoalloxazines--some of which are known to be antimalarial agents--were studied as inhibitors of human glutathione reductase (GR;NADPH + GSSG + H(+) <==> NADP(+) + 2GSH).  The flavoenzyme was inhibited with IC(50) values between </- 1 and 100 microM in the presence of 100 microM NADPH.  The isoalloxazines and N(3)-methylisoalloxazines with a 4'-chlorophenyl or a 3',5'-dichlorophenyl group at N10 were found to be the most promising inhibitors of GR, although even the bulkier 10-naphthyl and -anthryl derivatives were also effective inhibitors.  In contrast, at position N3 of the isoalloxazine ring, the size of the substituent was found to strongly influence the inhibitory effect.  Introduction of a carboxymethyl group at N3--which markedly increased the solubility of the derivative in aqueous solutions-- caused a rise in the IC(50) values by 1 order of magnitude. 8-Fluoro- and 8-azido-10-arylisoalloxazines were potent inhibitors of GR; consequently position C8 of the benzenoid subnucleus instead of N3 should be considered for introducing substituents.  No correlation was observed between the inhibitory strength of several isoalloxazines and their redox potential as measured by cyclovoltammetry.  The crystallographic analysis of GR complexed with 10-(4'-chlorophenyl)-3-(carboxymethyl)isoalloxazine and 10-(3',5'-dichlorophenyl)-3-(carboxymethyl)isoalloxazine, respectively, revealed the presence of one inhibitor molecule bound at the 2-fold axis of the homodimeric protein.  This location is consistent with fluorescence titration measurements and enzyme kinetic studies in solution which gave no indication for binding at the substrate sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1gt6RrGDwBD0SWnHPWbmmfW6udTcc2ea_Yt123IO5C7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287pslyrtw%253D%253D&md5=2bf9dd1a81169d5061fce3c69e8c4a12</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm950511%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950511%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nleben-Janas%26aufirst%3DA.%26aulast%3DKirsch%26aufirst%3DP.%26aulast%3DMittl%26aufirst%3DP.%2BR.%2BE.%26aulast%3DSchirmer%26aufirst%3DR.%2BH.%26aulast%3DKrauth-Siegel%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520human%2520glutathione%2520reductase%2520by%252010-arylisoalloxazines%253A%2520crystallographic%252C%2520kinetic%2520and%2520electrochemical%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1549%26epage%3D1554%26doi%3D10.1021%2Fjm950511%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stourac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavra, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brezovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damborsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, D.</span></span> <span> </span><span class="NLM_article-title">Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">W414</span>– <span class="NLM_lpage">W422</span>, <span class="refDoi"> DOI: 10.1093/nar/gkz378</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1093%2Fnar%2Fgkz378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=31114897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktVyitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=W414-W422&author=J.+Stouracauthor=O.+Vavraauthor=P.+Kokkonenauthor=J.+Filipovicauthor=G.+Pintoauthor=J.+Brezovskyauthor=J.+Damborskyauthor=D.+Bednar&title=Caver+Web+1.0%3A+identification+of+tunnels+and+channels+in+proteins+and+analysis+of+ligand+transport&doi=10.1093%2Fnar%2Fgkz378"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport</span></div><div class="casAuthors">Stourac, Jan; Vavra, Ondrej; Kokkonen, Piia; Filipovic, Jiri; Pinto, Gaspar; Brezovsky, Jan; Damborsky, Jiri; Bednar, David</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W414-W422</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Caver Web 1.0 is a web server for comprehensive anal. of protein tunnels and channels, and study of the ligands' transport through these transport pathways.  Caver Web is the first interactive tool allowing both the analyses within a single graphical user interface.  The server is built on top of the abundantly used tunnel detection tool Caver 3.02 and CaverDock 1.0 enabling the study of the ligand transport.  The program is easy-to-use as the only required inputs are a protein structure for a tunnel identification and a list of ligands for the transport anal.  The automated guidance procedures assist the users to set up the calcn. in a way to obtain biol. relevant results.  The identified tunnels, their properties, energy profiles and trajectories for ligands' passages can be calcd. and visualized.  The tool is very fast (2-20 min per job) and is applicable even for virtual screening purposes.  Its simple setup and comprehensive graphical user interface make the tool accessible for a broad scientific community.  The server is freely available at https://loschmidt.chemi.muni.cz/caverweb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprFB8ybCscXrVg90H21EOLACvtfcHk0lhnOMnfIi8fMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktVyitb4%253D&md5=46f31538c8da65018274d664803ac512</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkz378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkz378%26sid%3Dliteratum%253Aachs%26aulast%3DStourac%26aufirst%3DJ.%26aulast%3DVavra%26aufirst%3DO.%26aulast%3DKokkonen%26aufirst%3DP.%26aulast%3DFilipovic%26aufirst%3DJ.%26aulast%3DPinto%26aufirst%3DG.%26aulast%3DBrezovsky%26aufirst%3DJ.%26aulast%3DDamborsky%26aufirst%3DJ.%26aulast%3DBednar%26aufirst%3DD.%26atitle%3DCaver%2520Web%25201.0%253A%2520identification%2520of%2520tunnels%2520and%2520channels%2520in%2520proteins%2520and%2520analysis%2520of%2520ligand%2520transport%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2019%26volume%3D47%26spage%3DW414%26epage%3DW422%26doi%3D10.1093%2Fnar%2Fgkz378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0lhnOMnfIi8fMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">House, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, G. A.</span></span> <span> </span><span class="NLM_article-title">The chemistry of carbanions. VI. Stereochemistry of the Wittig reaction with stabilized ylids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3327</span>– <span class="NLM_lpage">3333</span>, <span class="refDoi"> DOI: 10.1021/jo01034a049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01034a049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADyaF2MXjtFyq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1964&pages=3327-3333&author=H.+O.+Houseauthor=V.+K.+Jonesauthor=G.+A.+Frank&title=The+chemistry+of+carbanions.+VI.+Stereochemistry+of+the+Wittig+reaction+with+stabilized+ylids&doi=10.1021%2Fjo01034a049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry of carbanions. VI. Stereochemistry of the Wittig reaction with stabilized ylides</span></div><div class="casAuthors">House, Herbert O.; Jones, Vera K.; Frank, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3327-33</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">cf. ibid. 28(12), 3362-79(1963); CA 58, 7959e.  The effect of various reaction conditions on the proportions of cis and trans olefinic products obtained from the Wittig reaction of stabilized ylides [Ph3P:CHCO2Me and (EtO)2P(ONa):CHCO2Me] with acetaldehyde and chloroacetaldehyde was studied.  The highest proportion of cis isomer was obtained by the use of the protonic solvent methanol.  Solns. of lithium salts were less effective and suspensions of lithium salts were without effect in enhancing the proportion of cis olefin in these cases.  This study of the Wittig reaction of the benzylidenephosphorane (Ph3P:CHPh) with EtCHO does not support the previous reports that the proportion of the cis isomer may be markedly enhanced by the presence of a suspension or a soln. of LiBr or LiI in the reaction mixt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolD-nxB1O1KLVg90H21EOLACvtfcHk0lj6RTz3qlwSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXjtFyq&md5=48fccb1c4f4c33d0298911000f968fdb</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo01034a049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01034a049%26sid%3Dliteratum%253Aachs%26aulast%3DHouse%26aufirst%3DH.%2BO.%26aulast%3DJones%26aufirst%3DV.%2BK.%26aulast%3DFrank%26aufirst%3DG.%2BA.%26atitle%3DThe%2520chemistry%2520of%2520carbanions.%2520VI.%2520Stereochemistry%2520of%2520the%2520Wittig%2520reaction%2520with%2520stabilized%2520ylids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1964%26volume%3D29%26spage%3D3327%26epage%3D3333%26doi%3D10.1021%2Fjo01034a049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitzler-Kunkel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bialas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brixner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würthner, F.</span></span> <span> </span><span class="NLM_article-title">Unraveling the structure and exciton coupling for multichromophoric merocyanine dye molecules</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6368</span>– <span class="NLM_lpage">6378</span>, <span class="refDoi"> DOI: 10.1039/C7CP00115K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1039%2FC7CP00115K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=28197618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1yktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=6368-6378&author=F.+Kochauthor=M.+Stolteauthor=A.+Zitzler-Kunkelauthor=D.+Bialasauthor=A.+Steinbacherauthor=T.+Brixnerauthor=F.+W%C3%BCrthner&title=Unraveling+the+structure+and+exciton+coupling+for+multichromophoric+merocyanine+dye+molecules&doi=10.1039%2FC7CP00115K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling the structure and exciton coupling for multichromophoric merocyanine dye molecules</span></div><div class="casAuthors">Koch, Federico; Stolte, Matthias; Zitzler-Kunkel, Andre; Bialas, David; Steinbacher, Andreas; Brixner, Tobias; Wuerthner, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6368-6378</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The relative orientation of chromophores is a key factor in detg. the relationship between the structure and the functionality in mol. multichromophore ensembles.  In the case of structurally flexible mol. systems in soln., the task to clarify the relevant effects of accessible chromophore orientations with spectroscopic observations is very demanding.  In this study, we address this issue by investigating a series of differently connected multichromophoric systems composed of highly dipolar merocyanine dyes that are systematically varied in their substitution pattern and the no. of chromophores attached to a bridging benzene ring.  Combining electro-optical absorption (EOA) and UV/Vis spectroscopy with d. functional theory (DFT) as well as exciton theory discloses conformational preferences and rationalizes the optical properties of the interacting chromophores.  Our findings suggest for all multichromophoric systems there is a relative orientation of the chromophores which compensates for the individual dipole moments of the merocyanine dyes by pointing preferably in opposing directions.  These orientations furthermore rationalize the obsd. spectral properties by partly excitonically-coupled subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOB0GilePfP7Vg90H21EOLACvtfcHk0lj6RTz3qlwSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1yktbg%253D&md5=4e3ac58c8cf4cf954116959f6ce8088f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1039%2FC7CP00115K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CP00115K%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DF.%26aulast%3DStolte%26aufirst%3DM.%26aulast%3DZitzler-Kunkel%26aufirst%3DA.%26aulast%3DBialas%26aufirst%3DD.%26aulast%3DSteinbacher%26aufirst%3DA.%26aulast%3DBrixner%26aufirst%3DT.%26aulast%3DW%25C3%25BCrthner%26aufirst%3DF.%26atitle%3DUnraveling%2520the%2520structure%2520and%2520exciton%2520coupling%2520for%2520multichromophoric%2520merocyanine%2520dye%2520molecules%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2017%26volume%3D19%26spage%3D6368%26epage%3D6378%26doi%3D10.1039%2FC7CP00115K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravanamuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Ellman’s-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>369</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1042/bj20021298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1042%2Fbj20021298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=12416994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1aqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2003&pages=529-537&author=C.+J.+Hamiltonauthor=A.+Saravanamuthuauthor=I.+M.+Egglestonauthor=A.+H.+Fairlamb&title=Ellman%E2%80%99s-reagent-mediated+regeneration+of+trypanothione+in+situ%3A+substrate-economical+microplate+and+time-dependent+inhibition+assays+for+trypanothione+reductase&doi=10.1042%2Fbj20021298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Ellman's-reagent-mediated regeneration of trypanothione in situ: Substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase</span></div><div class="casAuthors">Hamilton, Chris J.; Saravanamuthu, Ahilan; Eggleston, Ian M.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Trypanothione reductase (TryR) is a key enzyme involved in the oxidative stress management of the Trypanosoma and Leishmania parasites, which helps to maintain an intracellular reducing environment by redn. of the small-mol.-mass disulfide trypanothione (T[S]2) to its di-thiol deriv. dihydrotrypanothione (T[SH]2).  TryR inhibition studies are currently impaired by the prohibitive costs of the native enzyme substrate T[S]2.  Such costs are particularly notable in time-dependent and high-throughput inhibition assays.  In the present study we report a protocol that greatly decreases the substrate quantities needed for such assays.  This is achieved by coupling the assay with the chem. oxidant 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), which can rapidly re-oxidize the T[SH]2 product back into the disulfide substrate T[S]2, thereby maintaining const. substrate concns. and avoiding deviations from rate linearity due to substrate depletion.  This has enabled the development of a continuous microplate assay for both classical and time-dependent TryR inhibition in which linear reaction rates can be maintained for 60 min or more using minimal substrate concns. (< 1 μM, compared with a substrate Km value of 30 μM) that would normally be completely consumed within seconds.  In this manner, substrate requirements are decreased by orders of magnitude.  The characterization of a novel time-dependent inhibitor, cis-3-oxo-8,9b-bis-(N1-acrylamidospermidyl)-1,2,3,4,4a,9b-hexahydrobenzofuran (PK43), is also described using these procedures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT5qEv1mf2k7Vg90H21EOLACvtfcHk0lj6RTz3qlwSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1aqurc%253D&md5=813cc4af4076132e4d8f74f81ea669b4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1042%2Fbj20021298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021298%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DC.%2BJ.%26aulast%3DSaravanamuthu%26aufirst%3DA.%26aulast%3DEggleston%26aufirst%3DI.%2BM.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DEllman%25E2%2580%2599s-reagent-mediated%2520regeneration%2520of%2520trypanothione%2520in%2520situ%253A%2520substrate-economical%2520microplate%2520and%2520time-dependent%2520inhibition%2520assays%2520for%2520trypanothione%2520reductase%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D369%26spage%3D529%26epage%3D537%26doi%3D10.1042%2Fbj20021298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baici, A.</span></span> <span> </span><span class="NLM_article-title">Kinetics of Enzyme-Modifier Interactions</span>.  <i>Selected Topics in the Theory and Diagnosis of Inhibition and Activation Mechanisms</i>; <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Vienna, Austria</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=10.1007%2F978-3-7091-1402-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Baici&title=Selected+Topics+in+the+Theory+and+Diagnosis+of+Inhibition+and+Activation+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-1402-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-7091-1402-5%26sid%3Dliteratum%253Aachs%26aulast%3DBaici%26aufirst%3DA.%26atitle%3DKinetics%2520of%2520Enzyme-Modifier%2520Interactions%26btitle%3DSelected%2520Topics%2520in%2520the%2520Theory%2520and%2520Diagnosis%2520of%2520Inhibition%2520and%2520Activation%2520Mechanisms%26pub%3DSpringer%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georg, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepartz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">The ecstasy and agony of assay interference compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2165</span>– <span class="NLM_lpage">2168</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00229</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00229" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2165-2168&author=C.+Aldrichauthor=C.+Bertozziauthor=G.+I.+Georgauthor=L.+Kiesslingauthor=C.+Lindsleyauthor=D.+Liottaauthor=K.+M.+Merzauthor=A.+Schepartzauthor=S.+Wang&title=The+ecstasy+and+agony+of+assay+interference+compounds&doi=10.1021%2Facs.jmedchem.7b00229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Ecstasy and Agony of Assay Interference Compounds</span></div><div class="casAuthors">Aldrich, Courtney; Bertozzi, Carolyn; Georg, Gunda I.; Kiessling, Laura; Lindsley, Craig; Liotta, Dennis; Merz, Kenneth M.; Schepartz, Alanna; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2165-2168</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ecstasy of discovering a new hit from screening can lead to a highly productive research effort to discover new bioactive compds.  However, in too many cases this ecstasy is followed by the agony of realizing that the compds. are not active against the desired target.  Many of these false hits are Pan Assay INterference compds. (PAINS) 1 or colloidal aggregators.  Whether the screen is conducted in silico or in the lab. and whether screening libraries, natural products, or drugs are used, all discovery efforts that rely on some form of screening to identify bioactivity are susceptible to this phenomenon.  Studies that omit crit. controls against exptl. artifacts caused by PAINS may waste years of research effort as useless compds. are progressed.  The American Chem. Society (ACS) is eager to alert the scientific community to this problem and to recommend protocols that will eliminate the publication of research articles based on compds. with artificial activity.  This editorial aims to summarize relevant concepts and to set the framework by which relevant ACS journals will address this issue going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUf5u51VEpbVg90H21EOLACvtfcHk0lj5A0IK5HemHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtl2lsLY%253D&md5=64bf087659a47fe7769208217ef8c989</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00229%26sid%3Dliteratum%253Aachs%26aulast%3DAldrich%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DC.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DKiessling%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DLiotta%26aufirst%3DD.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DSchepartz%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DThe%2520ecstasy%2520and%2520agony%2520of%2520assay%2520interference%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2165%26epage%3D2168%26doi%3D10.1021%2Facs.jmedchem.7b00229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez-Salgado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortés-Cabrera, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perona, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Redondo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gago, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morreale, A.</span></span> <span> </span><span class="NLM_article-title">MM-ISMSA: an ultrafast and accurate scoring function for protein-protein docking</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3395</span>– <span class="NLM_lpage">3408</span>, <span class="refDoi"> DOI: 10.1021/ct300497z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300497z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=3395-3408&author=J.+Klettauthor=A.+N%C3%BA%C3%B1ez-Salgadoauthor=H.+G.+Dos+Santosauthor=A.+Cort%C3%A9s-Cabreraauthor=A.+Peronaauthor=R.+Gil-Redondoauthor=D.+Abiaauthor=F.+Gagoauthor=A.+Morreale&title=MM-ISMSA%3A+an+ultrafast+and+accurate+scoring+function+for+protein-protein+docking&doi=10.1021%2Fct300497z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">MM-ISMSA: An Ultrafast and Accurate Scoring Function for Protein-Protein Docking</span></div><div class="casAuthors">Klett, Javier; Nunez-Salgado, Alfonso; Dos Santos, Helena G.; Cortes-Cabrera, Alvaro; Perona, Almudena; Gil-Redondo, Ruben; Abia, David; Gago, Federico; Morreale, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3395-3408</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An ultrafast and accurate scoring function for protein-protein docking is presented.  It includes (1) a mol. mechanics (MM) part based on a 12-6 Lennard-Jones potential; (2) an electrostatic component based on an implicit solvent model (ISM) with individual desolvation penalties for each partner in the protein-protein complex plus a hydrogen bonding term; and (3) a surface area (SA) contribution to account for the loss of water contacts upon protein-protein complex formation.  The accuracy and performance of the scoring function, termed MM-ISMSA, have been assessed by (1) comparing the total binding energies, the electrostatic term, and its components (charge-charge and individual desolvation energies), as well as the per residue contributions, to results obtained with well-established methods such as APBSA or MM-PB(GB)SA for a set of 1242 decoy protein-protein complexes and (2) testing its ability to recognize the docking soln. closest to the exptl. structure as that providing the most favorable total binding energy.  For this purpose, a test set consisting of 15 protein-protein complexes with known 3D structure mixed with 10 decoys for each complex was used.  The correlation between the values afforded by MM-ISMSA and those from the other methods is quite remarkable (r2 ∼ 0.9), and only 0.2-5.0 s (depending on the no. of residues) are spent on a single calcn. including an all vs all pairwise energy decompn.  On the other hand, MM-ISMSA correctly identifies the best docking soln. as that closest to the exptl. structure in 80% of the cases.  Finally, MM-ISMSA can process mol. dynamics trajectories and reports the results as averaged values with their std. deviations.  MM-ISMSA has been implemented as a plug-in to the widely used mol. graphics program PyMOL, although it can also be executed in command-line mode.  MM-ISMSA is distributed free of charge to nonprofit organizations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru35V4Q0Syu7Vg90H21EOLACvtfcHk0lj5A0IK5HemHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCht7bI&md5=3f00ad1a76c3a7eece4c75df533a122a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fct300497z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300497z%26sid%3Dliteratum%253Aachs%26aulast%3DKlett%26aufirst%3DJ.%26aulast%3DN%25C3%25BA%25C3%25B1ez-Salgado%26aufirst%3DA.%26aulast%3DDos%2BSantos%26aufirst%3DH.%2BG.%26aulast%3DCort%25C3%25A9s-Cabrera%26aufirst%3DA.%26aulast%3DPerona%26aufirst%3DA.%26aulast%3DGil-Redondo%26aufirst%3DR.%26aulast%3DAbia%26aufirst%3DD.%26aulast%3DGago%26aufirst%3DF.%26aulast%3DMorreale%26aufirst%3DA.%26atitle%3DMM-ISMSA%253A%2520an%2520ultrafast%2520and%2520accurate%2520scoring%2520function%2520for%2520protein-protein%2520docking%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D3395%26epage%3D3408%26doi%3D10.1021%2Fct300497z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-ref56_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schrodinger, L. L. C.</span></span> <i>The PyMOL Molecular Graphics System, Version 1.8</i>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+L.+C.+Schrodinger&title=The+PyMOL+Molecular+Graphics+System%2C+Version+1.8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref56_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSchrodinger%26aufirst%3DL.%2BL.%2BC.%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%252C%2520Version%25201.8%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JK6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2JK6','PDB','2JK6'); return false;">PDB: 2JK6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XAN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XAN','PDB','1XAN'); return false;">PDB: 1XAN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i83"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00206">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_64882"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00206?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00206</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional synthesis; biological and computational assays; screening of representative compounds for PAINS; <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS spectra and HPLC chromatograms for all of the target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of the prepared compounds and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_002.csv">CSV</a>)</p></li><li><p class="inline">Movie of <i>Li</i>TryR-<b>19a</b> complex (Movie S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_003.avi">AVI</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_001.pdf">jm1c00206_si_001.pdf (7.24 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_002.csv">jm1c00206_si_002.csv (3.34 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00206/suppl_file/jm1c00206_si_003.avi">jm1c00206_si_003.avi (2.27 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00206&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00206%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00206" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                13MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995f70e802d1a3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
